WorldWideScience

Sample records for braquiterapia endoluminal hdr

  1. Strategies and technical aspects in endoluminal HDR brachytherapy

    International Nuclear Information System (INIS)

    Endoluminal brachytherapy is an effective palliative modality to relieve endoluminal obstruction (in bronchus. bile, bile ducts and oesophageal neoplasms) that can be used alone or definitively to boost the primary site after or during a course of external irradiation. It is known that those patients with local complete response after radiotherapy and/or brachytherapy survive longer than those with a worse regional control. So it is really important to deliver the highest dose to the tumour while minimizing side-effects. Our studies are now directed to focus tolerance of bronchial tree vs pulmonary parenchymal tissue of oesophageal mucosa vs pulmonary and gastrointestinal structures of biliary tree vs liver parenchyma. Recent reports relate about mucosal ulceration and stenosis with pseudomembrane build up and/or fatal haemoptysis and haemorrhage. The question that we address now is if it is possible to obtain a real three dimensional view of the isodose curves in patients instead of constantly relying on catheter placements controlling high dose side effects. In our department the operating room is planned for the patient preparation and to enable precise localization of applicators and accurate delivery of HDR brachytherapy. So in the same room anaestesy, endoscopy, X-rays and therapy are performed without the need to transfer patients elsewhere that can lead to catheter displacement. We are also trying to introduce systematically some marker near or in the tumour during endoscopy in order to verify the precise localization of our target in the radiogram. In bronchus HDR-brachytherapy we generally use a specific contrast medium (Hystrast) that allows us to see the entire region of the pulmonary tree where catheters are introduced. So we can conclude that the major improvements achieved because of the integration of application, planning and treatment are 1) Individualization of treatment planning with respect to the target volume. 2) Improvement of planning

  2. Simultaneous radiochemotherapy and endoluminal HDR brachytherapy in esophageal cancer; Simultane Radiochemotherapie mit intraluminaler HDR-Brachytherapie des Oesophaguskarzinoms

    Energy Technology Data Exchange (ETDEWEB)

    Patonay, P.; Naszaly, A.; Mayer, A. [Hauptstaedtisches Zentrum fuer Radioonkologie und Strahlentherapie, Budapest (Hungary)

    2007-02-15

    Purpose: to study efficacy and toxicity of radiochemotherapy in esophageal cancer including initial endoluminal high-dose-rate brachytherapy (HDR-BT). Patients and methods: between 01/1995 and 06/2005, 61 patients with esophageal cancer were treated preoperatively with definitive and palliative intent. Treatment started with intraluminal HDR-BT for recanalization of the esophagus (single fraction size of 8 Gy in 0.5 cm depth, three times, q7d) followed by external-beam radiation therapy (50 Gy total dose, 5 x 2 Gy/week, 25 fractions in 5 weeks). Chemotherapy was started simultaneously with external irradiation (three courses of cisplatin and 5-fluorouracil, q21d). Results: swallowing function improved in 55/61 patients (dysphagia classification according to the RTOG), and worsened in 6/61 patients, respectively. Median duration of symptomatic improvement was 11 months, median follow-up 12 months (range 3-68 months). Following simultaneous radiochemotherapy, tumor resectability was achieved in 7/25 patients of the neoadjuvant group, and the histological specimen showed complete remission in 6/7 patients. Conclusion: these results indicate a favorable effect of simultaneous radiochemotherapy starting with endoluminal HDR-after-loading-(AL-)BT in esophageal cancer. (orig.)

  3. Endoluminal occlusion devices: technology update

    OpenAIRE

    Zander, Tobias

    2014-01-01

    Tobias Zander,1 Samantha Medina,1 Guillermo Montes,1 Lourdes Nuñez-Atahualpa,1 Michel Valdes,1 Manuel Maynar1,2 1Endoluminal/Vascular Department, Hospiten Hospital Group, Santa Cruz de Tenerife, 2University of Las Palmas de Gran Canarias, Las Palmas, Canary Island, Spain Abstract: Endoluminal occlusion has been performed since the early beginning of interventional radiology. Over recent decades, major technological advances have improved the techniques used and different devices h...

  4. Endoluminal occlusion devices: technology update

    OpenAIRE

    Zander T.; Medina S; Montes G; Nuñez-Atahualpa L; Valdes M; Maynar M

    2014-01-01

    Tobias Zander,1 Samantha Medina,1 Guillermo Montes,1 Lourdes Nuñez-Atahualpa,1 Michel Valdes,1 Manuel Maynar1,2 1Endoluminal/Vascular Department, Hospiten Hospital Group, Santa Cruz de Tenerife, 2University of Las Palmas de Gran Canarias, Las Palmas, Canary Island, Spain Abstract: Endoluminal occlusion has been performed since the early beginning of interventional radiology. Over recent decades, major technological advances have improved the techniques used and different devices have ...

  5. Endoluminal occlusion devices: technology update

    Directory of Open Access Journals (Sweden)

    Zander T

    2014-12-01

    Full Text Available Tobias Zander,1 Samantha Medina,1 Guillermo Montes,1 Lourdes Nuñez-Atahualpa,1 Michel Valdes,1 Manuel Maynar1,2 1Endoluminal/Vascular Department, Hospiten Hospital Group, Santa Cruz de Tenerife, 2University of Las Palmas de Gran Canarias, Las Palmas, Canary Island, Spain Abstract: Endoluminal occlusion has been performed since the early beginning of interventional radiology. Over recent decades, major technological advances have improved the techniques used and different devices have been developed for changing conditions. Most of these occlusion devices have been implemented in the vascular territory. Early embolization materials included glass particles, hot contrast, paraffin, fibrin, and tissue fragments such as muscle fibers and blood clots; today, occlusion materials include metallic devices, particles, and liquid materials, which can be indicated for proximal or distal occlusion, high-flow and low-flow situations, and in large-caliber and small-caliber vessels, based on need. Technological progress has led to a decreased size of delivery catheters, and an increase in safety due to release systems that permit the withdrawing and replacement of embolization material. Furthermore, bioactive embolization materials have been developed to increase the efficacy of embolization or the biological effect of medication. Finally, materials have been modified for changing indications. Intravascular stents were initially developed to keep an artery open; however, by adding a covering membrane, these stents can be used to occlude the wall of a vessel or other endoluminal structures. This article gives an overview of the devices most utilized for occlusion of endoluminal structures, as well as their major purpose in the endovascular territory. Keywords: embolization, endovascular treatment, occlusion devices, hemorrhage, aneurysm, fistula

  6. Comparação dos tratamentos do carcinoma espinocelular avançado do esofago pela teleterapia exclusiva e pela teleterapia associada à braquiterapia Comparison of treatment using teletherapy (external beam radiation) alone versus teletherapy combined with brachytherapy for advanced squamous cell carcinoma of the esophagus

    OpenAIRE

    Renato Samea; Laercio Gomes Lourenço

    2011-01-01

    RACIONAL: O câncer do esôfago ainda constitui neoplasia de difícil tratamento e de prognóstico muito ruim. OBJETIVO: Comparar a resposta do tratamento exclusivo com teleterapia isolada versus teleterapia associada à braquiterapia endoluminal de doentes portadores de carcinoma espinocelular avançado do esôfago. MÉTODO: Foram estudados 49 doentes portadores de carcinoma espinocelular avançado do esôfago médio em estádio clínico III (TNM). Os doentes foram divididos em dois grupos de doentes. O ...

  7. Endoluminal treatment of aortic dissection

    Energy Technology Data Exchange (ETDEWEB)

    Chavan, Ajay; Lotz, Joachim; Galanski, Michael [Department of Diagnostic Radiology, Hannover Medical School, Carl Neuberg Strasse 1, 30625, Hannover (Germany); Oelert, Frank; Haverich, Axel; Karck, Matthias [Department of Thoracic and Cardiovascular Surgery, Hannover Medical School, Carl Neuberg Strasse 1, 30625, Hannover (Germany)

    2003-11-01

    Aortic dissection is most often a catastrophic medical emergency which, if untreated, can be potentially fatal. The intention of therapy in patients with aortic dissection is to prevent aortic rupture or aneurysm formation as well as to relieve branch vessel ischaemia. Patients with aortic dissection are often poor candidates for anaesthesia and surgery and the surgical procedure itself is challenging requiring thoracotomy, aortic cross clamping, blood transfusion as well as prolonged hospital stay in some cases. Operative mortality is especially high in patients with critical mesenteric or renal ischaemia. The past decade has experienced the emergence of a number of interventional radiological or minimally invasive techniques which have significantly improved the management of patients with aortic dissection. These include stent grafting for entry site closure to prevent aneurysmatic widening of the false lumen as well as percutaneous techniques such as balloon fenestration of the intimal flap and aortic true lumen stenting to alleviate branch vessel ischaemia. False lumen thrombosis following entry closure with stent grafts has been observed in 86-100% of patients, whereas percutaneous interventions are able to effectively relieve organ ischaemia in approximately 90% of the cases. In the years to come, it is to be expected that these endoluminal techniques will become the method of choice for treating most type-B dissections and will assist in significantly reducing the number of open surgical procedures required for type-A dissections. The intention of this article is to provide an overview of the current status of these endoluminal techniques based on our own experience as well as on a review of the relevant literature. (orig.)

  8. Endoluminal treatment of aortic dissection

    International Nuclear Information System (INIS)

    Aortic dissection is most often a catastrophic medical emergency which, if untreated, can be potentially fatal. The intention of therapy in patients with aortic dissection is to prevent aortic rupture or aneurysm formation as well as to relieve branch vessel ischaemia. Patients with aortic dissection are often poor candidates for anaesthesia and surgery and the surgical procedure itself is challenging requiring thoracotomy, aortic cross clamping, blood transfusion as well as prolonged hospital stay in some cases. Operative mortality is especially high in patients with critical mesenteric or renal ischaemia. The past decade has experienced the emergence of a number of interventional radiological or minimally invasive techniques which have significantly improved the management of patients with aortic dissection. These include stent grafting for entry site closure to prevent aneurysmatic widening of the false lumen as well as percutaneous techniques such as balloon fenestration of the intimal flap and aortic true lumen stenting to alleviate branch vessel ischaemia. False lumen thrombosis following entry closure with stent grafts has been observed in 86-100% of patients, whereas percutaneous interventions are able to effectively relieve organ ischaemia in approximately 90% of the cases. In the years to come, it is to be expected that these endoluminal techniques will become the method of choice for treating most type-B dissections and will assist in significantly reducing the number of open surgical procedures required for type-A dissections. The intention of this article is to provide an overview of the current status of these endoluminal techniques based on our own experience as well as on a review of the relevant literature. (orig.)

  9. Braquiterapia guiada por imagen Image-guided brachytherapy

    OpenAIRE

    E. Villafranca; Romero, P; A. Sola; G. Asín; Rico, M.; M.T. Vila

    2009-01-01

    La braquiterapia consiste en la administración de radiación en contacto íntimo con el tumor, con una baja exposición de los tejidos sanos circundantes. Empezó a utilizarse a comienzos del siglo XX y desde entonces ha ido desarrollándose: diferentes radioisótopos, sistemas de tratamiento a distancia, programas informáticos que permiten un cálculo individualizado de la dosis. Los cambios en los últimos años dentro de la braquiterapia han afectado a dos aspectos. En primer lugar, la incorporació...

  10. New coil concept for endoluminal MR imaging

    OpenAIRE

    Heye, Tobias; Kuntz, Christian; Düx, Marcus; Encke, Jens; Palmowski, Moritz; Autschbach, Frank; Volke, Frank; Kauffmann, Guenter Werner; Grenacher, Lars

    2006-01-01

    Our aim was to conduct a prospective study to evaluate staging accuracy of a new coil concept for endoluminal magnetic resonance imaging (MRI) on ex vivo gastric carcinomas. Twenty-eight consecutive patients referred to surgery with a clinically proven primary gastric malignancy were included. Surgical specimens were examined with a foldable and self-expanding loop coil (8-cm diameter) at 1.5 Tesla immediately after total gastrectomy. T1- and T2-weighted and opposed-phase sequences (axial, fr...

  11. Dosimetry in high dose rate endoluminal brachytherapy

    International Nuclear Information System (INIS)

    In endoluminal brachytherapy for the tracheobronchial tree, esophagus, and bile duct, a reference point for dose calculation has been often settled at 1 cm outside from the middle of source travel path. In the current study, a change in the ratio of the reference point dose on the convex to concave side (Dq/Dp) was calculated, provided the source travel path bends as is the case in most endoluminal brachytherapies. Point source was presumed to move stepwise at 1 cm interval from 4 to 13 locations. Retention time at each location was calculated by personal computer so as to deliver equal dose at 1 cm from the linear travel path. With the retention time remaining constant, the change of Dq/Dp was assessed by bending the source travel path. Results indicated that the length of the source travel path and radius of its curve influenced the pattern of change in Dq/Dp. Therefore, it was concluded that the difference in reference dose on the convex and concave side of the curved path is not negligible under certain conditions in endoluminal brachytherapy. In order to maintain the ratio more than 0.9, relatively greater radius was required when the source travel path was decreased. (author)

  12. A mucoadhesive endoluminal wearable sensory system.

    Science.gov (United States)

    Chan, Cecilia K W; Zheng, Yali; Siu, Elaine H L; Yu, Ruoxi; Leung, Billy H K; Zhang, R; Poon, C C Y

    2015-08-01

    Bio- or muco-adhesive anchoring is a challenge for the development of advanced gastrointestinal (GI) surgical instruments, endoluminal monitoring devices and drug delivery systems. In this paper, we present a polymeric bio-adhesive film embedded with an optical sensor that can potentially be used to detect gastrointestinal bleeding. Four different formulas of mucoadhesive polymers were synthesized based on various chemical components and concentration combinations, and they were further layered with miniature photoplethymographic (PPG) sensors. The adhesive ability of the proposed mucoadhesive-sensor module was tested by attaching it to the lumen of a porcine stomach and compared amongst the four formulas. pH testing was also implemented to simulate the performance of the film in gastric cavity. To demonstrate the signal quality of this module, we also tested on the skin of five healthy subjects for hours. The observed shear detachment force between mucoadhesive film and porcine stomach tissue of all four formulations ranged from 0.09 to 1.38 N, and the performance of mucoadhesive film in pH 7 and pH 2 were similar. The module can attach firmly onto the skin for 3-10 hours with comparable PPG signal quality to traditional clip-based setup. With the advent of mucosal tissue anchoring by means of bioadhensive film, a wider extent of endoluminal procedures may become feasible. This emerging technology can also help shape the future of in-body wearable devices in the GI tract or other endoluminal cavities. PMID:26737259

  13. ENDOLUMINAL TREATMENT OF THE VARICOSE VEINS OF THE LOWER LIMB

    OpenAIRE

    C. Lupascu; Gabriela Canschi

    2005-01-01

    Endoluminal surgery of the varicose veins it's not a recent technique but the new procedures using radiofrequency and laser considerably relaunced its interest. The thermic energy that this technique gives to the venous wall induces a fibrous retraction of the vein and its occlusion. There are detailed here the material needed, methods but also the difficulties, possible incidents and accidents during them. The indications of these endoluminal interventions are still a disputed subject. The e...

  14. HDR endobronchial brachytherapy

    International Nuclear Information System (INIS)

    Introduction: This is a restrospective study to review the palliation rate, survival rate and complications of high dose rate (HDR) endobronchial brachytherapy in the treatment of airway obstruction of recurrent lung cancer or metastasis. Material and method: Between september 1992 and may 1995 it has been treated forty (40) patients with endobronchial lesions. 38 patients with unique endobronchial lesion and 2 patients with double lesions. 32 had primary lung carcinoma: 27 with epidermoid carcinoma (1 bilateral), 2 with adenocarcinoma, 1 with small cell carcinoma, 1 with undifferentiated carcinoma and 1 with primary double (adenocarcinoma and large cell carcinoma). 8 patients had endobronchial metastasis: 2 hypernefroma, 3 breast carcinoma, 1 colon cancer, 1 seminoma and 1 Ewing sarcoma. 33 patients were male (82.5%) and 7 female (17.5%). The treatment was carried out in three weekly fractions with a dose of 750 cGy per fraction at 1 cm from the source. An afterloaded equipment was used (microselectron HDR). The most frequent sites were: right main stem bronchus 9 patients (22.5%), left main stem bronchus 7 patients (17.5%), and right middle bronchus 5 patients (12.5%). Results and discussion: The endoscopic global response assessed after three weeks was of 70%. The symptomatic response was 95% hemoptysis control, 87% dysnea control, 80% obstructive pneumonia control and 70% cough control. The minimum follow up was one year. There were three cases of massive hemoptysis and three patients developed local recurrence (one received a second brachytherapy treatment). Conclusion: HDR brachytherapy offers an excellent long term palliation for any of the obstructing symptoms, being effective in more than 70% in patients with recurrence lung primary cancer or endobronchial metastasis with a low complication rate

  15. Comparação dos tratamentos do carcinoma espinocelular avançado do esofago pela teleterapia exclusiva e pela teleterapia associada à braquiterapia Comparison of treatment using teletherapy (external beam radiation alone versus teletherapy combined with brachytherapy for advanced squamous cell carcinoma of the esophagus

    Directory of Open Access Journals (Sweden)

    Renato Samea

    2011-12-01

    Full Text Available RACIONAL: O câncer do esôfago ainda constitui neoplasia de difícil tratamento e de prognóstico muito ruim. OBJETIVO: Comparar a resposta do tratamento exclusivo com teleterapia isolada versus teleterapia associada à braquiterapia endoluminal de doentes portadores de carcinoma espinocelular avançado do esôfago. MÉTODO: Foram estudados 49 doentes portadores de carcinoma espinocelular avançado do esôfago médio em estádio clínico III (TNM. Os doentes foram divididos em dois grupos de doentes. O primeiro grupo foi submetido à teleterapia exclusiva com acelerador linear de partículas, dose média de 6000 cGy e o segundo à teleterapia na dose de 5040 cGy associada à braquiterapia endoluminal com Iridium 192 na dose de 1500 cGy. A braquiterapia foi iniciada uma a duas semanas após o término da teleterapia e dividida em três aplicações semanais de 500 cGy. Foram avaliadas as variáveis idade, sexo, raça, hábitos (tabagismo e etilismo, índice de massa corpórea (IMC, complicações com o tratamento, benefícios (melhora da dor e satisfação alimentar e sobrevivência. RESULTADOS: Os resultados quanto a qualidade de vida (satisfação alimentar, paliação da disfagia e dor foram melhores no grupo submetido à teleterapia associada a braquiterapia. A sobrevivência foi maior no grupo de teleterapia associada a braquiterapia. CONCLUSÃO: Apesar do índice de cura do câncer espinocelular do esôfago ser quase nulo quando tratado com irradiação isolada, esta terapêutica constitui-se em uma forma de tratamento paliativo para grande parte dos doentes em que existe contra-indicação cirúrgica.BACKGROUND: Squamous cell carcinoma of the esophagus is still a difficult tumor to treat with very poor prognosis. AIM: To compare the response to teletherapy treatment (external beam radiotherapy alone versus teletherapy combined with brachytherapy for patients with advanced squamous cell carcinoma of the esophagus. METHODS: Were studied 49

  16. Endoluminal contrast for abdomen and pelvis magnetic resonance imaging.

    Science.gov (United States)

    Gupta, Mohit K; Khatri, Gaurav; Bailey, April; Pinho, Daniella F; Costa, Daniel; Pedrosa, Ivan

    2016-07-01

    Magnetic resonance (MR) imaging of the abdomen and pelvis can be limited for assessment of different conditions when imaging inadequately distended hollow organs. Endoluminal contrast agents may provide improved anatomic definition and detection of subtle pathology in such scenarios. The available routes of administration for endoluminal contrast agents include oral, endorectal, endovaginal, intravesicular, and through non-physiologic accesses. Appropriate use of endoluminal contrast agents requires a thorough understanding of the clinical indications, available contrast agents, patient preparation, and interaction of the contrast agent with the desired MR imaging protocol. For example, biphasic oral enteric contrast agents are preferred in MR enterography as their signal properties on T1- and T2-weighted imaging allow for evaluation of both intraluminal and bowel wall pathology. In specific situations such as with MR enterography, MR defecography, and accurate local staging of certain pelvic tumors, the use of an endoluminal contrast agent is imperative in providing adequate diagnostic imaging. In other clinical scenarios, the use of an endoluminal contrast agent may serve as an indispensable problem-solving tool. PMID:26907710

  17. Estudo e implementação de dosimetria com Mosfet em braquiterapia de alta taxa de dose

    OpenAIRE

    Ribeiro, Tiago Nuno Ramos

    2010-01-01

    A dosimetria in vivo em braquiterapia, quando devidamente implementada, produz importantes beneficios, tais como a possibilidade de correccoes de fraccoes de dose, alertar para doses eventualmente excessivas em orgaos de risco, a avaliacao dose-efeito mais precisa, a deteccao de falhas e a comparacao de doses reais com doses planeadas. Estudos recentes mostram o uso de pequenos MOSFET em dosimetria in vivo de braquiterapia com incertezas totais de  8%. As dependencias com dose acumulada, ene...

  18. DNA repair by HDR in experimental tumorigenesis

    OpenAIRE

    Westermark, Ulrica

    2008-01-01

    The aim of this thesis was to further understand how defects in the homology-directed repair (HDR) pathway affect tumor formation and development. To study proteins involved in HDR is challenging since most of its members are required for cell viability. For our studies we have therefore taken a dominant-negative approach to address the importance of the BRCA1 interacting protein BARD1 in HDR (paper I) and investigate the role of HDR in PDGFB-induced gliomagenesis by interfe...

  19. Mature results of a randomized trial comparing two fractionation schedules of high dose rate endoluminal brachytherapy for the treatment of endobronchial tumors

    International Nuclear Information System (INIS)

    To determine the efficacy of high dose rate endobronchial brachytherapy (HDR-BT) for the treatment of centrally located lung tumors, two different fractionation schedules were compared regarding local tumor response, side effects and survival. Mature retrospective results with longer follow-up and more patients were analyzed. Initial results were published by Huber et al. in 1995. 142 patients with advanced, centrally located malignant tumors with preferential endoluminal growth were randomized to receive 4 fractions of 3.8 Gy (time interval: 1 week, n = 60, group I) or 2 fractions of 7.2 Gy (time interval: 3 weeks, n = 82, group II) endobronchial HDR-BT. Age, gender, tumor stage, Karnofsky Performance Score and histology were equally distributed between both groups. Local tumor response with 2 fractions of 7.2 Gy was significantly higher as compared to 4 fractions of 3.8 Gy (median 12 vs. 6 weeks; p ≤ 0.015). Median survival was similar in both groups (19 weeks in the 4 fractions group vs. 18 weeks in the 2 fractions group). Fatal hemoptysis was less frequent following irradiation with 2 × 7.2 Gy than with 4 × 3.8 Gy, although the difference did not achieve statistical significance (12.2% vs. 18.3%, respectively. p = 0,345). Patients presenting with squamous cell carcinoma were at higher risk of bleeding compared to other histology (21.9% vs. 9%, p = 0,035). Multivariate analysis with regard to overall survival, revealed histology (p = 0.02), Karnofsky Performance Score (p < 0.0001) and response to therapy (p < 0.0001) as significant prognostic factors. For patients showing complete response the median survival was 57 weeks, while for patients with progressive disease median survival time was 8 weeks, p < 0.0001. The KPS at the start of the treatment was significantly correlated with survival. Patients presenting with a KPS ≤ 60 at the start had a significantly (p = 0,032) shorter survival time (10 weeks) than patients with a KPS > 60 (29 weeks). Moreover

  20. Flexible platforms for natural orifice transluminal and endoluminal surgery

    OpenAIRE

    Patel, Nisha; Seneci, Carlo; Yang, Guang-Zhong; Darzi, Ara; Teare, Julian

    2014-01-01

    The flexible endoscope is playing an increasingly pivotal role in minimally invasive transluminal and endoluminal surgery. Whilst the flexible nature of the platform is desirable in order to navigate through the abdominal cavity or through a lumen, there are a number of issues with using the platform for this purpose. The challenges associated with using flexible endoscopes such as a lack of triangulation of instruments and force transmission, which is often inadequate for endoscopic surgery ...

  1. Determination of the dose around an ovoid for treatments in intracavitary brachytherapy Hdr; Determinacion de la dosis alrededor de un ovoide para tratamientos en braquiterapia intracavitaria HDR

    Energy Technology Data Exchange (ETDEWEB)

    Rivera M, T. [IPN, Centro de Investigacion en Ciencia Aplicada y Tecnologia Avanzada, Legaria No. 694, Col. Irrigacion, 11500 Mexico D. F. (Mexico); Velasco V, R. A. E. [Hospital Central Militar, Periferico y Ejercito Nacional s/n, Lomas de Sotelo, 11200 Mexico D. F. (Mexico); Serrano F, A. K. [Hospital Juarez de Mexico, Av. Instituto Politecnico Nacional No. 5190, Col. Magdalena de las Salinas, 03220 Mexico D. F. (Mexico); Azorin N, J., E-mail: trivera@ipn.m [Universidad Autonoma Metropolitana, Unidad Iztapalapa, Av. San Rafael Atlixco No. 186, Col. Vicentina, 09340 Mexico D. F. (Mexico)

    2010-09-15

    On this work the results of the dosimetric measurements are presented around an ovoid of 2 cm diameter. The measurements were carried out using a water mannequin, an ovoid, a radiation gamma source of {sup 192}Ir and thermoluminescent dosemeters. The dosimetry was realized in the direction of the rectum and bladder. To know the effect of the shielding of the devices type Manchester in the dose, the thermoluminescent dosemeters were irradiated to a radiation gamma source of {sup 192}Ir contained in the Gamma med Plus equipment. The planning was realized normalizing the calculation to 2.5 cm from the applicator center on the transverse plane (2.5, 0, 0). The results show that the dose distribution for an ovoid without shielding is more uniform in the transversal plane to the source axis. The results were compared with the calculated results by means of the planning system BrachyVision. While the absorbed dose distribution around an ovoid with shielding is completely anisotropic. This anisotropic is due to the shielding. (Author)

  2. Live HDR video streaming on commodity hardware

    Science.gov (United States)

    McNamee, Joshua; Hatchett, Jonathan; Debattista, Kurt; Chalmers, Alan

    2015-09-01

    High Dynamic Range (HDR) video provides a step change in viewing experience, for example the ability to clearly see the soccer ball when it is kicked from the shadow of the stadium into sunshine. To achieve the full potential of HDR video, so-called true HDR, it is crucial that all the dynamic range that was captured is delivered to the display device and tone mapping is confined only to the display. Furthermore, to ensure widespread uptake of HDR imaging, it should be low cost and available on commodity hardware. This paper describes an end-to-end HDR pipeline for capturing, encoding and streaming high-definition HDR video in real-time using off-the-shelf components. All the lighting that is captured by HDR-enabled consumer cameras is delivered via the pipeline to any display, including HDR displays and even mobile devices with minimum latency. The system thus provides an integrated HDR video pipeline that includes everything from capture to post-production, archival and storage, compression, transmission, and display.

  3. Implementation of microsource high dose rate (mHDR) brachytherapy in developing countries

    International Nuclear Information System (INIS)

    Brachytherapy using remote afterloading of a single high dose rate 192Ir microsource was developed in the 1970s. After its introduction to clinics, this system has spread rapidly among developed Member States and has become a highly desirable modality in cancer treatment. This technique is now gradually being introduced to the developing Member States. The 192Ir sources are produced with a high specific activity. This results in a high dose rate (HDR) to the tumour and shorter treatment times. The high specific activity simultaneously results in a much smaller source (so-called micro source, around I mm in diameter) which may be easily inserted into tissue through a thin delivery tube, the so-called interstitial treatment, as well as easily inserted into body cavities, the so-called intracavitary or endoluminal treatment. Another advantage is the ability to change dwell time (the time a source remains in one position) of the stepping source which allows dose distribution to match the target volume more closely. The purpose of this TECDOC is to advise radiation oncologists, medical physicists and hospital administrators in hospitals which are planning to introduce 192Ir microsource HDR (mHDR) remote afterloading systems. The document supplements IAEA-TECDOC-1040, Design and Implementation of a Radiotherapy Programme: Clinical, Medical Physics, Radiation Protection and Safety Aspects, and will facilitate implementation of this new brachytherapy technology, especially in developing countries. The operation of the system, 'how to use the system', is not within the scope of this document. This TECDOC is based on the recommendations of an Advisory Group meeting held in Vienna in April 1999

  4. Neurological Complications Following Endoluminal Repair of Thoracic Aortic Disease

    International Nuclear Information System (INIS)

    Open surgery for thoracic aortic disease is associated with significant morbidity and the reported rates for paraplegia and stroke are 3%-19% and 6%-11%, respectively. Spinal cord ischemia and stroke have also been reported following endoluminal repair. This study reviews the incidence of paraplegia and stroke in a series of 186 patients treated with thoracic stent grafts. From July 1997 to September 2006, 186 patients (125 men) underwent endoluminal repair of thoracic aortic pathology. Mean age was 71 years (range, 17-90 years). One hundred twenty-eight patients were treated electively and 58 patients had urgent procedures. Anesthesia was epidural in 131, general in 50, and local in 5 patients. Seven patients developed paraplegia (3.8%; two urgent and five elective). All occurred in-hospital apart from one associated with severe hypotension after a myocardial infarction at 3 weeks. Four of these recovered with cerebrospinal fluid (CSF) drainage. One patient with paraplegia died and two had permanent neurological deficit. The rate of permanent paraplegia and death was 1.6%. There were seven strokes (3.8%; four urgent and three elective). Three patients made a complete recovery, one had permanent expressive dysphasia, and three died. The rate of permanent stroke and death was 2.1%. Endoluminal treatment of thoracic aortic disease is an attractive alternative to open surgery; however, there is still a risk of paraplegia and stroke. Permanent neurological deficits and death occurred in 3.7% of the patients in this series. We conclude that prompt recognition of paraplegia and immediate insertion of a CSF drain can be an effective way of recovering spinal cord function and improving the prognosis

  5. Flexible platforms for natural orifice transluminal and endoluminal surgery.

    Science.gov (United States)

    Patel, Nisha; Seneci, Carlo; Yang, Guang-Zhong; Darzi, Ara; Teare, Julian

    2014-06-01

    The flexible endoscope is playing an increasingly pivotal role in minimally invasive transluminal and endoluminal surgery. Whilst the flexible nature of the platform is desirable in order to navigate through the abdominal cavity or through a lumen, there are a number of issues with using the platform for this purpose. The challenges associated with using flexible endoscopes such as a lack of triangulation of instruments and force transmission, which is often inadequate for endoscopic surgery are discussed in this review. As a result of these difficulties, a number of mechanically and robotically driven devices based upon the flexible endoscope are emerging. The design of these devices and potential problems are also reviewed. Finally, future robotic systems which are still in the development and validation stage are briefly discussed. The field of gastroenterology is diverging. The narrowing divide between minimally invasive and endoluminal surgery has led to a surge of innovative and novel devices which may in the future enable precise, seamless and scar less surgery. PMID:26135256

  6. Abdominal aortic aneurysms: treatment with Zenith endoluminal stent-graft

    International Nuclear Information System (INIS)

    Objective: To evaluate the efficacy and safety of Zenith transrenal stent-graft in repairing the abdominal aortic aneurysms. Methods: Endoluminal stent-grafts repair was performed in 5 male patients with abdominal aortic aneurysms. Their age ranged from 52 years to 73 years with a mean of 65 years. Three-dimensional CT angiography demonstrated Blum type B in 4 cases and Blum type C in 1 case. The diameter of aneurysmal neck was between 21 mm and 25 mm (mean 22.8 mm), and the length of aneurysmal neck was between 16.5 mm and 32.8 mm (mean 25.6mm). Stent-grafts were inserted through surgically exposed femoral arteries in general anesthesia with the fluoroscopic guidance. The Zenith transrenal bifurcated stent-grafts were applied in all 5 patients. Results: The endoluminal stent-graft repair was successful in all 5 patients with operational duration of 1.8-3.0 hours. The hospitalization duration was 7-14 days following the procedure. No endoleaks occurred in the 5 cases following the contrast-enhanced CT scans seven days after the interventions. Still no endoleaks or stent-grafts migration recurred in 2 patients followed up at the 2nd and 11th month, respectively. During the follow-up from 6 months to 55 months (mean 26.6 months), five patients were still asymptomatic. Conclusion: Zenith aortic stent-graft repair of abdominal aortic aneurysms is an effective and safe treatment method

  7. Braquiterapia endobronquial de alta tasa de dosis en pacientes con obstrucción de la vía aérea central: Experiencia en el Instituto Nacional del Cáncer y revisión de la literatura High dose rate endobronchial brachytherapy in patients with central airway obstruction

    Directory of Open Access Journals (Sweden)

    ALEJANDRO SANTINI B

    2010-09-01

    Full Text Available Introducción: La indicación principal de la braquiterapia endobronquial moderna (BTEB de alta tasa de dosis (HDR, es la paliación de síntomas por crecimiento endobronquial de cánceres pulmonares. Métodos: Se realizó BTEB HDR a 27 pacientes sintomáticos de patología tumoral endobronquial o traqueal, debido a patologías primarias bronquiales o secundarias metastásicas. Los tumores se ubicaban en tráquea, carina o a nivel bronquialproximal. Para observar mejorías en la sintomatología clínica, a todos se les realizó una fibrobroncoscopía (FBC para medir el grado de obstrucción bronquial e instalar catéteres endobronquiales de braquiterapia. Se administraron entre 1 y 4 fracciones de 7 a 7,5 Gy. Se registró subjetivamente la disnea, tos y hemoptisis antes y después del tratamiento, de acuerdo a una escala internacionalmente validada. Resultados: Tras el tratamiento todos los síntomas disminuyeron considerablemente, desapareciendo toda sintomatología severa. La hemoptisis y disnea desaparecieron en el 100% y 40% de los pacientes respectivamente, y la tos desapareció o disminuyó a grado leve en el 90% de los pacientes.Introduction: The main indication of modern high dose rate end bronchial brachyherapy (HDR EBBT is the palliation of symptoms related to the growth of the endobronchial lung cancer. Methods: EBBT was performed to 27 patients who suffered symptomatic tumoral endobronchial or tracheal pathology, due to primary bronchial disease or secondary metastasis cancer, evaluating the rate of clinical benefit. The tumors were located at tracheal, carinal or proximal bronchial level. Fibrobronchoscopy was performed to all the patients to measure the degree of airway obstruction and to install brachytherapy endobronchial catheters. Between 1 to 4 fractions of 7 to 7.5 Gy were administered. Dyspnea, cough and hemoptysis were subjectively registered before and after treatment, according to an international validated scale. Results

  8. The general solution to HDR rendering

    Science.gov (United States)

    McCann, John

    2012-03-01

    Our High-Dynamic-Range (HDR) world is the result of nonuniform illumination. We like to believe that 21st century technology makes it possible to accurately reproduce any scene. On further study, we find that scene rendition remains a best compromise. Despite all the remarkable accomplishments in digital imaging, we cannot capture and reproduce the light in the world exactly. With still further study, we find that accurate reproduction is not necessary. We need an interdisciplinary study of image making - painting, photography and image processing - to find the general solution. HDR imaging would be very confusing, without two observations that resolve many paradoxes. First, optical veiling glare, that depends on the scene content, severely limits the range of light on cameras' sensors, and on retinas. Second, the neural spatial image processing in human vision counteracts glare with variable scene dependent responses. The counter actions of these optical and neural processes shape the goals of HDR imaging. Successful HDR increases the apparent contrast of details lost in the shadows and highlights of conventional images. They change the spatial relationships by altering the local contrast of edges and gradients. The goal of HDR imaging is displaying calculated appearance, rather than accurate light reproduction. By using this strategy we can develop universal algorithms that process all images, LDR and HDR, achromatic and color, by mimicking human vision. The study of the general solution for HDR imaging incorporates painting photography, vision research, color constancy and digital image processing.

  9. Endoluminal pharmacologic stimulation of the upper urinary tract.

    Science.gov (United States)

    Jakobsen, Jørn Skibsted

    2013-05-01

    The experiments performed in this PhD thesis were conducted at the Institute of Experimental Surgery, Skejby Hospital, Aarhus, Denmark and at the Laboratory of Animal Science, Odense University Hospital, Denmark. The thesis is based on 3 peer review articles published in international journals and a review. Diagnostic or therapeutic endoscopic upper urinary tract procedures are usually characterised as minimal invasive procedures and associated with a low complication rate. Most often fever or pain are seen and sometimes septicaemia. However, mucosa lesion or even ureteric ruptures are known complications. Research has suggested that high renal pelvic pressures generated during these procedures, might contribute to per-/postoperative complications seen, and even possible renal parenchymal damage. Nevertheless, local administration (endoluminal) of a relaxant drug has not previously been tried in order to lower renal pelvic pressure. The purposes of this thesis were to examine the effect of local administration (endoluminal) of the nonspecific β-adrenergic agonist ISOproterenol (ISO) on: 1) The normal pressure flow relation in porcine ureter, 2) The effect of endoluminal ISO perfusion during flexible ureterorenoscopy, 3) The pressure flow relation during semirigid ureterorenoscopy and 4) The cardiovascular system. Among other receptor-types β-adrenergic receptor are located in the upper urinary tract and the activation thereof mediates smooth muscle relaxation. We have shown - in an animal experimental model - that ISO added to the irrigation fluid had significant impact on the renal pelvic pressures generated during upper urinary tract endoscopy. ISO significantly and dose dependently reduced the normal pressure flow relations by approximately 80% without concomitant cardiovascular side effects or measurable plasma levels of ISO. During flexible ureterorenoscopy 0.1 µg/ml ISO added to the irrigation fluid significantly reduced renal pelvic pressure during

  10. HDR Efex Pro After the Shoot

    CERN Document Server

    Sholik, Stan

    2011-01-01

    A concise, on-the-go guide to the new HDR Efex Pro imaging toolkit for photographers Now that you've gone mobile and HDR, you want to be able to download and enhance your favorite photos on the run, without having to return to the mother ship (i.e., your desktop computer). This book shows you just how to do that using the amazing HDR Efex Pro, the image editing toolset from Nik Software. In brilliant color and using plenty of show-stopping examples, this practical guide explains all tools and features. Follow numbered steps and you'll soon be handling things like alignment, ghosting control, h

  11. Endoluminal isoproterenol reduces renal pelvic pressure during semirigid ureterorenoscopy

    DEFF Research Database (Denmark)

    Jakobsen, Jørn S; Jung, Helene U; Gramsbergen, Jan B; Osther, Palle J; Walter, Steen

    2009-01-01

    OBJECTIVE To investigate the effects on the pressure-flow relation of renal pelvic pressure during semirigid ureterorenoscopy and endoluminal perfusion of isoproterenol (ISO) 0.1 microg/mL, with emphasis on local effects and cardiovascular side-effects, as topically administered ISO effectively and...... dose-dependently causes relaxation of the upper urinary tract in pigs with no concomitant cardiovascular side-effects. MATERIALS AND METHODS In anaesthetized female pigs (60 kg), 16 macroscopically normal upper urinary tract systems were subjected to ureterorenoscopy. Via a subcostal incision a 6-F...... flow rates (0, 4, 8, 12, 16, 25 and 33 mL/min) with saline alone or saline + ISO 0.1 microg/mL. Perfusion was initiated on the left side, with randomization for adding ISO or not. Thereafter perfusion was done on the right side as a control in each pig. The surgeons were unaware of whether ISO was...

  12. Histologic assessment of biliary obstruction with different percutaneous endoluminal techniques

    Directory of Open Access Journals (Sweden)

    Guido Giampiero

    2004-08-01

    Full Text Available Abstract Background Despite the sophisticated cross sectional image techniques currently available, a number of biliary stenosis or obstructions remain of an uncertain nature. In these pathological conditions, an "intrinsic" parietal alteration is the cause of biliary obstruction and it is very difficult to differentiate benign from malignant lesions using cross-sectional imaging procedures alone. We evaluated the efficacy of different endoluminal techniques to achieve a definitive pathological diagnosis in these situations. Methods Eighty patients underwent brushing, and or biopsy of the biliary tree through an existing transhepatic biliary drainage route. A subcoort of 12 patients needed balloon-dilatation of the bile duct and the material covering the balloon surface was also sent for pathological examination (balloon surface sampling. Pathological results were compared with surgical findings or with long-term clinical and instrumental follow-ups. Success rates, sensitivity, specificity, accuracy, confidential intervals, positive predictive value and negative predictive value of the three percutaneous techniques in differentiating benign from malignant disease were assessed. The agreement coefficient of biopsy and brushing with final diagnosis was calculated using the Cohen's "K" value. Results Fifty-six patients had malignant strictures confirmed by surgery, histology, and by clinical follow-ups. Success rates of brushing, balloon surface sampling, and biopsy were 90.7, 100, and 100%, respectively. The comparative efficacy of brushing, balloon-surface sampling, and biopsy resulted as follows: sensitivity of 47.8, 87.5, and 92.1%, respectively; specificity of 100% for all the techniques; accuracy of 69.2, 91.7 and 93.6%, Positive Predictive Value of 100% for all the procedures and Negative Predictive Value of 55, 80, and 75%, respectively. Conclusions Percutaneous endoluminal biopsy is more accurate and sensitive than percutaneous bile duct

  13. Histologic assessment of biliary obstruction with different percutaneous endoluminal techniques

    International Nuclear Information System (INIS)

    Despite the sophisticated cross sectional image techniques currently available, a number of biliary stenosis or obstructions remain of an uncertain nature. In these pathological conditions, an 'intrinsic' parietal alteration is the cause of biliary obstruction and it is very difficult to differentiate benign from malignant lesions using cross-sectional imaging procedures alone. We evaluated the efficacy of different endoluminal techniques to achieve a definitive pathological diagnosis in these situations. Eighty patients underwent brushing, and or biopsy of the biliary tree through an existing transhepatic biliary drainage route. A subcoort of 12 patients needed balloon-dilatation of the bile duct and the material covering the balloon surface was also sent for pathological examination (balloon surface sampling). Pathological results were compared with surgical findings or with long-term clinical and instrumental follow-ups. Success rates, sensitivity, specificity, accuracy, confidential intervals, positive predictive value and negative predictive value of the three percutaneous techniques in differentiating benign from malignant disease were assessed. The agreement coefficient of biopsy and brushing with final diagnosis was calculated using the Cohen's 'K' value. Fifty-six patients had malignant strictures confirmed by surgery, histology, and by clinical follow-ups. Success rates of brushing, balloon surface sampling, and biopsy were 90.7, 100, and 100%, respectively. The comparative efficacy of brushing, balloon-surface sampling, and biopsy resulted as follows: sensitivity of 47.8, 87.5, and 92.1%, respectively; specificity of 100% for all the techniques; accuracy of 69.2, 91.7 and 93.6%, Positive Predictive Value of 100% for all the procedures and Negative Predictive Value of 55, 80, and 75%, respectively. Percutaneous endoluminal biopsy is more accurate and sensitive than percutaneous bile duct brushing in the detection of malignant

  14. HDR ühest kaadrist? / Janno Loide

    Index Scriptorium Estoniae

    Loide, Janno

    2008-01-01

    HDR-töötluse (High dynamic range - pildi kõrge dünaamiline ulatus) ja toonide kohandamise (tone mapping) meetodite kasutamisest pildi digitaalsel salvestusel ning sobiva hele-tumeduse leidmisel loodusfotode parema kvaliteedi saamiseks

  15. Curative HDR brachytherapy for endobronchial carcinomas: the Oscar Lambret center experience

    International Nuclear Information System (INIS)

    From May 1993 to October 1995, 26 patients with limited endobronchial carcinomas were treated in a curative intent by HDR endoluminal brachytherapy. Patients were separated into 3 groups: Strictly endobronchial tumors in inoperable patients (group 1, n=21); recurrent lesions in non-previously irradiated patients (group 2, n=3); boost after external radiotherapy (group 3, n=3). Inclusion criteria were squamous cell carcinomas with a diameter less than 1 cm and normal CT scan. 1 patient was treated for 2 successive lesions, so a total of 27 treatments were applied. Patients received fractions of 6 Gy (n=3) or 7 Gy (n=24) specified at 1 cm from the source. 4 to 6 fractions were administered once a week to groups 1 and 2, in group 3 the protocol was limited to 2 fractions. 24 patients were evaluable for response with a median follow-up of 7 months (1-25). We noted 20 endoscopic and histological complete responses and 4 local failures. Median survival was 11 months. 12 patients died; 4 with evolutive neoplasic disease, 3 by hemoptysis, 5 by non-tumoral disease. 26 patients were evaluable for complications. No immediate complications were noted. 18 late complications observed were identified as radiation bronchitis which were symptomatic in 6 patients. The radiation bronchitis was distributed as follows: grade 1 in 7 patients, grade 2 in 4, grade 3 in 4 and grade 4 in 3 according to SPEISER's score. Because of the high rate of complete responses ((20(26))), we consider HDR brachytherapy as an effective treatment of limited endobronchial carcinoma in inoperable patients. However, our study was also marked by a high incidence of radiation bronchitis. So we suggest improving procedures for catheter placement to avoid close contact of the iridium source with the bronchial mucosa and using a lower dose per fraction (5 Gy/fraction with 6 fractions once a week)

  16. Management of Diminutive Colon Polyps Based on Endoluminal Imaging.

    Science.gov (United States)

    Lieberman, David; Brill, Joel; Canto, Marcia; DeMarco, Daniel; Fennerty, Brian; Gupta, Neil; Laine, Loren; Lightdale, Charles; Montgomery, Elizabeth; Odze, Robert; Rex, Douglas; Sharma, Prateek; Kochman, Michael; Tokar, Jeffrey

    2015-11-01

    Diminutive colon polyps, defined as 5 mm or less, are encountered increasingly at colonoscopy. The risk of serious pathology in such polyps is low. There is a risk and cost of resecting all such polyps and sending tissue for pathologic evaluation. Enhancement of endoluminal imaging may enable discrimination of neoplastic vs non-neoplastic polyps. If this discrimination can be performed accurately with high confidence, it may be possible to either resect and discard diminutive adenomas, or inspect and do-not-resect diminutive hyperplastic polyps. In 2011, an expert group recommended thresholds of 90% negative predictive value for adenomas, and 90% accuracy in predicting appropriate surveillance intervals. Since 2011, criteria for polyp discrimination have been published and validated by experts and nonexperts. In vivo studies have been performed to compare endoscopic impression and pathologic diagnosis. An expert panel was convened in late 2014 to review the literature to determine if the proposed thresholds for discrimination can be attained and to recommend the next steps for introducing changes in clinical practice. We conclude that threshold levels can be achieved with several endoscopic image enhancements. The next steps to implementation of practice change include acquiring data on training and competence, determining best practices for auditing performance, understanding patient education needs, and the potential cost benefit of such changes. PMID:26192139

  17. PCA-induced respiratory depression simulating stroke following endoluminal repair of abdominal aortic aneurysm: a case report

    OpenAIRE

    Ahmad Javed; Riley Richard; Sieunarine Kishore

    2007-01-01

    Abstract Aim To report a case of severe respiratory depression with PCA fentanyl use simulating stroke in a patient who underwent routine elective endoluminal graft repair for abdominal aortic aneurysm (AAA) Case presentation A 78-year-old obese lady underwent routine endoluminal graft repair for AAA that was progressively increasing in size. Following an uneventful operation postoperative analgesia was managed with a patient-controlled analgesia (PCA) device with fentanyl. On the morning fol...

  18. An endoluminal aortic prosthesis infection presenting as pneumoaorta and aortoduodenal fistula

    Institute of Scientific and Technical Information of China (English)

    Yung-Ta Kao; Chun-Ming Shih; Feng-Yen Lin; Nai-Wen Tsao; Nen-Chung Chang; Chun-Yao Huang

    2012-01-01

    Herein,we present a case of pneumoaorta and aortoduodenal fistula (ADF) caused by an endoluminal aortic prosthesis infection.An 82-year-old man underwent endovascular aneurysm repair with a stent graft to exclude a 5.1-cm abdominal aortic aneurysm.Three months after the index procedure,the patient was taken to the emergency department at a medical university hospital.He presented with a 2-d history of bloody diarrhea.An endoluminal aortic stent graft infection was diagnosed,and an ADF was identified.The patient died of septic shock despite emergency surgery and intensive care.When encountered,stent graft infections require appropriate antibiotics and graft explantation.The diagnosis of an ADF is important,and surgery remains the most effective management if septic shock presents despite conservative treatment.

  19. Effects of display rendering on HDR image quality assessment

    Science.gov (United States)

    Zerman, Emin; Valenzise, Giuseppe; De Simone, Francesca; Banterle, Francesco; Dufaux, Frederic

    2015-09-01

    High dynamic range (HDR) displays use local backlight modulation to produce both high brightness levels and large contrast ratios. Thus, the display rendering algorithm and its parameters may greatly affect HDR visual experience. In this paper, we analyze the impact of display rendering on perceived quality for a specific display (SIM2 HDR47) and for a popular application scenario, i.e., HDR image compression. To this end, we assess whether significant differences exist between subjective quality of compressed images, when these are displayed using either the built-in rendering of the display, or a rendering algorithm developed by ourselves. As a second contribution of this paper, we investigate whether the possibility to estimate the true pixel-wise luminance emitted by the display, offered by our rendering approach, can improve the performance of HDR objective quality metrics that require true pixel-wise luminance as input.

  20. HDR economy with special reference to conditions in Europe

    International Nuclear Information System (INIS)

    A cost benefit model for the economic evaluation of HDR energy production cost was developed. It can be used for systematic cost analyses of different components of a HDR plant. This relates to natural subsurface conditions (i.e., geothermal gradient, tectonic stress) as well as technical components (i.e., boreholes, heat/power conversion system). The model provides the limiting conditions for an economic HDR energy production. The economic model was applied for an evaluation of the natural parameters in the subsurface of Germany regarding their HDR-suitability. Within a site selection program in Europe the model is part of feasibility studies for the conceptual design of a HDR demonstration plant at three candidate sites: Bad Urach (Germany); Soultz-sous-Forets (France) and Cornwall (UK)

  1. HDR Image Quality Enhancement Based on Spatially Variant Retinal Response

    Directory of Open Access Journals (Sweden)

    Horiuchi Takahiko

    2010-01-01

    Full Text Available There is a growing demand for being able to display high dynamic range (HDR images on low dynamic range (LDR devices. Tone mapping is a process for enhancing HDR image quality on an LDR device by converting the tonal values of the original image from HDR to LDR. This paper proposes a new tone mapping algorithm for enhancing image quality by deriving a spatially-variant operator for imitating S-potential response in human retina, which efficiently improves local contrasts while conserving good global appearance. The proposed tone mapping operator is studied from a system construction point of view. It is found that the operator is regarded as a natural extension of the Retinex algorithm by adding a global adaptation process to the local adaptation. The feasibility of the proposed algorithm is examined in detail on experiments using standard HDR images and real HDR scene images, comparing with conventional tone mapping algorithms.

  2. Fracture of an endoluminal nitinol stent used in the treatment of tracheal collapse in a dog.

    Science.gov (United States)

    Mittleman, Elise; Weisse, Chick; Mehler, Stephen J; Lee, Justine A

    2004-10-15

    A 5-year-old castrated male Pomeranian was evaluated because of severe dyspnea and coughing, and a diagnosis of complete, static collapse of the trachea at the thoracic inlet was made. After failure to improve with medical management alone, an endoluminal tracheal stent was placed, which resulted in resolution of signs. Ten weeks after stent placement, the dog underwent tracheal resection and anastomosis because the stent had fractured at the level of the thoracic inlet. One year after surgery, the dog was doing well and required treatment with hydrocodone infrequently. Compared with other surgical treatment options, placement of an endoluminal tracheal stent is a relatively noninvasive intervention that can provide effective relief from the clinical signs associated with tracheal collapse in dogs. Implantation of endoluminal tracheal stents may be associated with complications; therefore, the procedure may best be regarded as a salvage procedure for dogs with end-stage disease that are refractory to appropriate medical management, have extensive collapse of the intrathoracic portion of the trachea, or are poor candidates for surgery. PMID:15521443

  3. Prospective randomised trial on the role of HDR-brachytherapy in addition to external beam radiotherapy for central bronchial carcinoma

    International Nuclear Information System (INIS)

    Objective: In a prospective, randomised trial we investigated the influence of additional High-Dose-Rate-(HDR)-brachytherapy on tumor control and overall survival of patients suffering from inoperable central lung tumors treated with loco-regional external beam radiotherapy (EB-RT). Special attention was given to dose limiting side effects. Methods: Patients randomised in group A received loco-regional EB-RT up to 50 Gy (5 x 2 Gy per week), followed by a boost of 10 Gy also 2 Gy 5 times a week to the primary and adjacent lymphonodular metastases. Patients in group B additionally received an endoluminal HDR-afterloading-radiotherapy (192Ir) with 10 Gy calculated for 5 mm depth one week before and three weeks after EB-RT. Due to the advanced tumor stage, none of the patients received surgery before irradiation. Patients treated with chemotherapy were excluded from the study. Results: Until February 1996 all of 98 patients were evaluated. Both groups are comparable regarding age, gender, Karnofsky Performance State, tumor stage (mostly stage IIIb and IV) and histology. Squamous cell carcinoma (SCC) were found in 69%, whereas the rest consisted of adeno carcinoma (15%), large cell carcinoma (6%) and non small cell carcinoma (NSCLC) (10%), all subsets equally distributed between group A and B. Local control in group A (n=42) lasted for a median of 12 weeks, in group B (n=56) for a median of 21 weeks, a difference which is just significant (p≤0,05). The median overall survival was nearly identical (28 weeks). The subgroup of SCC, however, showed a median survival of 33 (group A) versus 40 weeks (group B), a difference which is not significant (p≤0.09), but might indicate an advantage for this histological group. The most serious side effect was fatal bleeding with 15% in group A and 21% in group B. Conclusions: At present, this study reveals improved local control by a boost of 2x10 Gy 192Ir-HDR-AL in addition to definitive EB-RT (group B) compared to EB-RT alone

  4. A review of the HDR research programme

    International Nuclear Information System (INIS)

    In the German HDR (Heissdampfreaktor, hot steam reactor) reactor safety programme, experiments and simulating numerical analyses have been undertaken since 1976 to study the integrity and safety of light water reactors under operational and faulted conditions. The last experiments of the programme were conducted in 1991. The post test analyses have been finished by March 1994 and the last final reports were obtained a few months later. The report aims to inform the utilities and the regulatory body of Finland about the contents of the lokset HDR research programme and to consider the applicability of the results to safety analyses of Finnish nuclear power plants. The report centers around the thermal shock and piping component experiments within the last or third phase of the HDR programme. Investigations into severe reactor accidents, fire safety and non-destructive testing, also conducted during the third phase, are not considered. The report presents a review of the following experiment groups: E21 (crack growth under corrosive conditions, loading due to thermal stratification), E22 (leak rate and leak detection experiments of through-cracked piping), E23 (thermal transient and stratification experiments for a pipe nozzle), E31 (vibration of cracked piping due to blow down and closure of isolation valve), E32 (seismically induced vibrations of cracked piping), E33 (condensation phenomena in horizontal piping during emergency cooling). A comprehensive list of reference reports, received by VTT and containing a VTT more detailed description, is given for each experiment group. The review is focused on the loading conditions and their theoretical modelling. A comparison of theoretical and experimental results is presented for each experiment group. The safety margins are finally assessed with special reference to leak-before-break, a well known principle for assuring the integrity of primary circuit piping of nuclear power plants. (orig.) (71 figs., 5 tabs.)

  5. O custo da cura: vivências de conforto e desconforto de mulheres submetidas à braquiterapia

    Directory of Open Access Journals (Sweden)

    Míbsam Lysia Carvalho Alves Soares

    2016-06-01

    Full Text Available RESUMO Objetivo: Descrever as vivências de conforto e desconforto de mulheres que se submeteram à braquiterapia para tratamento de câncer do colo uterino. Métodos: Estudo qualitativo, desenvolvido em 2013, embasado na Teoria do Conforto de Kolcaba e realizado por meio de entrevistas semiestruturadas com oito mulheres que concluíram o tratamento há, no mínimo, seis meses. Resultados: Sobressaíram os seguintes desconfortos: dor do procedimento e dos efeitos pós-tratamento, no contexto físico; medo do desconhecido e do sofrimento, falta de acompanhante, estresse por sentir-se constrangida durante o tratamento, baixa autoestima e trauma psicológico pós-terapia, no contexto psicoespiritual. As medidas de conforto consistiram no diálogo com o profissional, administração de medicações e uso da fé e espiritualidade. Conclusão: Os resultados oferecem subsídios para a prática de profissionais de saúde em relação aos confortos e desconfortos que merecem ser alvo de intervenções na assistência à mulher com câncer.

  6. Touch HDR: photograph enhancement by user controlled wide dynamic range adaptation

    Science.gov (United States)

    Verrall, Steve; Siddiqui, Hasib; Atanassov, Kalin; Goma, Sergio; Ramachandra, Vikas

    2013-03-01

    High Dynamic Range (HDR) technology enables photographers to capture a greater range of tonal detail. HDR is typically used to bring out detail in a dark foreground object set against a bright background. HDR technologies include multi-frame HDR and single-frame HDR. Multi-frame HDR requires the combination of a sequence of images taken at different exposures. Single-frame HDR requires histogram equalization post-processing of a single image, a technique referred to as local tone mapping (LTM). Images generated using HDR technology can look less natural than their non- HDR counterparts. Sometimes it is only desired to enhance small regions of an original image. For example, it may be desired to enhance the tonal detail of one subject's face while preserving the original background. The Touch HDR technique described in this paper achieves these goals by enabling selective blending of HDR and non-HDR versions of the same image to create a hybrid image. The HDR version of the image can be generated by either multi-frame or single-frame HDR. Selective blending can be performed as a post-processing step, for example, as a feature of a photo editor application, at any time after the image has been captured. HDR and non-HDR blending is controlled by a weighting surface, which is configured by the user through a sequence of touches on a touchscreen.

  7. Harmony search optimization for HDR prostate brachytherapy

    Science.gov (United States)

    Panchal, Aditya

    In high dose-rate (HDR) prostate brachytherapy, multiple catheters are inserted interstitially into the target volume. The process of treating the prostate involves calculating and determining the best dose distribution to the target and organs-at-risk by means of optimizing the time that the radioactive source dwells at specified positions within the catheters. It is the goal of this work to investigate the use of a new optimization algorithm, known as Harmony Search, in order to optimize dwell times for HDR prostate brachytherapy. The new algorithm was tested on 9 different patients and also compared with the genetic algorithm. Simulations were performed to determine the optimal value of the Harmony Search parameters. Finally, multithreading of the simulation was examined to determine potential benefits. First, a simulation environment was created using the Python programming language and the wxPython graphical interface toolkit, which was necessary to run repeated optimizations. DICOM RT data from Varian BrachyVision was parsed and used to obtain patient anatomy and HDR catheter information. Once the structures were indexed, the volume of each structure was determined and compared to the original volume calculated in BrachyVision for validation. Dose was calculated using the AAPM TG-43 point source model of the GammaMed 192Ir HDR source and was validated against Varian BrachyVision. A DVH-based objective function was created and used for the optimization simulation. Harmony Search and the genetic algorithm were implemented as optimization algorithms for the simulation and were compared against each other. The optimal values for Harmony Search parameters (Harmony Memory Size [HMS], Harmony Memory Considering Rate [HMCR], and Pitch Adjusting Rate [PAR]) were also determined. Lastly, the simulation was modified to use multiple threads of execution in order to achieve faster computational times. Experimental results show that the volume calculation that was

  8. HDR Image Quality Enhancement Based on Spatially Variant Retinal Response

    OpenAIRE

    Horiuchi Takahiko; Tominaga Shoji

    2010-01-01

    There is a growing demand for being able to display high dynamic range (HDR) images on low dynamic range (LDR) devices. Tone mapping is a process for enhancing HDR image quality on an LDR device by converting the tonal values of the original image from HDR to LDR. This paper proposes a new tone mapping algorithm for enhancing image quality by deriving a spatially-variant operator for imitating S-potential response in human retina, which efficiently improves local contrasts while conserving g...

  9. Braquiterapia endobrônquica de alta taxa de dose: estudo dosimétrico High dose-rate endobronchial brachytherapy: a dosimetric study

    OpenAIRE

    Regina Maria Godoy Lopes; Laura Natal Rodrigues; Heloisa de Andrade Carvalho

    2010-01-01

    OBJETIVO: Avaliar a distribuição de dose em diferentes situações de braquiterapia endobrônquica de alta taxa de dose, com foco principalmente nos volumes de altas doses, e tentar definir situações de melhor ou pior distribuição de dose que possam servir de guia na prática clínica. MATERIAIS E MÉTODOS: Estudo teórico, simulando braquiterapia endobrônquica de alta taxa de dose utilizando dois cateteres, com variação da extensão de carregamento, angulação entre os cateteres, profundidade de cálc...

  10. Endoluminal non-contact soft tissue ablation using fiber-based Er:YAG laser delivery

    Science.gov (United States)

    Kundrat, Dennis; Fuchs, Alexander; Schoob, Andreas; Kahrs, Lüder A.; Ortmaier, Tobias

    2016-03-01

    The introduction of Er:YAG lasers for soft and hard tissue ablation has proven promising results over the last decades due to strong absorption at 2.94 μm wavelength by water molecules. An extension to endoluminal applications demands laser delivery without mirror arms due to dimensional constraints. Therefore, fiber-based solutions are advanced to provide exible access while keeping space requirements to a minimum. Conventional fiber-based treatments aim at laser-tissue interactions in contact mode. However, this procedure is associated with disadvantages such as advancing decrease in power delivery due to particle coverage of the fiber tip, tissue carbonization, and obstructed observation of the ablation progress. The objective of this work is to overcome aforementioned limitations with a customized fiber-based module for non-contact robot-assisted endoluminal surgery and its associated experimental evaluation. Up to the authors knowledge, this approach has not been presented in the context of laser surgery at 2.94 μm wavelength. The preliminary system design is composed of a 3D Er:YAG laser processing unit enabling automatic laser to fiber coupling, a GeO2 solid core fiber, and a customized module combining collimation and focusing unit (focal length of 20 mm, outer diameter of 8 mm). The performance is evaluated with studies on tissue substitutes (agar-agar) as well as porcine samples that are analysed by optical coherence tomography measurements. Cuts (depths up to 3mm) with minimal carbonization have been achieved under adequate moistening and sample movement (1.5mms-1). Furthermore, an early cadaver study is presented. Future work aims at module miniaturization and integration into an endoluminal robot for scanning and focus adaptation.

  11. The use of nomograms in LDR-HDR prostate brachytherapy

    OpenAIRE

    Pujades, Ma Carmen; Camacho, Cristina; Perez-Calatayud, Jose; Richart, José; Gimeno, Jose; Lliso, Françoise; Carmona, Vicente; Ballester, Facundo; Crispín, Vicente; Rodríguez, Silvia; Tormo, Alejandro

    2011-01-01

    Purpose The common use of nomograms in Low Dose Rate (LDR) permanent prostate brachytherapy (BT) allows to estimate the number of seeds required for an implant. Independent dosimetry verification is recommended for each clinical dosimetry in BT. Also, nomograms can be useful for dose calculation quality assurance and they could be adapted to High Dose Rate (HDR). This work sets nomograms for LDR and HDR prostate-BT implants, which are applied to three different institutions that use different...

  12. Endoluminal Repair of a Dardik Prosthesis Pseudoaneurysm Using the Wallgraft Endoprosthesis

    International Nuclear Information System (INIS)

    A 58-year-old man with a history of severe invalidating claudicatio intermittens underwent femoropopliteal bypass with a human umbilical vein graft. Seven years later he presented with a painful enlarging mass in the middle portion of his right thigh. The duplex scan showed a pseudoaneurysm of the body of the prosthesis, which was confirmed by angiography. As an alternative to surgical management, Wallgraft endoprosthesis was used for endoluminal exclusion of the pseudoaneurysm. To our knowledge, this technique has never been used before in such a case

  13. Noninvasive correction of a fractured endoluminal nitinol tracheal stent in a dog.

    Science.gov (United States)

    Ouellet, Mathieu; Dunn, Marilyn E; Lussier, Bertrand; Chailleux, Nadège; Hélie, Pierre

    2006-01-01

    An 11-year-old, castrated male Pomeranian was presented for intractable cough and dyspnea secondary to severe tracheal collapse. An endoluminal nitinol tracheal stent was placed with good results. Five months following placement of the prosthesis, clinical signs acutely recurred and failure of the implant was noted. A second stent was superimposed over the fractured stent and resulted in resolution of all clinical signs. The dog died several months later from progression of the tracheal collapse to the carina and mainstem bronchi. PMID:17088395

  14. A review of the HDR research programme; HDR-tutkimusohjelman tulosten arviointi

    Energy Technology Data Exchange (ETDEWEB)

    Talja, H.; Koski, K.; Rintamaa, R. [VTT Manufacturing Technology, Espoo (Finland); Keskinen, R. [Finnish Centre for Radiation and Nuclear Safety, Helsinki (Finland)

    1995-10-01

    In the German HDR (Heissdampfreaktor, hot steam reactor) reactor safety programme, experiments and simulating numerical analyses have been undertaken since 1976 to study the integrity and safety of light water reactors under operational and faulted conditions. The last experiments of the programme were conducted in 1991. The post test analyses have been finished by March 1994 and the last final reports were obtained a few months later. The report aims to inform the utilities and the regulatory body of Finland about the contents of the lokset HDR research programme and to consider the applicability of the results to safety analyses of Finnish nuclear power plants. The report centers around the thermal shock and piping component experiments within the last or third phase of the HDR programme. Investigations into severe reactor accidents, fire safety and non-destructive testing, also conducted during the third phase, are not considered. The report presents a review of the following experiment groups: E21 (crack growth under corrosive conditions, loading due to thermal stratification), E22 (leak rate and leak detection experiments of through-cracked piping), E23 (thermal transient and stratification experiments for a pipe nozzle), E31 (vibration of cracked piping due to blow down and closure of isolation valve), E32 (seismically induced vibrations of cracked piping), E33 (condensation phenomena in horizontal piping during emergency cooling). A comprehensive list of reference reports, received by VTT and containing a VTT more detailed description, is given for each experiment group. The review is focused on the loading conditions and their theoretical modelling. A comparison of theoretical and experimental results is presented for each experiment group. The safety margins are finally assessed with special reference to leak-before-break, a well known principle for assuring the integrity of primary circuit piping of nuclear power plants. (orig.) (71 figs., 5 tabs.).

  15. Braquiterapia com Cobalto 60 para o tratamento do melanoma da úvea: análise dos fatores prognósticos para melhor resposta local Cobalt - 60 brachytherapy for uveal melanoma: analysis of prognostic factors for local response

    OpenAIRE

    Martha Motono Chojniak; Clelia Maria Erwenne

    2002-01-01

    Objetivo: Determinar fatores prognósticos para resposta tumoral local ao tratamento do melanoma uveal por braquiterapia com cobalto 60, segundo parâmetros clínicos e próprios deste método. Métodos: Avaliamos os índices de controle tumoral, complicações, doença metastática e sobrevida global em 69 portadores de melanoma uveal tratados por braquiterapia com cobalto 60 de novembro de 1988 a outubro de 1994, no Hospital do Câncer - A.C.Camargo de São Paulo. Confrontamos estes índices com diferent...

  16. Malformaciones venosas orofaciales de bajo flujo: esclerosis endoluminal con láser de diodo Low-flow orofacial venous malformations: endoluminal sclerosis with a diode laser

    Directory of Open Access Journals (Sweden)

    M. Puche Torres

    2010-06-01

    Full Text Available Introducción: Las anomalías vasculares son procesos frecuentes que se localizan en más del 50% de los casos en la región de la cabeza y el cuello. Las técnicas clásicas de tratamiento, tales como la cirugía y la esclerosis química, han dado paso a modernas técnicas menos invasivas, tales como el láser Nd:YAG. Por otra parte, se ha utilizado con éxito el láser de diodo (980 nm para el tratamiento de varices mediante esclerosis endoluminal. Nuestra propuesta es la utilización del láser de diodo (l 980 nm para provocar una esclerosis por fotocoagulación intralesional de las malformaciones venosas de bajo flujo dada la capacidad de este láser de ser transmitido por fibra óptica. Objetivo: Exponer nuestros resultados en el tratamiento de malformaciones venosas de bajo flujo (MVBF orofaciales mediante la terapéutica de esclerosis endoluminal con láser de diodo. Material y métodos: Revisamos 84 pacientes que presentaban MVBF orofaciales tratados con láser de diodo. Describimos la técnica de realización y se muestran los resultados postoperatorios a corto plazo. Resultados: Tras un periodo de seguimiento no inferior a 12 meses se constató curación en el 95,24% aplicando una o dos sesiones y solamente en 4 casos se objetivó recidiva. Concluimos que la técnica de esclerosis endoluminal con láser de diodo de MVBF en el área orofacial se constituye como una nueva técnica de tratamiento, mínimamente invasiva, ambulatoria, y que permite la resolución de los casos sin tener que recurrir a cirugías más agresivas y con excelentes resultados funcionales y estéticos.Background: Vascular anomalies are common processes that involve the head and neck region in more than 50% of the cases. Traditional treatment options such as surgery and chemical sclerosis have given way to modern less-invasive techniques, including Nd:YAG laser treatment. On the other hand, 980 nm laser diode has been successfully used for the endovenous sclerosis

  17. Interstitial prostate brachytherapy. LDR-PDR-HDR

    International Nuclear Information System (INIS)

    The first comprehensive overview of interstitial brachytherapy for the management of local or locally advanced prostate cancer. Written by an interdisciplinary team who have been responsible for the successful GEC-ESTRO/EAU Teaching Course. Discusses in detail patient selection, the results of different methods, the role of imaging, and medical physics issues. Prostate brachytherapy has been the subject of heated debate among surgeons and the proponents of the various brachytherapy methods. This very first interdisciplinary book on the subject provides a comprehensive overview of innovations in low dose rate (LDR), high dose rate (HDR), and pulsed dose rate (PDR) interstitial brachytherapy for the management of local or locally advanced prostate cancer. In addition to detailed chapters on patient selection and the use of imaging in diagnostics, treatment guidance, and implantation control, background chapters are included on related medical physics issues such as treatment planning and quality assurance. The results obtained with the different treatment options and the difficult task of salvage treatment are fully discussed. All chapters have been written by internationally recognized experts in their fields who for more than a decade have formed the teaching staff responsible for the successful GEC-ESTRO/EAU Prostate Brachytherapy Teaching Course. This book will be invaluable in informing residents and others of the scientific background and potential of modern prostate brachytherapy. It will also prove a useful source of up-to-date information for those who specialize in prostate brachytherapy or intend to start an interstitial brachytherapy service.

  18. HDR quality assurance methods for personal digital assistants

    International Nuclear Information System (INIS)

    An important component of every clinical high-dose-rate (HDR) brachytherapy program is quality assurance (QA). One of the QA recommendations of the AAPM TG59 report is an independent verification on the results of treatment planning. It is desirable for the verification procedure to be as quick and easy to perform as possible and yet to have a high probability of detecting significant errors. The objective of this work is to describe the dosimetric methods and software developed to implement a departmental HDR QA program using personal digital assistants (PDAs). Verification of MammoSite treatment plans is presented as a practical example. PDAs that run the PalmOS were selected for their low cost and popularity among health care professionals. General-purpose applications were developed for linear sources, planar, and volume implants, that estimate the total dwell time of an HDR implant. This value can then be compared to the total dwell time calculated by the primary treatment planning system. The software incorporates the Paterson-Parker (PP) radium tables and the Greenfield-Tichman-Norman (GTN) version of the Quimby radium tables, which have been modified to a form more convenient for HDR calculations. A special purpose application based on the AAPM TG43 formalism was developed for the MammoSite breast applicator. For QA calculations perpendicular to the center of a single Iridium-192 (192I) HDR source, as exemplified by MammoSite treatments, linearly interpolating the PP or GTN tables is equivalent to applying the TG43 formalism at distances up to 5 cm from the source axis. The MammoSite-specific software also offers the option to calculate dosimetry based on the balloon volume. The PDA clock/calendar permits the software to automatically account for source decay. The touch-sensitive screen allows the familiar tabular format to be maintained while minimizing the effort required for calculations. The PP and GTN radium implant tables are easily modified to a form

  19. Traceable calibration of a reference well chamber at HDR 192Ir energy

    International Nuclear Information System (INIS)

    With the increasing use of the remote afterloading HDR 192Ir equipment in the country, an urgent need was felt to establish a Standard for the HDR 192Ir source. The objective of the programme was to offer traceable calibration to all the hospital well chambers, at HDR 192Ir energy

  20. Traceable calibration of hospital 192Ir HDR sources

    International Nuclear Information System (INIS)

    A HDR 1000 PLUS well type ionization chamber, procured from Standard Imaging, USA, and maintained by medical Physics and Safety Section (MPSS), Bhabha Atomic Research Centre (BARC), India, as a reference well chamber 1 (RWCH1), was traceably calibrated against the primary standard established by Radiological Standards Laboratory (RSL), BARC for 192Ir HDR source, in terms of air kerma strength (AKS). An indigenously developed well-type ionization chamber, reference well chamber 2 (RWCH2) and electrometer system, fabricated by CD High Tech (CDHT) Instruments Private Ltd., Bangalore, India, was in turn calibrated against RWCH1. The CDHT system (i.e. RWCH2 and CDHT electrometer system) was taken to several hospitals, in different regions of the country, to check the calibration status of 192Ir HDR sources. The result of this calibration audit work is reported here. (author)

  1. Evaluating HDR photos using Web 2.0 technology

    Science.gov (United States)

    Qiu, Guoping; Mei, Yujie; Duan, Jiang

    2011-01-01

    High dynamic range (HDR) photography is an emerging technology that has the potential to dramatically enhance the visual quality and realism of digital photos. One of the key technical challenges of HDR photography is displaying HDR photos on conventional devices through tone mapping or dynamic range compression. Although many different tone mapping techniques have been developed in recent years, evaluating tone mapping operators prove to be extremely difficult. Web2.0, social media and crowd-sourcing are emerging Internet technologies which can be harnessed to harvest the brain power of the mass to solve difficult problems in science, engineering and businesses. Paired comparison is used in the scientific study of preferences and attitudes and has been shown to be capable of obtaining an interval-scale ordering of items along a psychometric dimension such as preference or importance. In this paper, we exploit these technologies for evaluating HDR tone mapping algorithms. We have developed a Web2.0 style system that enables Internet users from anywhere to evaluate tone mapped HDR photos at any time. We adopt a simple paired comparison protocol, Internet users are presented a pair of tone mapped images and are simply asked to select the one that they think is better or click a "no difference" button. These user inputs are collected in the web server and analyzed by a rank aggregation algorithm which ranks the tone mapped photos according to the votes they received. We present experimental results which demonstrate that the emerging Internet technologies can be exploited as a new paradigm for evaluating HDR tone mapping algorithms. The advantages of this approach include the potential of collecting large user inputs under a variety of viewing environments rather than limited user participation under controlled laboratory environments thus enabling more robust and reliable quality assessment. We also present data analysis to correlate user generated qualitative

  2. Endoluminal embolization of bilateral atherosclerotic common iliac aneurysms with fibrin tissue glue (Beriplast)

    International Nuclear Information System (INIS)

    The standard surgical approach to nonleaking iliac aneurysms found at repair of a leaking abdominal aortic aneurysm is to minimize the operative risk by repairing the abdominal aorta only. This means that the bypassed iliac aneurysms may have to be repaired later. As this population of patients are usually elderly with coexisting medical problems, interventional radiology is being used to embolize these aneurysms, thus avoiding the morbidity and mortality associated with further general anesthesia and surgery. Various materials and stents have been reported to be effective in the treatment of iliac aneurysms. We report the successful use of endoluminal fibrin tissue glue (Beriplast) to treat two large iliac aneurysms in a patient who had had a previous abdominal aortic aneurysm repair. We discuss the technique involved and the reasons why we used tissue glue in this patient.

  3. CT Imaging for Gynecological HDR: Tools and Tricks

    International Nuclear Information System (INIS)

    Computerized tomography (CT)-assisted treatment planning for high-dose-rate (HDR) gynecological cancer treatments allows for better structure visualization and dose-volume histogram analysis definition. Problems associated with CT imaging are addressed. These pitfalls include the potential for multiple patient transfers and movement between applicator insertion, simulation, and treatment. Applicator CT imaging artifacts are also discussed. A modified transport table and a machined connection for a commercially available non-CT-compatible tandem and a CT-compatible ring applicator are described. These 2 modifications provide a safe and reliable method to utilize the advantages of CT imaging for gynecological HDR treatments

  4. Modeling of endoluminal and interstitial ultrasound hyperthermia and thermal ablation: applications to device design, feedback control, and treatment planning

    OpenAIRE

    Prakash, Punit; Salgaonkar, Vasant A.; Diederich, Chris J.

    2013-01-01

    Endoluminal and catheter-based ultrasound applicators are currently under development and are in clinical use for minimally invasive hyperthermia and thermal ablation of various tissue targets. Computational models play a critical role in in device design and optimization, assessment of therapeutic feasibility and safety, devising treatment monitoring and feedback control strategies, and performing patient-specific treatment planning with this technology. The critical aspect...

  5. Avaliação de planeamentos dosimétricos em doentes submetidas a braquiterapia ginecológica: uma revisão da literatura

    OpenAIRE

    Coelho, Carina Marques; Vale, Alexandra; Figueiredo, Ana; Braz, Ana; Esteves, Joana; Sá, Ana Cravo; Monsanto, Fátima

    2015-01-01

    Objetivo do estudo - Pretende-se analisar os diferentes parâmetros de avaliação dos planeamentos dosimétricos de doentes com tumores do colo do útero, tratadas com braquiterapia ginecológica de alta taxa de dose, nomeadamente a dose administrada no volume alvo e nos órgãos de risco (OR). Pretende-se ainda analisar a concordância dos dados obtidos com as recomendações da GEC-ESTRO.

  6. CT-based interstitial HDR brachytherapy

    Energy Technology Data Exchange (ETDEWEB)

    Kolotas, C.; Baltas, D.; Zamboglou, N. [Staedtische Kliniken Offenbach (Germany). Strahlenklinik

    1999-09-01

    Purpose: Development, application and evaluation of a CT-guided implantation technique and a fully CT-based treatment planning procedure for brachytherapy. Methods and Materials: A brachytherapy procedure based on CT-guided implantation technique and CT-based treatment planning has been developed and clinical evaluated. For this purpose a software system (PROMETHEUS) for the 3D reconstruction of brachytherapy catheters and patient anatomy using only CT scans has been developed. An interface for the Nucletron PLATO BPS treatment planning system for optimization and calculation of dose distribution has been devised. The planning target volume(s) are defined as sets of points using contouring tools and are used for optimization of the 3D dose distribution. Dose-volume histogram based analysis of the dose distribution (COIN analysis) enables a clinically realistic evaluation of the brachytherapy application to be made. The CT-guided implantation of catheters and the CT-based treatment planning procedure has been performed for interstitial brachytherapy and for different tumor sites in 197 patients between 1996 and 1997. Results: The accuracy of the CT reconstruction was tested using first a quality assurance phantom and second, a simulated interstitial implant of 12 needles. These were compared with the results of reconstruction using radiographs. Both methods gave comparable results with regard to accuracy, but the CT based reconstruction was faster. Clinical feasibility was proved in pre-irradiated recurrences of brain tumors, in pretreated recurrences or metastatic disease, and in breast carcinomas. The tumor volumes treated were in the range 5.1 to 2,741 cm{sup 3}. Analysis of implant quality showed a slightly significant lower COIN value for the bone implants, but no differences with respect to the planning target volume. Conclusions: The Offenbach system, incorporating the PROMETHEUS software for interstitial HDR brachytherapy has proved to be extremely valuable

  7. Inferior knee arterial endoluminal angioplasty in treating severe lower limb ischemia though the DEEP balloon catheter

    International Nuclear Information System (INIS)

    Objective: To evaluate the efficacy of inferior knee arterial endoluminal angioplasty for treating severe lower limb ischemia with the use of the DEEP balloon catheter. Methods: Eleven patients (17 limbs) with severe ischemia of lower extremities from August 2007 to April 2008 were retrospectively studied. All involved limbs suffered from rest pain including 6 limbs (6/17)complicated with ulcer, 2 (2/17) with toe gangrene or 3 (3/17)with both of the complaints. ABI (Ankle bxancial index) were 0.2-0.5 and 0.51-0.7 in 12 limbs and 5 limbs respectively, with average value 0.47. Results: The success rate of operation was 100% (17/17). Pain relieved obviously in 13 limbs (13/17) and reduced in 2 limbs (2/17). 2 limbs (2/17) still suffered from pain and underwent upper-knee amputation and other 2 with ulcerations(2/ 17)were healed. 3 (3/17) with toe gangrene underwent partial foot amputation, 1 with dried gangrene remained unchanged and the other was lost. Another one showed ulcer healed and toe was lost. Increase of ABI was more than 0.5 in 10 limbs(10/17) and 0.3-0.5 in 5 limbs(5/17) with average value of 0.83. 10 patients with sixteen limbs were followed up in an average period of 4.3 months (1-9 months). Of the 15 immediate pain-relieved limbs, 12(12/15) limbs remained free of pain and pain recurred in 3 other limbs; and 2 of them with pain-reduced after PTA again; the other 1 underwent amputation, Average value of ABI was 0.70. Conclusions: Inferior arterial endoluminal angioplasty for the treatment of severe limb ischemia with application of the DEEP balloon catheter show high successful rate and short-term encouraging clinical results but mid-term and long-terms follow up should be undertaken for further investigation. (authors)

  8. Endoluminal stent-graft management for type B aortic dissection and descending thoracic aortic aneurysm

    International Nuclear Information System (INIS)

    Objective: To evaluate the feasibility and short-term early results of endoluminal stent-graft placement in the Stanford B type aortic dissection and the descending thoracic aortic aneurysms. Methods: From March 2003 to September 2005, a total of 31 patients underwent placement of endovascular stent-grafts ,including the descending thoracic aortic aneurysm (n=2) and Standford B type aortic dissection (n=29). All patients had hypertension, with urgent onset of progressive thoracic pain in 27. Two kinds of stent-graft were used in this series: the Talent (Medtronic) in 15 and Aegis (Microportmedicine, Shanghai) in 16 patients. Follow-up was carried out with clinical observations and CTA. Results: Stent-graft implantation for the proximal entry closure was successfully performed in all patients. The DSA of immediately post deployment of the stent-graft showed complete occlusion the proximal entry tear in 23/29 patients with dissection, and complete isolation of the aneurysm in two patients with aortic aneurysm. Endoleak was revealed in 6 patients with dissection. No major complications related to the procedure were encountered. Conclusions: The interventional placement of stent-graft for Type B aortic dissection and descending thoracic aortic aneurysm is safe with satisfactory short-term outcomes. Nonetheless, longer follow-up is highly desirable to assess its real advantages. (authors)

  9. Diagnostic Metabolomic Blood Tests for Endoluminal Gastrointestinal Cancer--A Systematic Review and Assessment of Quality.

    Science.gov (United States)

    Antonowicz, Stefan; Kumar, Sacheen; Wiggins, Tom; Markar, Sheraz R; Hanna, George B

    2016-01-01

    Advances in analytics have resulted in metabolomic blood tests being developed for the detection of cancer. This systematic review aims to assess the diagnostic accuracy of blood-based metabolomic biomarkers for endoluminal gastrointestinal (GI) cancer. Using endoscopic diagnosis as a reference standard, methodologic and reporting quality was assessed using validated tools, in addition to pathway-based informatics to biologically contextualize discriminant features. Twenty-nine studies (15 colorectal, 9 esophageal, 3 gastric, and 2 mixed) with data from 10,835 participants were included. All reported significant differences in hematologic metabolites. In pooled analysis, 246 metabolites were found to be significantly different after multiplicity correction. Incremental metabolic flux with disease progression was frequently reported. Two promising candidates have been validated in independent populations (both colorectal biomarkers), and one has been approved for clinical use. Networks analysis suggested modulation of elements of up to half of Edinburgh Human Metabolic Network subdivisions, and that the poor clinical applicability of commonly modulated metabolites could be due to extensive molecular interconnectivity. Methodologic and reporting quality was assessed as moderate-to-poor. Serum metabolomics holds promise for GI cancer diagnostics; however, future efforts must adhere to consensus standardization initiatives, utilize high-resolution discovery analytics, and compare candidate biomarkers with peer nonendoscopic alternatives. PMID:26598534

  10. Investigation of superstructure damping identification for the HDR containment building

    International Nuclear Information System (INIS)

    A method for the estimation of first mode structural damping, developed by other investigators, was applied to shaker test data of the HDR containment building. Due to inadequate precision in the experimental phase measurements no valid results could be obtained. Based on modal analysis it was also noted that for systems such as the HDR building, contributions of higher modes are not negligible as was assumed in the original approach. Therefore, the procedure for the determination of superstructure damping using experimental data was extended to include the effects of higher modes. The extended method does not lead to any higher order nonlinear equations than the first mode approximation and was found to be as simple to apply as the original approach

  11. Vitamin D deficiency in a patient with HDR syndrome.

    Science.gov (United States)

    Kostoglou-Athanassiou, Ifigenia; Stefanopoulos, Dimitrios; Karfi, Areti; Athanassiou, Panagiotis

    2015-01-01

    The case of a patient with clinical symptoms, laboratory and imaging findings of hypoparathyroidism, sensorineural deafness, renal dysplasia HDR, or Barakat syndrome (hypoparathyroidism, deafness, renal dysplasia), and vitamin D deficiency, is presented. A Caucasian man aged 51 years with a history of chronic hypocalcaemia since childhood, was admitted with hypertonia of the body and extremities, and loss of consciousness. On admission, he was found to have severe hypocalcaemia, hyperphosphataemia, severe hypoparathyroidism, low serum magnesium and mild renal insufficiency. Calcium gluconate was administered intravenously supplemented with magnesium, and the patient recovered consciousness while clinical and laboratory findings improved. Evaluation revealed left renal aplasia and sensorineural deafness affecting both ears. Vitamin D deficiency was also present. He was given calcium and vitamin D supplements orally, and the hypocalcaemia was corrected. This case is described as it is an extremely rare case of HDR syndrome with concurrent vitamin D deficiency. PMID:26156834

  12. GATA3 abnormalities and the phenotypic spectrum of HDR syndrome

    OpenAIRE

    Muroya, K.; Hasegawa, T; Ito, Y.; Nagai, T.; Isotani, H.; Iwata, Y.; K. Yamamoto; Fujimoto, S.; Seishu, S.; Fukushima, Y.; Hasegawa, Y.; Ogata, T.

    2001-01-01

    We report on GATA3 analysis and the phenotypic spectrum in nine Japanese families with the HDR syndrome (hypoparathyroidism, sensorineural deafness, and renal dysplasia) (MIM 146255). Fluorescence in situ hybridisation and microsatellite analyses showed heterozygous gross deletions including GATA3 in four families. Sequence analysis showed heterozygous novel mutations in three families: a missense mutation within the first zinc finger domain at exon 4 (T823A, W275R), an unusual mutation at ex...

  13. A first experience of high dose rate (HDR) brachytherapy for tongue cancer

    International Nuclear Information System (INIS)

    We performed HDR brachytherapy for 12 patients with tongue cancer from April, 1996 to May, 1998. The patients included 7 men and 5 women. Ten of patients received HDR brachytherapy alone and two were treated with HDR brachytherapy and external irradiation and chemotherapy. In brachytherapy alone cases irradiated dose were between 42 Gy/14 fr and 60 Gy/10 fr, and the other two were irradiated 18 Gy/6 fr and 30 Gy/10 fr. We obtained CR for 12 patients and recurrence occurred in three cases. Late injury was observed in one case. In conclusion, HDR brachytherapy will be a promising therapeutic protocol for treatment of stage 1, 2 tongue cancer. (author)

  14. Vibrational experiments at the HDR [Heissdampfreaktor] German/US cooperation

    International Nuclear Information System (INIS)

    As part of an overall effort on the validation of seismic calculational methods, the US NRC/RES is collaborating with the Kernforschungszentrum Karlsruhe, FRG, in the vibrational/earthquake experiments conducted at the HDR (Heissdampfreaktor) Test Facility in Kahl/Main, FRG. In the most recent experiments (SHAG), high level excitations were produced in the HDR by means of an eccentric-mass coastdown shaker capable of developing 1000 tons of force. The purpose of the experiments was to investigate full-scale structural response, soil-structure interaction, and piping and equipment response. Data obtained in the tests serve to evaluate analysis methods. In the SHAG experiments, loadings of the HDR soil-structure system approached incipient failure levels as evidenced by high peak accelerations and displacements, local damage, nonlinear behavior, soil subsidence, and wall strains which exceeded estimated limit values. Also, the performance of different pipe hanger configurations for the VKL piping system was compared in these tests under high excitation levels. The support configurations ranged from very rigid systems (strut/snubbers) to very flexible configurations (spring and constant force supports). Pretest and post-test analyses for the building/soil and piping response were performed and are being validated with the test data

  15. WE-F-BRD-01: HDR Brachytherapy II: Integrating Imaging with HDR

    International Nuclear Information System (INIS)

    In recent years, with the advent of high/pulsed dose rate afterloading technology, advanced treatment planning systems, CT/MRI compatible applicators, and advanced imaging platforms, image-guided adaptive brachytherapy treatments (IGABT) have started to play an ever increasing role in modern radiation therapy. The most accurate way to approach IGABT treatment is to provide the infrastructure that combines in a single setting an appropriate imaging device, a treatment planning system, and a treatment unit. The Brachytherapy Suite is not a new concept, yet the modern suites are incorporating state-of-the-art imaging (MRI, CBCT equipped simulators, CT, and /or US) that require correct integration with each other and with the treatment planning and delivery systems. Arguably, an MRI-equipped Brachytherapy Suite is the ideal setup for real-time adaptive brachytherapy treatments. The main impediment to MRI-IGABT adoption is access to MRI scanners. Very few radiation oncology departments currently house MRI scanners, and even fewer in a dedicated Brachytherapy Suite. CBCT equipped simulators are increasingly offered by manufacturers as part of a Brachytherapy Suite installation. If optimized, images acquired can be used for treatment planning, or can be registered with other imaging modalities. This infrastructure is relevant for all forms of brachytherapy, especially those utilizing multi-fractionated courses of treatment such as prostate and cervix. Moreover, for prostate brachytherapy, US imaging systems can be part of the suite to allow for real-time HDR/LDR treatments. Learning Objectives: Understand the adaptive workflow of MR-based IGBT for cervical cancer. Familiarize with commissioning aspects of a CBCT equipped simulator with emphasis on brachytherapy applications Learn about the current status and future developments in US-based prostate brachytherapy

  16. WE-F-BRD-01: HDR Brachytherapy II: Integrating Imaging with HDR

    Energy Technology Data Exchange (ETDEWEB)

    Craciunescu, O [Duke University Medical Center, Durham, NC (United States); Todor, D [Virginia Commonwealth University, Richmond, VA (United States); Leeuw, A de

    2014-06-15

    In recent years, with the advent of high/pulsed dose rate afterloading technology, advanced treatment planning systems, CT/MRI compatible applicators, and advanced imaging platforms, image-guided adaptive brachytherapy treatments (IGABT) have started to play an ever increasing role in modern radiation therapy. The most accurate way to approach IGABT treatment is to provide the infrastructure that combines in a single setting an appropriate imaging device, a treatment planning system, and a treatment unit. The Brachytherapy Suite is not a new concept, yet the modern suites are incorporating state-of-the-art imaging (MRI, CBCT equipped simulators, CT, and /or US) that require correct integration with each other and with the treatment planning and delivery systems. Arguably, an MRI-equipped Brachytherapy Suite is the ideal setup for real-time adaptive brachytherapy treatments. The main impediment to MRI-IGABT adoption is access to MRI scanners. Very few radiation oncology departments currently house MRI scanners, and even fewer in a dedicated Brachytherapy Suite. CBCT equipped simulators are increasingly offered by manufacturers as part of a Brachytherapy Suite installation. If optimized, images acquired can be used for treatment planning, or can be registered with other imaging modalities. This infrastructure is relevant for all forms of brachytherapy, especially those utilizing multi-fractionated courses of treatment such as prostate and cervix. Moreover, for prostate brachytherapy, US imaging systems can be part of the suite to allow for real-time HDR/LDR treatments. Learning Objectives: Understand the adaptive workflow of MR-based IGBT for cervical cancer. Familiarize with commissioning aspects of a CBCT equipped simulator with emphasis on brachytherapy applications Learn about the current status and future developments in US-based prostate brachytherapy.

  17. SU-E-T-124: Dosimetric Comparison of HDR Brachytherapy and Intensity Modulated Proton Therapy

    Energy Technology Data Exchange (ETDEWEB)

    Wu, J [Purdue University, West Lafayette, IN (United States); Wu, H [IUPUI, Indianapolis, IN (United States); Das, I [Indiana University- School of Medicine, Indianapolis, IN (United States)

    2014-06-01

    Purpose: Brachytherapy is known to be able to deliver more radiation dose to tumor while minimizing radiation dose to surrounding normal tissues. Proton therapy also provides superior dose distribution due to Bragg peak. Since both HDR and Intensity Modulated Proton Therapy (IMPT) are beneficial for their quick dose drop off, our goal in this study is to compare the pace of dose gradient drop-off between HDR and IMPT plans based on the same CT image data-set. In addition, normal tissues sparing were also compared among HDR, IMPT and SBRT. Methods: Five cervical cancer cases treated with EBRT + HDR boost combination with Tandem and Ovoid applicator were used for comparison purpose. Original HDR plans with prescribed dose of 5.5 Gy x 5 fractions were generated and optimized. The 100% isodose line of HDR plans was converted to a dose volume, and treated as CTV for IMPT and SBRT planning. The same HDR CT scans were also used for IMPT plan and SBRT plan for direct comparison. The philosophy of the IMPT and SBRT planning was to create the same CTV coverage as HDR plans. All three modalities treatment plans were compared to each other with a set of predetermined criteria. Results: With similar target volume coverage in cervix cancer boost treatment, HDR provides a slightly sharper dose drop-off from 100% to 50% isodose line, averagely in all directions compared to IMPT. However, IMPT demonstrated more dose gradient drop-off at the junction of the target and normal tissues by providing more normal tissue sparing and superior capability to reduce integral dose. Conclusion: IMPT is capable of providing comparable dose drop-off as HDR. IMPT can be explored as replacement for HDR brachytherapy in various applications.

  18. Image-based rendering method for mapping endoscopic video onto CT-based endoluminal views

    Science.gov (United States)

    Rai, Lav; Higgins, William E.

    2006-03-01

    One of the indicators of early lung cancer is a color change in airway mucosa. Bronchoscopy of the major airways can provide high-resolution color video of the airway tree's mucosal surfaces. In addition, 3D MDCT chest images provide 3D structural information of the airways. Unfortunately, the bronchoscopic video contains no explicit 3D structural and position information, and the 3D MDCT data captures no color or textural information of the mucosa. A fusion of the topographical information from the 3D CT data and the color information from the bronchoscopic video, however, enables realistic 3D visualization, navigation, localization, and quantitative color-topographic analysis of the airways. This paper presents a method for topographic airway-mucosal surface mapping from bronchoscopic video onto 3D MDCT endoluminal views. The method uses registered video images and CT-based virtual endoscopic renderings of the airways. The visibility and depth data are also generated by the renderings. Uniform sampling and over-scanning of the visible triangles are done before they are packed into a texture space. The texels are then re-projected onto video images and assigned color values based on depth and illumination data obtained from renderings. The texture map is loaded into the rendering engine to enable real-time navigation through the combined 3D CT surface and bronchoscopic video data. Tests were performed on pre-recorded bronchoscopy patient video and associated 3D MDCT scans. Results show that we can effectively accomplish mapping over a continuous sequence of airway images spanning several generations of airways.

  19. Primary standardization of the HDR 192Ir source in terms of air kerma strength

    International Nuclear Information System (INIS)

    Establishing a primary standard of AKS at the Standards Laboratory and offering traceable calibration to all the hospitals that make use of HDR 192Ir, in brachytherapy is important. With this objective, the primary standardization of the HDR 192Ir source was undertaken. Details of the work are presented

  20. Robust Estimation of HDR in fMRI using H-infinity Filters

    DEFF Research Database (Denmark)

    Puthusserypady, Sadasivan; Jue, R.; Ratnarajah, T.

    2010-01-01

    Estimation and detection of the hemodynamic response (HDR) are of great importance in functional MRI (fMRI) data analysis. In this paper, we propose the use of three H-infinity adaptive filters (finite memory, exponentially weighted, and timevarying) for accurate estimation and detection of the HDR...

  1. HDR brachytherapy for superficial non-melanoma skin cancers

    International Nuclear Information System (INIS)

    Our initial experience using recommended high dose per fraction skin brachytherapy (BT) treatment schedules, resulted in poor cosmesis. This study aimed to assess in a prospective group of patients the use of Leipzig surface applicators for High Dose Rate (HDR) brachytherapy, for the treatment of small non-melanoma skin cancers (NMSC) using a protracted treatment schedule. Treatment was delivered by HDR brachytherapy with Leipzig applicators. 36Gy, prescribed to between 3 to 4mm, was given in daily 3Gy fractions. Acute skin toxicity was evaluated weekly during irradiation using the Radiation Therapy Oncology Group criteria. Local response, late skin effects and cosmetic results were monitored at periodic intervals after treatment completion. From March 2002, 200 patients with 236 lesions were treated. Median follow-up was 66 months (range 25–121 months). A total of 162 lesions were macroscopic, while in 74 cases, BT was given after resection because of positive microscopic margins. There were 121 lesions that were basal cell carcinomas, and 115 were squamous cell carcinomas. Lesions were located on the head and neck (198), the extremities (26) and trunk (12). Local control was 232/236 (98%). Four patients required further surgery to treat recurrence. Grade 1 acute skin toxicity was detected in 168 treated lesions (71%) and grade 2 in 81 (34%). Cosmesis was good or excellent in 208 cases (88%). Late skin hypopigmentation changes were observed in 13 cases (5.5%). Delivering 36Gy over 2 weeks to superficial NMSC using HDR brachytherapy is well tolerated and provides a high local control rate without significant toxicity.

  2. Aktuelle Entwicklungen in der Strahlentherapie des Prostatakarzinoms: HDR-Brachytherapie

    Directory of Open Access Journals (Sweden)

    Knocke-Abulesz TH

    2004-01-01

    Full Text Available In der primären Therapie des Prostatakarzinoms ist die Seed-Implantation neben der radikalen Prostatektomie und der konformalen 3D-geplanten Teletherapie in den letzten Jahren insbesondere bei den lokal begrenzten Tumoren die dritte etablierte Behandlungstechnik geworden. In den USA werden bereits fast ein Drittel der Patienten mit dieser Technik behandelt. Im Gegensatz hierzu wurde in der Strahlentherapie in den letzten beiden Jahrzehnten die Langzeit-Implantation von Nukliden bei den meisten Tumoren zugunsten der fraktionierten Afterloading-Bestrahlung in "high dose rate" (HDR- Technik ersetzt – wobei partiell für HNO- und gynäkologische Tumoren die HDR-Technik als "pulse-dose-rate" (PDR- Verfahren modifiziert wird, um die biologischen Vorteile der LDR- und die technologischen Vorteile der HDR-Anwendung zu vereinen. Vorteile der Methode im Vergleich zur Seed-Implantation sind: – Niedrigere Kosten, allgemeine Verfügbarkeit, – Idealer Strahlenschutz, – Zuverlässige Dosisverteilung, – Keine Migration von Seeds, – Durchführbar auch nach TURP, – Durchführbar bei manifesten Lokalrezidiven. Allerdings liegen bisher nur vereinzelte klinische Ergebnisse beim Prostatakarzinom vor, die zeigen, daß eine lokale Dosiserhöhung in Kombination mit der Teletherapie eine Verbesserung der lokalen Kontrolle bei kapselüberschreitenden Tumoren ermöglicht. Inwieweit der Einsatz der Technik bei Lokalrezidiven zu langandauernden Remissionen führen kann, ist Gegenstand von laufenden Untersuchungen. Der Ersatz der Seed-Implantation durch eine 2-tägige fraktionierte Brachytherapie mit vier Bestrahlungen ist derzeit Gegenstand einer prospektiven Studie, deren erste Langzeitergebnisse in diesem Jahr erwartet werden.

  3. Endoluminal bronchial valves: a replacement for lung volume reduction surgery (LVRS) in chronic obstructive airways disease (COAD)?

    International Nuclear Information System (INIS)

    Full text: The benefit of LVRS in COAD is controversial because of a high complication rate. A potentially effective less invasive method may be endoluminal placement of one-way valves to block air entry and thus collapse affected lung zones. Our study assessed the physiological effects of this procedure. Three patients with severe COAD suitable for LVRS, underwent this procedure to both upper lobe main bronchi. Assessment included pre-and post-operative Tc-99m Technegas and quantitative Tc-99m macroaggregated albumin (MAA) studies, and also measurement of regional ventilation dynamics using Xe-133, ( 80 seconds wash-in / equilibration and a 3.5 minutes wash-out phase). The index of wash-in was Xe-133 counts at 20 sees /Xe-133 counts at 80 seconds. In all 6 treated upper lobes in patients with COAD substantial ventilation and perfusion persisted, and no radiographic collapse occurred. % perfusion to upper lung zones fell slightly from 27+12% to 21+8% (mean +SD): (P<0.05). The decreased wash-in index to the treated lobes shows a significant effect of the endoluminal valve. The increased washout rate from the lower lobes suggests therapeutic benefit. However preserved volume, ventilation and perfusion in the treated lobes suggest continuing aeration via interlobar ventilatory connections with the untreated lobes. Copyright (2002) The Australian and New Zealand Society of Nuclear Medicine Inc

  4. PCA-induced respiratory depression simulating stroke following endoluminal repair of abdominal aortic aneurysm: a case report

    Directory of Open Access Journals (Sweden)

    Ahmad Javed

    2007-07-01

    Full Text Available Abstract Aim To report a case of severe respiratory depression with PCA fentanyl use simulating stroke in a patient who underwent routine elective endoluminal graft repair for abdominal aortic aneurysm (AAA Case presentation A 78-year-old obese lady underwent routine endoluminal graft repair for AAA that was progressively increasing in size. Following an uneventful operation postoperative analgesia was managed with a patient-controlled analgesia (PCA device with fentanyl. On the morning following operation the patient was found to be unusually drowsy and unresponsive to stimuli. Her GCS level was 11 with plantars upgoing bilaterally. A provisional diagnosis of stroke was made. Urgent transfer to a high-dependency unit (HDU was arranged and she was given ventilatory support with a BiPap device. CT was performed and found to be normal. Arterial blood gas (ABG analysis showed respiratory acidosis with PaCO2 81 mmHg, PaO2 140 mmHg, pH 7.17 and base excess -2 mmol/l. A total dose of 600 mcg of fentanyl was self-administered in the 16 hours following emergence from general anaesthesia. Naloxone was given with good effect. There was an increase in the creatinine level from 90 μmol/L preoperatively to 167 μmol/L on the first postoperative day. The patient remained on BiPap for two days that resulted in marked improvement in gas exchange. Recovery was complete.

  5. Peripheral vascular disease of iliac and femoro-popliteal arteries. State-of-the-art endoluminal revascularization

    International Nuclear Information System (INIS)

    Endoluminal therapy is indicated in lower extremity ischaemia with Fontaine grades IIb, III and IV. In the presence of significant limitations, interventions are carried out even in grade IIa claudicants. In addition to the TASC A and B lesions, TASC C and D lesions are increasingly being treated endoluminally as well. Presently, technical success rates of revascularization procedures are above 90% in the iliac vessels and between 79% and 95% in the femoro-popliteal segments. Concentric, non-calcified iliac stenoses are primarily treated with balloon angioplasty (PTA) followed by optional stenting when necessary. For occlusions and heavily calcified lesions, primary stenting is recommended. Primary PTA is the mainstay of treatment in femoro-popliteal vessels with stents being used as a ''bail-out'' option in case of suboptimal PTA. However, initial reports proving the superiority of primary stenting over PTA with optional stenting have already appeared. Results of PTA with drug-coated balloons for prevention of early restenosis are promising. In the near future, primary PTA with optional stenting in the femoro-popliteal segments may give way to drug-coated balloon angioplasty or primary stenting. (orig.)

  6. Síntese e caracterização de matrizes porosas de hidroxiapatita para aplicação como fontes radioativas em braquiterapia

    Directory of Open Access Journals (Sweden)

    Kássio André Lacerda

    2006-06-01

    Full Text Available Materiais cerâmicos porosos a base de compostos de fosfatos de cálcio (CFC vêm sendo estudados e desenvolvidos para várias aplicações biomédicas, tais como implantes, sistemas para liberação de drogas e fontes radioativas para braquiterapia. Dois tipos de hidroxiapatita e seus corpos cerâmicos foram caracterizados por uma combinação de diferentes técnicas (fluorescência e difração de raios X, espectroscopia no infravermelho, método BET, análise térmica e microscopia eletrônica de varredura para avaliar suas características físico-químicas e microestruturais em termos da composição química, fases segregadas, microestrutura, porosidade e estabilidade química e térmica. Os resultados revelaram que esses sistemas apresentaram potencial para o uso como fontes porosas radioativas biodegradáveis capazes de serem carregadas com uma ampla faixa de radionuclídeos para o tratamento do câncer pela técnica de braquiterapia.Porous ceramic materials based on calcium phosphate compounds (CPC have been studied aiming at different biomedical applications such as implants, drug delivery systems and radioactive sources for brachytherapy. Two kinds of hydroxyapatite (HAp powders and their ceramic bodies were characterized by a combination of different techniques (X-rays diffraction and fluorescence, infrared spectrophotometry, BET method, thermal analysis, and scanning electron microscopy to evaluate their physico-chemical and microstructural characteristics in terms of chemical composition, segregated phases, microstructure, porosity, and chemical and thermal stability. The results revealed that these systems presented potential for use as porous biodegradable radioactive sources able to be loaded with a wide range of radionuclides for cancer treatment by the brachytherapy technique.

  7. Seismic investigations of the HDR Safety Program. Summary report

    International Nuclear Information System (INIS)

    The primary objective of the seismic investigations, performed at the HDR facility in Kahl/Main, FRG was to validate calculational methods for the seismic evaluation of nuclear-reactor systems, using experimental data from an actual nuclear plant. Using eccentric mass shaker excitation the HDR soil/structure system was tested to incipient failure, exhibiting highly nonlinear response and demonstrating that structures not seismically designed can sustain loads equivalent to a design basin earthquake (DBE). Load transmission from the structure to piping/equipment indicated significant response amplifications and shifts to higher frequencies, while the response of tanks/vessels depended mainly on their support conditions. The evaluation of various piping support configurations demonstrated that proper system design (for a given spectrum) rather than number of supports or system stiffness is important to limiting pipe greens. Piping at loads exceeding the DBE eightfold still had significant margins and failure is improbable inspite of multiple support failures. The mean value for pipe damping, even under extreme loads, was found to be about 4%. Comparison of linear and nonlinear computational results with piping response measurements showed that predictions have a wide scatter and do not necessarily yield conservative responses underpredicting, in particular, peak support forces. For the soil/structure system the quality of the predictions did not depend so much on the complexity of the modeling, but rather on whether the model captured the salient features and nonlinearities of the system

  8. HDR IMAGING FOR FEATURE DETECTION ON DETAILED ARCHITECTURAL SCENES

    Directory of Open Access Journals (Sweden)

    G. Kontogianni

    2015-02-01

    Full Text Available 3D reconstruction relies on accurate detection, extraction, description and matching of image features. This is even truer for complex architectural scenes that pose needs for 3D models of high quality, without any loss of detail in geometry or color. Illumination conditions influence the radiometric quality of images, as standard sensors cannot depict properly a wide range of intensities in the same scene. Indeed, overexposed or underexposed pixels cause irreplaceable information loss and degrade digital representation. Images taken under extreme lighting environments may be thus prohibitive for feature detection/extraction and consequently for matching and 3D reconstruction. High Dynamic Range (HDR images could be helpful for these operators because they broaden the limits of illumination range that Standard or Low Dynamic Range (SDR/LDR images can capture and increase in this way the amount of details contained in the image. Experimental results of this study prove this assumption as they examine state of the art feature detectors applied both on standard dynamic range and HDR images.

  9. HDR neutron brachytherapy for cervix carcinoma in Lithuania

    International Nuclear Information System (INIS)

    Between 1988 and December 1995, a total of 285 patients with stage I-17, with stage II-157, with stage III-104 and stage IV-7 carcinoma of the cervix were treated with a combination of external beam radiation or surgery and HDR brachytherapy. The dose prescription for HDR brachytherapy was point A. The goals of combined radiation therapy were to deliver a total dose of 60.5-68.5 Gy to point A and 53-58 Gy to the pelvic lymph nodes (point B) or 14 Gy-eq to point A in case of preoperative brachytherapy. Dosimetric planning was performed in Gray- equivalents by the use of PC-based computer programme. Relative biological effectiveness of the Cf-252 neutrons was physical gamma and neutron dose rate dependent. Most of the insertions were performed weekly when dose per fraction was 8-10 Gy or 2 insertions were done in one week at lower fractions. The median follow-up for the various stages of disease ranged from 0.5 to 6.5 year. Treatment results, acute and late toxicity will be discussed

  10. WE-E-BRD-01: HDR Brachytherapy I: Overview of Clinical Application and QA

    International Nuclear Information System (INIS)

    With the increased usage of high dose rate (HDR) brachytherapy and the introduction of dedicated image guided brachytherapy suites, it is necessary to review the processes and procedures associated with safely delivering these treatments in the expedited time scales that dedicated treatment suites afford. The speakers will present the clinical aspects of switching from LDR to HDR treatments, including guidelines for patient selection, and the clinical outcomes comparing LDR to HDR. The speakers will also discuss the HDR treatment process itself, because the shortened clinical timeline involved with a streamlined scan/plan/treat workflow can introduce other issues. Safety and QA aspects involved with the streamlined process, including increased personnel required for parallel tasks, and possible interfering tasks causing delays in patient treatments will also be discussed. Learning Objectives: To understand the clinical aspects of HDR Brachytherapy, including common clinical indications, patient selection, and the evolving evidence in support of this therapeutic modality To review the current prominent clinical trials for HDR brachytherapy To interpret the established guidelines for HDR brachytherapy quality assurance for implementation into practical clinical settings. To introduce the basic requirements for image guided brachytherapy

  11. Relocation of a nucletron microselectron-HDR brachytherapy system

    International Nuclear Information System (INIS)

    Full text: For a period of four weeks, our clinical Nucletron microSelectron high dose rate (HDR) brachytherapy system was pulled out of clinical use and relocated to a new building. During this period decommission tests, de-wiring of the treatment unit and its associated safety system (such as radiation detector, emergency off circuits and door interlocks), transportation of all equipment, re-wiring of this equipment in the new location and recommission tests were carried out. The decommission and recommission test program was designed upon consultation with the manufacturer's (Nucletron) acceptance test procedures and work carried out by others. The ACPSEM tolerances for remote afterloaders was used as a guideline. In addition to mandatory dosimetry, positional, workstation database and safety tests, two Australian Standard compliance tests were carried out. The compliance tests involved one for remote afterloaders and another for treatment room design. This testing program was designed and implemented with the aim of ensuring ongoing safe delivery of brachytherapy doses to the patient. The testing program consisted of two parts. The first involved a series of decommissioning tests that consisted of dosimetry tests such as source and check cable positional accuracy and source calibration tests. In addition to these tests an inventory of standard plans, patient records and system configuration information was catalogued. The second part involved a series of recommission tests and involved carrying out dosimetry tests on the brachytherapy system (positional accuracy and calibration tests), simulating common treatment scenarios (prostate, cervical, vaginal and bile duct) and checking standard plans; patient records and system configuration had remained unchanged. During this period, other tests were carried out. These included Nucletron acceptance and preventative maintenance tests, Australian Standards compliance testing and integrity of network transfer of

  12. Microseismicity and Stimulated Hydrogeologic Structures in HDR/HWR Reservoirs

    Science.gov (United States)

    Niitsuma, H.

    2006-12-01

    Fluid injection to enhance productivity in oil and geothermal reservoir has been widely conducted since 1980's. The fluid injection is also one of the key technologies to create artificial circulation system in Hot Dry Rock (HDR)/ Hot Wet Rock (HWR) geothermal development. It is advantageous for understanding fluid induced faulting to analyze the subsurface response during the fluid injections, because the injection processes are controlled and hydraulic data are recorded. Some of this information can be obtained from well logs such as flow, temperature, pressure, BHTV, FMI, etc. However, they only provide restricted information near the well. Microseismic monitoring is currently the best available method for obtaining three-dimensional information about reservoirs and fracture systems at locations remote from boreholes. The primary problem of the method is its location accuracy. When located with conventional location algorithms, the events are frequently seen to be distributed as a cloud with little macro- or microstructure. It is difficult to meaningfully correlate such images with logging data of existing wells. Therefore, information on detailed reservoir structure, fracture orientation, and hydraulic behavior cannot be obtained from the application of conventional microseismic location techniques. There have been considerable improvements in microseismic mapping technology in these fifteen years. Various techniques to reduce location error have been developed which include collapsing, doublet/multiplet analysis, double-difference method, and multiplet-clustering analysis. These high resolution mapping techniques demonstrate that the diffuse clouds obtained using conventional techniques are largely artefacts of location error, and reveal macro- and microstructures within the cloud that can be correlated with geological and hydraulic structures identified from well logs. These high-resolution seismic mapping techniques have been applied to the microseismic data

  13. Dosimetric influence of hyaluronic acid in patients with prostate cancer treated with RT3D; Influencia dosimetrica del acido hialuronico en pacientes cancer de prostata tratados con RT3D externa+HDR braquiterapia

    Energy Technology Data Exchange (ETDEWEB)

    Sanchez, J.; Vazquez, J. A.; Garcia Blanco, A. S.; Gomez, F.; Montejo, A.; Raba, J. I.; Pacheco, M. T.; Cardenal Carro, J.; Mendigueren, M. A.

    2013-07-01

    This study aims to assess the influence on dosimetry by the introduction of hyaluronic acid and assess the need for the realization of a second CT scan and consequent re-planning of RT3D treatment. (Author)

  14. Endoluminal calprotectin measurement in assessment of pouchitis and a new index of disease activity: a pilot study

    Directory of Open Access Journals (Sweden)

    Annamaria Pronio

    2016-04-01

    Full Text Available Pouchitis is the most common complication following proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis (UC. To provide a standardized definition of pouchitis clinical, endoscopic and histological markers were grouped and weighted in the pouch disease activity index (PDAI. However, the delay in the assessment of the final score due to the time requested for histological analysis remains the main obstacle to the index implementation in clinical practice so that the use of modified-PDAI (mPDAI with exclusion of histologic subscore has been proposed. We tested the ability of calprotectin measurement in the pouch endoluminal content to mimic the histologic score as defined in the PDAI, the index that we adopted as gold standard for pouchitis diagnosis. Calprotectin was measured by ELISA in the pouch endoluminal content collected during endoscopy in 40 consecutive patients with J-pouch. In each patient PDAI and mPDAI were calculated and 15% of patients were erroneously classified by mPDAI. ROC analysis of calprotectin values vs. acute histological subscore ≥ 3 identified different calprotectin cut-off values with corresponding sensitivity and specificity allowing the definition and scoring of different range of calprotectin subscores. We incorporated the calprotectin score in the mPDAI obtaining a new score that shows the same specificity as PDAI for diagnosis of pouchitis and higher sensitivity when compared with mPDAI. The use of the proposed new score, once validated in a larger series of patients, might be useful in the early management of patients with symptoms of pouchitis.

  15. HDR neutron brachytherapy for prostatic cancer in lithuania

    International Nuclear Information System (INIS)

    The purpose of this report is to analyse the physical and radiobiological background of the HDR Cf-252 Neutron brachytherapy boost in the combined radiation therapy for locally advanced prostatic cancer. The treatment schedule:two fractions of the Cf-252 brachytherapy(5Gy-eq at the dose point 2 cm from source movement trajectory) with interval 24 hours; 5-8 fractions of the photon beam external radiation therapy(5 fractions per week, 2 Gy per fraction) to the prostate, two fractions of the Cf-252 brachytherapy and after that external beam radiation therapy is continued till total dose 40-45 Gy. Six patients completed the proposed combined radiation therapy. The results of this trial will be discussed

  16. 192Ir high dose rate (HDR) interstitial brain implant: optimisation

    International Nuclear Information System (INIS)

    The new modality of stepping source dosimetry system (SSDs) illustrates a remarkable improvement in attaining the uniform and homogeneous dose distribution within the target volume. The technique enables the physicist to correct for a certain amount of misplacement or curvature of implant geometry. The short course of brachytherapy provides good palliation in terms of functional improvements with low and acceptable toxicity in high-grade glioma. With continual refinements of the technique, brachytherapy performed by a skilled brachytherapy team offers an opportunity to improve patient survival and quality of life. Since 1997, micro selectron HDR 192Ir treatments are done including gynecological, oesophageal, breast, surface mould, soft tissue sarcoma (STS) and brain in our hospital. In this paper, procedure of interstitial brain implant in glioma as implant technique, simulation and treatment planning will be discussed

  17. HDR brachytherapy with surface applicators: technical considerations and dosimetry.

    Science.gov (United States)

    Sabbas, Albert M; Kulidzhanov, Fridon G; Presser, Joseph; Hayes, Mary K; Nori, Dattatreyudu

    2004-06-01

    HDR surface molds offer an alternative radiotherapy modality to electrons for the treatment of skin lesions. Treatment planning and dosimetry are discussed for two types of surface molds used in our clinic. Standard rectangular applicators are used on a variety of sites where surface curvature is minimal. In these cases an idealized planar geometry is used for treatment planning dose calculations. The calculations yield treatment dose uniformity at the prescription depth in tissue as well as skin dose, as a percentage of the treatment dose, and its dose uniformity. The availability of optimization techniques results in superior dose uniformity at depth but the dose at the skin has to be carefully evaluated. We have studied the dependence of these dosimetric parameters on the size of the surface mold and the type of optimization procedure used in the dosimetry calculations. The second type of surface applicator involves the use of a customized silicone rubber mold attached to a thermoplastic mask of the patient. We have used them to treat lesions of the face where surface curvatures are appreciable and reproducibility of setup is more critical. In these cases a CT data set is used for reconstruction of the catheters, activation of relevant dwell positions and dosimetry, including optimization. Towards establishing effective methods for quality assurance of the optimized HDR surface mold planning calculations, we have compared their dosimetry to both a classical brachytherapy system and to one based on an analytical model of the applicator. The classical system yields an independent verification of the integrated activity used in the planning calculations, whereas the analytical model is used to evaluate depth dose dependence on mold size and optimization. PMID:15161319

  18. The emerging role of high-dose-rate (HDR) brachytherapy as monotherapy for prostate cancer

    International Nuclear Information System (INIS)

    High-dose-rate (HDR) brachytherapy as monotherapy is a comparatively new brachytherapy procedure for prostate cancer. In addition to the intrinsic advantages of brachytherapy, including radiation dose concentration to the tumor and rapid dose fall-off at the surrounding normal tissue, HDR brachytherapy can yield a more homogeneous and conformal dose distribution through image-based decisions for source dwell positions and by optimization of individual source dwell times. Indication can be extended even to T3a/b or a part of T4 tumors because the applicators can be positioned at the extracapsular lesion, into the seminal vesicles, and/or into the bladder, without any risk of source migration or dropping out. Unlike external beam radiotherapy, with HDR brachytherapy inter-/intra-fraction organ motion is not problematic. However, HDR monotherapy requires patients to stay in bed for 1-4 days during hospitalization, even though the actual overall treatment time is short. Recent findings that the α/β value for prostate cancer is less than that for the surrounding late-responding normal tissue has made hypofractionation attractive, and HDR monotherapy can maximize this advantage of hypofractionation. Research on HDR monotherapy is accelerating, with a growing number of publications reporting excellent preliminary clinical results due to the high 'biologically effective dose (BED)' of >200 Gy. Moreover, the findings obtained for HDR monotherapy as an early model of extreme hypofractionation tend to be applied to other radiotherapy techniques such as stereotactic radiotherapy. All these developments point to the emerging role of HDR brachytherapy as monotherapy for prostate cancer. (author)

  19. Air kerma strength calibration of 0.6 cc Farmer chamber for 192Ir HDR source

    International Nuclear Information System (INIS)

    One of the methods adopted by hospitals for the calibration of the HDR 192Ir source, in terms of Air Kerma Strength (AKS) is to use 0.6cc chamber at short source to chamber distances for measuring the air kerma rate at the chamber position and then compute the AKS using the appropriate correction factors. However, the 0.6 cc Farmer type chambers purchased by the users for the calibration of the HDR 192Ir source, are not generally provided with an HDR 192Ir calibration factor. With the result, many hospitals that have purchased the Farmer type chamber for the calibration of 192Ir HDR sources, use the 60Co calibration factor for this purpose. The use of 60Co calibration factor for the 192Ir HDR source would unnecessarily increase the uncertainty of the measured AKS. Again, because of the low chamber sensitivity, hospitals often use, source to chamber distances as small as a few cm for calibrating the 192Ir HDR source. In the absence of a rigid source-chamber positioning system, this can lead to several percent errors in AKS determination. Also, hospitals often don't take into account corrections for the room scatter or the fluence non-uniformity across the chamber, which further increase the uncertainty of the measured AKS

  20. The first Korean case of HDR syndrome confirmed by clinical and molecular investigation.

    Science.gov (United States)

    Cheon, Chong Kun; Kim, Gu Hwan; Yoo, Han Wook

    2015-01-01

    Hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome is a rare condition inherited as autosomal dominant trait and characterized by hypoparathyroidism, sensorineural deafness, and renal dysplasia. HDR syndrome is caused by haploinsufficiency of the GATA3 gene located on chromosome 10p15. Here, we report the case of a 32-day-old Korean male with HDR syndrome. He was presented due to repeated seizures over previous 3 days. The patient was born after 40 weeks of gestation with birth weight of 2930 g, and was the first-born baby of healthy Korean parents. Hypoparathyroidism was first noticed due to seizure. A multicystic left dysplastic kidney and vesicoureteral reflux were detected by ultrasound after birth. Auditory brainstem response (ABR) testing revealed that the patient had moderate sensorineural deafness, with hearing losses of 80 dB at the mid and higher frequencies for both ears. Echocardiography finding revealed secundum atrial septal deftect. Based on biochemical results and clinical findings, a presumptive diagnosis of HDR syndrome was made. GATA3 mutation analysis identified a heterozygous deletion, c.153del (p.Phe51Leufs*144) in exon 1 causing a frameshift mutation, which is a novel de novo mutation. Therefore, we suggest that HDR syndrome should be considered in the differential diagnosis in symptomatic or asymptomatic patients with hypoparathyroidism, and that renal ultrasound or ABR testing be performed to prevent a missed diagnosis. This is the first report on Korean patient with confirmed HDR syndrome with novel mutation. PMID:25510779

  1. High dose-rate brachytherapy as a treatment option in primary tracheal tumors Braquiterapia de alta taxa de dose como opção terapêutica nos tumores primários da traquéia

    Directory of Open Access Journals (Sweden)

    Heloisa de Andrade Carvalho

    2005-08-01

    Full Text Available PURPOSE: To present experience with high dose-rate endobronchial brachytherapy in the treatment of primary tracheal tumors. PATIENTS AND METHODS: Four patients with nonresected primary tracheal tumors are presented: 2 cases of squamous cell carcinoma of the trachea, 1 of recurrent adenoid cystic carcinoma, and 1 with recurrent plasmacytoma. All received brachytherapy, alone or as a boost for primary irradiation, in 3 or 4 fractions of 7.5 Gy, calculated at a depth of 1 cm. Follow-up was considered to start from the end of brachytherapy. RESULTS: Local control was achieved in all cases at the time of first bronchoscopic evaluation. Two patients with squamous cell carcinoma died at 6th and 33rd months after brachytherapy, respectively. The first had no evidence of disease, and the latter had local recurrence. The other 2 patients were alive after 64 and 110 months of follow-up, respectively, both with no evidence of disease. Tracheal stenosis developed in these 2 cases, 22 and 69 months after brachytherapy. Tracheal stent placement was needed only for the patient with an adenoid cystic carcinoma. CONCLUSIONS: Endobronchial high dose-rate brachytherapy may be used for tracheal tumors, even as a boost for external beam irradiation, or in recurrences. Local control in 3 out of 4 patients indicates that individual cases may benefit from the treatment. Long-term survival may also be expected, mainly for tumors with adenoid cystic histology.OBJETIVO: Apresentar a experiência do tratamento de 4 pacientes com tumores primários de traquéia, não operados, submetidos à braquiterapia endobrônquica de alta taxa de dose. PACIENTES E MÉTODOS: Dois casos de carcinoma espinocelular, uma recidiva de carcinoma adenóide cístico e uma recidiva de plasmocitoma primário da traquéia. Todos receberam braquiterapia endobrônquica, exclusiva ou como reforço de dose da radioterapia externa. Foram administradas 3 ou 4 frações de 7,5 Gy cada, calculados a 1 cm de

  2. Optimization in brachytherapy with the implementation of Radiobiology; Optimizacion en Braquiterapia con la implementacion de la Radiobiologia

    Energy Technology Data Exchange (ETDEWEB)

    Duran, M.P.; Bourel, V.J.; Rodriguez, I.; Torre, M. de la; Caneva, S. [Braqui S.R.L. Viamonte 1861, Buenos Aires (Argentina)

    1998-12-31

    In the brachytherapy planning treatments with High dose rates (HDR), the optimization algorithms used are based in dosimetric considerations and/or geometric ones, ignoring the radiobiological response of the tissue treated. In this work we wish to show the implementation of radiobiological concepts in the optimization. Assuming that the subtiles differences that result in the dose distribution among the different optimization models which are not visible in an isodose plane, it is studied how is classically make it , the quality implant through natural histograms about dose volumes and the resulting parameters. Also is studied the necrosis probability which may be caused by the choice of some optimization model, allowing with this the choice of the best implant. (Author)

  3. Tratamiento combinado de los queloides mediante cirugía y braquiterapia Treatment of queloids with surgical resection and brachytherapy

    Directory of Open Access Journals (Sweden)

    J. Bisbal

    2009-12-01

    Full Text Available Presentamos nuestra experiencia en el tratamiento de los queloides mediante resección quirúrgica y radioterapia inmediata posterior. La radioterapia transforma el queloide en un tejido hipocelular, hipovascular e hipóxico, impidiendo la excesiva migración de fibroblastos. Si se administra la dosis adecuada de radiación, se consigue un equilibrio entre la formación de cicatriz y la proliferación excesiva de tejido, evitando la formación de queloide, sin impedir la cicatrización normal. Nuestro protocolo se divide en dos fases: la primera consiste en la exéresis del queloide mediante una incisión que sigue el trayecto del mismo, con un cuidadoso cierre en dos planos siendo siempre el superficial una sutura intradérmica. La segunda fase será la radioterapia, con dos modalidades posibles de tratamiento: 1- Braquiterapia (tratamiento a corta distancia, requiere la colocación de un catéter bajo la sutura, a través del cual se introduce una fuente radiactiva, normalmente Ir192. Se emplea especialmente en heridas longitudinales. 2- Radioterapia externa con electrones de baja energía. Se emplea en heridas complejas o extensas. Generalmente, dosis de 20 Gy. en 4 fracciones de 500 cGy, ofrecen excelentes resultados con mínimas secuelas o efectos secundarios. El volumen blanco debe incluir la herida quirúrgica más un margen de 4 mm. alrededor de ella. Con este procedimiento, hemos observado unos excelentes resultados, con un índice de recidivas inferior al 4%, y una mejora en los síntomas clínicos en el 100% de los casos. Como efectos secundarios observamos telangiectasias (15,4 % o cambios en la pigmentación cutánea (5,9%.We present our experience in treatment of keloid scars with surgical resection and immediately postoperative radiotherapy. Radiotherapy changes keloid into an hypocellular, hypovascular and hypotoxic tissue, avoiding the excessive migration of fibroblasts. If the suitable dose of radiation is delivered, balance

  4. Panoramic endoluminal display with minimal image distortion using circumferential radial ray-casting for primary three-dimensional interpretation of CT colonography

    International Nuclear Information System (INIS)

    The purpose of this study was to develop a panoramic endoluminal display technique, the band view, which causes minimal image distortion, and to determine its feasibility as a time-efficient primary three-dimensional review method of CT colonography (CTC). Image distortion was compared between the band view and four other three-dimensional review modes using ten 10-mm and ten 20-mm electronically generated polyps. Diagnostic performance and interpretation time were compared between the band view and the conventional endoluminal view by two independent readers in 52 patients who underwent CTC and colonoscopy on the same day. Mean image distortion index values, in which 1 indicates no distortion and the larger value represents greater distortion, were significantly smaller with the band view (1.03 and 1.01 for 10-mm and 20-mm polyps, respectively) than with the filet view (1.65 and 1.55) or the virtual colon dissection (3.27 and 3.85) (P≤0.004). The sensitivity and specificity for detecting adenomatous polyps ≥6 mm did not differ, but the mean interpretation time was significantly shorter with the band view than with the conventional endoluminal view by 1.8 and 4.5 minutes in readers 1 and 2, respectively (P<0.0001). The band view can be a time-efficient alternative for primary three-dimensional review of CTC. (orig.)

  5. Panoramic endoluminal display with minimal image distortion using circumferential radial ray-casting for primary three-dimensional interpretation of CT colonography

    Energy Technology Data Exchange (ETDEWEB)

    Lee, Seung Soo; Park, Seong Ho; Kim, Namkug; Lee, Jeongjin; Kim, Ah Young; Ha, Hyun Kwon [University of Ulsan College of Medicine, Asan Medical Center, Department of Radiology and Research Institute of Radiology, Seoul (Korea); Kim, Jin Kook [INFINITT Co., Ltd., Seoul (Korea); Park, Beom Jin [Korea University College of Medicine, Department of Radiology, Seoul (Korea); Kim, Young Jun [Konkuk University School of Medicine, Konkuk University Hospital, Department of Radiology, Seoul (Korea); Lee, Min Woo [Konkuk University School of Medicine, Konkuk University Hospital, Department of Radiology, Seoul (Korea); Samsung Medical Center, Sungkyunkwan University School of Medicine, Department of Radiology, Seoul (Korea)

    2009-08-15

    The purpose of this study was to develop a panoramic endoluminal display technique, the band view, which causes minimal image distortion, and to determine its feasibility as a time-efficient primary three-dimensional review method of CT colonography (CTC). Image distortion was compared between the band view and four other three-dimensional review modes using ten 10-mm and ten 20-mm electronically generated polyps. Diagnostic performance and interpretation time were compared between the band view and the conventional endoluminal view by two independent readers in 52 patients who underwent CTC and colonoscopy on the same day. Mean image distortion index values, in which 1 indicates no distortion and the larger value represents greater distortion, were significantly smaller with the band view (1.03 and 1.01 for 10-mm and 20-mm polyps, respectively) than with the filet view (1.65 and 1.55) or the virtual colon dissection (3.27 and 3.85) (P{<=}0.004). The sensitivity and specificity for detecting adenomatous polyps {>=}6 mm did not differ, but the mean interpretation time was significantly shorter with the band view than with the conventional endoluminal view by 1.8 and 4.5 minutes in readers 1 and 2, respectively (P<0.0001). The band view can be a time-efficient alternative for primary three-dimensional review of CTC. (orig.)

  6. Análisis dosimétrico de la técnica de braquiterapia oftálmica de baja tasa de dosis (LDR) con placas epiesclerales de 125I

    OpenAIRE

    Mariño Barreto, John Manuel

    2012-01-01

    La braquiterapia epiescleral constituye junto a la enucleación y otras modalidades terapéuticas, una de las técnicas más utilizadas en el tratamiento curativo del retinoblastoma y melanoma uveal en estadíos tempranos. La dosimetría de radiaciones juega un papel fundamental, puesto que permite conocer la distribución de dosis tanto en el tumor como en las estructuras críticas intraoculares, siendo en estas localizaciones específicas bastante relevante debido a la relativa cercanía existente en...

  7. Análisis dosimétrico de la braquiterapia de alta tasa en pacientes con cáncer de próstata con afectación de vesículas seminales (T3b)

    OpenAIRE

    Soler Catalán, Pablo

    2015-01-01

    La cobertura de las vesículas seminales en el implante de Braquiterapia Alta Tasa como sobreimpresión de dosis (boost), en pacientes de alto riesgo con afectación de vesículas seminales, no es un impedimento para lograr una dosimetría adecuada en el paciente, en comparación con el grupo de pacientes de alto riego sin afectación de vesículas seminales. Se podría plantear por tanto, una escalada de dosis en este grupo de pacientes. Objetivos : Demostrar que los parámetros dosimétricos e...

  8. HDR Opportunities and Challenges Beyond the Long-Term Flow Test

    Energy Technology Data Exchange (ETDEWEB)

    Duchane, David

    1992-03-24

    The long term flow test (LTFT) of the worlds largest, deepest, and hottest hot dry rock (HDR) reservoir currently underway at Fenton Hill, NM, is expected to demonstrate that thermal energy can be mined from hot rock within the earth on a sustainable basis with minimal water consumption. This test will simulate the operations of a commercial facility in some ways, but it will not show that energy from HDR can be produced at a variety of locations with different geological settings. Since the Fenton Hill system was designed as a research facility rather than strictly for production purposes, it will also not demonstrate economic viability, although it may well give indications of system modifications needed for economic HDR operations. A second production site must be constructed, ideally under the direction of the private geothermal community, to begin the process of proving that the vast HDR resources can be accessed on a worldwide scale. This facility should be designed and engineered to produce and market energy at competitive prices. At the same time, a wide variety of techniques to advance the state-of-the-art of HDR technology must be pursued to develop this infant technology rapidly to its maximum potential. A number of design and operational techniques have been conceived which may lead to improved economics in HDR systems. After careful technical and economic scrutiny, those showing merit should be vigorously pursued. Finally, research and development work in areas such as reservoir interrogation, and system modeling must be accelerated to increase the competitiveness and geographical applications of HDR and the geothermal industry in general. This paper addresses the above issues in detail and outlines possible paths to future prosperity for the commercial geothermal industry.

  9. A new CT prostate segmentation for CT-based HDR brachytherapy

    Science.gov (United States)

    Yang, Xiaofeng; Rossi, Peter; Ogunleye, Tomi; Jani, Ashesh B.; Curran, Walter J.; Liu, Tian

    2014-03-01

    High-dose-rate (HDR) brachytherapy has become a popular treatment modality for localized prostate cancer. Prostate HDR treatment involves placing 10 to 20 catheters (needles) into the prostate gland, and then delivering radiation dose to the cancerous regions through these catheters. These catheters are often inserted with transrectal ultrasound (TRUS) guidance and the HDR treatment plan is based on the CT images. The main challenge for CT-based HDR planning is to accurately segment prostate volume in CT images due to the poor soft tissue contrast and additional artifacts introduced by the catheters. To overcome these limitations, we propose a novel approach to segment the prostate in CT images through TRUS-CT deformable registration based on the catheter locations. In this approach, the HDR catheters are reconstructed from the intra-operative TRUS and planning CT images, and then used as landmarks for the TRUS-CT image registration. The prostate contour generated from the TRUS images captured during the ultrasound-guided HDR procedure was used to segment the prostate on the CT images through deformable registration. We conducted two studies. A prostate-phantom study demonstrated a submillimeter accuracy of our method. A pilot study of 5 prostate-cancer patients was conducted to further test its clinical feasibility. All patients had 3 gold markers implanted in the prostate that were used to evaluate the registration accuracy, as well as previous diagnostic MR images that were used as the gold standard to assess the prostate segmentation. For the 5 patients, the mean gold-marker displacement was 1.2 mm; the prostate volume difference between our approach and the MRI was 7.2%, and the Dice volume overlap was over 91%. Our proposed method could improve prostate delineation, enable accurate dose planning and delivery, and potentially enhance prostate HDR treatment outcome.

  10. Helicobacter pylori and urinary system stones: endoluminal damage as sub-hypothesis to support the current stone theory.

    Science.gov (United States)

    Verit, Ayhan; Güner, Numan Dogu

    2014-12-01

    Helicobacter pylori (H. pylori) is a atypical gram-negative bacteria preferring gastric mucosa which also have bizarre multisystem effects extended to some malignancies, hematologic and vascular disorders through some not well defined pathophysiologic pathways. Our pioneer data was pointing that the urinary system stone existence was seemed to be high in the group of H. pylori+cases. While the explanation of the reason of the coincidence of renal-gall bladder stones, it was previously suggested that there may be a shift mechanism of intestinal microbial flora, from Oxalobacter formigenes that may reduce the risk of renal stone by consuming intestinal oxalate, to H. pylori which is known to induce gallstone by unknown mechanism. This hypothesis is an indirect one and highly controversial for the effect of H. pylori in the renal stone formation because intestinal absorption of oxalate is not significant when it is compared with the endogen oxalate. The present preliminary unique data in connection with our hypothesis claimed that a possible relation between H. pylori and renal stones. We think that this detrimental effect is due to the possible systemic influence such as vascular and/or endoluminal sickness due to the H. pylori other than directs bacteriologic colonization. There is strong evidence that H. pylori have some role in the atherosclerotic procedure. The vascular theory of Randall plaque formation at renal papilla and subsequent calcium oxalate stone development that suggests microvascular injury of renal papilla in an atherosclerotic-like fashion results in calcification near vessel walls that eventually erodes as a calculus format into the urinary system. Briefly, theories of stone and atherosclerosis seemed to be overlap and H. pylori is one of the factor of both processes. In addition to our hypothesis, we claimed that H. pylori might have same detrimental effect on endoluminal surfaces of urinary and genital systems and resulting in some special

  11. Requirements tests for QC of microSelectron-HDR

    International Nuclear Information System (INIS)

    The Quality Control (QC) considers checks and measurements with the purpose of reconstruction, maintaining and increasing the quality of medical procedures and equipment. The QC tests for micro Selectron HDR afterloading machine with 192 Ir which allows more precise calculation and realisation of the tumour's dose have been created and introduced regularly in National Oncological Centre, Sofia. This paper has been cover the machine and software performance, source positioning, application equipment and radiation safety. A list of tests, their frequency, tolerance and action levels, as well as the tests' procedures have been worked out. The used methods are based on establishment of QC protocols. The documents have achieved for a certain period of time and they are available at any time. The experience shows drastically reduction of failures during medical treatment, ensuring the reliability of the used equipment and confidence that all the patients have treated adequate. Where some parameter is above the tolerance is it possible to do proper corrections measures immediately. This QA protocols give assurance that specific objectives being successfully met

  12. MAGIC with formaldehyde applied to dosimetry of HDR brachytherapy source

    International Nuclear Information System (INIS)

    The use of polymer gel dosimeters in brachytherapy can allow the determination of three-dimensional dose distributions in large volumes and with high spatial resolution if an adequate calibration process is performed. One of the major issues in these experiments is the polymer gel response dependence on dose rate when high dose rate sources are used and the doses in the vicinity of the sources are to be determinated. In this study, the response of a modified MAGIC polymer gel with formaldehyde around an Iridium-192 HDR brachytherapy source is presented. Experimental results obtained with this polymer gel were compared with ionization chamber measurements and with Monte Carlo simulation with PENELOPE. A maximum difference of 3.10% was found between gel dose measurements and Monte Carlo simulation at a radial distance of 18 mm from the source. The results obtained show that the gel's response is strongly influenced by dose rate and that a different calibration should be used for the vicinity of the source and for regions of lower dose rates. The results obtained in this study show that, provided the proper calibration is performed, MAGIC with formaldehyde can be successfully used to accurate determinate dose distributions form high dose rate brachytherapy sources.

  13. Crowdsourcing-based evaluation of privacy in HDR images

    Science.gov (United States)

    Korshunov, Pavel; Nemoto, Hiromi; Skodras, Athanassios; Ebrahimi, Touradj

    2014-05-01

    The ability of High Dynamic Range imaging (HDRi) to capture details in high-contrast environments, making both dark and bright regions clearly visible, has a strong implication on privacy. However, the extent to which HDRi affects privacy when it is used instead of typical Standard Dynamic Range imaging (SDRi) is not yet clear. In this paper, we investigate the effect of HDRi on privacy via crowdsourcing evaluation using the Microworkers platform. Due to the lack of HDRi standard privacy evaluation dataset, we have created such dataset containing people of varying gender, race, and age, shot indoor and outdoor and under large range of lighting conditions. We evaluate the tone-mapped versions of these images, obtained by several representative tone-mapping algorithms, using subjective privacy evaluation methodology. Evaluation was performed using crowdsourcing-based framework, because it is a popular and effective alternative to traditional lab-based assessment. The results of the experiments demonstrate a significant loss of privacy when even tone-mapped versions of HDR images are used compared to typical SDR images shot with a standard exposure.

  14. BrachyView, a novel in-body imaging system for HDR prostate brachytherapy: Experimental evaluation

    Energy Technology Data Exchange (ETDEWEB)

    Safavi-Naeini, M.; Han, Z.; Alnaghy, S.; Cutajar, D.; Petasecca, M.; Lerch, M. L. F.; Rosenfeld, A. B., E-mail: anatoly@uow.edu.au [Centre for Medical Radiation Physics, University of Wollongong, Wollongong 2522 (Australia); Franklin, D. R. [Faculty of Engineering and Information Technology, University of Technology, Sydney 2007 (Australia); Bucci, J. [St George Hospital Cancer Care Centre, Kogarah 2217 (Australia); Carrara, M. [Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133 (Italy); Zaider, M. [Memorial Sloan Kettering Cancer Center, New York, New York 10065 (United States)

    2015-12-15

    Purpose: This paper presents initial experimental results from a prototype of high dose rate (HDR) BrachyView, a novel in-body source tracking system for HDR brachytherapy based on a multipinhole tungsten collimator and a high resolution pixellated silicon detector array. The probe and its associated position estimation algorithms are validated and a comprehensive evaluation of the accuracy of its position estimation capabilities is presented. Methods: The HDR brachytherapy source is moved through a sequence of positions in a prostate phantom, for various displacements in x, y, and z. For each position, multiple image acquisitions are performed, and source positions are reconstructed. Error estimates in each dimension are calculated at each source position and combined to calculate overall positioning errors. Gafchromic film is used to validate the accuracy of source placement within the phantom. Results: More than 90% of evaluated source positions were estimated with an error of less than one millimeter, with the worst-case error being 1.3 mm. Experimental results were in close agreement with previously published Monte Carlo simulation results. Conclusions: The prototype of HDR BrachyView demonstrates a satisfactory level of accuracy in its source position estimation, and additional improvements are achievable with further refinement of HDR BrachyView’s image processing algorithms.

  15. A Survey on the Acceptance and the Use of HDR Photography Among Croatian Photographers

    Directory of Open Access Journals (Sweden)

    Maja Strgar Kurecic

    2013-04-01

    Full Text Available The emerging field of high dynamic range (HDR imaging is directly linked to diverse existing disciplines such as radiometry, photometry, colorimetry and colour appearance - each dealing with specific aspects of light and its perception by humans. Although the idea is not new, it has not been widely used until just a few years ago when digital cameras gained popularity and the computers processing power increased significantly. Now this photographic technique is widely spread and used, but even more often – misused. A research was conducted by means of a questionnaire in order to get some actual information about how Croatian photographers see the HDR photography and how they employ it. The results of the survey proved that indeed a great interest exists in the technique, but that many photographers are scared away from the HDR photography because of the misconception that the artificial look is an unavoidable side effect of the HDR processing. The fact is, however, that the final HDR image is a result of the tone mapping process and post-corrections and adjustments, entirely dependent on the photographer’s intent and vision, as well as his understanding of various adjustments available. The results of the questionnaire have also pointed out to other widely spread misconceptions which are discussed in this paper.

  16. Palliative endobronchial HDR-brachytherapy in obstructing malignancies: influence on survival and pattern of failure

    International Nuclear Information System (INIS)

    To evaluate the influence of endobronchial HDR-brachytherapy on survival and pattern of failure 117 patients with central obstructing bronchial carcinoma with EBRT and endobronchial brachytherapy were prospectively investigated and retrospectively matched with a group of patients who received EBRT but no HDR-brachytherapy. The matching criteria were Sex, Age, Histology, TNM-status and EBRT dose. 94 pairs of patient could be evaluated. Taken the two groups as a whole, no difference in suvival could be detected in both groups. However, those patients in whom (by endoscopic findings) a complete remission could be achieved by HDR-brachytherapy, had a significant (p< 0,01) longer survival than the matched group. Patients with endobronchial HDR-brachytherapy died significantly more often by final hemorrhage (26 versus 10). However, survival in the combined modality group was significantly longer. 90 % of the patients in both groups who died by final hemorrhage had a squamous cell carcinoma. In conclusion palliative endobronchial HDR-brachytherapy offers not always benefit in survival to patients with a far advanced disease. However those patients who achieve a complete remission have a significant survival benefit, but with a consequence of a higher rate of final hemorrhage

  17. BrachyView, a novel in-body imaging system for HDR prostate brachytherapy: Experimental evaluation

    International Nuclear Information System (INIS)

    Purpose: This paper presents initial experimental results from a prototype of high dose rate (HDR) BrachyView, a novel in-body source tracking system for HDR brachytherapy based on a multipinhole tungsten collimator and a high resolution pixellated silicon detector array. The probe and its associated position estimation algorithms are validated and a comprehensive evaluation of the accuracy of its position estimation capabilities is presented. Methods: The HDR brachytherapy source is moved through a sequence of positions in a prostate phantom, for various displacements in x, y, and z. For each position, multiple image acquisitions are performed, and source positions are reconstructed. Error estimates in each dimension are calculated at each source position and combined to calculate overall positioning errors. Gafchromic film is used to validate the accuracy of source placement within the phantom. Results: More than 90% of evaluated source positions were estimated with an error of less than one millimeter, with the worst-case error being 1.3 mm. Experimental results were in close agreement with previously published Monte Carlo simulation results. Conclusions: The prototype of HDR BrachyView demonstrates a satisfactory level of accuracy in its source position estimation, and additional improvements are achievable with further refinement of HDR BrachyView’s image processing algorithms

  18. Dosimetry of iridium-192 sources used in brachytherapy; Dosimetria de fontes de iridio-192 utilizadas em braquiterapia

    Energy Technology Data Exchange (ETDEWEB)

    Henn, Keli Cristina

    1999-09-01

    The use of high dose rate brachytherapy (HDR) has been increasing in recent years, due to several advantages relative to conventional low dose rate brachytherapy, such as: shorter treatment times, the ability to fractionate treatment (and thus perform many treatments on an outpatient basis) and reduced worker exposures. Most HDR equipment uses small, high activity {sup 192} Ir sources, which are introduced into the patient using a remote system. The dose distribution around these sources is strongly dependent on the size and shape of the active volume and on the encapsulation of the source. The objective of this work is to compare two methods of calibrating sources of {sup 192} Ir, mamely, measurements in air with an ionization thimble chamber or with a well-type ionization chamber. In addition, we measured the anisotropy of the sources and made comparisons with values supplied by the manufacturer, since this factor is taken into account in the planning system algorithm when dose distributions are calculated. The dose was also evaluated at points of clinical interest (i.e. in the rectum and bladder) and compared to values obtained with the Nucletron PLATO-BPS planning system. The use of lead for rectal protection was evaluated in a cylindrical applicator, aiming the further development of a gynecological applicator. The results of the calibration of seven sources showed that the uncertainty in the calibration in a 'jig' system is smaller than 1%, compared to the value supplied by the source manufacturer. The differences between the results obtained with the well-type ionization camera and the 'jig' system were around 2%. The anisotropy showed good agreement with the values supplied by the manufacturer. The results show that the anisotropy factors, in air and water, are approximately constant and equal to 1.0, for angles between 70 deg and 150 deg. For angles smaller than 70 deg the anisotropy factor in water is larger than in air. Results are

  19. Towards real-time 3D ultrasound planning and personalized 3D printing for breast HDR brachytherapy treatment

    International Nuclear Information System (INIS)

    Two different end-to-end procedures were tested for real-time planning in breast HDR brachytherapy treatment. Both methods are using a 3D ultrasound (3DUS) system and a freehand catheter optimization algorithm. They were found fast and efficient. We demonstrated a proof-of-concept approach for personalized real-time guidance and planning to breast HDR brachytherapy treatments

  20. IPIP: A New Approach to Inverse Planning for HDR Brachytherapy by Directly Optimizing Dosimetric Indices

    CERN Document Server

    Siauw, Timmy; Atamturk, Alper; Hsu, I-Chow; Pouliot, Jean; Goldberg, Ken

    2010-01-01

    Purpose: Many planning methods for high dose rate (HDR) brachytherapy treatment planning require an iterative approach. A set of computational parameters are hypothesized that will give a dose plan that meets dosimetric criteria. A dose plan is computed using these parameters, and if any dosimetric criteria are not met, the process is iterated until a suitable dose plan is found. In this way, the dose distribution is controlled by abstract parameters. The purpose of this study is to improve HDR brachytherapy planning by developing a new approach that directly optimizes the dose distribution based on dosimetric criteria. Method: We develop Inverse Planning by Integer Program (IPIP), an optimization model for computing HDR brachytherapy dose plans and a fast heuristic for it. We used our heuristic to compute dose plans for 20 anonymized prostate cancer patient image data sets from our clinic database. Dosimetry was evaluated and compared to dosimetric criteria. Results: Dose plans computed from IPIP satis?ed al...

  1. Physical, technical and dosimetric aspects of high dose rate (HDR) interstitial implants for carcinoma breast

    International Nuclear Information System (INIS)

    Brachytherapy using iridium-192 HDR remote afterloading system is a fast developing modality being witnessed in modern radiation therapy. The dose distribution of HDR interstitial implants are controlled by a single high activity iridium-192 stepping source by changing the dwell times. The purpose of this paper is to bring out the important physical, technical and dosimetric aspects of high dose rate (HDR) interstitial implants for carcinoma breast. A dosimetric comparison of the Stepping Source Dosimetry System (SSDS) and Paris system of implants revealed that the SSDS offers more uniform dose than the Paris system of implants traditionally used for low dose rate brachytherapy applications. Also, SSDS demands less number of catheters compared to Paris system for a given target volume. The analysis of natural Dose Volume Histograms (nDVH) eliminates the error in the dose delivery by correcting the dose prescription and normalisation. (author)

  2. Quality assurance of HDR prostate plans: Program implementation at a community hospital

    International Nuclear Information System (INIS)

    Adenocarcinoma of the prostate is currently the most commonly diagnosed cancer in men in the United States, and the second leading cause of cancer mortality. The utilization of radiation therapy is regarded as the definitive local therapy of choice for intermediate- and high-risk disease, in which there is increased risk for extracapsular extension, seminal vesicle invasion, or regional node involvement. High-dose-rate (HDR) brachytherapy is a logical treatment modality to deliver the boost dose to an external beam radiation therapy (EBRT) treatment to increase local control rates. From a treatment perspective, the utilization of a complicated treatment delivery system, the compressed time frame in which the procedure is performed, and the small number of large dose fractions make the implementation of a comprehensive quality assurance (QA) program imperative. One aspect of this program is the QA of the HDR treatment plan. Review of regulatory and medical physics professional publications shows that substantial general guidance is available. We provide some insight to the implementation of an HDR prostate plan program at a community hospital. One aspect addressed is the utilization of the low-dose-rate (LDR) planning system and the use of existing ultrasound image sets to familiarize the radiation therapy team with respect to acceptable HDR implant geometries. Additionally, the use of the LDR treatment planning system provided a means to prospectively determine the relationship between the treated isodose volume and the product of activity and time for the department's planning protocol prior to the first HDR implant. For the first 12 HDR prostate implants, the root-mean-square (RMS) deviation was 3.05% between the predicted product of activity and time vs. the actual plan values. Retrospective re-evaluation of the actual implant data reduced the RMS deviation to 2.36%

  3. Acceptance testing and commissioning of a new model HDR afterloader

    International Nuclear Information System (INIS)

    We have recently performed acceptance testing procedures and have commissioned a new model HDR afterloader, the Varian VariSource with ''Intelligent Drive.'' Our site was one of the first installations worldwide. It is our intent to describe our tests and the results of the tests particularly as they may differ from other afterloaders. The Ir-192 source is unique among afterloaders marketed in the US in that it is very slender (OD of source wire is 0.59 mm) and relatively long (two 0.5 cm sources for a total active length of 1.0 cm). A check of source homogeneity by autoradiograph as urged by the US Nuclear Regulatory Commission demonstrates no detectable source inhomogeneity. Reentrant well ionization chambers are calibrated in the US with a 3.5 mm long source at Accredited Dosimetry Calibration Laboratories. Therefore calibration needs to be considered with some care. Calibration of the first delivered source with a well ionization chamber indicated agreement with the manufacturer's stated activity to within 0.5%. Source positioning is checked with a device called a 'cam scale'. Tests have been carried out on this system and it has been found to accurately indicate source position to within ±0.5 mm. Timer accuracy has been found to be better than 0.1% for dwell times of several hundred seconds. The intelligent drive system and the small source diameter allow the source wire to negotiate paths with small radius of curvature. A series of tests have been made in which the source is forced to negotiate 'U' turns of decreasing radius of curvature. A 4.7 F, 100 cm long catheter was used for these tests and the 'U' turn was positioned at approximately 90 cm. Under these conditions, the VariSource was consistently able to traverse a 1.25 cm radius of curvature, which is better than the manufacturer's stated limit of 1.5 cm

  4. Gel dosimetry for HDR Brachytherapy 3-D distribution through MRI

    International Nuclear Information System (INIS)

    Gel dosimetry using MRI is increasingly being utilized in contemporary literature. In our work we investigated the calibration of an acrylic gel by means of imaging with magnetic resonance and its application to the dose measurement in a 3D distribution 192Ir HDR brachytherapy treatment. Early gel dosimetry used Fricke gels and T1 relaxation time. In 2001 Fong et al. introduced a new normoxic gel known as ''MAGIC'' gel, the main components of which are Metacrylic Acid (polymer) and Hydroquinone ( polymerizing inhibitor). For this material, the evidence of radiation dose is indicated by a change in the T2 relaxation time on an MR image. Later studies varied concentrations of the MAGIC gel components in order to observe its effect and the behavior of the gel sensitivity, for magnetic fields over 0.5 T. In the 1980s a series of studies on dose quantification using magnetic resonance images and Fricke gels were performed by evaluating T1 signal through means of an Inversion Recovery technique. Polymer gels have been developed to avoid the adverse effects of oxygen that plague Fricke gels. Normoxic gels have a component which helps to capture the oxygen dissolved in the gel (MAGIC). For these type of gels, measurements of T2 are made using a Spin-Echo technique. For both groups of gels, the Relaxativity compared to either T1 or T2 varies linearly with the absorbed dose. Novotny et al. has obtained a dose response curve for BANG-2 gel showing a linear relationship of 1/T2 vs D[Gy]. In the work presented here we tested and found the same linear relation between spin-spin relaxation (R2=1/T2) versus dose up to 8.0Gy

  5. SU-D-19A-07: Dosimetric Comparison of HDR Plesiotherapy and Electron Beam Therapy for Superficial Lesions

    Energy Technology Data Exchange (ETDEWEB)

    Mitchell, A; Jacob, D; Andreou, K; Raben, A; Chen, H; Koprowski, C; Mourtada, F [Christiana Care Hospital, Newark, DE (United States)

    2014-06-01

    Purpose: Large superficial (skin, soft tissue sarcoma) lesions located on curved areas are hard to treat with electrons. The Freiburg Flap (Nucletron, Netherlands) is a flexible mesh style surface which can be easily shaped to fit curved surfaces for reproducible HDR fraction delivery. To understand the fundamental dosimetric differences, a dosimetric comparison was made between HDR plesiotherapy (Freiburg applicator for lesions over 4cm) and external electron beam radiotherapy over cases with varying target curvature (both stylized and clinical cases). Methods: Four stylized cases with variable complexity were created using artificial DICOM axial CT slices and RT structures (a square and three curved structures on a 4.5cm radius cylinder). They were planned using Oncentra v4.3 and exported to Pinnacle v9.6 for electrons planning. The HDR source dwell positions were optimized for the best coverage of the targets using graphical optimization. Electron treatment plans were created in Pinnacle using the same CT and RT structures of three HDR cases with surface lesions previously treated with the Freiburg flap. The En face electron plans used 6-12 MeV electrons and 0.5–1 cm bolus was added to increase surface dose. The electron plans were prescribed to an isodose line to conform to the target. Results: For all lesions, the average target dose coverage was similar (D90ave of 100% for HDR vs 101% for electrons). For lesions with high curvature, the HDR coverage was better (D90 102% vs D90 97% for electron). For all cases, adjacent structures high dose region was lower for HDR than electrons (D1cc 100% for HDR vs D1cc 111% for electrons). Conclusion: HDR plesiotherapy offers excellent target conformity for superficial targets similar to electrons. However, for lesions with complex curved surfaces, HDR has the advantage to achieve better dose distributions using graphical optimization to spare adjacent normal tissue while maximizing target coverage.

  6. A Prospective Cohort Study to Compare Treatment Results Between 2 Fractionation Schedules of High-Dose-Rate Intracavitary Brachytherapy (HDR-ICBT) in Patients With Cervical Cancer

    Energy Technology Data Exchange (ETDEWEB)

    Huang, Eng-Yen [Department of Radiation Oncology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan (China); School of Traditional Chinese Medicine, Chang Gung University College of Medicine, Taiwan (China); Sun, Li-Min [Department of Radiation Oncology, Zuoying Armed Forces General Hospital, Kaohsiung, Taiwan (China); Lin, Hao [Department of Gynecologic Oncology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan (China); Lan, Jen-Hong [Department of Radiation Oncology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan (China); Chanchien, Chan-Chao [Department of Gynecologic Oncology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan (China); Huang, Yu-Jie; Wang, Chang-Yu [Department of Radiation Oncology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan (China); Wang, Chong-Jong, E-mail: cjw1010@adm.cgmh.org.tw [Department of Radiation Oncology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan (China)

    2013-01-01

    Purpose: To compare the treatment results of 2 fractionation schedules for high-dose-rate intracavitary brachytherapy (HDR-ICBT) in patients with cervical cancer. Methods and Materials: From June 2001 through January 2008, 267 patients with stage IB-IVA cervical cancer were enrolled in the study. All patients underwent 4-field pelvic irradiation and HDR-ICBT. The median central and parametrial doses were 39.6 Gy and 45 Gy, respectively. Patient underwent either 6 Gy Multiplication-Sign 4 (HDR-4) (n=144) or 4.5 Gy Multiplication-Sign 6 (HDR-6) (n=123) to point A of ICBT using {sup 192}Ir isotope twice weekly. The rates of overall survival, locoregional failure, distant metastasis, proctitis, cystitis, and enterocolitis were compared between HDR-4 and HDR-6. Results: There were no significant differences in the demographic data between HDR-4 and HDR-6 except for total treatment time. The 5-year proctitis rates were 23.0% and 21.5% in HDR-4 and HDR-6 (P=.399), respectively. The corresponding rates of grade 2-4 proctitis were 18.7% and 9.6% (P=.060). The corresponding rates of grades 3-4 proctitis were 5.2% and 1.3% (P=.231). Subgroup analysis revealed that HDR-4 significantly increased grade 2-4 proctitis in patients aged {>=}62 years old (P=.012) but not in patients aged <62 years (P=.976). The rates of overall survival, locoregional failure, distant metastasis, cystitis, and enterocolitis were not significantly different between HDR-4 and HDR-6 schedules. Conclusion: The small fraction size of HDR-ICBT is associated with grade 2 proctitis without compromise of prognosis in elderly patients. This schedule is suggested for patients who tolerate an additional 2 applications of HDR-ICBT.

  7. Earthquake experiments at the HDR (Heissdampf Reaktor) test facility using an eccentric mass vibrator

    International Nuclear Information System (INIS)

    As part of he earthquake investigations carried out by the Karlsruhe Nuclear Research Center, Project HDR, at the HDR Test Facility near Frankfurt/Main, high level shaker test were performed during June/July 1986. The purpose of these tests, supported by the German and U.S. governments was to investigate full scale structural response involving significant concrete and soil strain as well as strong indirect excitation of vessels, pipes and other mechanical equipment. The calculational efforts included predictions of the building and piping response stress analyses. Within these test series, the reactor building was brought to its ultimate loading capacity. (author)

  8. Trans-Pacific HDR Satellite Communications Experiment Phase-2 Project Plan and Experimental Network

    Science.gov (United States)

    Hsu, Eddie; Kadowaki, Naoto; Yoshimura, Naoko; Takahashi, Takashi; Yoshikawa, Makoto; Bergman, Larry; Bhasin, Kul

    2000-01-01

    The trans-Pacific high data rate (TP-HDR) satellite communications experiment was proposed at the Japan-U.S. Cooperation in Space (JUCS) Program Workshop held in Hawaii in 1993 and remote high definition video post-production was demonstrated as the first phase trial. ATM-based 45 Mbps trans-Pacific link was established in the first phase, and the following experiments with 155 Mbps was planned as the phase 2. This paper describes the experimental network configuration and project plan of TP-HDR experiment phase 2. Additional information is provided in the original.

  9. Augmentation of Enhanced HDR Utilizing Encoder to Estimate Yaw-angle of Cleaning Robots

    Directory of Open Access Journals (Sweden)

    Yoon Hee Cho

    2016-03-01

    Full Text Available This paper proposes an improved algorithm for augmenting the enhanced HDR by utilizing encoder readings to achieve further minimized drift on the yaw-angle estimation of cleaning robots. The primary idea of the proposed approach consists of two phases: 1 classifying the manoeuvre (stop, straight and curving being carried out using logic as a function of encoder readings; 2 controlling the Attenuator gain, resetting the Binary I-controller and switching Integrator in the enhanced HDR structure, taking into account the identified manoeuvring conditions. The proposed algorithm is applied to a cleaning robot and the experimental data demonstrate the effectiveness of this approach.

  10. Endovascular aneurysm treatment: Radiological and macropathological findings of the endoluminal surface of modular stent grafts; Endovaskulaere Aneurysmatherapie: Radiologisch-makropathologische Befundkorrelation der endoluminalen Oberflaeche einer modularen Stentprothese

    Energy Technology Data Exchange (ETDEWEB)

    Pitton, M.B.; Hillebrand, J.; Schmenger, P.; Thelen, M. [Klinikum Mannheim (Germany). Klinik fuer Radiologie; Dueber, C. [Inst. fuer Radiologie, Klinikum Mannheim (Germany); Neufang, A. [Klinik fuer Herz-, Thorax- und Gefaesschirurgie, Mainz (Germany); Konerding, M.A. [Inst. fuer Anatomie, Johannes Gutenberg Univ., Mainz (Germany); Krummenauer, F. [Inst. fuer medizinische Statistik und Dokumentation, Johannes Gutenberg Univ., Mainz (Germany)

    2002-05-01

    Purpose: Characterization of the endoluminal surface of a modular stent graft and correlation of macropathological findings with results of radiological methods. Methods: Aneurysms of the infrarenal aorta were created in 36 mongrel FBI dogs using autologous material. Endovascular treatment was performed with modular stent grafts using two polyester-covered nitinol stents connected with overlap within the aneurysm. Follow-up was 1 and 6 weeks, and 6 months for 12 animals, respectively. Results were documented using sonography, intravascular ultrasound (IVUS), spiral CT, MRI, and digital subtraction angiography (DSA). After fixation, the aorta was prepared and incised lengthwise. Before histopathological work-up, the different segments were macropathologically characterized and correlated with the respective findings of the radiological methods. Results: 4 cases showed high grade stenosis within the stent grafts and graft occlusion occurred in two cases. The connection sites of these modular stent grafts showed steps and partial separation of the graft components was causative in 5 of these cases. Migration of graft components occurred in three cases, one of them with complete disconnection of the modular device. Irregulartities and deposits on the endoluminal surface were systematically underestimated with all radiological techniques used. IVUS showed moderate concordance concerning deployment and unfolding of the stent graft, however, irregularities of the endoluminal surface were systematically underestimated. Concordance of MRI, sonography, and CT was worse. Contrast-enhanced T{sub 1}-w MRI detected endoluminal deposits with moderate concordance. However, the thickness of deposits was underestimated. DSA, IVUS, and CT showed only poor concordance with macropathological findings. Conclusions: The connection site of modular stent grafts predisposes to stenosis, occlusion, and disconnection of the modular device. Stent deployment and unfolding of the membrane might

  11. External radiation and HDR-brachytherapy in the treatment of breast cancer. Externe Bestrahlung und interstitielle HDR-Brachytherapie in der Bestrahlung des Mammakarzinoms

    Energy Technology Data Exchange (ETDEWEB)

    Track, C. (Abt. fuer Radioonkologie, Krankenhaus der Barmherzigen Schwestern, Linz (Austria)); Seewald, D.H. (Abt. fuer Radioonkologie, Krankenhaus der Barmherzigen Schwestern, Linz (Austria)); Zoidl, J.P. (Abt. fuer Radioonkologie, Krankenhaus der Barmherzigen Schwestern, Linz (Austria)); Hammer, J. (Abt. fuer Radioonkologie, Krankenhaus der Barmherzigen Schwestern, Linz (Austria))

    1994-04-01

    In the breast conserving management of mammary cancer a high-dose-rate (HDR)-Iridium-192 source is used for interstitial boosting of the primary tumor site after external radiotherapy. We want to show the clinical results and side effects and to demonstrate the safe use of a HDR source. From December 1984 until November 1988, 154 patients with breast cancer stage T1-2, N0-1 were treated by conservative surgery and radiation. A dose of 45 to 50 Gy was given to the whole breast by external radiotherapy, and the previous tumor area was boosted by an interstitial implant with Iridium-192 HDR. We applied 10 Gy in one or two fractions. The mean follow-up period of survivors is 76 months (range 57 to 107 months). In 36 patients failures occured: eight patients (5%) developed local recurrences, 31 patients (20%) had distant metastases, and 19 (12%) died with cancer. The Kaplan-Meier estimation for five year overall survival is 86.9%, for disease-specific survival 89.3%, for local control 95.8%, and for disease free survival 80.1%. The most frequent late effects were telangiectasia (11%), fibrotic masses in the previous tumor area (6.5%), and lymphedema of the arm (6.5%). No serious complications could be observed. (orig./MG)

  12. Braquiterapia endobrônquica de alta taxa de dose: estudo dosimétrico High dose-rate endobronchial brachytherapy: a dosimetric study

    Directory of Open Access Journals (Sweden)

    Regina Maria Godoy Lopes

    2010-02-01

    Full Text Available OBJETIVO: Avaliar a distribuição de dose em diferentes situações de braquiterapia endobrônquica de alta taxa de dose, com foco principalmente nos volumes de altas doses, e tentar definir situações de melhor ou pior distribuição de dose que possam servir de guia na prática clínica. MATERIAIS E MÉTODOS: Estudo teórico, simulando braquiterapia endobrônquica de alta taxa de dose utilizando dois cateteres, com variação da extensão de carregamento, angulação entre os cateteres, profundidade de cálculo e o intervalo entre as paradas da fonte. Com prescrição de 7,5 Gy, foram calculados os volumes englobados pelas isodoses correspondentes a 100%, 150% e 200% da dose prescrita (V100, V150 e V200, respectivamente e as razões V150/V100 e V200/V100. RESULTADOS: Os volumes aumentaram com o aumento da extensão de carregamento dos cateteres, profundidade de cálculo e angulação, com tendência a um aumento proporcionalmente menor para angulações maiores. As relações V150/V100 e V200/V100 foram, em geral, homogêneas, ao redor de 0,50 e 0,30, respectivamente. CONCLUSÃO: A distribuição de dose na situação considerada padrão é em geral adequada. Nenhum parâmetro específico que pudesse ser relacionado à maior toxicidade foi identificado. Recomendamos uma avaliação rápida da qualidade do implante por meio da análise das relações V150/V100 e V200/V100.OBJECTIVE: To evaluate the dose distribution in different situations of high dose-rate endobronchial brachytherapy, focusing especially on high-dose volumes, and try to identify better or worse situations in terms of dose distribution to aid as guidance in the clinical practice. MATERIALS AND METHODS: Theoretical study simulating high dose-rate endobronchial brachytherapy utilizing two catheters, varying the loading extent, angle between the catheters, prescription depth, and source step. With a prescription dose of 7.5 Gy, the volumes involved by the 100%, 150% and 200

  13. Dosimetria comparativa de braquiterapia de próstata com sementes de I-125 e Pd-103 via SISCODES/MCNP

    Directory of Open Access Journals (Sweden)

    Bruno Machado Trindade

    2012-10-01

    Full Text Available OBJETIVO: O presente artigo visa apresentar um estudo dosimétrico comparativo de braquiterapia de próstata com sementes de I-125 e Pd-103. MATERIAIS E MÉTODOS: Um protocolo adotado para ambos os implantes com 148 sementes foi simulado em um fantoma tridimensional heterogêneo de pelve por meio dos códigos SISCODES/MCNP5. Histogramas dose-volume na próstata, bexiga e reto, índices de doses D10, D30, D90, D0,5cc, D2cc e D7cc, e representações de distribuição espacial de dose foram avaliados. RESULTADOS: A atividade inicial de cada semente de I-125, para que D90 seja equivalente à dose de prescrição, foi calculada em 0,42 mCi, e de Pd-103, em 0,94 mCi. A dose máxima na uretra foi 90% e 108% da dose de prescrição para I-125 e Pd-103, respectivamente. A D2cc para I-125 foi 30 Gy no reto e 127 Gy na bexiga, e para Pd-103 foi 29 Gy no reto e 189 Gy na bexiga. A D10 no osso do púbis foi 144 Gy para I-125 e 66 Gy para Pd-103. CONCLUSÃO: Os resultados indicam que os implantes de Pd-103 e I-125 puderam depositar a dose prescrita no volume alvo. Entre os achados, observou-se excessiva exposição de radiação nos ossos da pelve, principalmente no protocolo com I-125.

  14. A gEUD-based inverse planning technique for HDR prostate brachytherapy: Feasibility study

    International Nuclear Information System (INIS)

    Purpose: The purpose of this work was to study the feasibility of a new inverse planning technique based on the generalized equivalent uniform dose for image-guided high dose rate (HDR) prostate cancer brachytherapy in comparison to conventional dose-volume based optimization. Methods: The quality of 12 clinical HDR brachytherapy implants for prostate utilizing HIPO (Hybrid Inverse Planning Optimization) is compared with alternative plans, which were produced through inverse planning using the generalized equivalent uniform dose (gEUD). All the common dose-volume indices for the prostate and the organs at risk were considered together with radiobiological measures. The clinical effectiveness of the different dose distributions was investigated by comparing dose volume histogram and gEUD evaluators. Results: Our results demonstrate the feasibility of gEUD-based inverse planning in HDR brachytherapy implants for prostate. A statistically significant decrease in D10 or/and final gEUD values for the organs at risk (urethra, bladder, and rectum) was found while improving dose homogeneity or dose conformity of the target volume. Conclusions: Following the promising results of gEUD-based optimization in intensity modulated radiation therapy treatment optimization, as reported in the literature, the implementation of a similar model in HDR brachytherapy treatment plan optimization is suggested by this study. The potential of improved sparing of organs at risk was shown for various gEUD-based optimization parameter protocols, which indicates the ability of this method to adapt to the user's preferences.

  15. Comparing subjective and objective quality assessment of HDR images compressed with JPEG-XT

    DEFF Research Database (Denmark)

    Mantel, Claire; Ferchiu, Stefan Catalin; Forchhammer, Søren

    2014-01-01

    In this paper a subjective test in which participants evaluate the quality of JPEG-XT compressed HDR images is presented. Results show that for the selected test images and display, the subjective quality reached its saturation point starting around 3bpp. Objective evaluations are obtained by...

  16. Speedup of optimization-based approach to local backlight dimming of HDR displays

    DEFF Research Database (Denmark)

    Burini, Nino; Nadernejad, Ehsan; Korhonen, Jari;

    2012-01-01

    Local backlight dimming in Liquid Crystal Displays (LCD) is a technique for reducing power consumption and simultaneously increasing contrast ratio to provide a High Dynamic Range (HDR) image reproduction. Several backlight dimming algorithms exist with focus on reducing power consumption, while ...

  17. Calibration of well-type chambers in Brazil using 192Ir HDR sources

    International Nuclear Information System (INIS)

    The results obtained by performing of a traceable calibration service for well-type reentrant ionization chamber for HDR 192Ir sources used in brachytherapy physical procedures at the Laboratorio de Ciencias Radiologicas from Universidade do Estado do Rio de Janeiro -LCR/UERJ are described. (author)

  18. Determination of the dose of traffic in HDR brachytherapy with ALANINE/R PE technique

    International Nuclear Information System (INIS)

    It determines, experimentally, the dose of traffic in brachytherapy for High Dose Rate (HDR), using for the first-time the Electronic Paramagnetic Resonance (EPR) technique with alanine detectors. The value obtained is the published next to obtained using lithium fluoride thermoluminescent dosimeters

  19. SU-E-T-574: Fessiblity of Using the Calypso System for HDR Interstitial Catheter Reconstruction

    Energy Technology Data Exchange (ETDEWEB)

    Li, J S; Ma, C [Fox Chase Cancer Center, Philadelphia, PA (United States)

    2014-06-01

    Purpose: It is always a challenge to reconstruct the interstitial catheter for high dose rate (HDR) brachytherapy on patient CT or MR images. This work aims to investigate the feasibility of using the Calypso system (Varian Medical, CA) for HDR catheter reconstruction utilizing its accuracy on tracking the electromagnetic transponder location. Methods: Experiment was done with a phantom that has a HDR interstitial catheter embedded inside. CT scan with a slice thickness of 1.25 mm was taken for this phantom with two Calypso beacon transponders in the catheter. The two transponders were connected with a wire. The Calypso system was used to record the beacon transponders’ location in real time when they were gently pulled out with the wire. The initial locations of the beacon transponders were used for registration with the CT image and the detected transponder locations were used for the catheter path reconstruction. The reconstructed catheter path was validated on the CT image. Results: The HDR interstitial catheter was successfully reconstructed based on the transponders’ coordinates recorded by the Calypso system in real time when the transponders were pulled in the catheter. After registration with the CT image, the shape and location of the reconstructed catheter are evaluated against the CT image and the result shows an accuracy of 2 mm anywhere in the Calypso detectable region which is within a 10 cm X 10 cm X 10 cm cubic box for the current system. Conclusion: It is feasible to use the Calypso system for HDR interstitial catheter reconstruction. The obstacle for its clinical usage is the size of the beacon transponder whose diameter is bigger than most of the interstitial catheters used in clinic. Developing smaller transponders and supporting software and hardware for this application is necessary before it can be adopted for clinical use.

  20. SU-E-T-574: Fessiblity of Using the Calypso System for HDR Interstitial Catheter Reconstruction

    International Nuclear Information System (INIS)

    Purpose: It is always a challenge to reconstruct the interstitial catheter for high dose rate (HDR) brachytherapy on patient CT or MR images. This work aims to investigate the feasibility of using the Calypso system (Varian Medical, CA) for HDR catheter reconstruction utilizing its accuracy on tracking the electromagnetic transponder location. Methods: Experiment was done with a phantom that has a HDR interstitial catheter embedded inside. CT scan with a slice thickness of 1.25 mm was taken for this phantom with two Calypso beacon transponders in the catheter. The two transponders were connected with a wire. The Calypso system was used to record the beacon transponders’ location in real time when they were gently pulled out with the wire. The initial locations of the beacon transponders were used for registration with the CT image and the detected transponder locations were used for the catheter path reconstruction. The reconstructed catheter path was validated on the CT image. Results: The HDR interstitial catheter was successfully reconstructed based on the transponders’ coordinates recorded by the Calypso system in real time when the transponders were pulled in the catheter. After registration with the CT image, the shape and location of the reconstructed catheter are evaluated against the CT image and the result shows an accuracy of 2 mm anywhere in the Calypso detectable region which is within a 10 cm X 10 cm X 10 cm cubic box for the current system. Conclusion: It is feasible to use the Calypso system for HDR interstitial catheter reconstruction. The obstacle for its clinical usage is the size of the beacon transponder whose diameter is bigger than most of the interstitial catheters used in clinic. Developing smaller transponders and supporting software and hardware for this application is necessary before it can be adopted for clinical use

  1. A New Occlusion Device: Application of the ArtVentive Endoluminal Occlusion System (EOS)—First in Human Clinical Trial

    International Nuclear Information System (INIS)

    PurposeThe purpose of this study was to determine the safety and efficacy of a new endoluminal occlusion device, ArtVentive endoluminal occlusion system (EOS), to occlude the spermatic vein in symptomatic males with varicoceles.MethodsThe ArtVentive EOS device has been developed for percutaneous, peripheral occlusion of the peripheral arterial and venous vasculature. The system is comprised of an implantable occlusion device and a delivery catheter. At present, there are two device sizes: (a) size 1 for target vessels ranging between 3.5 and 5.5 mm in diameter, and (b) size 2 for target vessels 5.5–8.5 mm in diameter. The treatment group included six adult males, ages 22–34 years. Nine target vessels were occluded. A total of 20 devices were implanted in six subjects.ResultsThe acute occlusion rate at the end of the procedure was 100 % occurring in nine of nine vessels. The spermatic veins of all patients remained occluded on venography at 30 days follow-up. Pain scores related to varicoceles decreased in five of six patients.ConclusionsAlthough we recognize this study is limited, initial experience indicates that the ArtVentive EOS is a safe and effective new device for occlusion of vessels (varicoceles). The device has potential applications in other clinical conditions requiring occlusion of veins or arteries

  2. A New Occlusion Device: Application of the ArtVentive Endoluminal Occlusion System (EOS)—First in Human Clinical Trial

    Energy Technology Data Exchange (ETDEWEB)

    Venbrux, Anthony C., E-mail: avenbrux@mfa.gwu.edu [The George Washington University Medical Center, Division of Vascular and Interventional Radiology (United States); Rudakov, Leon, E-mail: leonrudakov@artventivemedical.com [Artventive Medical Group, Inc. (United States); Plass, Andre, E-mail: andre.plass@usz.ch; Emmert, Maximilian Y., E-mail: maximilian.emmert@usz.ch [University Hospital Zurich, Clinic for Cardiac and Vascular Surgery (Switzerland); Ebner, Adrian, E-mail: adrianebner@fundacor.com.py [Sanatorio Privado Santa Clara, Cath Lab Department (Paraguay)

    2013-05-24

    PurposeThe purpose of this study was to determine the safety and efficacy of a new endoluminal occlusion device, ArtVentive endoluminal occlusion system (EOS), to occlude the spermatic vein in symptomatic males with varicoceles.MethodsThe ArtVentive EOS device has been developed for percutaneous, peripheral occlusion of the peripheral arterial and venous vasculature. The system is comprised of an implantable occlusion device and a delivery catheter. At present, there are two device sizes: (a) size 1 for target vessels ranging between 3.5 and 5.5 mm in diameter, and (b) size 2 for target vessels 5.5–8.5 mm in diameter. The treatment group included six adult males, ages 22–34 years. Nine target vessels were occluded. A total of 20 devices were implanted in six subjects.ResultsThe acute occlusion rate at the end of the procedure was 100 % occurring in nine of nine vessels. The spermatic veins of all patients remained occluded on venography at 30 days follow-up. Pain scores related to varicoceles decreased in five of six patients.ConclusionsAlthough we recognize this study is limited, initial experience indicates that the ArtVentive EOS is a safe and effective new device for occlusion of vessels (varicoceles). The device has potential applications in other clinical conditions requiring occlusion of veins or arteries.

  3. A high spatial and temporal resolutions quality assurance tool for checking the accuracy of HDR source dwell positions and times

    OpenAIRE

    Shum, Tsz-hang; 岑梓恆

    2013-01-01

    In High Dose Rate (HDR) brachytherapy, treatment dose to patients is highly dependent on the accuracy of positioning and duration of the source. Source misplacement or wrong duration of treatment could potentially result in adverse clinical side effects to patients. In order to maintain successful treatment for patients, an independent Quality Assurance (QA) verification is crucial to measure the High Dose Rate (HDR) source positioning and dwell time periodically to ensure the prescribed dose...

  4. An Uncommon Presentation of HDR Syndrome: Distal Renal Tubular Acidosis in a Patient with Sjögren's Syndrome

    Directory of Open Access Journals (Sweden)

    Ebru Sevinç OK

    2015-12-01

    Full Text Available HDR syndrome is an autosomal dominant disorder characterized by hypoparathyroidism, sensorineural deafness and renal dysplasia. Haploinsufficiency of GATA3 on chromosome 10p15 is implicated in the pathogenesis of the syndrome. It may manifest itself with clinical features other than the classical triad. Here we report a case of HDR syndrome with concomitant Sjögren’s syndrome in a 33-year-old who female presented with distal renal tubular acidosis (dRTA.

  5. Dosimetry experience of 192IR sources used In HDR brachytherapy for cervical cancer

    International Nuclear Information System (INIS)

    Purpose/Objective: The 192IR Sources are the most commonly used in radiotherapy treatments HDR worldwide. According to international recommendations on quality assurance in HDR brachytherapy, an acceptance test based on the determination of the source strength of any new source shall be carried out before first application to verify the manufacturer’s calibration data. The present paper gives the experimental determination of the source strength for our brachytherapy sources used until now in brachytherapy treatments. Materials/Methods: At Mother Teresa University Hospital we have a cost-effective gynecological brachytherapy unit from Eckert & Ziegler BEBIG named GyneSource® that is a five channel HDR after loader equipped with an 192IR source. The software used is HDR plus™ 2.5 that delivers an optimized treatment plan and makes the process especially fast and we use intracavitary BEBIG applicators. From April 2009 up to December 2012, we have imported nine HDR 192IR Sources. The exchange of the source and acceptance test is done by the physicist of the clinic once the source is imported. The measurements are done with a Well-type ionization chamber HDR1000 Plus and the electrometer used is MAX4000. Only seven sources are compared as we miss the dosimetry data of the first source, and the forth source was not measured and not used because the machine was not working in that time. Results/Conclusions: Eight sources were accepted for clinically use as the measurement were within the tolerance. The source number four with e deviation of -1.92% has been double checked compared with a free in-air measurement with farmer type chamber that gave a deviation to source certificate of 4% that is still inside the tolerance to accept a source for clinical use. The deviations of measured Air Kerma rate to the value of the sources certificates of all our used 192IR sources are less than 2%, which are within the tolerance. The checked value of updated source strength in

  6. Dosimetric equivalence of non-standard high dose rate (HDR) brachytherapy catheter patterns

    CERN Document Server

    Cunha, J Adam M; Pouliot, Jean

    2009-01-01

    Purpose: To determine whether alternative HDR prostate brachytherapy catheter patterns can result in improved dose distributions while providing better access and reducing trauma. Methods: Prostate HDR brachytherapy uses a grid of parallel needle positions to guide the catheter insertion. This geometry does not easily allow the physician to avoid piercing the critical structures near the penile bulb nor does it provide position flexibility in the case of pubic arch interference. On CT data from ten previously-treated patients new catheters were digitized following three catheter patterns: conical, bi-conical, and fireworks. The conical patterns were used to accommodate a robotic delivery using a single entry point. The bi-conical and fireworks patterns were specifically designed to avoid the critical structures near the penile bulb. For each catheter distribution, a plan was optimized with the inverse planning algorithm, IPSA, and compared with the plan used for treatment. Irrelevant of catheter geometry, a p...

  7. Quality control for cervical cancer treatments on Hdr brachytherapy with Ir-192

    International Nuclear Information System (INIS)

    This work, developed at the National Cancer Institute in partnership with Universidad Nacional de Colombia located in Bogota, Colombia, presents the results of simulations of cervical cancer treatments, on Hdr brachytherapy with Ir-192, using as a physical simulator a natural female pelvis bone with soft tissue elaborated with the experimental material JJT. The doses were measured experimentally, prior to dosimetric characterization, with crystal thermoluminescence 100 LiF: Mg, Ti, located in the organs at risk: rectum and bladder. On the other hand, these treatments were planned and calculated theoretically by the system Micro-Selectron Hdr, with Plato brachytherapy software V 14.1 from the Netherlands Nucletron, and doses obtained in the same organs were compared with experimental results using dosimeters. The comparison of these results shows the correlation degree between the planning of dosimetric treatments and the experimental results, making the process in a form of quality control in vivo, of this type of procedure. (Author)

  8. Management of a HDR brachytherapy system in the Hospital Juarez of Mexico

    International Nuclear Information System (INIS)

    Full text: In the Hospital Juarez of Mexico, it is carried out a project to implement a Brachytherapy system with high dose rate (HDR) through a Management quality program. In our work center this treatment modality in patients with cervicouterine cancer is used (CaCu), and constantly it is necessary to carry out improvements in the procedures, with the purpose of optimizing them and in consequence to complete the principles of the Radiological Protection, guaranteeing this way, an attention with the quality and safety, such that allow to diminish the risks to the patients and to assure that the received dose in critical organs it finds inside the permitted therapeutic limits, without commit the radiosensitive response of healthy organs. In this work an analysis of the implementation of this system is presented, detailing the procedures so much in the technological infrastructure like human and indicating the necessary technical and operative requirements to reach an adequate practice in HDR brachytherapy. (Author)

  9. Response of an implantable MOSFET dosimeter to 192Ir HDR radiation.

    Science.gov (United States)

    Fagerstrom, Jessica M; Micka, John A; DeWerd, Larry A

    2008-12-01

    New in vivo dosimetry methods would be useful for clinical HDR brachytherapy. An implantable MOSFET Dose Verification System designed by Sicel Technologies, Inc. was examined for use with 192Ir HDR applications. This investigation demonstrated that varying the dose rate from 22 to 84 cGy/min did not change detector response. The detectors exhibited a higher sensitivity to 192Ir energies than 60Co energies. A nonlinear accumulated dose effect was characterized by three third-order polynomials fit to data from detectors placed at three different distances from the source. The detectors were found to have minimal rotational angular dependence. A strong longitudinal angular dependence was found when the detector's copper coil and electronics assembly were aligned between the MOSFETs and incident radiation. This orientation showed a 16% decrease in response relative to other orientations tested. PMID:19175130

  10. Response of an implantable MOSFET dosimeter to {sup 192}Ir HDR radiation

    Energy Technology Data Exchange (ETDEWEB)

    Fagerstrom, Jessica M.; Micka, John A.; DeWerd, Larry A. [Department of Medical Physics, University of Wisconsin-Madison, Madison, Wisconsin 53706 (United States)

    2008-12-15

    New in vivo dosimetry methods would be useful for clinical HDR brachytherapy. An implantable MOSFET Dose Verification System designed by Sicel Technologies, Inc. was examined for use with {sup 192}Ir HDR applications. This investigation demonstrated that varying the dose rate from 22 to 84 cGy/min did not change detector response. The detectors exhibited a higher sensitivity to {sup 192}Ir energies than {sup 60}Co energies. A nonlinear accumulated dose effect was characterized by three third-order polynomials fit to data from detectors placed at three different distances from the source. The detectors were found to have minimal rotational angular dependence. A strong longitudinal angular dependence was found when the detector's copper coil and electronics assembly were aligned between the MOSFETs and incident radiation. This orientation showed a 16% decrease in response relative to other orientations tested.

  11. Trans-Pacific HDR Satellite Communications Experiment Phase-2: Experimental Network and Demonstration Plan

    Science.gov (United States)

    Kadowaki, Naoto; Yoshimura, Naoko; Takahashi, Takashi; Yoshikawa, Makoto; Hsu, Eddie; Bergman, Larry; Bhasin, Kul; Gary, Pat

    1998-01-01

    The trans-Pacific high data rate (TP-HDR) satellite communications experiment was proposed at the Japan-U.S. Cooperation in Space (JUCS) Program Workshop held in Hawaii in 1993 and remote high definition video post-production was demonstrated as the first phase trial. Following the first phase, the second phase experiment is currently prepared. This paper describes the experimental network configuration, application demonstration, and performance evaluation plan of the second phase experiment.

  12. Prostate CT segmentation method based on nonrigid registration in ultrasound-guided CT-based HDR prostate brachytherapy

    Energy Technology Data Exchange (ETDEWEB)

    Yang, Xiaofeng, E-mail: xyang43@emory.edu; Rossi, Peter; Ogunleye, Tomi; Marcus, David M.; Jani, Ashesh B.; Curran, Walter J.; Liu, Tian [Department of Radiation Oncology and Winship Cancer Institute, Emory University, Atlanta, Georgia 30322 (United States); Mao, Hui [Department of Radiology and Imaging Sciences, Emory University, Atlanta, Georgia 30322 (United States)

    2014-11-01

    Purpose: The technological advances in real-time ultrasound image guidance for high-dose-rate (HDR) prostate brachytherapy have placed this treatment modality at the forefront of innovation in cancer radiotherapy. Prostate HDR treatment often involves placing the HDR catheters (needles) into the prostate gland under the transrectal ultrasound (TRUS) guidance, then generating a radiation treatment plan based on CT prostate images, and subsequently delivering high dose of radiation through these catheters. The main challenge for this HDR procedure is to accurately segment the prostate volume in the CT images for the radiation treatment planning. In this study, the authors propose a novel approach that integrates the prostate volume from 3D TRUS images into the treatment planning CT images to provide an accurate prostate delineation for prostate HDR treatment. Methods: The authors’ approach requires acquisition of 3D TRUS prostate images in the operating room right after the HDR catheters are inserted, which takes 1–3 min. These TRUS images are used to create prostate contours. The HDR catheters are reconstructed from the intraoperative TRUS and postoperative CT images, and subsequently used as landmarks for the TRUS–CT image fusion. After TRUS–CT fusion, the TRUS-based prostate volume is deformed to the CT images for treatment planning. This method was first validated with a prostate-phantom study. In addition, a pilot study of ten patients undergoing HDR prostate brachytherapy was conducted to test its clinical feasibility. The accuracy of their approach was assessed through the locations of three implanted fiducial (gold) markers, as well as T2-weighted MR prostate images of patients. Results: For the phantom study, the target registration error (TRE) of gold-markers was 0.41 ± 0.11 mm. For the ten patients, the TRE of gold markers was 1.18 ± 0.26 mm; the prostate volume difference between the authors’ approach and the MRI-based volume was 7.28% ± 0

  13. Normal tissue dosimetric comparison between hdr prostate implant boost and conformal external beam radiotherapy boost: potential for dose escalation

    International Nuclear Information System (INIS)

    Purpose: To compare the dose and volume of bladder and rectum treated using high-dose-rate (HDR) prostate implant boost versus conformal external beam radiotherapy boost, and to use the dose-volume information to perform a critical volume tolerance (CVT) analysis and then estimate the potential for further dose escalation using HDR brachytherapy boost. Methods and Materials: Using CT scan data collected before and after patients underwent HDR prostate implant, a 7-field conformal prostate-only external beam treatment plan and HDR brachytherapy treatment plan were constructed for each patient. Doses to the normal structures were calculated. Dose-volume histograms (DVH) were plotted for comparison of the two techniques. Wilcoxon signed rank test was performed at four dose levels to compare the dose to normal structures between the two treatment techniques. The acute and late effects of HDR brachytherapy were calculated based on the linear-quadratic (LQ) model. CVT analyses were performed to calculate the potential dose gain (PDG) using HDR brachytherapy boost. Results: The volume of bladder and rectum receiving high dose was significantly less from implant boost. On the average, 0.19 cc of the bladder received 100% of the brachytherapy prescription dose, compared with 5.1 cc of the bladder receiving 100% of the prescription dose in the 7-field conformal external beam radiotherapy boost. Similarly, 0.25 cc of the rectum received 100% of the dose with the implant boost, as compared to 2.9 cc in the conformal external beam treatment. The implant also delivered higher doses inside the prostate volume. On average, 47% of the prostate received ≥150% of the prescription dose. The CVT analysis revealed a range of PDG using the HDR brachytherapy boost which depended on the following variables: critical volume (CV), critical volume tolerance dose (CVTD), number of HDR fractions (N), and the dose of external beam radiotherapy (XRT) delivered with brachytherapy boost. The PDG

  14. Audit on source strength determination for HDR and PDR 192Ir brachytherapy in Sweden

    International Nuclear Information System (INIS)

    Background and purpose: To investigate the status of source strength determination in terms of reference air kerma rate (RAKR) for HDR and PDR 192Ir brachytherapy in Sweden. Materials and methods: RAKR was determined in each of the 14 Swedish afterloaders, using calibrated equipment from the Swedish Secondary Standard Dosimetry Laboratory. Results: Values of RAKR from the external audit, the hospitals and vendors agreed within the uncertainty limits guaranteed by the vendors. Conclusions: The accuracy in RAKR determination has increased over the last years as a result of increased availability of interpolation standards for HDR 192Ir and the increased use of robust well-type ion chambers designed for brachytherapy. It is recommended to establish a ratio between the RAKR value from own measurements at the hospital and that of the vendor since such a ratio embeds constant systematic differences due to e.g. varying traceability and therefore has the potential of being less uncertain than the RAKR alone. Traceability to primary standards for HDR 192Ir sources will in the future significantly decrease the uncertainty in RAKR of 192Ir brachytherapy

  15. Determination of the Fricke G value for HDR 192Ir sources using ionometric measurements

    International Nuclear Information System (INIS)

    High Dose Rate (HDR) brachytherapy using 192Ir is widely accepted as an important treatment option, and it thus requires an accurate dosimetry standard. However, a dosimetry standard for the direct measurement of absolute dose to water is currently not available. The dose to water conversion is calculated via the dose rate constant Λ and several correction factors accounting for the scatter, attenuation, and anisotropy of the dose distribution, among other effects. Two potentially useful procedures have been reported, including one by Sarfehnia et al. [3,4], which used a water-based calorimeter with an uncertainty of 1.9% for k=1, and a second by Austerlitz et al. and de Almeida et al., which used Fricke dosimetry with estimated uncertainties of 3.9% for k=1 and 1.4% for k=1, respectively. Chemical dosimetry using a standard FeSO4 solution has shown potential to be a reliable standard of absorbed dose for the HDR 192Ir source. A major uncertainty is associated with the G values reported by Fregene, which had a numerical value of 1.1 %. However, that reference provided very little detail of the experimental procedures for the 192Ir source. The G value may be obtained by using a calorimeter or ionometric measurements. In the absence of calorimetric data, this paper makes an attempt to measure the G value for the HDR 192Ir sources using ionometric measurements and recommendations from dosimetry protocols. (author)

  16. Independent verification of the delivered dose in High-Dose Rate (HDR) brachytherapy

    International Nuclear Information System (INIS)

    An important aspect of a Quality Assurance program in Clinical Dosimetry is an independent verification of the dosimetric calculation done by the Treatment Planning System for each radiation treatment. The present paper is aimed at creating a spreadsheet for the verification of the dose recorded at a point of an implant with radioactive sources and HDR in gynecological injuries. An 192Ir source automatic differed loading equipment, GammaMedplus model, Varian Medical System with HDR installed at the Angel H. Roffo Oncology Institute has been used. The planning system implemented for getting the dose distribution is the BraquiVision. The sources coordinates as well as those of the calculation point (Rectum) are entered into the Excel-devised verification program by assuming the existence of a point source in each one of the applicators' positions. Such calculation point has been selected as the rectum is an organ at risk, therefore determining the treatment planning. The dose verification is performed at points standing at a sources distance having at least twice the active length of such sources, so they may be regarded as point sources. Most of the sources used in HDR brachytherapy with 192Ir have a 5 mm active length for all equipment brands. Consequently, the dose verification distance must be at least of 10 mm. (author)

  17. Determination of the Fricke G value for HDR {sup 192}Ir sources using ionometric measurements

    Energy Technology Data Exchange (ETDEWEB)

    Franco, L.; Coelho, M.; Almeida, C.E. de [Universidade do Estado do Rio de Janeiro (UERJ), RJ (Brazil). Lab. de Ciencias Radiologicas; Gavazza, S. [Instituto Militar de Engenharia (IME), Rio de Janeiro, RJ (Brazil)

    2011-07-01

    High Dose Rate (HDR) brachytherapy using {sup 192}Ir is widely accepted as an important treatment option, and it thus requires an accurate dosimetry standard. However, a dosimetry standard for the direct measurement of absolute dose to water is currently not available. The dose to water conversion is calculated via the dose rate constant {Lambda} and several correction factors accounting for the scatter, attenuation, and anisotropy of the dose distribution, among other effects. Two potentially useful procedures have been reported, including one by Sarfehnia et al. [3,4], which used a water-based calorimeter with an uncertainty of 1.9% for k=1, and a second by Austerlitz et al. and de Almeida et al., which used Fricke dosimetry with estimated uncertainties of 3.9% for k=1 and 1.4% for k=1, respectively. Chemical dosimetry using a standard FeSO{sub 4} solution has shown potential to be a reliable standard of absorbed dose for the HDR {sup 192}Ir source. A major uncertainty is associated with the G values reported by Fregene, which had a numerical value of 1.1 %. However, that reference provided very little detail of the experimental procedures for the {sup 192}Ir source. The G value may be obtained by using a calorimeter or ionometric measurements. In the absence of calorimetric data, this paper makes an attempt to measure the G value for the HDR {sup 192}Ir sources using ionometric measurements and recommendations from dosimetry protocols. (author)

  18. Characterization of HDR Ir-192 source for 3D planning system

    Energy Technology Data Exchange (ETDEWEB)

    Fonseca, Gabriel P.; Yoriyaz, Helio; Antunes, Paula C.G.; Siqueira, Paulo T.D., E-mail: gabriel.fonseca@usp.b, E-mail: hyoriyaz@ipen.b, E-mail: ptsiquei@ipen.b [Instituto de Pesquisas Energeticas e Nucleares (IPEN/CNEN-SP), Sao Paulo, SP (Brazil); Rubo, Rodrigo [Universidade de Sao Paulo (HC/FMUSP), Sao Paulo, SP (Brazil). Hospital das Clinicas. Servico de Radioterapia; Minamisawa, Renato A., E-mail: renato.minamisawa@psi.c [Paul Scherrer Institut (PSI), Villigen (Switzerland); Ferreira, Louise A. [Universidade Estadual de Maringa (UEM), PR (Brazil). Fac. de Medicina

    2011-07-01

    Brachytherapy treatment involves surgical or cavitary insertion of radioactive sources for diseases treatments, such as: lung, gynecologic or prostate cancer. This technique has great ability to administer high doses to the tumor, with adjacent normal tissue preservation equal or better than external beam radiation therapy. Several innovations have been incorporated in this treatment technique, such as, 3D treatment planning system and computer guided sources. In detriment to scientific advances there are no protocols that relate dose with tumor volume, organs or A point, established by ICRU38 and used to prescribe dose in treatment planning system. Several international studies, like as EMBRACE, the multicentre international study, has been trying to correlate the dose volume using 3D planning systems and medical images, as those obtained by CT or MRI, to establish treatment protocols. With the objective of analyzing the 3D dose distribution, a micro Selectron-HDR remote afterloading device for high dose-rate (HDR) was characterized in the present work. Through the data provided by the manufacturer the source was simulated, using the MCNP5 code to calculate American Association of Physicists in Medicine Task Group No. 43 report (AAPM TG43) specified parameters. The simulations have shown great agreement when compared to the ONCENTRA planning system results and those provided by literature. The micro Selectron-HDR remote afterloading device will be utilized to simulate 3D dose distribution through CT images processed by an auxiliary software which process DICOM images. (author)

  19. CT-guided interstitial HDR brachytherapy for recurrent glioblastoma multiforme. Long-term results

    Energy Technology Data Exchange (ETDEWEB)

    Tselis, N.; Roeddiger, S.; Filipowicz, I.; Kontova, M.; Heyd, R.; Zamboglou, N. [Offenbach Hospital (Germany). Dept. of Radiotherapy and Interdisciplinary Oncology; Kolotas, C. [Offenbach Hospital (Germany). Dept. of Radiotherapy and Interdisciplinary Oncology; Hirslanden Medical Center, Aarau (Switzerland). Inst. of Radiotherapy; Birn, G. [Offenbach Hospital (Germany). Dept. of Neurosurgery; Fountzilas, G.; Selviaridis, P. [Aristotle Univ. of Thessaloniki School of Medicine, Thessaloniki (Greece); Baltas, D.; Anagnostopoulos, G. [Offenbach Hospital (Germany). Dept. of Medical Physics and Engineering

    2007-10-15

    Background and Purpose: Recurrences of glioblastoma multiforme (GBM) within previously irradiated volumes pose a serious therapeutic challenge. This retrospective study evaluates the long-term tumor control of recurrent GBM treated with interstitial high-dose-rate brachytherapy (HDR-BRT). Patients and Methods: Between 1995 and 2003, 84 patients were treated for recurrent cerebral GBM located within previously irradiated volumes. All patients had received adjuvant external radiotherapy following primary surgery, with a focal dose up to 60 Gy. The median recurrent tumor volume was 51 cm{sup 3} (3-207 cm{sup 3}), and the HDR-BRT consisted of an afterloading {sup 192}Ir implant which delivered a median dose of 40 Gy (30-50 Gy). Catheter implantation was implemented using interactive computed tomography (CT) guidance under local anesthesia and sedoanalgesia. Results: After a median follow-up of 61 months, 5/84 patients (6%) were alive. The median post-BRT survival was 37 weeks, and the median overall survival 78 weeks. Moderate to severe complications occurred in 5/84 cases (6%). Conclusion: For patients with recurrences of GBM within previously irradiated volumes, CT-guided interstitial HDR-BRT is a feasible treatment option that can play an important role in providing palliation. (orig.)

  20. Interactive multiobjective optimization for anatomy-based three-dimensional HDR brachytherapy

    Science.gov (United States)

    Ruotsalainen, Henri; Miettinen, Kaisa; Palmgren, Jan-Erik; Lahtinen, Tapani

    2010-08-01

    In this paper, we present an anatomy-based three-dimensional dose optimization approach for HDR brachytherapy using interactive multiobjective optimization (IMOO). In brachytherapy, the goals are to irradiate a tumor without causing damage to healthy tissue. These goals are often conflicting, i.e. when one target is optimized the other will suffer, and the solution is a compromise between them. IMOO is capable of handling multiple and strongly conflicting objectives in a convenient way. With the IMOO approach, a treatment planner's knowledge is used to direct the optimization process. Thus, the weaknesses of widely used optimization techniques (e.g. defining weights, computational burden and trial-and-error planning) can be avoided, planning times can be shortened and the number of solutions to be calculated is small. Further, plan quality can be improved by finding advantageous trade-offs between the solutions. In addition, our approach offers an easy way to navigate among the obtained Pareto optimal solutions (i.e. different treatment plans). When considering a simulation model of clinical 3D HDR brachytherapy, the number of variables is significantly smaller compared to IMRT, for example. Thus, when solving the model, the CPU time is relatively short. This makes it possible to exploit IMOO to solve a 3D HDR brachytherapy optimization problem. To demonstrate the advantages of IMOO, two clinical examples of optimizing a gynecologic cervix cancer treatment plan are presented.

  1. HDR- and PDR-brachytherapy of soft tissue sarcoma in children

    International Nuclear Information System (INIS)

    Radiotherapy is part of the combined modality treatment of soft tissue sarcoma in children. Sparing of normal tissue, which is of special importance in children, is a potential advantage of brachytherapy in local treatment. There is only limited experience with brachytherapy in pediatric malignancies gained by a few centers with LDR techniques. Since 1991 twelve patients with tumors at different sites (pelvis, head and neck, orbit, chest wall, limbs) were treated with HDR- or PDR brachytherapy as part of the combined modality treatment according to the treatment protocols CWS-86/91 and CESS/CWS-REZ-91 at the departments of radiotherapy in Vienna, Kiel and Muenster. With eight patients brachytherapy was part of the recurrence treatment regime, with four patients part of the primary treatment alone or in combination with external beam therapy. In HDR treatment a dose of 15 to 43 Gy was delivered in 3 to 16 fractions, in PDR treatment 13 to 36 Gy in fractions of 1Gy/hour. Follow-up is 3 to 39 months (median 14 months), 7 children show no evidence of disease, with 9 the tumor is locally controlled and with 3 it progressed locoregionally. Although these preliminary results with HDR and PDR brachytherapy are encouraging further experience regarding long term survival, local control and late side effects must be gained prospectively and systematically in specialized collaborating centers

  2. Vibrational experiments at the HDR [Heissdampfreaktor]: SHAG results and planning for SHAM

    International Nuclear Information System (INIS)

    As part of the second phase of vibrational/earthquake investigations at the HDR (Heissdampfreaktor) Test Facility in Kahl/Main, FRG, high-level shaker tests (SHAG) were performed during June and July 1986 using a coast-down shaker capable of generating 1000 tons of force. The purpose of these experiments was to investigate full-scale structural response, soil/structure interaction, and piping and equipment response under strong excitation conditions. While global safety considerations imposed load limitations, the HDR soil/structure system was nevertheless tested to incipient failure. The performance of pipe support systems in as many as seven different multiple support pipe hanger configurations, ranging from flexible to stiff systems, was evaluated in the tests. Data obtained in the tests are used to validate analysis methods. The vibrational/earthquake investigations at the HDR are continuing with the SHAM experiments, planned for the spring of 1988. In these experiments the VKL piping loop will be subjected to direct multiple-point excitation at extremely high levels. The objective is to investigate different pipe support configurations at extreme loading, to establish seismic margins for piping, and to investigate possible failure/plastification modes in an in situ piping system

  3. Comparison of a unidirectional panoramic 3D endoluminal interpretation technique to traditional 2D and bidirectional 3D interpretation techniques at CT colonography: preliminary observations

    Energy Technology Data Exchange (ETDEWEB)

    Lenhart, D.K.; Babb, J.; Bonavita, J.; Kim, D. [Department of Radiology, NYU Medical Center, 560 First Avenue, Suite HW-202, New York, NY 10016 (United States); Bini, E.J. [Department of Medicine, NYU School of Medicine, NYU Medical Center, 560 First Avenue, Suite HW-202, New York, NY 10016 (United States); Megibow, A.J. [Department of Radiology, NYU Medical Center, 560 First Avenue, Suite HW-202, New York, NY 10016 (United States); Macari, M., E-mail: michael.macari@med.nyu.ed [Department of Radiology, NYU Medical Center, 560 First Avenue, Suite HW-202, New York, NY 10016 (United States)

    2010-02-15

    Aim: To compare the evaluation times and accuracy of unidirectional panoramic three-dimensional (3D) endoluminal interpretation to traditional two-dimensional (2D) and bidirectional 3D endoluminal techniques. materials and methods: Sixty-nine patients underwent computed tomography colonography (CTC) after bowel cleansing. Forty-five had no polyps and 24 had at least one polyp >=6 mm. Patients underwent same-day colonoscopy with segmental unblinding. Three experienced abdominal radiologists evaluated the data using one of three primary interpretation techniques: (1) 2D; (2) bidirectional 3D; (3) panoramic 3D. Mixed model analysis of variance and logistic regression for correlated data were used to compare techniques with respect to time and sensitivity and specificity. Results: Mean evaluation times were 8.6, 14.6, and 12.1 min, for 2D, 3D, and panoramic, respectively. 2D was faster than either 3D technique (p < 0.0001), and the panoramic technique was faster than bidirectional 3D (p = 0.0139). The overall sensitivity of each technique per polyp and per patient was 68.4 and 76.7% for 2D, 78.9 and 93.3% for 3D; and 78.9 and 86.7% for panoramic 3D. Conclusion: 2D interpretation was the fastest overall, the panoramic technique was significantly faster than the bidirectional with similar sensitivity and specificity. The sensitivity for a single reader was significantly lower using the 2D technique. Each reader should select the technique with which they are most successful.

  4. Anatomy-based inverse planning dose optimization in HDR prostate implant: A toxicity study

    International Nuclear Information System (INIS)

    Background and purpose: The aim of this study is to evaluate the acute and late complications in patients who have received HDR implant boost using inverse planning, and to determine dose volume correlations. Patients and methods: Between September 1999 and October 2002, 44 patients with locally advanced prostate cancer (PSA ≥10 ng/ml, and/or Gleason score ≥7, and/or Stage T2c or higher) were treated with 40-45 Gy external pelvic field followed by 2-3 fraction of inverse-planned HDR implant boost (6-9.5 Gy /fraction). Median follow-up time was 1.7 years with 81.8% of patients who had at least 12 months of follow up (range 8.6-42.5. Acute and late morbidity data were collected and graded according to RTOG criteria. Questionnaires were used to collect prostate related measures of quality of life, and international prostate symptom score (IPSS) before and after treatment. Dose-volume histograms for prostate, urethra, bladder, penis bulb and rectum were analyzed. Results: The median patient age was 64 years. Of these, 32% were in the high risk group, and 61% in the intermediate risk group. 3 patients (7%) had no adverse prognostic factors. A single grade 3 GU acute toxicity was reported but no grade 3-4 acute GI toxicity. No grade 3-4 late GU or GI toxicity was reported. Acute (late) grade 2 urinary and rectal symptoms were reported in 31.8 (11.4%) and 4.6% (4.6%) of patients, respectively. A trend for predicting acute GU toxicity is seen for total HDR dose of more than 18 Gy (OR=3.6, 95%CI=[0.96-13.5], P=0.058). The evolution of toxicity is presented for acute and late GU/GI toxicity. Erectile dysfunction occurs in approximately 27% of patients who were not on hormonal deprivation, but may be taking sildenafil. The IPSS peaked on averaged 6 weeks post-implant and returned to the baseline at a median of 6 months. Conclusions: Inverse-planned HDR brachytherapy is a viable option to deliver higher dose to the prostate as a boost without increasing GU or rectal

  5. Study of forty-three patients treated with HDR or LDR pre-operative brachytherapy for IIb cervical cancer

    International Nuclear Information System (INIS)

    We have studied 43 patients with IIB cervical cancer who were underwent to pre-operatory treatment. The biological effects between both modalities of treatment were analysed. All patient received EBRT to a total dose of 45Gy - fx 1,8Gy plus brachytherapy. EBRT was performed with a Linac 4MV, in box arrangement. The Brachytherapy was performed through Fletcher Colpostats in association with intrauterine tamdens, in both arms. Brachytherapy starts in HDR group after ten days of the beginning of the treatment. The scheme was the following: 1-HDR - 2 weekly insertions of 6,0Gy at point A 2-LDR - one insertiont of 15Gy at point A. Four to six weeks after the end of the irradiation course, we performed the surgical procedure with Total Hysterectomy and Salpingoforectomy (Piver second level). Results: - HDR - No residual tumor - 21/35 -60% Residual tumor - 14/35 - 40% Negative linph. - 29/35 - 83% Positive linph.- 05/35 - 14% LDR - No residual tumor - 05/08 - 62.5% Residual tumor - 03/08 - 37.5% Negative linph. - 06/08 - 75% Positive linph. - 02/08 - 25% Conclusions - This avaliation showed that local control and survival in HDR and LDR are similar. Treatment with HDR devices are safer for patients and staff, with no need of anesthesia

  6. A study on room design and radiation safety around room for Co-60 after loading HDR brachytherapy unit converted from room for Ir-192 after loading HDR brachytherapy unit

    Directory of Open Access Journals (Sweden)

    Om Prakash Gurjar

    2015-01-01

    Full Text Available Context: Use of Co-60 source in place of Ir-192 in high dose rate brachytherapy unit (HDR unit has come for discussion in recent publications. Co-60 based system has been advocated for centers which have fewer brachytherapy procedures as it has comparative economically and administrative advantage. This study has direct practical application for such institutions, which are at the cusp of moving from Ir-192 to Co-60 based brachytherapy. Aims: Conversion of Ir-192 HDR room to Co-60 HDR room and to analyze radiation safety around the room. Materials and Methods: Uniform thickness of 15 cm concrete was added to all walls (except one wall adjoining to linear accelerator bunker to convert existing room forIr-192 HDR unit to suitable room for Co-60 HDR unit. Radiation survey around room was done. Actual and calculated wall thicknesses were compared. Results: Radiation survey data indicates that modified room is suitable for Co-60 HDR unit and all values are in full conformity to annual dose limits mentioned in Safety Code for Radiation Therapy Sources (SCRTS, Atomic Energy Regulatory Body (AERB; the regulatory body in India. Also, modified wall thicknesses are appropriate for annual design dose limits mentioned in Safety Report Series No. 47 of International Atomic Energy Agency (IAEA. However, console wall thickness (0.45 m is less than the calculated thickness (0.53 m for instantaneous dose rate (IDR design dose limit (7.5 ΅Sv/h as perabove safety report of IAEA. Conclusions: The modified wall thicknesses are appropriate for annual design dose limits. However, console wall thickness is less than the required thickness for IDR design dose limit. It has been suggested to add 2.64 cm steel on console wall. It has been found that design dose limits should be considered while making room layout plan and regulatory body should add these constraints inSCRTS.

  7. Dosimetric characterization of round HDR {sup 192}Ir AccuBoost applicators for breast brachytherapy

    Energy Technology Data Exchange (ETDEWEB)

    Rivard, Mark J.; Melhus, Christopher S.; Wazer, David E.; Bricault, Raymond J. Jr. [Department of Radiation Oncology, Tufts University School of Medicine, Boston, Massachusetts 02111 (United States); Advanced Radiation Therapy, Billerica, Massachusetts 01821 (United States)

    2009-11-15

    Purpose: The AccuBoost brachytherapy system applies HDR {sup 192}Ir beams peripherally to the breast using collimating applicators. The purpose of this study was to benchmark Monte Carlo simulations of the HDR {sup 192}Ir source, to dosimetrically characterize the round applicators using established Monte Carlo simulation and radiation measurement techniques and to gather data for clinical use. Methods: Dosimetric measurements were performed in a polystyrene phantom, while simulations estimated dose in air, liquid water, polystyrene and ICRU 44 breast tissue. Dose distribution characterization of the 4-8 cm diameter collimators was performed using radiochromic EBT film and air ionization chambers. Results: The central axis dose falloff was steeper for the 4 cm diameter applicator in comparison to the 8 cm diameter applicator, with surface to 3 cm depth-dose ratios of 3.65 and 2.44, respectively. These ratios did not considerably change when varying the phantom composition from breast tissue to polystyrene, phantom thickness from 4 to 8 cm, or phantom radius from 8 to 15 cm. Dose distributions on the central axis were fitted to sixth-order polynomials for clinical use in a hand calculation spreadsheet (i.e., nomogram). Dose uniformity within the useful applicator apertures decreased as depth-dose increased. Conclusions: Monte Carlo benchmarking simulations of the HDR {sup 192}Ir source using the MCNP5 radiation transport code indicated agreement within 1% of the published results over the radial/angular region of interest. Changes in phantom size and radius did not cause noteworthy changes in the central axis depth-dose. Polynomial fit depth-dose curves provide a simple and accurate basis for a nomogram.

  8. Dosimetric characterization of round HDR 192Ir AccuBoost applicators for breast brachytherapy

    International Nuclear Information System (INIS)

    Purpose: The AccuBoost brachytherapy system applies HDR 192Ir beams peripherally to the breast using collimating applicators. The purpose of this study was to benchmark Monte Carlo simulations of the HDR 192Ir source, to dosimetrically characterize the round applicators using established Monte Carlo simulation and radiation measurement techniques and to gather data for clinical use. Methods: Dosimetric measurements were performed in a polystyrene phantom, while simulations estimated dose in air, liquid water, polystyrene and ICRU 44 breast tissue. Dose distribution characterization of the 4-8 cm diameter collimators was performed using radiochromic EBT film and air ionization chambers. Results: The central axis dose falloff was steeper for the 4 cm diameter applicator in comparison to the 8 cm diameter applicator, with surface to 3 cm depth-dose ratios of 3.65 and 2.44, respectively. These ratios did not considerably change when varying the phantom composition from breast tissue to polystyrene, phantom thickness from 4 to 8 cm, or phantom radius from 8 to 15 cm. Dose distributions on the central axis were fitted to sixth-order polynomials for clinical use in a hand calculation spreadsheet (i.e., nomogram). Dose uniformity within the useful applicator apertures decreased as depth-dose increased. Conclusions: Monte Carlo benchmarking simulations of the HDR 192Ir source using the MCNP5 radiation transport code indicated agreement within 1% of the published results over the radial/angular region of interest. Changes in phantom size and radius did not cause noteworthy changes in the central axis depth-dose. Polynomial fit depth-dose curves provide a simple and accurate basis for a nomogram.

  9. Westinghouse-GOTHIC distributed parameter modelling for HDR test E11.2

    International Nuclear Information System (INIS)

    The Westinghouse-GOTHIC (WGOTHIC) code is a sophisticated mathematical computer code designed specifically for the thermal hydraulic analysis of nuclear power plant containment and auxiliary buildings. The code is capable of sophisticated flow analysis via the solution of mass, momentum, and energy conservation equations. Westinghouse has investigated the use of subdivided noding to model the flow patterns of hydrogen following its release into a containment atmosphere. For the investigation, several simple models were constructed to represent a scale similar to the German HDR containment. The calculational models were simplified to test the basic capability of the plume modeling methods to predict stratification while minimizing the number of parameters. A large empty volume was modeled, with the same volume and height as HDR. A scenario was selected that would be expected to stably stratify, and the effects of noding on the prediction of stratification was studied. A single phase hot gas was injected into the volume at a height similar to that of HDR test E11.2, and there were no heat sinks modeled. Helium was released into the calculational models, and the resulting flow patterns were judged relative to the expected results. For each model, only the number of subdivisions within the containment volume was varied. The results of the investigation of noding schemes has provided evidence of the capability of subdivided (distributed parameter) noding. The results also showed that highly inaccurate flow patterns could be obtained by using an insufficient number of subdivided nodes. This presents a significant challenge to the containment analyst, who must weigh the benefits of increased noding with the penalties the noding may incur on computational efficiency. Clearly, however, an incorrect noding choice may yield erroneous results even if great care has been taken in modeling accurately all other characteristics of containments. (author). 9 refs., 9 figs

  10. Anisotropy measurement of {sup 192} Ir sources used in high dose rate brachytherapy; Medida da anisotropia de fontes de Ir-192 utilizadas em braquiterapia de altas taxa de dose

    Energy Technology Data Exchange (ETDEWEB)

    Henn, Keli Cristina; Khoury, Helen J.; Luz, Lidia Cristina P. da [Pernambuco Univ., Recife, PE (Brazil). Dept. de Energia Nuclear

    1998-07-01

    This paper presents the dose distribution around the Ir-192 source used in MicroSelectron-HDR remote after loader system. The measurements were made in air with the source stationary, positioned at the position 1, from the indexer of the microSelectron-HDR. Measurements were made using TLD and for radial distances of 3.0, 5.0 and 7.0 cm, for values of the angle from 0 deg c to 360 deg C in steps of 15 deg C. (author)

  11. MO-C-17A-11: A Segmentation and Point Matching Enhanced Deformable Image Registration Method for Dose Accumulation Between HDR CT Images

    International Nuclear Information System (INIS)

    Purpose: To propose and validate a novel and accurate deformable image registration (DIR) scheme to facilitate dose accumulation among treatment fractions of high-dose-rate (HDR) gynecological brachytherapy. Method: We have developed a method to adapt DIR algorithms to gynecologic anatomies with HDR applicators by incorporating a segmentation step and a point-matching step into an existing DIR framework. In the segmentation step, random walks algorithm is used to accurately segment and remove the applicator region (AR) in the HDR CT image. A semi-automatic seed point generation approach is developed to obtain the incremented foreground and background point sets to feed the random walks algorithm. In the subsequent point-matching step, a feature-based thin-plate spline-robust point matching (TPS-RPM) algorithm is employed for AR surface point matching. With the resulting mapping, a DVF characteristic of the deformation between the two AR surfaces is generated by B-spline approximation, which serves as the initial DVF for the following Demons DIR between the two AR-free HDR CT images. Finally, the calculated DVF via Demons combined with the initial one serve as the final DVF to map doses between HDR fractions. Results: The segmentation and registration accuracy are quantitatively assessed by nine clinical HDR cases from three gynecological cancer patients. The quantitative results as well as the visual inspection of the DIR indicate that our proposed method can suppress the interference of the applicator with the DIR algorithm, and accurately register HDR CT images as well as deform and add interfractional HDR doses. Conclusions: We have developed a novel and robust DIR scheme that can perform registration between HDR gynecological CT images and yield accurate registration results. This new DIR scheme has potential for accurate interfractional HDR dose accumulation. This work is supported in part by the National Natural ScienceFoundation of China (no 30970866 and no

  12. Dose verification using a pelvic phantom in high dose rate (HDR) brachytherapy

    International Nuclear Information System (INIS)

    High dose rate (HDR) brachytherapy for treating a cervix carcinoma has become popular, because it eliminates many of the problems associated with conventional brachytherapy. In order to improve the clinical effectiveness with HDR brachytherapy, a dose calculation algorithm, optimization procedures, and image registrations need to be verified by comparing the dose distributions from a planning computer and those from a humanoid phantom. In this study, the humanoid phantom was fabricated in order to verify the absolute doses and the relative dose distributions. The measured doses from the humanoid phantom were then compared with the treatment planning system for the dose verification. The humanoid phantom needs to be designed such that the dose distributions can be quantitatively evaluated thermoluminescent dosimeter (TLD) chips with a dimension of 1/8 and film dosimetry with a spatial resolution of <1 mm used to measure the radiation dosages in the phantom. The humanoid phantom called a pelvic phantom was made from water and the tissue-equivalent acrylic plates. In order to firmly hold the HDR applicators in the water phantom, the applicators were inserted into the grooves of the applicator holder. The dose distributions around the applicators, such as Point A and B, were measured by placing a series of TLD chips (TLD-tp-TLD distance: 5mm) in the three TLD holders, and placing three verification films in the orthogonal planes. This study used a Nucletron Plato treatment planning system and a Microselectron Ir-192 source unit. The results showed good agreement between the treatment plan and measurement. The comparisons of the absolute dose showed agreement within 1.48 %-2.95 % of the dose at point A and B, and 2.07 %-3.74 % of the dose at the bladder and rectum point. In addition, the relative dose distributions by film dosimetry and those calculated by the planning computer show good agreement. This pelvic phantom could be a useful to verify the dose calculation

  13. Design and evaluation of a HDR skin applicator with flattening filter.

    Science.gov (United States)

    Granero, D; Pérez-Calatayud, J; Gimeno, J; Ballester, F; Casal, E; Crispín, V; van der Laarse, R

    2008-02-01

    The purposes of this study are: (i) to design field flattening filters for the Leipzig applicators of 2 and 3 cm of inner diameter with the source traveling parallel to the applicator contact surface, which are accessories of the microSelectron-HDR afterloader (Nucletron, Veenendaal, The Netherlands). These filters, made of tungsten, aim to flatten the heterogeneous dose distribution obtained with the Leipzig applicators. (ii) To estimate the dose rate distributions for these Leipzig+filter applicators by means of the Monte Carlo (MC) method. (iii) To experimentally verify these distributions for prototypes of these new applicators, and (iv) to obtain the correspondence factors to measure the output of the applicators by the user using an insert into a well chamber. The MC GEANT4 code has been used to design the filters and to obtain the dose rate distributions in liquid water for the two Leipzig+filter applicators. In order to validate this specific application and to guarantee that realistic source-applicator geometry has been considered, an experimental verification procedure was implemented in this study, in accordance with the updated recommendations of the American Association of Physicists in Medicine Task Group No. 43 U1 Report. Thermoluminescent dosimeters, radiochromic film, and a pin-point ionization chamber in a plastic [polymethylmethacrylate (PMMA)] phantom were used to verify the MC results for the two applicators of a microSelectron-HDR afterloader with the mHDR-v2 source. To verify the output of the Leipzig +filter applicators, correspondence factors were deduced for the well chambers HDR100-plus (Standard Imaging, Inc., Middleton, WI) and TM33004 (PTW, Freiburg, Germany) using a specific insert for both applicators. The doses measured in the PMMA phantom agree within experimental uncertainties with the dose obtained by the MC calculations. Percentage depth dose and off-axis profiles were obtained normalized at a depth of 3 mm along the central

  14. Salvage prostate HDR brachytherapy combined with interstitial hyperthermia for local recurrence after radiation therapy failure

    Energy Technology Data Exchange (ETDEWEB)

    Kukielka, A.M.; Hetnal, M.; Dabrowski, T.; Walasek, T.; Brandys, P.; Reinfuss, M. [Centre of Oncology, M. Sklodowska - Curie Institute, Krakow Branch, Department of Radiotherapy, Krakow (Poland); Nahajowski, D.; Kudzia, R.; Dybek, D. [Centre of Oncology, M. Sklodowska - Curie Institute, Krakow Branch, Department of Medical Physics, Department of Radiotherapy, Krakow (Poland)

    2014-02-15

    The aim of the present retrospective study is to evaluate toxicity and early clinical outcomes of interstitial hyperthermia (IHT) combined with high-dose rate (HDR) brachytherapy as a salvage treatment in patients with biopsy-confirmed local recurrence of prostate cancer after previous external beam radiotherapy. Between September 2008 and March 2013, 25 patients with local recurrence of previously irradiated prostate cancer were treated. The main eligibility criteria for salvage prostate HDR brachytherapy combined with interstitial hyperthermia were biopsy confirmed local recurrence and absence of nodal and distant metastases. All patients were treated with a dose of 30 Gy in 3 fractions at 21-day intervals. We performed 62 hyperthermia procedures out of 75 planned (83 %). The aim of the hyperthermia treatment was to heat the prostate to 41-43 C for 60 min. Toxicity for the organs of the genitourinary system and rectum was assessed according to the Common Terminology Criteria for Adverse Events (CTCAE, v. 4.03). Determination of subsequent biochemical failure was based on the Phoenix definition (nadir + 2 ng/ml). The median age was 71 years (range 62-83 years), the median initial PSA level was 16.3 ng/ml (range 6.37-64 ng/ml), and the median salvage PSA level was 2.8 ng/ml (1.044-25.346 ng/ml). The median follow-up was 13 months (range 4-48 months). The combination of HDR brachytherapy and IHT was well tolerated. The most frequent complications were nocturia, weak urine stream, urinary frequency, hematuria, and urgency. Grade 2 rectal hemorrhage was observed in 1 patient. No grade 3 or higher complications were observed. The 2-year Kaplan-Meier estimate of biochemical control after salvage treatment was 74 %. The PSA in 20 patients decreased below the presalvage level, while 11 patients achieved a PSA nadir < 0.5 ng/ml. All patients are still alive. Of the 7 patients who experienced biochemical failure, bone metastases were found in 2 patients. IHT in combination

  15. Results of thermal stratification tests in a horizontal pipe line at the HDR-facility

    International Nuclear Information System (INIS)

    Global and local stresses of the pipe wall have been analyzed based on the HDR thermal stratification experiments, existing of the simulation of typical feedwater stratification phenomena in both pressurized and boiling water reactors. The measured global stresses due to the wall temperature differences have been compared to analytical values. The effect of support conditions of the piping has been clarified by an example. The highly transient local stresses due to the temperature fluctuations in the mixing layer have been evaluated on the basis of measured inside wall surface temperatures. The measured fluid and wall temperature fluctuations have been compared. Also the effect of stress fluctuations on fatigue has been estimated. (orig.)

  16. Radioterapia adjuvante no tratamento do câncer de endométrio: experiência com a associação de radio-terapia externa e braquiterapia de alta taxa de dose Adjuvant radiation therapy for the treatment of endometrial cancer: experience with combination of external radiation therapy and high-dose rate brachytherapy

    OpenAIRE

    Michael Jenwei Chen; Inês Nobuko Nishimoto; Paulo Eduardo Ribeiro Soares Novaes; Antônio Cássio Assis Pellizzon; Robson Ferrigno; Ricardo César Fogaroli; Maria Aparecida Conte Maia; João Victor Salvajoli

    2005-01-01

    OBJETIVO: Analisar, retrospectivamente, os resultados da radioterapia externa (RT) combinada a braquiterapia de alta taxa de dose (BATD), adjuvantes à cirurgia para o carcinoma de endométrio. MATERIAIS E MÉTODOS: Avaliamos 141 pacientes tratados com RT e BATD adjuvantes à cirurgia, no período de janeiro de 1993 a janeiro de 2001. RT pélvica foi realizada com dose mediana de 45 Gy, e BATD realizada na dose mediana de 24 Gy, em quatro inserções semanais de 6 Gy. A idade mediana das pacientes fo...

  17. A multicentre ‘end to end’ dosimetry audit for cervix HDR brachytherapy treatment

    International Nuclear Information System (INIS)

    Purpose: To undertake the first multicentre fully ‘end to end’ dosimetry audit for HDR cervix brachytherapy, comparing planned and delivered dose distributions around clinical treatment applicators, with review of local procedures. Materials and methods: A film-dosimetry audit was performed at 46 centres, including imaging, applicator reconstruction, treatment planning and delivery. Film dose maps were calculated using triple-channel dosimetry and compared to RTDose data from treatment planning systems. Deviations between plan and measurement were quantified at prescription Point A and using gamma analysis. Local procedures were also discussed. Results: The mean difference between planned and measured dose at Point A was −0.6% for plastic applicators and −3.0% for metal applicators, at standard uncertainty 3.0% (k = 1). Isodose distributions agreed within 1 mm over a dose range 2–16 Gy. Mean gamma passing rates exceeded 97% for plastic and metal applicators at 3% (local) 2 mm criteria. Two errors were found: one dose normalisation error and one applicator library misaligned with the imaged applicator. Suggestions for quality improvement were also made. Conclusions: The concept of ‘end to end’ dosimetry audit for HDR brachytherapy has been successfully implemented in a multicentre environment, providing evidence that a high level of accuracy in brachytherapy dosimetry can be achieved

  18. Monte Carlo angular dose distribution of the microselectron HDR 192Ir brachytherapy source

    International Nuclear Information System (INIS)

    Polar dose profiles around the Nucletron MicroSelectron high dose rate (HDR) 192Ir brachytherapy source were calculated using the Monte Carlo radiation transport code MCNP (Monte Carlo N Particle) version 4A. The geometry modeled consisted of an identical simulation of the construction of the MicroSelectron HDR source located at the centre of a spherical water phantom of 100cm radius. Doses were calculated using a spherical coordinate system at 5 degree intervals (measured relative to the cable) at radii of 0.25, 0.5,1.0, 3.0, 5.0 and 7.0cm. These polar doses were compared to equivalent profiles from the Nucletron PLATO Brachytherapy Planning System (BPS) version 13.X. At 3.0, 5.0 and 7.0cm radii, the Monte Carlo and BPS profiles are generally within 3%. The near field polar dose profiles however, are in significant disagreement. At 1.0cm radius, the discrepancy can exceed 5%. At 0.5cm this figure rises to 15%, and even 60% at 0.25cm radius

  19. HDR imaging evaluation of a NT-proBNP test with a mobile phone.

    Science.gov (United States)

    Preechaburana, P; Macken, S; Suska, A; Filippini, D

    2011-01-15

    The determination of NT-proBNP levels is key for the monitoring of patients with diagnosed heart failure and it is a routine measurement typically performed at health care centers, which would benefit from decentralized alternatives. Here we investigate the quantitative evaluation of a well-established NT-proBNP test using a standard mobile phone (Nokia 6720) as measuring platform rather than a dedicated instrument. A Java ME software developed for this application controls the illumination and imaging of the proBNP test under defined time intervals, which enables the composition of multi-exposure sets that are processed as high dynamic range (HDR) images for contrast enhancement. The results show that HDR processing significantly increases the sensitivity and resolution of the technique achieving a performance within the diagnostics range. These results demonstrate the feasibility to exploit a ubiquitous device to decentralize the evaluation of a routine test and identify key processing alternatives to bring the performance of such systems within the diagnostics range. PMID:20926279

  20. Quality control of the breast cancer treatments on Hdr brachytherapy with TLD-100

    International Nuclear Information System (INIS)

    An anthropomorphic Phantom, a female trunk, was built with a natural bone structure and experimental material coated, glycerin and water-based material called JJT to build soft tissue equivalent to the muscle of human tissue, and a polymer (styrofoam) to build the lung as critical organ to simulate the treatment of breast cancer, with high dose rate brachytherapy (Hdr) and sources of Ir-192. The treatments were planned and calculated for the critical organ: Lung, and injury of 2 cm in diameter in breast with Micro Selectron Hdr system and the software Plato Brachytherapy V 14.1 of the Nucletron (Netherlands) which uses the standard protocol of radiotherapy for brachytherapy treatments. The dose experimentally measured with dosimeters TLD-100 LiF: Mg; Ti, which were previously calibrated, were placed in the same positions and bodies mentioned above, with less than 5% uncertainty. The reading dosimeters was carried out in a Harshaw TLD 4500. The results obtained for calculated treatments, using the standard simulator, and the experimental with TLD-100, show a high concordance, as they are on average a ± 1.1% making process becomes in a quality control of this type of treatments. (Author)

  1. Monte Carlo and experimental dosimetric study of the mHDR-v2 brachytherapy source

    Directory of Open Access Journals (Sweden)

    Chandola Rakesh

    2010-01-01

    Full Text Available The conventional treatment planning system (TPS gives analytical calculations with ± 15 to 20% dose, which may lead to over exposure of critical organs or under dose of target. It is to obtain dose distribution parameters of nucletron high dose rate (HDR microselectron v2 (mHDR-v2 192 Ir brachytherapy source by experiment and by calculated study using Monte Carlo (MC EGSnrc code, and to find the similarity between them, and with any past study. To validate data, another MC GEANT4 study done in this work on the same source is also presented. Different software of the computer e.g. paint, excel, etc are employed for preparation of figures and graphs. The measured study of the source was done using an in-air ionization chamber, water phantom, and measurement set-up, while the calculated study was done by modeling the set up of the measured study by using the MC EGSnrc and GEANT4. Mean and probability are used in calculation of average values, and calculation of the uncertainties in result and discussion. The measured and calculated values of dose rate constant, radial dose function, and 2D anisotropy function were found to be in agreement with each other as well as with published data. The results of this study can be used as input to TPS.

  2. Seismic tests at the HDR facility using explosives and solid propellant rockets

    International Nuclear Information System (INIS)

    In blast tests the HDR reactor building and its mechanical equipment were subjected to earthquake-type excitations through the soil and the foundation. A series of six tests was carried out, two tests being made with HDR facility under operating conditions (BWR conditions, 2850C, 70 bar). The charges were placed in boreholes at a depth of 4 to 10 m and a distance of 16 to 25 m from the reactor building. The tests with solid propellant rockets were made in order to try a new excitation technique. The rockets used in these tests were of compact design and had a short combustion period (500 ms) at high constant thrust (100 kN per combustion chamber). These rockets were fixed to the concrete dome of the building in such a way that the thrust generated during the combustion of the propellant resulted in an impulsive load acting on the building. This type of excitation was selected with a view to investigating the global effects of the load case 'aircraft impact' on the building and the mechanical equipment. In the four tests made so far, up to four rockets were ignited simultaneously, so that the maximum impulse was 2 x 105 Ns. The excitation level can be markedly increased by adding further rockets. This excitation technique was characterised by excellent reproducibility of the load parameters. (orig./HP)

  3. Image guided Brachytherapy: The paradigm of Gynecologic and Partial Breast HDR Brachytherapy

    Science.gov (United States)

    Diamantopoulos, S.; Kantemiris, I.; Konidari, A.; Zaverdinos, P.

    2015-09-01

    High dose rate (HDR) brachytherapy uses high strength radioactive sources and temporary interstitial implants to conform the dose to target and minimize the treatment time. The advances of imaging technology enable accurate reconstruction of the implant and exact delineation of high-risk CTV and the surrounding critical structures. Furthermore, with sophisticated treatment planning systems, applicator devices and stepping source afterloaders, brachytherapy evolved to a more precise, safe and individualized treatment. At the Radiation Oncology Department of Metropolitan Hospital Athens, MRI guided HDR gynecologic (GYN) brachytherapy and accelerated partial breast irradiation (APBI) with brachytherapy are performed routinely. Contouring and treatment planning are based on the recommendations of the GEC - ESTRO Working group. The task of this presentation is to reveal the advantages of 3D image guided brachytherapy over 2D brachytherapy. Thus, two patients treated at our department (one GYN and one APBI) will be presented. The advantage of having adequate dose coverage of the high risk CTV and simultaneous low doses to the OARs when using 3D image- based brachytherapy will be presented. The treatment techniques, equipment issues, as well as implantation, imaging and treatment planning procedures will be described. Quality assurance checks will be treated separately.

  4. Verification of experimental modal modeling using HDR (Heissdampfreaktor) dynamic test data

    International Nuclear Information System (INIS)

    Experimental modal modeling involves the determination of the modal parameters of the model of a structure from recorded input-output data from dynamic tests. Though commercial modal analysis algorithms are being widely used in many industries their ability to identify a set of reliable modal parameters of an as-built nuclear power plant structure has not been systematically verified. This paper describes the effort to verify MODAL-PLUS, a widely used modal analysis code, using recorded data from the dynamic tests performed on the reactor building of the Heissdampfreaktor, situated near Frankfurt, Federal Republic of Germany. In the series of dynamic tests on HDR in 1979, the reactor building was subjected to forced vibrations from different types and levels of dynamic excitations. Two sets of HDR containment building input-output data were chosen for MODAL-PLUS analyses. To reduce the influence of nonlinear behavior on the results, these sets were chosen so that the levels of excitation are relatively low and about the same in the two sets. The attempted verification was only partially successful in that only one modal model, with a limited range of validity, could be synthesized and in that the goodness of fit could be verified only in this limited range

  5. Quality control of the breast cancer treatments on Hdr brachytherapy with TLD-100

    Energy Technology Data Exchange (ETDEWEB)

    Torres H, F. [Universidad de Cordoba, Materials and Applied Physics Group, 230002 Monteria, Cordoba (Colombia); De la Espriella V, N. [Universidad de Cordoba, Grupo Avanzado de Materiales y Sistemas Complejos, 230002 Monteria, Cordoba (Colombia); Sanchez C, A., E-mail: franciscotorreshoyos@yahoo.com [Universidad de Cordoba, Departamento de Enfermeria, 230002 Monteria, Cordoba (Colombia)

    2014-07-01

    An anthropomorphic Phantom, a female trunk, was built with a natural bone structure and experimental material coated, glycerin and water-based material called JJT to build soft tissue equivalent to the muscle of human tissue, and a polymer (styrofoam) to build the lung as critical organ to simulate the treatment of breast cancer, with high dose rate brachytherapy (Hdr) and sources of Ir-192. The treatments were planned and calculated for the critical organ: Lung, and injury of 2 cm in diameter in breast with Micro Selectron Hdr system and the software Plato Brachytherapy V 14.1 of the Nucletron (Netherlands) which uses the standard protocol of radiotherapy for brachytherapy treatments. The dose experimentally measured with dosimeters TLD-100 LiF: Mg; Ti, which were previously calibrated, were placed in the same positions and bodies mentioned above, with less than 5% uncertainty. The reading dosimeters was carried out in a Harshaw TLD 4500. The results obtained for calculated treatments, using the standard simulator, and the experimental with TLD-100, show a high concordance, as they are on average a ± 1.1% making process becomes in a quality control of this type of treatments. (Author)

  6. Implementation of the technique of partial irradiation accelerated the breast with high doses (HDR) brachytherapy; Puesta en marcha de la tecnica de irradiacion parcial acelerada de la mama con braquterapia de alta tasa de dosis (HDR)

    Energy Technology Data Exchange (ETDEWEB)

    Molina Lopez, M. Y.; Pardo Perez, E.; Castro Novais, J.; Martinez Ortega, J.; Ruiz Maqueda, S.; Cerro Penalver, E. del

    2013-07-01

    The objective of this work is presents procedure carried out in our Centre for the implementation of the accelerated partial breast irradiation (APBI, accelerated partial-breast irradiation) with high-rate brachytherapy (HDR), using plastic tubes as applicators. Carried out measures, the evaluation of the dosimetric parameters analyzing and presenting the results. (Author)

  7. Verification of dosimetry planning in brachytherapy in format Dicom and EUD calculation of Risk in bodies; Verificacion de la planificacion dosimetria en braquiterapia en formato Dicom y calculo del EUD en organos de riesgo

    Energy Technology Data Exchange (ETDEWEB)

    Garcia Hernandez, M. J.; Sendon del Rio, J. R.; Ayala Lazaro, R.; Jimenez Rojas, M. R.; Gomez Cores, S.; Polo Cezon, R.; Lopez Bote, M. A.

    2013-07-01

    This work Describes a program that automates the verification of the schedules in brachytherapy (configuration and dosimetric treatment parameters) for sources of Ir-192 (mHDR v2) and Co-60 (Co0.A86) from the plan exported in DICOM format data. (Author)

  8. Calculation Monte Carlo equivalent dose to organs in a treatment of prostate with Brachytherapy of high rate; Calculo Monte Carlo de dosis equivalente a organos en un tratamiento de prostata con braquiterapia de alta tasa

    Energy Technology Data Exchange (ETDEWEB)

    Candela-Juan, C.; Vijande, J.; Granero, D.; Ballester, F.; Perez-Calatayud, J.; Rivard, M. J.

    2013-07-01

    The objective of this study was to obtain equivalent dose to radiosensitive organs when applies brachytherapy high dose (HDR) with sources of 60 Co or 192 Go to a localized carcinoma of the prostate. The results are compared with those reported in the literature on treatment with protons and intensity modulated (IMRT) radiation therapy. (Author)

  9. Endoluminal ultrasound applicator with an integrated RF coil for high-resolution magnetic resonance imaging-guided high-intensity contact ultrasound thermotherapy

    Energy Technology Data Exchange (ETDEWEB)

    Rata, Mihaela; Salomir, Rares; Lafon, Cyril [Inserm, U556, Universite de Lyon, Lyon, F-69003 (France); Umathum, Reiner; Jenne, Juergen; Bock, Michael [DKFZ, Innovative Cancer Diagnostics and Therapy, Heidelberg (Germany); Cotton, Francois [Universite Claude Bernard Lyon 1, Lyon F-69003 (France)], E-mail: rares.salomir@inserm.fr

    2008-11-21

    High-intensity contact ultrasound (HICU) under MRI guidance may provide minimally invasive treatment of endocavitary digestive tumors in the esophagus, colon or rectum. In this study, a miniature receive-only coil was integrated into an endoscopic ultrasound applicator to offer high-resolution MRI guidance of thermotherapy. A cylindrical plastic support with an incorporated single element flat transducer (9.45 MHz, water cooling tip) was made and equipped with a rectangular RF loop coil surrounding the active element. The integrated coil provided significantly higher sensitivity than a four-element extracorporeal phased array coil, and the standard deviation of the MR thermometry (SDT) improved up to a factor of 7 at 10 mm depth in tissue. High-resolution morphological images (T1w-TFE and IR-T1w-TSE with a voxel size of 0.25 x 0.25 x 3 mm{sup 3}) and accurate thermometry data (the PRFS method with a voxel size of 0.5 x 0.5 x 5 mm{sup 3}, 2.2 s/image, 0.3 deg. C voxel-wise SDT) were acquired in an ex vivo esophagus sample, on a clinical 1.5T scanner. The endoscopic device was actively operated under automatic temperature control, demonstrating a high level of accuracy (1.7% standard deviation, 1.1% error of mean value), which indicates that this technology may be suitable for HICU therapy of endoluminal cancer.

  10. Endoluminal Revision (OverStitch (TM) , Apollo Endosurgery) of the Dilated Gastroenterostomy in Patients with Late Dumping Syndrome After Proximal Roux-en-Y Gastric Bypass.

    Science.gov (United States)

    Stier, Christine; Chiappetta, Sonja

    2016-08-01

    Dumping syndrome is a long-term postoperative complication of Roux-en-Y gastric bypass procedures. Morphologically, dumping syndrome usually correlates with a dilatation of the gastroenterostomy with accelerated pouch emptying. Conservative therapy includes diet changes, complementary pharmacotherapy and, if symptoms persist, surgical revision. Surgical options include endoscopic, endoluminal surgery to constrict the gastrojejunostomy using a novel endoscopic suturing device (OverStitch(TM), Apollo). In our study, we aimed to assess the viability, safety and efficacy of this procedure in patients with late dumping; 14 patients who had developed late dumping syndrome underwent surgery using an endoscopic suturing technique (OverStitch(TM), Apollo). Late dumping was confirmed by Sigstad score and an oral glucose tolerance test (OGTT). Prior to surgery, objective analysis of pouch emptying speed was assessed by gastric scintigraphy. Surgery was performed under general anaesthesia. None of the 14 patients suffered intra- or postoperative complications. No postsurgical increase in inflammation parameters was observed. The postinterventional pain scale (visual analogue scale) showed a mean score of 0.5 (range 0-10). In 13 of the 14 patients, no dumping was observed 1-month postsurgery. The postoperative Sigstad score (3.07 ± 2.06; range 1-9) showed an impressive reduction compared with the preoperative score (12.71 ± 4.18; range 7-24) (p dumping syndrome involving minimal trauma and offering rapid reconvalescence. PMID:27318467

  11. Balloon-based adjuvant radiotherapy in breast cancer: comparison between 99mTc and HDR 192Ir*

    Science.gov (United States)

    de Campos, Tarcísio Passos Ribeiro; de Lima, Carla Flavia; Cuperschmid, Ethel Mizrahy

    2016-01-01

    Objective To perform a comparative dosimetric analysis, based on computer simulations, of temporary balloon implants with 99mTc and balloon brachytherapy with high-dose-rate (HDR) 192Ir, as boosts to radiotherapy. We hypothesized that the two techniques would produce equivalent doses under pre-established conditions of activity and exposure time. Materials and Methods Simulations of implants with 99mTc-filled and HDR 192Ir-filled balloons were performed with the Siscodes/MCNP5, modeling in voxels a magnetic resonance imaging set related to a young female. Spatial dose rate distributions were determined. In the dosimetric analysis of the protocols, the exposure time and the level of activity required were specified. Results The 99mTc balloon presented a weighted dose rate in the tumor bed of 0.428 cGy.h-1.mCi-1 and 0.190 cGyh-1.mCi-1 at the balloon surface and at 8-10 mm from the surface, respectively, compared with 0.499 and 0.150 cGyh-1.mCi-1, respectively, for the HDR 192Ir balloon. An exposure time of 24 hours was required for the 99mTc balloon to produce a boost of 10.14 Gy with 1.0 Ci, whereas only 24 minutes with 10.0 Ci segments were required for the HDR 192Ir balloon to produce a boost of 5.14 Gy at the same reference point, or 10.28 Gy in two 24-minutes fractions. Conclusion Temporary 99mTc balloon implantation is an attractive option for adjuvant radiotherapy in breast cancer, because of its availability, economic viability, and similar dosimetry in comparison with the use of HDR 192Ir balloon implantation, which is the current standard in clinical practice. PMID:27141131

  12. An innovative method for 192Ir HDR calibration by farmer chamber, V-film, and solid phantom

    International Nuclear Information System (INIS)

    A simple, practical and economical technique was proposed to calibrate an 192Ir HDR brachytherapy source in terms of air kerma strength. This technique makes use of the 0.6 cm3 Farmer type ion chamber, radiographic film and polystyrene phantom. These tools are commonly used for dosimetry quality assurance of the clinical linear accelerator. In this study, the Exradin A19, PTW N30004 and TM30001 Farmer type ion chambers were used for the calibration of the 192Ir HDR source. To perform the calibration, a 25.4x30.5 cm2 radiographic film was taped on a piece of polystyrene plate, and a straight applicator probe of a HDR brachytherapy unit and the Farmer type ion chamber were affixed to the film envelope. The film was irradiated by the 192Ir source, followed by an exposure in the simulator X-ray beam. The film set with the film removed was then placed on a 5 cm thick polystyrene phantom for calibration measurement. Based on the electrometer reading from the Farmer type ion chamber irradiated by 192Ir and the measured source-to-chamber distance by means of the images on the developed film, we can calculate the air kerma strength of the 192Ir using the new technique. Our calibration results were compared to the data provided by the manufacturer and that of five different well type ion chambers, namely, Sun Nuclear cooperation (SNC) 1008, Nucletron SDS 077.091, SDS 077.094, PTW TN33004 and Standard Imaging (SI) HDR-1000 Plus. The differences were all within 1.6%. Relative to the '7-distance measurement technique' by Stump et al., 2002, our method is more efficient if our empirical formula was used. In summary, our method is simpler and cost-effective to calibrate an 192Ir HDR brachytherapy source for those hospitals without a calibration jig or a well type ion chamber.

  13. MRS-guided HDR brachytherapy boost to the dominant intraprostatic lesion in high risk localised prostate cancer

    International Nuclear Information System (INIS)

    It is known that the vast majority of prostate cancers are multifocal. However radical radiotherapy historically treats the whole gland rather than individual cancer foci. Magnetic resonance spectroscopy (MRS) can be used to non-invasively locate individual cancerous tumours in prostate. Thus an intentionally non-uniform dose distribution treating the dominant intraprostatic lesion to different dose levels than the remaining prostate can be delivered ensuring the maximum achievable tumour control probability. The aim of this study is to evaluate, using radiobiological means, the feasibility of a MRS-guided high dose rate (HDR) brachytherapy boost to the dominant lesion. Computed tomography and MR/MRS were performed for treatment planning of a high risk localised prostate cancer. Both were done without endorectal coil, which distorts shape of prostate during the exams. Three treatment plans were compared: - external beam radiation therapy (EBRT) only - combination of EBRT and HDR brachytherapy - combination of EBRT and HDR brachytherapy with a synchronous integrated boost to the dominant lesion The criteria of plan comparison were: the minimum, maximum and average doses to the targets and organs at risk; dose volume histograms; biologically effective doses for organs at risk and tumour control probability for the target volumes consisting of the dominant lesion as detected by MR/MRS and the remaining prostate volume. Inclusion of MRS information on the location of dominant lesion allows a safe increase of the dose to the dominant lesion while dose to the remaining target can be even substantially decreased keeping the same, high tumour control probability. At the same time an improved urethra sparing was achieved comparing to the treatment plan using a combination of EBRT and uniform HDR brachytherapy. MRS-guided HDR brachytherapy boost to dominant lesion has the potential to spare the normal tissue, especially urethra, while keeping the tumour control probability

  14. Balloon-based adjuvant radiotherapy in breast cancer: comparison between {sup 99m}Tc and HDR {sup 192}Ir

    Energy Technology Data Exchange (ETDEWEB)

    Campos, Tarcisio Passos Ribeiro de; Lima, Carla Flavia de; Cuperschmid, Ethel Mizrahy, E-mail: tprcampos@pq.cnpq.br [Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG (Brazil)

    2016-03-15

    Objective: To perform a comparative dosimetric analysis, based on computer simulations, of temporary balloon implants with {sup 99m}Tc and balloon brachytherapy with high-dose-rate (HDR) {sup 192}Ir, as boosts to radiotherapy. We hypothesized that the two techniques would produce equivalent doses under pre-established conditions of activity and exposure time. Materials and methods: simulations of implants with {sup 99m}Tc-filled and HDR {sup 192}Ir-filled balloons were performed with the Siscodes/MCNP5, modeling in voxels a magnetic resonance imaging set related to a young female. Spatial dose rate distributions were determined. In the dosimetric analysis of the protocols, the exposure time and the level of activity required were specified. Results: the {sup 99m}Tc balloon presented a weighted dose rate in the tumor bed of 0.428 cGy.h{sup -1}.mCi{sup -1} and 0.190 cGyh{sup -1} at the balloon surface and at 8-10 mm from the surface, respectively, compared with 0.499 and 0.150 cGyh{sup -1}.mCi{sup -1}, respectively, for the HDR {sup 192}Ir balloon. An exposure time of 24 hours was required for the {sup 99m}Tc balloon to produce a boost of 10.14 Gy with 1.0 Ci, whereas only 24 minutes with 10.0 Ci segments were required for the HDR {sup 192}Ir balloon to produce a boost of 5.14 Gy at the same reference point, or 10.28 Gy in two 24-minutes fractions. Conclusion: temporary {sup 99m}Tc balloon implantation is an attractive option for adjuvant radiotherapy in breast cancer, because of its availability, economic viability, and similar dosimetry in comparison with the use of HDR {sup 192}Ir balloon implantation, which is the current standard in clinical practice. (author)

  15. Source position verification and dosimetry in HDR brachytherapy using an EPID

    International Nuclear Information System (INIS)

    Purpose: Accurate treatment delivery in high dose rate (HDR) brachytherapy requires correct source dwell positions and dwell times to be administered relative to each other and to the surrounding anatomy. Treatment delivery inaccuracies predominantly occur for two reasons: (i) anatomical movement or (ii) as a result of human errors that are usually related to incorrect implementation of the planned treatment. Electronic portal imaging devices (EPIDs) were originally developed for patient position verification in external beam radiotherapy and their application has been extended to provide dosimetric information. The authors have characterized the response of an EPID for use with an 192Ir brachytherapy source to demonstrate its use as a verification device, providing both source position and dosimetric information.Methods: Characterization of the EPID response using an 192Ir brachytherapy source included investigations of reproducibility, linearity with dose rate, photon energy dependence, and charge build-up effects associated with exposure time and image acquisition time. Source position resolution in three dimensions was determined. To illustrate treatment verification, a simple treatment plan was delivered to a phantom and the measured EPID dose distribution compared with the planned dose.Results: The mean absolute source position error in the plane parallel to the EPID, for dwells measured at 50, 100, and 150 mm source to detector distances (SDD), was determined to be 0.26 mm. The resolution of the z coordinate (perpendicular distance from detector plane) is SDD dependent with 95% confidence intervals of ±0.1, ±0.5, and ±2.0 mm at SDDs of 50, 100, and 150 mm, respectively. The response of the EPID is highly linear to dose rate. The EPID exhibits an over-response to low energy incident photons and this nonlinearity is incorporated into the dose calibration procedure. A distance (spectral) dependent dose rate calibration procedure has been developed. The

  16. Neodadjuvante und adjuvante Kurzzeit-Hormontherapie in Kombination mit konformaler HDR-Brachytherapie beim Prostatakarzinom

    Directory of Open Access Journals (Sweden)

    Martin T

    2004-01-01

    Full Text Available Zielsetzung: Auswertung der Behandlungsergebnisse der neoadjuvanten und adjuvanten Kurzzeit-Hormontherapie kombiniert mit konformaler HDR-Brachytherapie und externer Radiotherapie beim Prostatakarzinom. Patienten und Methoden: Von 01/97 bis 09/99 behandelten wir 102 Patienten mit Prostatakarzinomen im Stadium T1–3 N0 M0. Im Stadium T1–2 befanden sich 71, im Stadium T3 31 Patienten. Der mediane prätherapeutische PSA-Wert betrug 15,3 ng/ml. Nach ultraschallgesteuerter transrektaler Implantation von vier Afterloadingnadeln erfolgte die CT-gestützte 3D-Brachytherapie- Planung. Alle Patienten erhielten vier HDR-Implantate mit einer Referenzdosis von 5 Gy oder 7 Gy pro Implantat. Die Zeit zwischen jedem Implantat betrug jeweils 14 Tage. Nach der Brachytherapie folgte die externe Radiotherapie bis 39,6 Gy oder 45,0 Gy. Alle Patienten erhielten eine neoadjuvante und adjuvante Kurzzeit-Hormontherapie, die 2–19 Monate vor der Brachytherapie eingeleitet und 3 Monate nach Abschluß der externen Radiotherapie abgesetzt wurde (mediane Dauer: 9 Monate. Ergebnisse: Die mediane Nachbeobachtungszeit war 2,6 Jahre (range: 2,0–4,1 Jahre. Die biochemische Kontrollrate betrug 82 % nach 3 Jahren. Bei 14/102 Patienten registrierten wir ein biochemisches Rezidiv, bei 5/102 Patienten ein klinisches Rezidiv. Das Gesamtüberleben betrug 90 %, das krankheitsspezifische Überleben 98,0 % nach 3 Jahren. Ein Patient entwickelte eine prostato-urethro-rektale Fistel als späte Grad 4-Toxizität. Akute Grad-3 Toxizitäten traten bei 4 %, späte Grad-3 Toxizitäten bei 5 % der Patienten auf. Schlußfolgerung: Die neoadjuvante und adjuvante Kurzzeit-Hormontherapie kombiniert mit konformaler HDR-Brachytherapie und externer Radiotherapie erweist sich als sichere und wirksame Behandlungsmodalität beim Prostatakarzinom mit minimalen behandlungsbedingten Toxizitäten und einer vielversprechenden biochemischen Kontrollrate nach medianer Nachbeobachtungszeit von 2,6 Jahren.

  17. Comparison of air-kerma strength determinations for HDR 192Ir sources

    International Nuclear Information System (INIS)

    Purpose: To perform a comparison of the interim air-kerma strength standard for high dose rate (HDR) 192Ir brachytherapy sources maintained by University of Wisconsin Accredited Dosimetry Calibration Laboratory (UWADCL) with measurements of the various source models using modified techniques from the literature. The current interim standard was established by Goetsch et al. in 1991 and has remained unchanged to date. Methods: The improved, laser-aligned seven-distance apparatus of University of Wisconsin Medical Radiation Research Center (UWMRRC) was used to perform air-kerma strength measurements of five different HDR 192Ir source models. The results of these measurements were compared with those from well chambers traceable to the original standard. Alternative methodologies for interpolating the 192Ir air-kerma calibration coefficient from the NIST air-kerma standards at 137Cs and 250 kVp x rays (M250) were investigated and intercompared. As part of the interpolation method comparison, the Monte Carlo code EGSnrc was used to calculate updated values of Awall for the Exradin A3 chamber used for air-kerma strength measurements. The effects of air attenuation and scatter, room scatter, as well as the solution method were investigated in detail. Results: The average measurements when using the inverse NK interpolation method for the Classic Nucletron, Nucletron microSelectron, VariSource VS2000, GammaMed Plus, and Flexisource were found to be 0.47%, -0.10%, -1.13%, -0.20%, and 0.89% different than the existing standard, respectively. A further investigation of the differences observed between the sources was performed using MCNP5 Monte Carlo simulations of each source model inside a full model of an HDR 1000 Plus well chamber. Conclusions: Although the differences between the source models were found to be statistically significant, the equally weighted average difference between the seven-distance measurements and the well chambers was 0.01%, confirming that it is

  18. Video Enhancement and Dynamic Range Control of HDR Sequences for Automotive Applications

    Directory of Open Access Journals (Sweden)

    Giovanni Ramponi

    2007-01-01

    Full Text Available CMOS video cameras with high dynamic range (HDR output are particularly suitable for driving assistance applications, where lighting conditions can strongly vary, going from direct sunlight to dark areas in tunnels. However, common visualization devices can only handle a low dynamic range, and thus a dynamic range reduction is needed. Many algorithms have been proposed in the literature to reduce the dynamic range of still pictures. Anyway, extending the available methods to video is not straightforward, due to the peculiar nature of video data. We propose an algorithm for both reducing the dynamic range of video sequences and enhancing its appearance, thus improving visual quality and reducing temporal artifacts. We also provide an optimized version of our algorithm for a viable hardware implementation on an FPGA. The feasibility of this implementation is demonstrated by means of a case study.

  19. HDR Brachytherapy in the Management of High-Risk Prostate Cancer

    Directory of Open Access Journals (Sweden)

    Susan Masson

    2012-01-01

    Full Text Available High-dose-rate (HDR brachytherapy is used with increasing frequency for the treatment of prostate cancer. It is a technique which allows delivery of large individual fractions to the prostate without exposing adjacent normal tissues to unacceptable toxicity. This approach is particularly favourable in prostate cancer where tumours are highly sensitive to dose escalation and to increases in radiotherapy fraction size, due to the unique radiobiological behaviour of prostate cancers in contrast with other malignancies. In this paper we discuss the rationale and the increasing body of clinical evidence for the use of this technique in patients with high-risk prostate cancer, where it is combined with external beam radiotherapy. We highlight practical aspects of delivering treatment and discuss toxicity and limitations, with particular reference to current practice in the United Kingdom.

  20. Implementation of GaN based real-time source position monitoring in HDR brachytherapy

    International Nuclear Information System (INIS)

    For High Dose Rate (HDR) brachytherapy Quality Assurance (QA), we propose a seed position verification method by using two GaN dosimetric probes integrated in an instrumented phantom. As dose rate measured from one probe is related to the seed distance, seed position inside catheter can be determined. The proposed two-probe method extends measureable range and improves accuracy in comparison with the use of one single probe. One instrumented phantom implementing the method was designed, fabricated and tested in clinical conditions. The measureable range of the two-probe method is 105 mm compared to 36 mm using single probe. The validity of the method was experimentally verified. - Highlights: • A simple brachytherapy QA phantom has been instrumented. • Dwell positions have been estimated according to measured dose rate by GaN probes. • Measured dose rate shows 1% average deviation from calculated results. • Determined dwell position precision and measureable range was studied

  1. Mixed integer programming improves comprehensibility and plan quality in inverse optimization of prostate HDR-brachytherapy

    CERN Document Server

    Gorissen, Bram L; Hoffmann, Aswin L

    2014-01-01

    Current inverse treatment planning methods that optimize both catheter positions and dwell times in prostate HDR brachytherapy use surrogate linear or quadratic objective functions that have no direct interpretation in terms of dose-volume histogram (DVH) criteria, do not result in an optimum or have long solution times. We decrease the solution time of existing linear and quadratic dose-based programming models (LP and QP, respectively) to allow optimizing over potential catheter positions using mixed integer programming. An additional average speed-up of 75% can be obtained by stopping the solver at an early stage, without deterioration of the plan quality. For a fixed catheter configuration, the dwell time optimization model LP solves to optimality in less than 15 seconds, which confirms earlier results. We propose an iterative procedure for QP that allows to prescribe the target dose as an interval, while retaining independence between the solution time and the number of dose calculation points. This iter...

  2. Recalculations of HDR test T31.5 analyses with contain version 1.1

    International Nuclear Information System (INIS)

    This document presents the results of recalculations of the ISP-23 analysis and the additional hydrogen benchmark analysis. Both analyses were based on test T31.5 as performed in the HDR test facility in Germany. ECN participated in these analyses in the period 1988-1989. The new analyses have been performed to gain a better insight on how to model complex volume containment geometries with the CONTAIN computer program. Two recalculations have been performed: 1. a recalculation with a modified version of the 14 cell input model as has been used in the original calculation; 2. a recalculation with a more detailed input model. This latter model will also serve as basis for the upcoming ISP-29. (author). 8 refs.; 31 figs.; 1 tab

  3. Analytical simulation of seismic testing of VKL piping system at the HDR test facility

    International Nuclear Information System (INIS)

    The paper describes the analytical modeling, calculations, and results of the posttest simulation of seismic testing of the VKL piping system at the HDR Test Facility in West Germany. A main objective of the tests was to evaluate analytical methods for calculating the seismic response of realistic piping systems subjected to seismic excitation. Six different pipe-support configurations, ranging from a stiff system with struts and snubbers to a very flexible system with practically no seismic supports, were subjected to simulated earthquakes. The posttest calculations cover the stiffest system with snubbers, and a reasonably compliant system with only rigid struts. Responses for 100 to 300% safe-shutdown-earthquake loading were calculated using the piping response module of the SMACS code with multiple, independent support acceleration input. Analytical simulation of the tests was found to somewhat underestimate the responses. The paper discusses the possible explanation for this and the effect on the results of the damping ratios assumed

  4. SW England seismic monitoring for the HDR geothermal programme in Cornwall 1989 to September 1991

    International Nuclear Information System (INIS)

    The potential for earthquakes to be triggered by fluid injected into boreholes has been recognised for 25 years and natural earthquakes in Cornwall have been reported for over 250 years. As a result, the Geothermal Steering Committee advising the Hot Dry Rock project recommended that background seismic monitoring be undertaken around the HDR experimental site at Rosemanowes. A network of seismographs was established for this purpose by the British Geological Survey (BGS) in late 1980 and has been operated continuously through September 1991. The primary aim of the network has been to provide an independent, continuous assessment of all vibrational transients in order to discriminate between those caused by the Hot Dry Rock experiments and those of natural origin or from other man-made sources. In this respect, the work provides an insurance against claims that extraneous seismic activity is related to those experiments. (author)

  5. Measurement of pre-assembled source trains using HDR-1000 plus well-chamber

    International Nuclear Information System (INIS)

    Manual afterloading kit for intracavitary irradiation often makes use of spring-loaded multiple source assembly. The pre-assembled source trains pose problem for verification of source strength, quoted by the supplier. Measurements have been carried out to estimate the correction required for measurement of spring loaded source trains, supplied by BRIT, using HDR-1000 Plus well-type ionisation chamber. The correction factor required for measurement of medium tandem loading worked out to be about 1.015 and that for long tandem about 1.026. It has also been observed that marginal differences in the length and relative activity of individual sources do not make significant difference in the estimated correction factor. (author)

  6. Enhancement and validation of Geant4 Brachytherapy application on clinical HDR 192Ir source

    International Nuclear Information System (INIS)

    The Geant4 Monte Carlo MC associated Brachytherapy example was adapted, enhanced and several analysis techniques have been developed. The simulation studies the isodose distribution of the total, primary and scattered doses around a Nucletron microSelectron 192Ir source. Different phantom materials were used (water, tissue and bone) and the calculation was conducted at various depths and planes. The work provides an early estimate of the required number of primary events to ultimately achieve a given uncertainty at a given distance, in the otherwise CPU and time consuming clinical MC calculation. The adaptation of the Geant4 toolkit and the enhancements introduced to the code are all validated including the comprehensive decay of the 192Ir source, the materials used to build the geometry, the geometry itself and the calculated scatter to primary dose ratio. The simulation quantitatively illustrates that the scattered dose in the bone medium is larger than its value in water and tissue. As the distance away from the source increases, scatter contribution to dose becomes more significant as the primary dose decreases. The developed code could be viewed as a platform that contains detailed dose calculation model for clinical application of HDR 192Ir in Brachytherapy. - Highlights: • We enhanced and validated the Geant4 associated Brachytherapy code. • Primary and scattered doses from an actual 192Ir source are separated. • Different phantom materials are investigated. • The number of primary events to achieve a given uncertainty is provided. • A platform for detailed dose for clinical HDR Brachytherapy is established

  7. An automated optimization tool for high-dose-rate (HDR) prostate brachytherapy with divergent needle pattern

    Science.gov (United States)

    Borot de Battisti, M.; Maenhout, M.; de Senneville, B. Denis; Hautvast, G.; Binnekamp, D.; Lagendijk, J. J. W.; van Vulpen, M.; Moerland, M. A.

    2015-10-01

    Focal high-dose-rate (HDR) for prostate cancer has gained increasing interest as an alternative to whole gland therapy as it may contribute to the reduction of treatment related toxicity. For focal treatment, optimal needle guidance and placement is warranted. This can be achieved under MR guidance. However, MR-guided needle placement is currently not possible due to space restrictions in the closed MR bore. To overcome this problem, a MR-compatible, single-divergent needle-implant robotic device is under development at the University Medical Centre, Utrecht: placed between the legs of the patient inside the MR bore, this robot will tap the needle in a divergent pattern from a single rotation point into the tissue. This rotation point is just beneath the perineal skin to have access to the focal prostate tumor lesion. Currently, there is no treatment planning system commercially available which allows optimization of the dose distribution with such needle arrangement. The aim of this work is to develop an automatic inverse dose planning optimization tool for focal HDR prostate brachytherapy with needle insertions in a divergent configuration. A complete optimizer workflow is proposed which includes the determination of (1) the position of the center of rotation, (2) the needle angulations and (3) the dwell times. Unlike most currently used optimizers, no prior selection or adjustment of input parameters such as minimum or maximum dose or weight coefficients for treatment region and organs at risk is required. To test this optimizer, a planning study was performed on ten patients (treatment volumes ranged from 8.5 cm3to 23.3 cm3) by using 2-14 needle insertions. The total computation time of the optimizer workflow was below 20 min and a clinically acceptable plan was reached on average using only four needle insertions.

  8. The contribution from transit dose for 192Ir HDR brachytherapy treatments

    Science.gov (United States)

    Fonseca, G. P.; Landry, G.; Reniers, B.; Hoffmann, A.; Rubo, R. A.; Antunes, P. C. G.; Yoriyaz, H.; Verhaegen, F.

    2014-04-01

    Brachytherapy treatment planning systems that use model-based dose calculation algorithms employ a more accurate approach that replaces the TG43-U1 water dose formalism and adopt the TG-186 recommendations regarding composition and geometry of patients and other relevant effects. However, no recommendations were provided on the transit dose due to the source traveling inside the patient. This study describes a methodology to calculate the transit dose using information from the treatment planning system (TPS) and considering the source's instantaneous and average speed for two prostate and two gynecological cases. The trajectory of the 192Ir HDR source was defined by importing applicator contour points and dwell positions from the TPS. The transit dose distribution was calculated using the maximum speed, the average speed and uniform accelerations obtained from the literature to obtain an approximate continuous source distribution simulated with a Monte Carlo code. The transit component can be negligible or significant depending on the speed profile adopted, which is not clearly reported in the literature. The significance of the transit dose can also be due to the treatment modality; in our study interstitial treatments exhibited the largest effects. Considering the worst case scenario the transit dose can reach 3% of the prescribed dose in a gynecological case with four catheters and up to 11.1% when comparing the average prostate dose for a case with 16 catheters. The transit dose component increases by increasing the number of catheters used for HDR brachytherapy, reducing the total dwell time per catheter or increasing the number of dwell positions with low dwell times. This contribution may become significant (>5%) if it is not corrected appropriately. The transit dose cannot be completely compensated using simple dwell time corrections since it may have a non-uniform distribution. An accurate measurement of the source acceleration and maximum speed should be

  9. The contribution from transit dose for 192Ir HDR brachytherapy treatments

    International Nuclear Information System (INIS)

    Brachytherapy treatment planning systems that use model-based dose calculation algorithms employ a more accurate approach that replaces the TG43-U1 water dose formalism and adopt the TG-186 recommendations regarding composition and geometry of patients and other relevant effects. However, no recommendations were provided on the transit dose due to the source traveling inside the patient. This study describes a methodology to calculate the transit dose using information from the treatment planning system (TPS) and considering the source's instantaneous and average speed for two prostate and two gynecological cases. The trajectory of the 192Ir HDR source was defined by importing applicator contour points and dwell positions from the TPS. The transit dose distribution was calculated using the maximum speed, the average speed and uniform accelerations obtained from the literature to obtain an approximate continuous source distribution simulated with a Monte Carlo code. The transit component can be negligible or significant depending on the speed profile adopted, which is not clearly reported in the literature. The significance of the transit dose can also be due to the treatment modality; in our study interstitial treatments exhibited the largest effects. Considering the worst case scenario the transit dose can reach 3% of the prescribed dose in a gynecological case with four catheters and up to 11.1% when comparing the average prostate dose for a case with 16 catheters. The transit dose component increases by increasing the number of catheters used for HDR brachytherapy, reducing the total dwell time per catheter or increasing the number of dwell positions with low dwell times. This contribution may become significant (>5%) if it is not corrected appropriately. The transit dose cannot be completely compensated using simple dwell time corrections since it may have a non-uniform distribution. An accurate measurement of the source acceleration and maximum speed

  10. Ir-192 HDR transit dose and radial dose function determination using alanine/EPR dosimetry

    Energy Technology Data Exchange (ETDEWEB)

    Calcina, Carmen S Guzman [Departamento de FIsica e Matematica, FFCLRP, Universidade de Sao Paulo, Av Bandeirantes 3900, 14040-901, Ribeirao Preto, SP (Brazil); Almeida, Adelaide de [Departamento de FIsica e Matematica, FFCLRP, Universidade de Sao Paulo, Av Bandeirantes 3900, 14040-901, Ribeirao Preto, SP (Brazil); Rocha, Jose R Oliveira [Setor de FIsica Medica-CEB-UNICAMP e Setor de Radioterapia-CAISM-UNICAMP (Brazil); Abrego, Felipe Chen [Departamento de FIsica e Matematica, FFCLRP, Universidade de Sao Paulo, Av Bandeirantes 3900, 14040-901, Ribeirao Preto, SP (Brazil); Baffa, Oswaldo [Departamento de FIsica e Matematica, FFCLRP, Universidade de Sao Paulo, Av Bandeirantes 3900, 14040-901, Ribeirao Preto, SP (Brazil)

    2005-03-21

    Source positioning close to the tumour in high dose rate (HDR) brachytherapy is not instantaneous. An increment of dose will be delivered during the movement of the source in the trajectory to its static position. This increment is the transit dose, often not taken into account in brachytherapeutic treatment planning. The transit dose depends on the prescribed dose, number of treatment fractions, velocity and activity of the source. Combining all these factors, the transit dose can be 5% higher than the prescribed absorbed dose value (Sang-Hyun and Muller-Runkel, 1994 Phys. Med. Biol. 39 1181-8, Nath et al 1995 Med. Phys. 22 209-34). However, it cannot exceed this percentage (Nath et al 1995). In this work, we use the alanine-EPR (electron paramagnetic resonance) dosimetric system using analysis of the first derivative of the signal. The transit dose was evaluated for an HDR system and is consistent with that already presented for TLD dosimeters (Bastin et al 1993 Int. J. Radiat. Oncol. Biol. Phys. 26 695-702). Also using the same dosimetric system, the radial dose function, used to evaluate the geometric dose degradation around the source, was determined and its behaviour agrees better with those obtained by Monte Carlo simulations (Nath et al 1995, Williamson and Nath 1991 Med. Phys. 18 434-48, Ballester et al 1997 Med. Phys. 24 1221-8, Ballester et al 2001 Phys. Med. Biol. 46 N79-90) than with TLD measurements (Nath et al 1990 Med. Phys. 17 1032-40)

  11. An automated optimization tool for high-dose-rate (HDR) prostate brachytherapy with divergent needle pattern.

    Science.gov (United States)

    Borot de Battisti, M; Maenhout, M; Denis de Senneville, B; Hautvast, G; Binnekamp, D; Lagendijk, J J W; van Vulpen, M; Moerland, M A

    2015-10-01

    Focal high-dose-rate (HDR) for prostate cancer has gained increasing interest as an alternative to whole gland therapy as it may contribute to the reduction of treatment related toxicity. For focal treatment, optimal needle guidance and placement is warranted. This can be achieved under MR guidance. However, MR-guided needle placement is currently not possible due to space restrictions in the closed MR bore. To overcome this problem, a MR-compatible, single-divergent needle-implant robotic device is under development at the University Medical Centre, Utrecht: placed between the legs of the patient inside the MR bore, this robot will tap the needle in a divergent pattern from a single rotation point into the tissue. This rotation point is just beneath the perineal skin to have access to the focal prostate tumor lesion. Currently, there is no treatment planning system commercially available which allows optimization of the dose distribution with such needle arrangement. The aim of this work is to develop an automatic inverse dose planning optimization tool for focal HDR prostate brachytherapy with needle insertions in a divergent configuration. A complete optimizer workflow is proposed which includes the determination of (1) the position of the center of rotation, (2) the needle angulations and (3) the dwell times. Unlike most currently used optimizers, no prior selection or adjustment of input parameters such as minimum or maximum dose or weight coefficients for treatment region and organs at risk is required. To test this optimizer, a planning study was performed on ten patients (treatment volumes ranged from 8.5 cm(3)to 23.3 cm(3)) by using 2-14 needle insertions. The total computation time of the optimizer workflow was below 20 min and a clinically acceptable plan was reached on average using only four needle insertions. PMID:26378657

  12. Dosimetric analysis at ICRU reference points in HDR-brachytherapy of cervical carcinoma

    International Nuclear Information System (INIS)

    In vivo dosimetry in bladder and rectum as well as determining doses on suggested reference points following the ICRU report 38 contribute to quality assurance in HDR-brachytherapy of cervical carcinoma, especially to minimize side effects. In order to gain information regarding the radiation exposure at ICRU reference points in rectum, bladder, ureter and regional lymph nodes those were calculated (digitalisation) by means of orthogonal radiography of 11 applications in patients with cervical carcinoma, who receiver primary radiotherapy. In addition, the doses at the ICRU rectum reference point was compared to the results of in vivo measurements in the rectum. The in vivo measurements were by factor 1.5 below the doses determined for the ICRU rectum reference point (4.05±0.68 Gy versus 6.11±1.63 Gy). Reasons for this were: Calibration errors, non-orthogonal radiographs, movement of applicator and probe in the time span between X-ray and application, missing connection of probe and anterior rectal wall. The standard deviation of calculations at ICRU reference points was on average ±30%. Possible reasons for the relatively large standard deviation were difficulties in defining the points, identifying them on radiographs and the different locations of the applicators. Although 3 D CT, US or MR based treatment planning using dose volume histogram analysis is more and more established, this simple procedure of marking and digitising the ICRU reference points lengthened treatment planning only by 5 to 10 minutes. The advantages of in vivo dosimetry are easy practicability and the possibility to determine rectum doses during radiation. The advantages of computer-aided planning at ICRU reference points are that calculations are available before radiation and that they can still be taken into account for treatment planning. Both methods should be applied in HDR-brachytherapy of cervical carcinoma. (orig.)

  13. Enrichment of G2/M cell cycle phase in human pluripotent stem cells enhances HDR-mediated gene repair with customizable endonucleases

    OpenAIRE

    Diane Yang; Scavuzzo, Marissa A.; Jolanta Chmielowiec; Robert Sharp; Aleksandar Bajic; Malgorzata Borowiak

    2016-01-01

    Efficient gene editing is essential to fully utilize human pluripotent stem cells (hPSCs) in regenerative medicine. Custom endonuclease-based gene targeting involves two mechanisms of DNA repair: homology directed repair (HDR) and non-homologous end joining (NHEJ). HDR is the preferred mechanism for common applications such knock-in, knock-out or precise mutagenesis, but remains inefficient in hPSCs. Here, we demonstrate that synchronizing synchronizing hPSCs in G2/M with ABT phase increases ...

  14. Carcinoma of the cervix: analysis of complications after primary external beam radiation and Ir-192 HDR brachytherapy

    International Nuclear Information System (INIS)

    Background and purpose: There is still a concern that the use of HDR brachytherapy might result in an increase of late tissue damage. This retrospective study evaluates the incidence and severity of late complications in patients with carcinoma of the cervix who underwent combined external beam radiation (EBR) and Ir-192 HDR brachytherapy and attempts to identify pretreatment and treatment parameters correlating with late complications. Material and methods: Between 1985 and 1992, 161 patients with carcinoma of the cervix (FIGO stages IB-IVB) received EBR to the pelvis (ave. max. dose 48.8 Gy) followed by 1-6 Ir-192 HDR placements (median 2). Doses to point A ranged from 8.5 to 38.7 Gy (median 17 Gy). Parameters examined included age, diabetes, obesity, history of inflammatory bowel disease or diverticulitis, prior surgery, hemoglobin level, FIGO stage, EBR dose, technique and daily dose fraction, number of HDR treatments and total dose to point A, maximum doses to bladder and rectum delivered by brachytherapy and cumulative dose to point A. Median follow-up for all patients was 37 months. Complications were rated using an in-house scoring system and according to the French-Italian Glossary (FIG). Results: Actuarial 5-year survival was 93%, 57%, 46%, and 0% for stages IB, II, IIIB, and IV, respectively. Of 161 patients, 11% developed moderate and 3.7% severe sequelae (FIG: 2.5%, 3.7%). Since some patients experienced more than one complication, the overall incidence was 13.6% and 4.9% (FIG: 3.1%, 4.9%) with respective 5-year actuarial rates of 14% and 5% for moderate, and 2% and 8% for severe bowel and genitourinary tract complications (FIG: 3.5%, 0, and 2%, 8%). All severe bowel complications occurred within 1.5 years whereas urinary tract sequelae continued to develop throughout the follow-up period. FIGO stage was associated with a significant increase in late sequelae (P=0.015). Analysis of the remaining pretreatment and treatment parameters failed to reveal

  15. Characterization of 75:25 poly(l-lactide-co-epsilon-caprolactone) thin films for the endoluminal delivery of adipose-derived stem cells to abdominal aortic aneurysms.

    Science.gov (United States)

    Burks, Chris A; Bundy, Kirk; Fotuhi, Parwis; Alt, Eckhard

    2006-09-01

    Abdominal aortic aneurysms occur in 5-7% of men over the age of 60 and their incidence is rising. Current therapies remove the affected tissue or prevent blood flow through the aneurysm, but do not repair the underlying structural changes of the vascular wall. Adipose tissue derived stem cells (ADSCs) seeded on a biodegradable thin film and delivered endoluminally to the aneurysm site could potentially repair the vessel wall, preventing growth and rupture of the aneurysm. In this study, the mechanical and degradation properties of a novel 75:25 poly(l-lactide-co-epsilon-caprolactone) (PLCL) thin film, as well as, the effects of different surface structures on stem cell adherence and resistance to shear stress was investigated. It was possible to reproducibly create films of consistent physical properties. These films degraded approximately 50% in 6 month, which would be a sufficient time to allow cells to engraft in the aortic wall. Ethylene oxide treatment significantly increased the stiffness and yield stress of the films, which exhibit >700% elongation. Treatment of the films with NaOH and HCl induced the formation of surface texture on the films; however, this texture did not affect stem cell adherence or resistance to delamination by shear stress when compared to nontreated or fibronectin-coated films. These results indicate that PLCL thin films have a sufficient degradation time and mechanical strength to serve as a scaffold in vivo for ADSCs, and that ADSCs seeded on the thin film can withstand a range of physiologic shear stresses. PMID:16995792

  16. Adaptive error detection for HDR/PDR brachytherapy: Guidance for decision making during real-time in vivo point dosimetry

    DEFF Research Database (Denmark)

    Kertzscher Schwencke, Gustavo Adolfo Vladimir; Andersen, Claus E.; Tanderup, Kari

    2014-01-01

    Purpose:This study presents an adaptive error detection algorithm (AEDA) for real-timein vivo point dosimetry during high dose rate (HDR) or pulsed dose rate (PDR) brachytherapy (BT) where the error identification, in contrast to existing approaches, does not depend on an a priori reconstruction of...... identify all false errors represented by mispositioned dosimeters contrary to an error detection algorithm relying on the original reconstruction. Conclusions:The study demonstrates that the AEDA error identification during HDR/PDR BT relies on a stable dosimeter position rather than on an accurate...... dosimeter reconstruction, and the AEDA’s capacity to distinguish between true and false error scenarios. The study further shows that the AEDA can offer guidance in decision making in the event of potential errors detected with real-time in vivo point dosimetry....

  17. 13. status report of the project HDR safety program of Kernforschungszentrum Karlsruhe. Working report 05.46/89

    International Nuclear Information System (INIS)

    The programme phase III, which extends to the end of 1991, is divided into the part projects containment behaviour in extreme accidents, long-term damage and monitoring the components in operation, behaviour of damaged components in dynamic accidents and large fires of actual materials. The main aims, state of the HDR safety programme, main points of the programme for 1990 and 8 technical reports on phase II and III are documented. There is a survey of costs. (DG)

  18. Dosimetry of HDR afterloading machines with Ir-192- und Co-60-sources. Comparison of different international protocols

    International Nuclear Information System (INIS)

    The air kerma rate in air at a reference distance of 1 meter from the source is the recommended quantity for the specification of gamma ray source in brachytherapy. The absorbed dose for the patients is directly proportional to the air kerma rate. Therefore the air kerma rate should be determined before the first use of the source on patients by a medical physicist who is independent from the source manufacturer. The air kerma rate will then be applied in the calculation of the dose delivered to patients. In practice, high dose rate (HDR) Ir-192 afterloading machines are mostly used in brachytherapy treatment. Currently HDR-Co-60 increasingly come into operation, too. The essential advantage of the use of Co-60 sources is its longer half-life compared to Ir-192. In addition, the purchasing and disposal costs are lower. The use of HDR-Co-60- afterloading machines is also quite interesting for developing countries. This work describes the dosimetry at HDR afterloading machines according to the protocols DIN 6809-2 (1993) in relation to the DGMP-Report 13 (2006), IAEA-TECDOC-1274 (2002) and AAPM Report 41 (1993) with the nuclides Ir-192 and Co-60. We have used 3 different measurement methods (with a cylindrical chamber in solid phantom and in free air and with a well chamber) in dependence of each of the protocols. We have shown that the standard deviations of the measured air kerma rate for the Co-60 source are generally larger than those of the Ir-192 source. The measurements with the well chamber had the lowest deviation from the certificate value. In all protocols and methods the deviations stood for both nuclides by a maximum of about 1.2% for Ir-192 and 2.5% for Co-60-sources respectively. (orig.)

  19. High-dose rate brachytherapy in the treatment of prostate cancer: acute toxicity and biochemical behavior analysis; Braquiterapia de alta taxa de dose no tratamento do carcinoma da prostata: analise da toxicidade aguda e do comportamento bioquimico

    Energy Technology Data Exchange (ETDEWEB)

    Esteves, Sergio Carlos Barros; Oliveira, Antonio Carlos Zuliani de; Cardoso, Herbeni; Tagawa, Eduardo Komai; Castelo, Roberto [Beneficencia Portuguesa de Sao Paulo, SP (Brazil). Hospital Sao Joaquim. Servico de Radioterapia]. E-mail: estevesrt@uol.com.br; D' Imperio, Marcio [Beneficencia Portuguesa de Sao Paulo, SP (Brazil). Hospital Sao Joaquim. Servico de Urologia

    2006-03-15

    Objective: this study focuses on the biochemical response of the following variables: prostate volume, prostate-specific antigen (PSA) value, Gleason scores, staging, the risk of the disease, and hormone therapy. Objective: in the period between February of 1998 and July of 2001, 46 patients with prostate cancer were treated with radiotherapy, in a combination of teletherapy and high-dose rate (HDR) brachytherapy. The age ranged from 51 to 79 years (averaging 66.4 years). T1c stage was the most frequent one: 30 (65%). The Gleason score was below 7 in 78% of the patients. PSA ranged from 3.4 to 33.3, being below 10 in 39% of the cases. The average prostatic volume was 32.3 cc. Twenty-eight percent of the patients received hormone therapy. Teletherapy dose ranged from 45 to 50.4 Gy, associated to four fractions of 4 Gy of HDR brachytherapy. Results: the follow-up period varied from 6 to 43 months. Four patients missed the follow-up and four died (one due to the disease). Out of the 39 patients that were analyzed, 76% presented a less than 1.5 PSA. None of the analyzed variables were found to be of statistical significance (p > 0.05) regarding biochemical control. Conclusion: the use of HDR brachytherapy was found to be effective in the treatment of prostate cancer and, in this study, the variables considered as prognostic factors did not interfere in the biochemical control. (author)

  20. Effectiveness of interstitial brachytherapy HDR combined with surgery in the treatment of locally advanced carcinoma of the vulva

    International Nuclear Information System (INIS)

    To asses the potential improvement of local control and survival of patients operated for stage III carcinoma of the vulva with adjuvant interstitial brachytherapy HDR. The potential for sparing the urethral and anal sphincter was also examined. Thirty one patients with stage III carcinoma of vulva were treated primarily with radical vulctomy. Due to proximity of tumor to the urethra or anus flexible or rigid catheters were placed in the involved area for perioperative interstitial brachytherapy HDR. Total dose delivered to the treatment volume was 30 Gy (6Gy per fraction) or 25 Gy (6 Gy per fraction) if external beam irradiation was given. Follow-up ranged from 12 to 48 months (median 29 months). The 3-year overall survival was 74 %. Eight patients (26 %) died of the disease. Eleven patients (34.5 %) recurred: 8 locally, 3 had distant metastases. A multivariate analysis indicated that tumor size and nodal status were independent prognostic factors for survival and local control. Eleven patients (34.5%) developed grade 3 or 4 (EORTC scoring system) complications. Preservation of sphincter function was obtained in all but one patient. The addition of interstitial brachytherapy HDR to primary surgery for locally advanced carcinoma of the vulva has a potential for improving local control and survival. By limiting the need for exonerative surgery, it also contributes to a significantly better quality of due to preservation of the urethra and anus. Further improvement in the stability of the catheters is needed to improve the incidence of severe complications. (author)

  1. Optical spectroscopy combined with high-resolution magnetic resonance imaging for digestive wall assessment: endoluminal bimodal probe conception and characterization in vitro, on organic sample and in vivo on a rabbit.

    Science.gov (United States)

    Ramgolam, Anoop; Sablong, Raphaël; Lafarge, Lionel; Saint-Jalmes, Hervé; Beuf, Olivier

    2011-11-01

    Colorectal cancer is a major health issue worldwide. Conventional white light endoscopy (WLE) coupled to histology is considered as the gold standard today and is the most widespread technique used for colorectal cancer diagnosis. However, during the early stages, colorectal cancer is very often characterized by flat adenomas which develop just underneath the mucosal surface. The use of WLE, which is heavily based on the detection of morphological changes, becomes quite delicate due to subtle or quasi-invisible morphological changes of the colonic lining. Several techniques are currently being investigated in the scope of providing new tools that would allow such a diagnostic or assist actual techniques in so doing. We hereby present a novel technique where high spatial resolution MRI is combined with autofluorescence and reflectance spectroscopy in a bimodal endoluminal probe to extract morphological data and biochemical information, respectively. The design and conception of the endoluminal probe are detailed and the promising preliminary results obtained in vitro (home-built phantom containing eosin and rhodamine B), on an organic sample (the kiwi fruit) and in vivo on a rabbit are presented and discussed. PMID:22112137

  2. Cloning and Functional Analysis of HDR Gene from Ginkgo biloba L.%银杏HDR基因的克隆与功能分析

    Institute of Scientific and Technical Information of China (English)

    杨颖舫; 杨春贤; 冯国庆; 成瑜; 李郑娜; 陈敏; 廖志华

    2010-01-01

    [Objective] The aims were to obtain cloning of HDR gene from Ginkgo biloba.and study its function.[Method] The coding sequence of HDR gene was cloned from G.biloba by reversed transcription polymerase chain reaction,which was designated as GbHDR (GenBank accession No.:DQ364231).The cDNA full-length of GbHDR is 1 827 bp containing a 1 425-bp open reading frame (ORF) encoding a 474-amino-acid polypeptide and constructed into the prokaryotic expression vector pTrcGbHDR.The β-carotene biosynthetic pathway in E.coli strain XL1-Blue was reconstructed by transforming with pAC-BETA.This engineered XL1-Blue was transformed with pTrcGbHDR.[Result] A 1 441 bp GbHDR was obtained containing a 1 425-bp ORF encoding a 474-amino-acid residues of protein,the predicted molecular weight was 53.2 kD,and predicted isoelectric point was 5.76.Functional complementation assay indicated that GbHDR could promote theβ-carotene accumulation in engineered XL1-Blue harboring pTrcGbHDR and pAC-BETA,and as a result,the engineered bacteria showed the brightly orange given by β-carotene.This suggested that GbHDR had the typical function of known HDR genes.[Conclusion] A engineered bacteria of E.coli which could highly accumulate β-carotene was obtained,which will provide candidate genes and targets for realizing β-carotene metabolic engineering.%[目的]获得银杏HDR基因的克隆并研究HDR基因的功能.[方法]采用RT-PCR技术获得银杏HDR的全长cDNA,命名为GbHDR(GenBank登录号:DQ364231),该基因cDNA全长为1 827 bp,包含1 425 bp的开放阅读框,编码474个氨基酸残基的蛋白;并构建GbHDR的原核表达载体pTrcGbHDR,与原核表达载体pAC-BETA共转入大肠杆菌XL1-Blue,获得β-胡萝卜素工程菌.[结果]克隆基因实际长度为1 441 bp的GbHDR基因,该序列包含1 425 bp的HDR基因ORF,编码474个氨基酸残基的蛋白,其预测分子量为53.2 kD,等电点预测为5.76.功能互补分析表明,GbHDR能推动工程菌XL1-Blue+pTrcGbHDR+pAC

  3. Avaliação da dose no reto em pacientes submetidas a braquiterapia de alta taxa de dose para o tratamento do câncer do colo uterino Rectal dose assessment in patients submitted to high-dose-rate brachytherapy for uterine cervix cancer

    Directory of Open Access Journals (Sweden)

    Jetro Pereira de Oliveira

    2009-04-01

    Full Text Available OBJETIVO: O objetivo deste trabalho foi desenvolver um sistema dosimétrico termoluminescente capaz de avaliar as doses administradas ao reto de pacientes submetidas a braquiterapia de alta taxa de dose para o tratamento do câncer do colo uterino. MATERIAIS E MÉTODOS: O material termoluminescente utilizado para a avaliação da dose no reto foi o LiF:Mg,Ti,Na na forma de pó. O pó foi separado em pequenas porções de 34 mg, que foram acomodadas em um tubo capilar. Este tubo foi colocado em uma sonda retal, que era introduzida no reto da paciente. RESULTADOS: As doses administradas ao reto de seis pacientes submetidas a braquiterapia de alta taxa de dose para o tratamento do câncer do colo uterino foram avaliadas com dosímetros termoluminescentes e apresentaram boa concordância com os valores planejados, com base em duas radiografias ortogonais da paciente, imagens ântero-posterior e lateral. CONCLUSÃO: O sistema de dosimetria termoluminescente utilizado no presente trabalho é simples e de fácil utilização quando comparado a outros métodos de dosimetria do reto. Ele mostrou-se eficiente na avaliação da dose no reto de pacientes submetidas a braquiterapia de alta taxa de dose para o tratamento do câncer do colo uterino.OBJECTIVE: The present study was aimed at developing a thermoluminescent dosimetric system capable of assessing the doses delivered to the rectum of patients submitted to high-dose-rate brachytherapy for uterine cervix cancer. MATERIALS AND METHODS: LiF:Mg,Ti,Na powder was the thermoluminescent material utilized for evaluating the rectal dose. The powder was divided into small portions (34 mg which were accommodated in a capillary tube. This tube was placed into a rectal probe that was introduced into the patient's rectum. RESULTS: The doses delivered to the rectum of six patients submitted to high-dose-rate brachytherapy for uterine cervix cancer evaluated by means of thermoluminescent dosimeters presented a good

  4. Fast, automatic, and accurate catheter reconstruction in HDR brachytherapy using an electromagnetic 3D tracking system

    Energy Technology Data Exchange (ETDEWEB)

    Poulin, Eric; Racine, Emmanuel; Beaulieu, Luc, E-mail: Luc.Beaulieu@phy.ulaval.ca [Département de physique, de génie physique et d’optique et Centre de recherche sur le cancer de l’Université Laval, Université Laval, Québec, Québec G1V 0A6, Canada and Département de radio-oncologie et Axe Oncologie du Centre de recherche du CHU de Québec, CHU de Québec, 11 Côte du Palais, Québec, Québec G1R 2J6 (Canada); Binnekamp, Dirk [Integrated Clinical Solutions and Marketing, Philips Healthcare, Veenpluis 4-6, Best 5680 DA (Netherlands)

    2015-03-15

    Purpose: In high dose rate brachytherapy (HDR-B), current catheter reconstruction protocols are relatively slow and error prone. The purpose of this technical note is to evaluate the accuracy and the robustness of an electromagnetic (EM) tracking system for automated and real-time catheter reconstruction. Methods: For this preclinical study, a total of ten catheters were inserted in gelatin phantoms with different trajectories. Catheters were reconstructed using a 18G biopsy needle, used as an EM stylet and equipped with a miniaturized sensor, and the second generation Aurora{sup ®} Planar Field Generator from Northern Digital Inc. The Aurora EM system provides position and orientation value with precisions of 0.7 mm and 0.2°, respectively. Phantoms were also scanned using a μCT (GE Healthcare) and Philips Big Bore clinical computed tomography (CT) system with a spatial resolution of 89 μm and 2 mm, respectively. Reconstructions using the EM stylet were compared to μCT and CT. To assess the robustness of the EM reconstruction, five catheters were reconstructed twice and compared. Results: Reconstruction time for one catheter was 10 s, leading to a total reconstruction time inferior to 3 min for a typical 17-catheter implant. When compared to the μCT, the mean EM tip identification error was 0.69 ± 0.29 mm while the CT error was 1.08 ± 0.67 mm. The mean 3D distance error was found to be 0.66 ± 0.33 mm and 1.08 ± 0.72 mm for the EM and CT, respectively. EM 3D catheter trajectories were found to be more accurate. A maximum difference of less than 0.6 mm was found between successive EM reconstructions. Conclusions: The EM reconstruction was found to be more accurate and precise than the conventional methods used for catheter reconstruction in HDR-B. This approach can be applied to any type of catheters and applicators.

  5. Fast, automatic, and accurate catheter reconstruction in HDR brachytherapy using an electromagnetic 3D tracking system

    International Nuclear Information System (INIS)

    Purpose: In high dose rate brachytherapy (HDR-B), current catheter reconstruction protocols are relatively slow and error prone. The purpose of this technical note is to evaluate the accuracy and the robustness of an electromagnetic (EM) tracking system for automated and real-time catheter reconstruction. Methods: For this preclinical study, a total of ten catheters were inserted in gelatin phantoms with different trajectories. Catheters were reconstructed using a 18G biopsy needle, used as an EM stylet and equipped with a miniaturized sensor, and the second generation Aurora® Planar Field Generator from Northern Digital Inc. The Aurora EM system provides position and orientation value with precisions of 0.7 mm and 0.2°, respectively. Phantoms were also scanned using a μCT (GE Healthcare) and Philips Big Bore clinical computed tomography (CT) system with a spatial resolution of 89 μm and 2 mm, respectively. Reconstructions using the EM stylet were compared to μCT and CT. To assess the robustness of the EM reconstruction, five catheters were reconstructed twice and compared. Results: Reconstruction time for one catheter was 10 s, leading to a total reconstruction time inferior to 3 min for a typical 17-catheter implant. When compared to the μCT, the mean EM tip identification error was 0.69 ± 0.29 mm while the CT error was 1.08 ± 0.67 mm. The mean 3D distance error was found to be 0.66 ± 0.33 mm and 1.08 ± 0.72 mm for the EM and CT, respectively. EM 3D catheter trajectories were found to be more accurate. A maximum difference of less than 0.6 mm was found between successive EM reconstructions. Conclusions: The EM reconstruction was found to be more accurate and precise than the conventional methods used for catheter reconstruction in HDR-B. This approach can be applied to any type of catheters and applicators

  6. An innovative method for {sup 192}Ir HDR calibration by farmer chamber, V-film, and solid phantom

    Energy Technology Data Exchange (ETDEWEB)

    Chang, Liyun; Ding, Hueisch-Jy [Department of Medical Imaging and Radiological Sciences, I-Shou University, Kaohsiung, Taiwan (China); Ho, Sheng-Yow, E-mail: shengho@seed.net.tw [Department of Radiation Oncology, Sinlau Christian Hospital, Tainan, Taiwan (China)

    2011-08-01

    A simple, practical and economical technique was proposed to calibrate an {sup 192}Ir HDR brachytherapy source in terms of air kerma strength. This technique makes use of the 0.6 cm{sup 3} Farmer type ion chamber, radiographic film and polystyrene phantom. These tools are commonly used for dosimetry quality assurance of the clinical linear accelerator. In this study, the Exradin A19, PTW N30004 and TM30001 Farmer type ion chambers were used for the calibration of the {sup 192}Ir HDR source. To perform the calibration, a 25.4x30.5 cm{sup 2} radiographic film was taped on a piece of polystyrene plate, and a straight applicator probe of a HDR brachytherapy unit and the Farmer type ion chamber were affixed to the film envelope. The film was irradiated by the {sup 192}Ir source, followed by an exposure in the simulator X-ray beam. The film set with the film removed was then placed on a 5 cm thick polystyrene phantom for calibration measurement. Based on the electrometer reading from the Farmer type ion chamber irradiated by {sup 192}Ir and the measured source-to-chamber distance by means of the images on the developed film, we can calculate the air kerma strength of the {sup 192}Ir using the new technique. Our calibration results were compared to the data provided by the manufacturer and that of five different well type ion chambers, namely, Sun Nuclear cooperation (SNC) 1008, Nucletron SDS 077.091, SDS 077.094, PTW TN33004 and Standard Imaging (SI) HDR-1000 Plus. The differences were all within 1.6%. Relative to the '7-distance measurement technique' by Stump et al., 2002, our method is more efficient if our empirical formula was used. In summary, our method is simpler and cost-effective to calibrate an {sup 192}Ir HDR brachytherapy source for those hospitals without a calibration jig or a well type ion chamber.

  7. Catheter-based ultrasound hyperthermia with HDR brachytherapy for treatment of locally advanced cancer of the prostate and cervix

    Science.gov (United States)

    Diederich, Chris J.; Wootton, Jeff; Prakash, Punit; Salgaonkar, Vasant; Juang, Titania; Scott, Serena; Chen, Xin; Cunha, Adam; Pouliot, Jean; Hsu, I. C.

    2011-03-01

    A clinical treatment delivery platform has been developed and is being evaluated in a clinical pilot study for providing 3D controlled hyperthermia with catheter-based ultrasound applicators in conjunction with high dose rate (HDR) brachytherapy. Catheter-based ultrasound applicators are capable of 3D spatial control of heating in both angle and length of the devices, with enhanced radial penetration of heating compared to other hyperthermia technologies. Interstitial and endocavity ultrasound devices have been developed specifically for applying hyperthermia within HDR brachytherapy implants during radiation therapy in the treatment of cervix and prostate. A pilot study of the combination of catheter based ultrasound with HDR brachytherapy for locally advanced prostate and cervical cancer has been initiated, and preliminary results of the performance and heating distributions are reported herein. The treatment delivery platform consists of a 32 channel RF amplifier and a 48 channel thermocouple monitoring system. Controlling software can monitor and regulate frequency and power to each transducer section as required during the procedure. Interstitial applicators consist of multiple transducer sections of 2-4 cm length × 180 deg and 3-4 cm × 360 deg. heating patterns to be inserted in specific placed 13g implant catheters. The endocavity device, designed to be inserted within a 6 mm OD plastic tandem catheter within the cervix, consists of 2-3 transducers × dual 180 or 360 deg sectors. 3D temperature based treatment planning and optimization is dovetailed to the HDR optimization based planning to best configure and position the applicators within the catheters, and to determine optimal base power levels to each transducer section. To date we have treated eight cervix implants and six prostate implants. 100 % of treatments achieved a goal of >60 min duration, with therapeutic temperatures achieved in all cases. Thermal dosimetry within the hyperthermia target

  8. A summary of the Fire Testing Program at the German HDR Test Facility

    International Nuclear Information System (INIS)

    This report provides an overview of the fire safety experiments performed under the sponsorship of the German government in the containment building of the decommissioned pilot nuclear power plant known as HDR. This structure is a highly complex, multi-compartment, multi-level building which has been used as the test bed for a wide range of nuclear power plant operation safety experiments. These experiments have included numerous fire tests. Test fire fuel sources have included gas burners, wood cribs, oil pools, nozzle release oil fires, and cable in cable trays. A wide range of ventilation conditions including full natural ventilation, full forced ventilation, and combined natural and forced ventilation have been evaluated. During most of the tests, the fire products mixed freely with the full containment volume. Macro-scale building circulation patterns which were very sensitive to such factors as ventilation configuration were observed and characterized. Testing also included the evaluation of selective area pressurization schemes as a means of smoke control for emergency access and evacuation stairwells

  9. SHAM: High-level seismic tests of piping at the HDR

    International Nuclear Information System (INIS)

    As part of the second phase of vibrational/earthquake investigations at the HDR (Heissdampfreaktor) Test Facility in Kahl/Main, FRG, high-level simulated seismic tests (SHAM) were performed during April--May 1988 on the VKL (Versuchskreislauf) in-plant piping system with two servohydraulic actuators, each capable of generating 40 tons of force. The purpose of these experiments was to study the behavior of piping subjected to seismic excitation levels that exceed design levels manifold and may result in failure/plastification of pipe supports and pipe elements, and to establish seismic margins for piping and pipe supports. The performance of six different dynamic pipe support systems was compared in these tests and the response, operability, and fragility of dynamic supports and of a typical US gate valve were investigated. Data obtained in the tests are used to validate analysis methods. Very preliminary evaluations lead to the observation that, in general, failures of dynamic supports (in particular snubbers) occur only at load levels that substantially exceed the design capacity. Pipe strains at load levels exceeding the design level threefold are quite small, and even when exceeding the design level eightfold are quite tolerable. Hence, under seismic loading, even at extreme levels and in spite of multiple support failures, pipe failure is unlikely. 5 refs., 16 figs

  10. Monte Carlo characterization of the Gamma-Med Hdr plus Ir-192 brachytherapy source

    International Nuclear Information System (INIS)

    Full text: The MCNP4C Monte Carlo code was used to simulate the dosimetry around the Gamma-Med Hdr Plus iridium-192 brachytherapy source in both air/vacuum and water environments. Dosimetry data in water was calculated and are presented into an away-along table. All dosimetric quantities recommended by the AAPM Task Group 43 report have been also calculated. These quantities are air kerma strength, dose rate constant, radial dose function and anisotropy function. The obtained data are compared to this source reference data, finding results in good agreement with them. In this study, recommendations of the AAPM TG-43U1 report have been followed and comply with the most recent AAPM and ESTRO physics committee recommendations about Monte Carlo techniques. The data in the present study complement published data and can be used as input in the Tps or as benchmark data to verify the results of the treatment planning systems as well as a means of comparison with other datasets from this source. (Author)

  11. Feasibility of MatriXX 2D detector array for HDR brachytherapy planning system assessment

    International Nuclear Information System (INIS)

    IBA Dosimetry GmbH participated in the Joint Research Project 'Increasing cancer treatment efficacy using 3D brachytherapy' as a non-funded partner in the work package which was mostly dedicated to the determination of dose-to-water distribution from a high-dose-rate (HDR) brachytherapy source. The dose distribution was measured with a MatriXX (MXX) 2D detector array and compared with Dose Cube Data, calculated by treatment planning systems (TPS). All measurements and calculations were performed in cooperation with OUSA, Bratislava and FNB, Prague. The comparison has been carried out for three irradiation geometries: single source position, single line and four line motions of the source, and with the effective point of measurement in a plane at 6 mm, 10 mm and 20 mm distance from the source position. The comparison of the MXX measurements and the TPS calculations was evaluated by the commercial IBA Dosimetry software OmniPro I'mRT (1) as the difference between maximum of measured and calculated values and (2) as the maximum difference between the two-dimensional distributions of measured and calculated values. The dose distribution was evaluated by the gamma method with parameters 3 mm and 3%. All differences of comparison of the MXX measurements and TPS calculations were within the range ±10% and the γ -index was less than 1 for 96% (or 97%, respectively) of the dose distribution in the plane at 10 mm distance from the source position. (authors)

  12. Air-kerma evaluation at the maze entrance of HDR brachytherapy facilities

    International Nuclear Information System (INIS)

    In the absence of procedures for evaluating the design of brachytherapy (BT) facilities for radiation protection purposes, the methodology used for external beam radiotherapy facilities is often adapted. The purpose of this study is to adapt the NCRP 151 methodology for estimating the air-kerma rate at the door in BT facilities. Such methodology was checked against Monte Carlo (MC) techniques using the code Geant4. Five different facility designs were studied for 192Ir and 60Co HDR applications to account for several different bunker layouts. For the estimation of the lead thickness needed at the door, the use of transmission data for the real spectra at the door instead of the ones emitted by 192Ir and 60Co will reduce the lead thickness by a factor of five for 192Ir and ten for 60Co. This will significantly lighten the door and hence simplify construction and operating requirements for all bunkers. The adaptation proposed in this study to estimate the air-kerma rate at the door depends on the complexity of the maze: it provides good results for bunkers with a maze (i.e. similar to those used for linacs for which the NCRP 151 methodology was developed) but fails for less conventional designs. For those facilities, a specific Monte Carlo study is in order for reasons of safety and cost-effectiveness. (paper)

  13. A novel optical calorimetry dosimetry approach applied to an HDR Brachytherapy source

    International Nuclear Information System (INIS)

    The technique of Digital Holographic Interferometry (DHI) is applied to the measurement of radiation absorbed dose distribution in water. An optical interferometer has been developed that captures the small variations in the refractive index of water due to the radiation induced temperature increase ΔT. The absorbed dose D is then determined with high temporal and spatial resolution using the calorimetric relation D=cΔT (where c is the specific heat capacity of water). The method is capable of time resolving 3D spatial calorimetry. As a proof-of-principle of the approach, a prototype DHI dosimeter was applied to the measurement of absorbed dose from a High Dose Rate (HDR) Brachytherapy source. Initial results are in agreement with modelled doses from the Brachyvision treatment planning system, demonstrating the viability of the system for high dose rate applications. Future work will focus on applying corrections for heat diffusion and geometric effects. The method has potential to contribute to the dosimetry of diverse high dose rate applications which require high spatial resolution such as microbeam radiotherapy (MRT) or small field proton beam dosimetry but may potentially also be useful for interface dosimetry.

  14. Analytical simulation of nonlinear response to seismic test excitations of HDR-VKL piping system

    International Nuclear Information System (INIS)

    Dynamic tests with simulated earthquake excitation (SHAM) were performed during April--May 1988 on the Versuchskreislauf (VKL) piping system at the Heissdampfreaktor (HDR) Test Facility in Kahl/Main, Federal Republic of Germany. The major objectives of these tests were to study the behavior of a full-scale in-plant piping system subjected to a range of seismic excitation levels (from design levels to those that might induce either failure of pipe supports or plasticity in the pipe runs) and to establish seismic margins for piping and pipe supports. Data obtained in the tests are also being used to validate analytical methods for piping response calculation. Detailed reports on the SHAM experiments are given elsewhere by Kot et al. (1990). This paper describes an effort to evaluate the computer code NONPIPE (proprietary to Nutech Engineers) with data from one of the SHAM tests. NONPIPE is a nonlinear finite-element program capable of calculating the elastic-plastic response of piping systems subjected to seismic excitation. The special characteristic of this code is the simplified or approximate approach it uses for modeling the elastic behavior which makes the calculations relatively less resource intensive than those of other nonlinear codes. The evaluation is based on a comparison of computational results of simulation of a SHAM test with corresponding test measurements. 6 refs., 10 figs

  15. A review of 15 years full-scale seismic testing at the HDR

    International Nuclear Information System (INIS)

    The HDR Safety Program is carried out by the Karlsruhe Nuclear Research Center (KfK) on behalf of the German Federal Ministry for Research and Technology (BMFT). The Program has been subdivided into several Sub Projects according to the main activities in the field of Reactor Safety Research and actual questions of licensing procedure and public interest. This presentation deals with the earthquake investigations, exclusively. The general objective of the project is the experimental verification of calculation tools and procedures. To get an objective picture about the capability of design calculation methods, the activities within the whole program are usually carried out as a joint effort by various parties: while KfK is responsible for the performance of the experiments, data acquisition, comparisons and evaluations, the calculations are performed by specialized institutions. Here, the project management tries to maintain a reasonable balance between industrial participants, independent institutions and authorities responsible for the licensing of nuclear power plants. Besides the independence of the results obtained, this procedure has another advantage: the findings and conclusions of the evaluation process are directly transferred to the engineering community. (author)

  16. Monte Carlo characterization of the Gamma-Med Hdr plus Ir-192 brachytherapy source

    Energy Technology Data Exchange (ETDEWEB)

    Reyes, E.; Sosa, M. A.; Gil V, A. [Universidad de Guanajuato, Division de Ciencias e Ingenierias, Av. Insurgentes 2354, 37150 Leon, Guanajuato (Mexico); Monzon, E., E-mail: eric_1985@fisica.ugto.mx [IMSS, Unidad Medica de Alta Especialidad No. 1, Av. Adolfo Lopez Mateos 1813, 37340 Leon, Guanajuato (Mexico)

    2015-10-15

    Full text: The MCNP4C Monte Carlo code was used to simulate the dosimetry around the Gamma-Med Hdr Plus iridium-192 brachytherapy source in both air/vacuum and water environments. Dosimetry data in water was calculated and are presented into an away-along table. All dosimetric quantities recommended by the AAPM Task Group 43 report have been also calculated. These quantities are air kerma strength, dose rate constant, radial dose function and anisotropy function. The obtained data are compared to this source reference data, finding results in good agreement with them. In this study, recommendations of the AAPM TG-43U1 report have been followed and comply with the most recent AAPM and ESTRO physics committee recommendations about Monte Carlo techniques. The data in the present study complement published data and can be used as input in the Tps or as benchmark data to verify the results of the treatment planning systems as well as a means of comparison with other datasets from this source. (Author)

  17. Verification of experimental modal modeling using HDR (Heissdampfreaktor) dynamic test data

    International Nuclear Information System (INIS)

    An attempt to verify the reliability of the experimental modal modeling code, MODAL-PLUS, is described in this report. MODAL-PLUS is capable of synthesizing a modal model of a structure using data from dynamic testing of a structue. The objective was to determine whether a modal model synthesized from one set of test data would be capable of correctly predicting response to a different form of excitation from a different set of data. Recorded test data from the shaker and rocket tests on the containment building of the HDR (Heissdampfreaktor) were used in the effort. The attempted verification was only partially successful in that only one modal model with a limited range of validity could be synthesized from the shaker test data. The goodness of fit in this limited range was adequate. The rocket test data could not be used to synthesize a modal model due to numerical difficulties. However, the effort was useful in showing the need for taking into account the possible use of the data, and the data analysis method to be employed, at an early stage when the tests are being designed

  18. Large-scale HDR-hydrogen mixing experiments - Test Group E 11

    International Nuclear Information System (INIS)

    During severe accidents in light-water reactors, substantial amounts of hydrogen can be generated by the metal-water reaction during core heat-up and by core-uncovery as well as by virtue of core-concrete interactions after vessel lower head failure. This hydrogen is released into the containment. A key issue within this context relates to the global and local hydrogen distributions and associated mixing phenomena in multi-compartment geometry in order to plan for proper mitigation measures. In the case, that no mitigating measures are provided it has to be demonstrated at least that the containment integrity is not threatened by the combustion of hydrogen including local detonations. On the basis of the experiences gained both with respect to experimental and computational aspects, a complete, major test group, E 11, was designed and performed in the context of HDR-Safety Program Phase III in the summer of 1989. This test series consisted of eight different experiments covering all aspects of H2-distribution and mitigation features such as: small and large LOCA controlled containment atmosphere conditions, axially different injection positions, multiple injections of gas mixtures, multiple steam injections into different compartments internal and external spray initiations, boiling sump simulation, dry energy addition and venting measures at three different axial positions. The paper outlines all major facility features used during the individual experiments and presents the detailed experimental procedures as performed, along with results

  19. Ahsa1 and Hsp90 activity confers more severe craniofacial phenotypes in a zebrafish model of hypoparathyroidism, sensorineural deafness and renal dysplasia (HDR

    Directory of Open Access Journals (Sweden)

    Kelly Sheehan-Rooney

    2013-09-01

    The severity of most human birth defects is highly variable. Our ability to diagnose, treat and prevent defects relies on our understanding of this variability. Mutation of the transcription factor GATA3 in humans causes the highly variable hypoparathyroidism, sensorineural deafness and renal dysplasia (HDR syndrome. Although named for a triad of defects, individuals with HDR can also exhibit craniofacial defects. Through a forward genetic screen for craniofacial mutants, we isolated a zebrafish mutant in which the first cysteine of the second zinc finger of Gata3 is mutated. Because mutation of the homologous cysteine causes HDR in humans, these zebrafish mutants could be a quick and effective animal model for understanding the role of gata3 in the HDR disease spectrum. We demonstrate that, unexpectedly, the chaperone proteins Ahsa1 and Hsp90 promote severe craniofacial phenotypes in our zebrafish model of HDR syndrome. The strengths of the zebrafish system, including rapid development, genetic tractability and live imaging, make this an important model for variability.

  20. Observation and simulation of non-laminar flow phenomena at the HDR site near Soulth-sous-forets; Beobachtung und Simulation von nicht-laminarem Fliessverhalten am HDR-Standort Soultz

    Energy Technology Data Exchange (ETDEWEB)

    Kohl, T. [ETH Hoenggerberg, Zuerich (Switzerland). Inst. fuer Geophysik; Evans, K.F.; Hopkirk, R.J. [Polydynamics Engineering, Maennedorf (Switzerland); Jung, R. [Bundesanstalt fuer Geowissenschaften und Rohstoffe, Hannover (Germany); Rybach, L. [ETH Hoenggerberg, Zuerich (Switzerland). Inst. fuer Geophysik und Radiometrie

    1997-12-01

    Three independent multi-rate flow experiments were conducted in 1994 and 1995 in the open hole depth interval of a wellbore at the Hot-Dry-Rocks (HDR) test site Soultz. The steady state and transient dowmhole pressure records gave clear indications of non-Darcian flow. A numerical model has been set-up to evaluate these two measurements. An excellent fit of the transient pressure responses of all three flow tests could be achieved by assuming a simple model geometry. The models predict fluid transport along a conduit with substantial surface area in which fully-turbulent flow is occurring. The parameters required by our best-fit simulation all fall into a physically reasonable range. Sensitivity analysis demonstrates a non-Darcian flow regime along highly conductive features. The existence of high capacity far-field faults as postulated in our model confirms earlier characterisations of the Soultz test site. (orig.) [Deutsch] In den Jahren 1994 und 1995 wurden drei unabhaengige Druck- bzw. Fliessratentests in den Bohrungen GPK1 und GPK2 des HDR Standortes Soultz durchgefuehrt. Sowohl die stationaeren wie auch die instationaeren Druckaufzeichnungen gaben bereits klare Hinweise auf nichtlaminare, turbulent-aehnliche Stroemungsverhaeltnisse. Zur genaueren Interpretation dieser Daten wurde das numerische Programm FRACTure erweitert. Unter der Annahme eines geometrisch einfachen Modells konnten die instationaeren Druckantworten sehr gut angepasst werden. Es gelang sogar, die beiden in GPK1 durchgefuehrten Tests durch dieselben Modelle zu erklaeren. Die hierfuer benoetigten Modellparameter liegen in einem physikalisch sinnvollem Rahmen und bestaetigen z.T. fruehere Untersuchungen. Die Existenz grosser Stoerungszonen, welche von den Modellen vorausgesetzt werden, bestaetigt ebenfalls fruehere Charakterisierungen des HDR Standortes Soultz als ein teilweise offenes hydraulisches System. (orig.)

  1. Additional androgen deprivation makes the difference. Biochemical recurrence-free survival in prostate cancer patients after HDR brachytherapy and external beam radiotherapy

    Energy Technology Data Exchange (ETDEWEB)

    Schiffmann, Jonas; Tennstedt, Pierre; Beyer, Burkhard; Boehm, Katharina; Tilki, Derya; Salomon, Georg; Graefen, Markus [University Medical Center Hamburg-Eppendorf, Martini-Clinic Prostate Cancer Center, Hamburg (Germany); Lesmana, Hans; Platz, Volker; Petersen, Cordula; Kruell, Andreas; Schwarz, Rudolf [University Medical Center Hamburg-Eppendorf, Department of Radiation oncology, Hamburg (Germany)

    2015-04-01

    The role of additional androgen deprivation therapy (ADT) in prostate cancer (PCa) patients treated with combined HDR brachytherapy (HDR-BT) and external beam radiotherapy (EBRT) is still unknown. Consecutive PCa patients classified as D'Amico intermediate and high-risk who underwent HDR-BT and EBRT treatment ± ADT at our institution between January 1999 and February 2009 were assessed. Multivariable Cox regression models predicting biochemical recurrence (BCR) were performed. BCR-free survival was assessed with Kaplan-Meier analyses. Overall, 392 patients were assessable. Of these, 221 (56.4 %) underwent trimodality (HDR-BT and EBRT and ADT) and 171 (43.6 %) bimodality (HDR-BT and EBRT) treatment. Additional ADT administration reduced the risk of BCR (HR: 0.4, 95 % CI: 0.3-0.7, p < 0.001). D'Amico high-risk patients had superior BCR-free survival when additional ADT was administered (log-rank p < 0.001). No significant difference for BCR-free survival was recorded when additional ADT was administered to D'Amico intermediate-risk patients (log-rank p = 0.2). Additional ADT administration improves biochemical control in D'Amico high-risk patients when HDR-BT and EBRT are combined. Physicians should consider the oncological benefit of ADT administration for these patients during the decision-making process. (orig.) [German] Der Nutzen einer zusaetzlichen Hormonentzugstherapie (ADT, ''androgen deprivation therapy'') fuer Patienten mit Prostatakarzinom (PCa), welche mit einer Kombination aus HDR-Brachytherapie (HDR-BT) und perkutaner Bestrahlung (EBRT) behandelt werden, ist weiterhin ungeklaert. Fuer diese Studie wurden konsekutive, nach der D'Amico-Risikoklassifizierung in ''intermediate'' und ''high-risk'' eingeteilte Patienten ausgewaehlt, die zwischen Januar 1999 und Februar 2009 in unserem Institut eine kombinierte Therapie aus HDR-BT, EBRT ± ADT erhalten haben. Eine

  2. Estimation of distance error by fuzzy set theory required for strength determination of HDR 192Ir brachytherapy sources

    International Nuclear Information System (INIS)

    Verification of the strength of high dose rate (HDR) 192Ir brachytherapy sources on receipt from the vendor is an important component of institutional quality assurance program. Either reference air-kerma rate (RAKR) or air-kerma strength (AKS) is the recommended quantity to specify the strength of gamma-emitting brachytherapy sources. The use of Farmer-type cylindrical ionization chamber of sensitive volume 0.6 cm3 is one of the recommended methods for measuring RAKR of HDR 192Ir brachytherapy sources. While using the cylindrical chamber method, it is required to determine the positioning error of the ionization chamber with respect to the source which is called the distance error. An attempt has been made to apply the fuzzy set theory to estimate the subjective uncertainty associated with the distance error. A simplified approach of applying this fuzzy set theory has been proposed in the quantification of uncertainty associated with the distance error. In order to express the uncertainty in the framework of fuzzy sets, the uncertainty index was estimated and was found to be within 2.5%, which further indicates that the possibility of error in measuring such distance may be of this order. It is observed that the relative distance li estimated by analytical method and fuzzy set theoretic approach are consistent with each other. The crisp values of li estimated using analytical method lie within the bounds computed using fuzzy set theory. This indicates that li values estimated using analytical methods are within 2.5% uncertainty. This value of uncertainty in distance measurement should be incorporated in the uncertainty budget, while estimating the expanded uncertainty in HDR 192Ir source strength measurement. (author)

  3. Estimation of distance error by fuzzy set theory required for strength determination of HDR (192)Ir brachytherapy sources.

    Science.gov (United States)

    Kumar, Sudhir; Datta, D; Sharma, S D; Chourasiya, G; Babu, D A R; Sharma, D N

    2014-04-01

    Verification of the strength of high dose rate (HDR) (192)Ir brachytherapy sources on receipt from the vendor is an important component of institutional quality assurance program. Either reference air-kerma rate (RAKR) or air-kerma strength (AKS) is the recommended quantity to specify the strength of gamma-emitting brachytherapy sources. The use of Farmer-type cylindrical ionization chamber of sensitive volume 0.6 cm(3) is one of the recommended methods for measuring RAKR of HDR (192)Ir brachytherapy sources. While using the cylindrical chamber method, it is required to determine the positioning error of the ionization chamber with respect to the source which is called the distance error. An attempt has been made to apply the fuzzy set theory to estimate the subjective uncertainty associated with the distance error. A simplified approach of applying this fuzzy set theory has been proposed in the quantification of uncertainty associated with the distance error. In order to express the uncertainty in the framework of fuzzy sets, the uncertainty index was estimated and was found to be within 2.5%, which further indicates that the possibility of error in measuring such distance may be of this order. It is observed that the relative distance li estimated by analytical method and fuzzy set theoretic approach are consistent with each other. The crisp values of li estimated using analytical method lie within the bounds computed using fuzzy set theory. This indicates that li values estimated using analytical methods are within 2.5% uncertainty. This value of uncertainty in distance measurement should be incorporated in the uncertainty budget, while estimating the expanded uncertainty in HDR (192)Ir source strength measurement. PMID:24872605

  4. Estimation of distance error by fuzzy set theory required for strength determination of HDR 192Ir brachytherapy sources

    Science.gov (United States)

    Kumar, Sudhir; Datta, D.; Sharma, S. D.; Chourasiya, G.; Babu, D. A. R.; Sharma, D. N.

    2014-01-01

    Verification of the strength of high dose rate (HDR) 192Ir brachytherapy sources on receipt from the vendor is an important component of institutional quality assurance program. Either reference air-kerma rate (RAKR) or air-kerma strength (AKS) is the recommended quantity to specify the strength of gamma-emitting brachytherapy sources. The use of Farmer-type cylindrical ionization chamber of sensitive volume 0.6 cm3 is one of the recommended methods for measuring RAKR of HDR 192Ir brachytherapy sources. While using the cylindrical chamber method, it is required to determine the positioning error of the ionization chamber with respect to the source which is called the distance error. An attempt has been made to apply the fuzzy set theory to estimate the subjective uncertainty associated with the distance error. A simplified approach of applying this fuzzy set theory has been proposed in the quantification of uncertainty associated with the distance error. In order to express the uncertainty in the framework of fuzzy sets, the uncertainty index was estimated and was found to be within 2.5%, which further indicates that the possibility of error in measuring such distance may be of this order. It is observed that the relative distance li estimated by analytical method and fuzzy set theoretic approach are consistent with each other. The crisp values of li estimated using analytical method lie within the bounds computed using fuzzy set theory. This indicates that li values estimated using analytical methods are within 2.5% uncertainty. This value of uncertainty in distance measurement should be incorporated in the uncertainty budget, while estimating the expanded uncertainty in HDR 192Ir source strength measurement. PMID:24872605

  5. An Eight-Year Experience of HDR Brachytherapy Boost for Localized Prostate Cancer: Biopsy and PSA Outcome

    International Nuclear Information System (INIS)

    Purpose: To evaluate the biochemical recurrence-free survival (bRFS), the 2-year biopsy outcome and the prostate-specific antigen (PSA) bounce in patients with localized prostate cancer treated with an inversely planned high-dose-rate (HDR) brachytherapy boost. Materials and methods: Data were collected from 153 patients treated between 1999 and 2006 with external beam pelvic radiation followed by an HDR Ir-192 prostate boost. These patients were given a boost of 18 to 20 Gy using inverse-planning with simulated annealing (IPSA).We reviewed and analyzed all prostate-specific antigen levels and control biopsies. Results: The median follow-up was 44 months (18-95 months). When categorized by risk of progression, 74.5% of patients presented an intermediate risk and 14.4% a high one. Prostate biopsies at 2 years posttreatment were negative in 86 of 94 patients (91.5%), whereas two biopsies were inconclusive. Biochemical control at 60 months was at 96% according to the American Society for Therapeutic Radiology and Oncology and the Phoenix consensus definitions. A PSA bounce (PSA values of 2 ng/mL or more above nadir) was observed in 15 patients of 123 (9.8%). The median time to bounce was 15.2 months (interquartile range, 11.0-17.7) and the median bounce duration 18.7 months (interquartile range, 12.1-29). The estimate of overall survival at 60 months was 97.1% (95% CI, 91.6-103%). Conclusions: Considering that inverse planned HDR brachytherapy prostate boosts led to an excellent biochemical response, with a 2-year negative biopsy rate, we recommend a conservative approach in face of a PSA bounce even though it was observed in 10% of patients

  6. Dynamic fracture analysis of HDR-E31 pipe system experiments

    International Nuclear Information System (INIS)

    This paper presents analyses of circumferentially surface-cracked pipe system experiments that were conducted under blowdown (water-hammer) loading as part of the German HDR program. Two analysis procedures are compared to the experimental results: (1) typical engineering pipe fracture analyses using the uncracked pipe elastic stress analysis, and (2) nonlinear cracked-pipe time-history analyses. The nonlinear time-history analysis uses a nonlinear spring element at the crack location to simulate the rotations due to the crack at the crack section, with the rest of the pipe system modeled using typical pipe and elbow beam elements. Such a FEM approach was very economical to run compared with three-dimensional modeling of a surface crack in a pipe system. The results show that using the elastic uncracked pipe dynamic analysis, all the pipe fracture analyses predict the pipe will reach the maximum load. Because such calculations consider the dynamic stresses to be statically applied, these analyses would all predict a double-ended guillotine break (DEGB). The most conservative analyses was the ASME Section 11 IWB-3650 analysis for ferritic pipe (without the Code applied safety factors) which predicted failure loads less than half of the other analysis methods. The nonlinear cracked-pipe element time-history FEM analysis predictions of surface-crack penetration were much closer to the experiments but still slightly conservative. Using this method, the extent of the crack growth after the surface crack penetration is also predicted. The nonlinear time-history calculations predicted that a DEGB would not occur, consistent with experimental behavior. The extent of the predicted through-wall crack penetration was slightly conservative compared to the experimental results

  7. HDR {sup 192}Ir source speed measurements using a high speed video camera

    Energy Technology Data Exchange (ETDEWEB)

    Fonseca, Gabriel P. [Instituto de Pesquisas Energéticas e Nucleares—IPEN-CNEN/SP, São Paulo 05508-000, Brazil and Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht 6201 BN (Netherlands); Viana, Rodrigo S. S.; Yoriyaz, Hélio [Instituto de Pesquisas Energéticas e Nucleares—IPEN-CNEN/SP, São Paulo 05508-000 (Brazil); Podesta, Mark [Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht 6201 BN (Netherlands); Rubo, Rodrigo A.; Sales, Camila P. de [Hospital das Clínicas da Universidade de São Paulo—HC/FMUSP, São Paulo 05508-000 (Brazil); Reniers, Brigitte [Department of Radiation Oncology - MAASTRO, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht 6201 BN (Netherlands); Research Group NuTeC, CMK, Hasselt University, Agoralaan Gebouw H, Diepenbeek B-3590 (Belgium); Verhaegen, Frank, E-mail: frank.verhaegen@maastro.nl [Department of Radiation Oncology - MAASTRO, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht 6201 BN (Netherlands); Medical Physics Unit, Department of Oncology, McGill University, Montréal, Québec H3G 1A4 (Canada)

    2015-01-15

    Purpose: The dose delivered with a HDR {sup 192}Ir afterloader can be separated into a dwell component, and a transit component resulting from the source movement. The transit component is directly dependent on the source speed profile and it is the goal of this study to measure accurate source speed profiles. Methods: A high speed video camera was used to record the movement of a {sup 192}Ir source (Nucletron, an Elekta company, Stockholm, Sweden) for interdwell distances of 0.25–5 cm with dwell times of 0.1, 1, and 2 s. Transit dose distributions were calculated using a Monte Carlo code simulating the source movement. Results: The source stops at each dwell position oscillating around the desired position for a duration up to (0.026 ± 0.005) s. The source speed profile shows variations between 0 and 81 cm/s with average speed of ∼33 cm/s for most of the interdwell distances. The source stops for up to (0.005 ± 0.001) s at nonprogrammed positions in between two programmed dwell positions. The dwell time correction applied by the manufacturer compensates the transit dose between the dwell positions leading to a maximum overdose of 41 mGy for the considered cases and assuming an air-kerma strength of 48 000 U. The transit dose component is not uniformly distributed leading to over and underdoses, which is within 1.4% for commonly prescribed doses (3–10 Gy). Conclusions: The source maintains its speed even for the short interdwell distances. Dose variations due to the transit dose component are much lower than the prescribed treatment doses for brachytherapy, although transit dose component should be evaluated individually for clinical cases.

  8. HDR 192Ir source speed measurements using a high speed video camera

    International Nuclear Information System (INIS)

    Purpose: The dose delivered with a HDR 192Ir afterloader can be separated into a dwell component, and a transit component resulting from the source movement. The transit component is directly dependent on the source speed profile and it is the goal of this study to measure accurate source speed profiles. Methods: A high speed video camera was used to record the movement of a 192Ir source (Nucletron, an Elekta company, Stockholm, Sweden) for interdwell distances of 0.25–5 cm with dwell times of 0.1, 1, and 2 s. Transit dose distributions were calculated using a Monte Carlo code simulating the source movement. Results: The source stops at each dwell position oscillating around the desired position for a duration up to (0.026 ± 0.005) s. The source speed profile shows variations between 0 and 81 cm/s with average speed of ∼33 cm/s for most of the interdwell distances. The source stops for up to (0.005 ± 0.001) s at nonprogrammed positions in between two programmed dwell positions. The dwell time correction applied by the manufacturer compensates the transit dose between the dwell positions leading to a maximum overdose of 41 mGy for the considered cases and assuming an air-kerma strength of 48 000 U. The transit dose component is not uniformly distributed leading to over and underdoses, which is within 1.4% for commonly prescribed doses (3–10 Gy). Conclusions: The source maintains its speed even for the short interdwell distances. Dose variations due to the transit dose component are much lower than the prescribed treatment doses for brachytherapy, although transit dose component should be evaluated individually for clinical cases

  9. SU-E-T-560: Commissioning An HDR Freiburg Flap Applicator for Skin Lesion Treatment

    Energy Technology Data Exchange (ETDEWEB)

    Dou, K; Li, B; Lerma, F; Aroumougame, V; Sarfaraz, M [RadAmerica, LLC--MedStar Health, Baltimore, MD (United States); Laser, B; Jacobs, M [Mercy Medical Center, Baltimore, MD (United States)

    2014-06-01

    Purpose: Flexible Freiburg flap used with high dose rate afterloaders is easy to cut into any size for any body site and to dwell with a precise source position, conforms to curved skin surface and then to the planned target. However, unlike intracavity or interstitial situations, incomplete scatter environment due to flap applicators exposed to air might lead to dose difference between the delivered and planned. This research is focused on the dose deviation of incomplete scatter versus full scatter. Methods: A 12x12 cm of Freiburg flap applicator was used for the validation. A Nucletron Oncentra Brachy Ver. 4.3 treatment planning system (TPS) was used for treatment planning. However, no heterogeneity correction incorporated into the brachytherap TPS needs to be considered. A Philips Brilliance CT Big Bore was employed for CT scan. Radiation was delivered using a Nucletron HDR remote afterloader system. A 10cm bolus was used to cover the flap for obtaining a full scatter. An OSL, ion chamber, and Gafchromic EBT2 film were used for commissioning the flap applicator. Results: The applicator calibration at 5mm depth was performed using an OSL dosimeter. Applicator source dwelling positions with 1D and 2D array exposed to and recorded by Gafchromic EBT2 film showed an agreement within 1mm. 1D array of Freiburg flap exhibited 4.2% cooler in dose with incomplete scatter than full scatter. 2D array showed 7.1% lower in dose for incomplete scatter than full scatter. The deviation was found more than 10% beyond 8cm in depth. Conclusion: Significant dose deviation caused by the incomplete scatter environment was found to be 7.1% at 1cm depth. This deviation was increased with increasing depth. The inaccuracy resulted from the incomplete scatter can be fixed by either placing a bolus on the top of the flap or making the plan at least 7% hotter.

  10. Experimental and computed results for fluid-structure interactions with impacts in the HDR blowdown experiment

    International Nuclear Information System (INIS)

    This paper describes a new type of HDR experiment (V34) and compares the experimental results with the FLUX-code results. As novel feature, the core barrel is not rigidly clamped to the vessel as in earlier experiments but supported with gaps such that the core barrel can move freely upwards for about 2 mm and horizontally for 0.3 mm at the upper flange. At the lower core-barrel edge, snubbers restrict the horizontal motion to about + 1.4 mm and -2.8 mm. The experimental results show that the core barrel is deflected sidewards until it hits the snubber at the lower edge and then swings back to hit the opposite snubber. By this some kinetic energy is lost due to plastic snubber deformations. At the same time, the measurements show that the core barrel lifts rather uniformly from its support upwards until it hits the upper constraint. Several bounces up and down are observed until the core barrel becomes fixed probably due to friction from the side. This situation has been pre- and post-computed with the new FLUX-version which contains a very effective algorithm to treat supports with gaps and resultant impacts. For treatment of plastic supports, a simple model is added. Pre-computations were not meaningful because of large deviations in the pre-estimated initial gaps. However the computed pressure-field is not influenced very much by these parameters and predicted very well. This was favoured by the isothermal fluid initial conditions. Post-computations show sufficient agreement with respect to computed core barrel motion. The axial motion is described very well. Some problems remain which are due to the model for the upper flange support. Impacts do not result in greatly enlarged loadings, strains or accelerations for this situation. (orig./RW)

  11. Determination of the G value for HDR 192Ir sources using ionometric measurements

    International Nuclear Information System (INIS)

    A dosimetry standard for the direct measurement of absolute dose to water for 192Ir source is currently still under development. For the time being, the dose to water conversion is done via a dose rate constant Λ and several correction factors accounting for scatter, attenuation, and anisotropy of the dose distribution among other effects. Recently a report has been published on a water-based calorimeter with an overall uncertainties of 1.9 % k=1. Chemical dosimetry using a standard FeS04 solution has shown to be a reliable absorbed dose standard. Absolute absorbed dose to water measurement has been explored using Fricke for 192Ir HDR sources with uncertainties estimated of 3.9 % k=1 and very recently similar work has reported improved results with much lower uncertainties of 1.24% k=1. The G values previously reported is the major uncertainty associated to this technique and this paper presents new G values measured with ion chambers using recent dosimetry protocols. For this study, the source was positioned in a PMMA holder with its center coinciding with the center of a Framer type the ion chamber and the Fricke solution holder. The solution container was constructed with the same volume and dimensions of the ion chamber. The measurements were taken with the ion chamber placed in one of the holders and the Fricke solutions in the other three holders. The chamber and the Fricke were irradiated in all four times around the source in order to minimize the positioning uncertainties and the average reading values for each one were taken. For the 60Co and 6 MV, the beam measurements were made with the chamber at the center and the solutions on each side

  12. Evaluation of PC-ISO for customized, 3D Printed, gynecologic 192-Ir HDR brachytherapy applicators.

    Science.gov (United States)

    Cunha, J Adam M; Mellis, Katherine; Sethi, Rajni; Siauw, Timmy; Sudhyadhom, Atchar; Garg, Animesh; Goldberg, Ken; Hsu, I-Chow; Pouliot, Jean

    2015-01-01

    The purpose of this study was to evaluate the radiation attenuation properties of PC-ISO, a commercially available, biocompatible, sterilizable 3D printing material, and its suitability for customized, single-use gynecologic (GYN) brachytherapy applicators that have the potential for accurate guiding of seeds through linear and curved internal channels. A custom radiochromic film dosimetry apparatus was 3D-printed in PC-ISO with a single catheter channel and a slit to hold a film segment. The apparatus was designed specifically to test geometry pertinent for use of this material in a clinical setting. A brachytherapy dose plan was computed to deliver a cylindrical dose distribution to the film. The dose plan used an 192Ir source and was normalized to 1500 cGy at 1 cm from the channel. The material was evaluated by comparing the film exposure to an identical test done in water. The Hounsfield unit (HU) distributions were computed from a CT scan of the apparatus and compared to the HU distribution of water and the HU distribution of a commercial GYN cylinder applicator. The dose depth curve of PC-ISO as measured by the radiochromic film was within 1% of water between 1 cm and 6 cm from the channel. The mean HU was -10 for PC-ISO and -1 for water. As expected, the honeycombed structure of the PC-ISO 3D printing process created a moderate spread of HU values, but the mean was comparable to water. PC-ISO is sufficiently water-equivalent to be compatible with our HDR brachytherapy planning system and clinical workflow and, therefore, it is suitable for creating custom GYN brachytherapy applicators. Our current clinical practice includes the use of custom GYN applicators made of commercially available PC-ISO when doing so can improve the patient's treatment.  PMID:25679174

  13. Neonatal diagnosis of a patient with hypoparathyroidism, sensorineural deafness and renal dysplasia (HDR) syndrome associated with cerebral infarction.

    Science.gov (United States)

    Mejia, Juan Diego; Cervantes, Luisa; Puerta, Herminia; Bauer, Mislen; Diaz, Alejandro

    2014-09-01

    Hypoparathyroidism, sensorineural deafness and renal dysplasia syndrome (HDRS) is comprised of a triad of conditions. It is an autosomal dominant condition caused by mutations in the GATA3 gene, located at 10p15, a critical region in the development of the embryonic parathyroid glands, inner ear, and kidneys. Here we describe the case of a patient with all three components of HDR syndrome diagnosed in the neonatal period who presented with cerebral infarction, hypocalcemia, and renal anomalies. Upon chromosomal microarray he was found to have an interstitial deletion at 10p, which produced a partial deletion in the GATA3 gene. PMID:24859509

  14. Detailed Fracture System of the Soultz-sous-Forêts HDR Field Evaluated Using Microseismic Multiplet Analysis

    Science.gov (United States)

    Moriya, H.; Nakazato, K.; Niitsuma, H.; Baria, R.

    - The reservoir structure of the Soultz HDR field has been investigated by examining induced microearthquake multiplets. Microseismic events with similar waveforms have been selected from microseismic data obtained during a 1993 hydraulic fracturing experiment. Precise relative arrival times and source locations have been determined by cross-spectrum analysis. The cross-spectrum analysis decreased the residual from 0.75ms to 0.1ms. The estimated orientations of the multiplet planes are consistent with fracture orientations detected in Soultz boreholes. A comparison between the stress field and the orientation of structural planes suggests that the structural planes were under a critical condition of frictional slip.

  15. Distribution of hydrogen within the HDR-containment under severe accident conditions. OECD standard problem. Final comparison report

    International Nuclear Information System (INIS)

    The present report summarizes the results of the International Standard Problem Exercise ISP-29, based on the HDR Hydrogen Distribution Experiment E11.2. Post-test analyses are compared to experimentally measured parameters, well-known to the analysis. This report has been prepared by the Institute for Reactor Dynamics and Reactor Safety of the Technical University Munich under contract with the Gesellschaft fuer Anlagen- und Reaktorsicherheit (GRS) which received funding for this activity from the German Ministry for Research and Technology (BMFT) under the research contract RS 792. The HDR experiment E11.2 has been performed by the Kernforschungszentrum Karlsruhe (KfK) in the frame of the project 'Projekt HDR-Sicherheitsprogramm' sponsored by the BMFT. Ten institutions from eight countries participated in the post-test analysis exercise which was focussing on the long-lasting gas distribution processes expected inside a PWR containment under severe accident conditions. The gas release experiment was coupled to a long-lasting steam release into the containment typical for an unmitigated small break loss-of-coolant accident. In lieu of pure hydrogen a gas mixture consisting of 15% hydrogen and 85% helium has been applied in order to avoid reaching flammability during the experiment. Of central importance are common overlay plots comparing calculated transients with measurements of the global pressure, the local temperature-, steam- and gas concentration distributions throughout the entire HDR containment. The comparisons indicate relatively large margins between most calculations and the experiment. Having in mind that this exercise was specified as an 'open post-test' analysis of well-known measured data the reasons for discrepancies between measurements and simulations were extensively discussed during a final workshop. It was concluded that analytical shortcomings as well as some uncertainties of experimental boundary conditions may be responsible for deviations

  16. COMMIX model investigations for the HDR main test T32.11 and T32.36

    International Nuclear Information System (INIS)

    In order to investigate the effect of the k-turbulence model of COMMIX-1B, the HDR main tests T32.11 and T32.36 were recalculated for laminar and turbulent flow conditions. Part of the turbulent flow calculations were duplicated using the KfK-reference version of COMMIX-2. In an additional effort, a benchmark calculation for thermal buoyancy phenomena at a pipe/plenum interface proposed by ANL experimenters and organized by IAHR was conducted up to 2000 s transient time. (orig./DG)

  17. Direct measurement of instantaneous source speed for a HDR brachytherapy unit using an optical fiber based detector

    Energy Technology Data Exchange (ETDEWEB)

    Minamisawa, R. A.; Rubo, R. A.; Seraide, R. M.; Rocha, J. R. O.; Almeida, A. [Department of Physics and Mathematics, FFCLRP, University of Sao Paulo, 14040-901, Ribeirao Preto-SP (Brazil); INRAD, Medical School - University of Sao Paulo, Clinical Hospital (HCUSP), 05403-001, Sao Paulo-SP (Brazil); CAISM Radiotherapy Service, CEB, State University of Campinas, 13083-881, Campinas-SP (Brazil); Department of Physics and Mathematics, FFCLRP, University of Sao Paulo, 14040-901, Ribeirao Preto-SP (Brazil)

    2010-10-15

    Purpose: Several attempts to determine the transit time of a high dose rate (HDR) brachytherapy unit have been reported in the literature with controversial results. The determination of the source speed is necessary to accurately calculate the transient dose in brachytherapy treatments. In these studies, only the average speed of the source was measured as a parameter for transit dose calculation, which does not account for the realistic movement of the source, and is therefore inaccurate for numerical simulations. The purpose of this work is to report the implementation and technical design of an optical fiber based detector to directly measure the instantaneous speed profile of a {sup 192}Ir source in a Nucletron HDR brachytherapy unit. Methods: To accomplish this task, we have developed a setup that uses the Cerenkov light induced in optical fibers as a detection signal for the radiation source moving inside the HDR catheter. As the {sup 192}Ir source travels between two optical fibers with known distance, the threshold of the induced signals are used to extract the transit time and thus the velocity. The high resolution of the detector enables the measurement of the transit time at short separation distance of the fibers, providing the instantaneous speed. Results: Accurate and high resolution speed profiles of the {sup 192}Ir radiation source traveling from the safe to the end of the catheter and between dwell positions are presented. The maximum and minimum velocities of the source were found to be 52.0{+-}1.0 and 17.3{+-}1.2 cm/s. The authors demonstrate that the radiation source follows a uniformly accelerated linear motion with acceleration of |a|=113 cm/s{sup 2}. In addition, the authors compare the average speed measured using the optical fiber detector to those obtained in the literature, showing deviation up to 265%. Conclusions: To the best of the authors' knowledge, the authors directly measured for the first time the instantaneous speed

  18. Direct measurement of instantaneous source speed for a HDR brachytherapy unit using an optical fiber based detector

    International Nuclear Information System (INIS)

    Purpose: Several attempts to determine the transit time of a high dose rate (HDR) brachytherapy unit have been reported in the literature with controversial results. The determination of the source speed is necessary to accurately calculate the transient dose in brachytherapy treatments. In these studies, only the average speed of the source was measured as a parameter for transit dose calculation, which does not account for the realistic movement of the source, and is therefore inaccurate for numerical simulations. The purpose of this work is to report the implementation and technical design of an optical fiber based detector to directly measure the instantaneous speed profile of a 192Ir source in a Nucletron HDR brachytherapy unit. Methods: To accomplish this task, we have developed a setup that uses the Cerenkov light induced in optical fibers as a detection signal for the radiation source moving inside the HDR catheter. As the 192Ir source travels between two optical fibers with known distance, the threshold of the induced signals are used to extract the transit time and thus the velocity. The high resolution of the detector enables the measurement of the transit time at short separation distance of the fibers, providing the instantaneous speed. Results: Accurate and high resolution speed profiles of the 192Ir radiation source traveling from the safe to the end of the catheter and between dwell positions are presented. The maximum and minimum velocities of the source were found to be 52.0±1.0 and 17.3±1.2 cm/s. The authors demonstrate that the radiation source follows a uniformly accelerated linear motion with acceleration of |a|=113 cm/s2. In addition, the authors compare the average speed measured using the optical fiber detector to those obtained in the literature, showing deviation up to 265%. Conclusions: To the best of the authors' knowledge, the authors directly measured for the first time the instantaneous speed profile of a radiation source in a HDR

  19. Single institutional retrospective analysis: treatment of choroidal melanomas with cobalt-60 brachytherapy Análise retrospectiva uni-institucional: tratamento de melanomas de coróide com braquiterapia utilizando cobalto-60

    Directory of Open Access Journals (Sweden)

    Antônio Cássio Assis Pellizzon

    2004-06-01

    Full Text Available PURPOSE: To evaluate the outcome of patients with choroidal melanoma treated with conservative therapy with brachytherapy (episcleral Co-60 plaque therapy at the "Hospital do Cancer" São Paulo, Brazil. METHODS: We evaluated 102 patients consecutively treated from January, 1999 to June, 1999. Median age, maximum tumor base diameter and apex size were 55.5 years, 9.75 mm and 5 mm, respectively. Doses at the base of the tumor, including 1 mm of sclera, ranged from 157 to 487 Gy (median 284.5 Gy and to the apex from 37 to 220 Gy (median 106 Gy. RESULTS: The crude eye preservation rate with conservative therapy alone was 78.5%. Five-year overall actuarial survival rate was 92.2% and eye conservation rate was 78%. Side effects were mostly an uncomplicated retinopathy in 39/102 patients (38.2%; macular degeneration or scarring led to poor central vision in 31/102 patients (30.3% of cases. CONCLUSION: Our experience with cobalt-60 plaque brachytherapy achieved a satisfactory rate of local tumor control, despite the oversized base diameters of treated tumors.OBJETIVOS: Para avaliar o resultado de tratamento pacientes portadores de melanoma de coróide tratados com braquiterapia (placas episclerais de Co-60 no Hospital do Câncer, São Paulo, Brasil. MÉTODOS: Foram avaliados 108 pacientes tratados consecutivamente de janeiro de 1995 a junho de 1999, com idade mediana de 55,5 anos, diâmetro da base do tumor e altura máximos 9,75 mm e 5 mm, respectivamente. As doses na base do tumor, incluindo 1 mm de esclera variaram de 157 a 487 Gy (mediana 284,5 Gy e para o ápice de 37 até 220 Gy (mediana 106 Gy. RESULTADOS: A taxa de preservação ocular foi 78,5%, com sobrevida atuarial global em cinco anos, e a taxa de conservação ocular atuarial foram 92,2% e 78%, respectivamente. Os principais efeitos colaterais relacionados ao tratamento foram retinopatia em 39/102 (38,2% pacientes e degeneração macular, levando a déficit visual central em 31/102 (30

  20. Air kerma rate measurements of 192Ir source in Gammamed 12i HDR/PDR unit using well type ionization chamber

    International Nuclear Information System (INIS)

    The use of high dose rate (HDR) brachytherapy in radiotherapy department has increased nowadays. The initial activity of 192Ir sources, used in high dose rate brachytherapy unit is approximately 10 Ci. About 3 to 4 times per year, a replacement is made of these sources, because of the decay half-life of 192Ir with 73.83 days. It is recommended that each time a new HDR source is installed for use in clinical routine, a source calibration in the hospital should be carried out

  1. Analysis of risk assessment of brachytherapy from the radiotherapy services of the metropolitan region of Rio de Janeiro, RJ, Brazil; Analise da percepcao de risco da braquiterapia dos servicos de radioterapia da regiao metropolitana do Rio de Janeiro

    Energy Technology Data Exchange (ETDEWEB)

    Burgos, Adam de Freitas; Paiva, Eduardo de, E-mail: adam@bolsista.ird.gov.br, E-mail: epaiva@ird.gov.br [Instituto de Radioprotecao e Dosimetria (IRD/CNEN-RJ),Rio de Janeiro, RJ (Brazil); Souza, Roberto Salomon de, E-mail: salomon@inca.gov.br [Instituto Nacional de Cancer (PQRT/INCA), Rio de Janeiro, RJ (Brazil). Programa de Qualidade em Radioterapia

    2014-07-01

    Currently there are few applications on the risk analysis procedures related to radiotherapy, mainly in the practice of brachytherapy. The objective of this study was to analyze the perception of risk levels, present in the practice of high dose rate brachytherapy (HDR), using a form based on the concept of the risk matrix and a database (SEVRRA) containing information about the processes related to routine brachytherapy. A form containing information regarding the brachytherapy procedure HDR and an attachment indicating how to complete it properly was delivered to a medical physicist of each service/institution. The reference value for the risk levels found, considered acceptable for all performed analyzes, was set at a percentage limit of 33% (assuming a failure in each 3 existing processes). The results showed that the overall risk analysis showed a value for average percentage of prioritized risk of 18% below the recommended range. About the analyzed groups, the higher average percentage of relative risk was found less than 12% of the recommended range, associated with the group of patients. On existing steps, the highest average percentage of relative risk was found less than 1% of the recommended range, associated with stage records and treatment planning. This study showed that although this procedure does not have a large history of accidents, still poses risks considerable that must be managed with great accuracy and immediate action to an effective decrease these risk percentages.

  2. Characterization of a Ce3+ doped SiO2 optical dosimeter for dose measurements in HDR brachytherapy

    International Nuclear Information System (INIS)

    Aim of this work was to study the application of a new miniaturized Ce3+ doped SiO2 scintillation detector to in vivo dosimetry in high dose rate brachytherapy. Energy, dose-rate, temperature and angular dependences of the detector response to 192Ir HDR brachytherapy fields were investigated, as well as sensitivity reproducibility and linearity. To this aim, two ad hoc phantoms were designed and developed to perform measurements in water. Intra-session reproducibility resulted to be very high, however inter-session reproducibility showed too high statistical variation. Detector response resulted to increase linearly with dose (R2 = 0.997), with no evidence of energy and dose-rate dependence. Sensitivity resulted to increase linearly with temperature (R2 = 0.995), with a 0.2% increase each °C. Finally, no significant angular dependence for the source moving around a circle in the azimuthal plane centered at the scintillator was observed. The obtained results show that the proposed detector is suitable for in vivo real-time dosimetry in high dose rate brachytherapy. -- Highlights: •A Ce3+ doped SiO2 scintillation detector was applied to 192Ir HDR brachytherapy. •Detector response resulted to be linear with the delivered dose. •No evidence of energy and dose rate dependence resulted from the study

  3. Dosimetric impact of applicator displacement during high dose rate (HDR) Cobalt-60 brachytherapy for cervical cancer: A planning study

    Science.gov (United States)

    Yong, J. S.; Ung, N. M.; Jamalludin, Z.; Malik, R. A.; Wong, J. H. D.; Liew, Y. M.; Ng, K. H.

    2016-02-01

    We investigated the dosimetric impact of applicator displacement on dose specification during high dose rate (HDR) Cobalt-60 (Co-60) brachytherapy for cervical cancer through a planning study. Eighteen randomly selected HDR full insertion plans were restrospectively studied. The tandem and ovoids were virtually shifted translationally and rotationally in the x-, y- and z-axis directions on the treatment planning system. Doses to reference points and volumes of interest in the plans with shifted applicators were compared with the original plans. The impact of dose displacement on 2D (point-based) and 3D (volume-based) treatment planning techniques was also assessed. A ±2 mm translational y-axis applicator shift and ±4° rotational x-axis applicator shift resulted in dosimetric changes of more than 5% to organs at risk (OAR) reference points. Changes to the maximum doses to 2 cc of the organ (D2cc) in 3D planning were statistically significant and higher than the reference points in 2D planning for both the rectum and bladder (pbrachytherapy.

  4. Cyclic and transient thermal loading of the HDR reactor pressure vessel with respect to crack initiation and crack propagation

    International Nuclear Information System (INIS)

    In a series of thermal loading tests at the HDR reactor pressure vessel - thermal stratification, cyclic thermal shock and pressurized thermal shock - the methods applied in safety analysis had to become qualified by a continuous intercomparison of calculated results and experimental data. Above all the complex boundary conditions of the HDR-tests offer a close approximation to the original components, so that they provide a real assessment of the transferability. The results of the thermal mixing tests indicated that during cold water inflow into the RPV longitudinal strains build up in the cylindrical wall which dominate over that in circumferential direction. During the cyclic thermal fatigue tests incipient crack formation in the cladding as well as the behaviour of crack propagation in the cladding and in the base material was analyzed. In the pressurized thermal shock tests, the nozzle region and the cylinder wall in the incipient crack condition were loaded by long cooling streaks. Even in the aggravated loading condition as the result of a routed cold water streak no remarkable indications of crack growth were noticed. In both cases, cyclic and pressurized thermal shock loading, the expected crack propagation was overpredicted by the fracture mechanical methods used. The non-destructive examination methods used were able to locate all of the cracks but they mostly overpredicted the actual crack depth. (orig.)

  5. Dosimetric impact of applicator displacement during high dose rate (HDR) Cobalt-60 brachytherapy for cervical cancer: A planning study

    Science.gov (United States)

    Yong, J. S.; Ung, N. M.; Jamalludin, Z.; Malik, R. A.; Wong, J. H. D.; Liew, Y. M.; Ng, K. H.

    2016-02-01

    We investigated the dosimetric impact of applicator displacement on dose specification during high dose rate (HDR) Cobalt-60 (Co-60) brachytherapy for cervical cancer through a planning study. Eighteen randomly selected HDR full insertion plans were restrospectively studied. The tandem and ovoids were virtually shifted translationally and rotationally in the x-, y- and z-axis directions on the treatment planning system. Doses to reference points and volumes of interest in the plans with shifted applicators were compared with the original plans. The impact of dose displacement on 2D (point-based) and 3D (volume-based) treatment planning techniques was also assessed. A ±2 mm translational y-axis applicator shift and ±4° rotational x-axis applicator shift resulted in dosimetric changes of more than 5% to organs at risk (OAR) reference points. Changes to the maximum doses to 2 cc of the organ (D2cc) in 3D planning were statistically significant and higher than the reference points in 2D planning for both the rectum and bladder (p<0.05). Rectal D2cc was observed to be the most sensitive to applicator displacement among all dose metrics. Applicator displacement that is greater than ±2 mm translational y-axis and ±4° rotational x-axis resulted in significant dose changes to the OAR. Thus, steps must be taken to minimize the possibility of applicator displacement during brachytherapy.

  6. A linear programming model for optimizing HDR brachytherapy dose distributions with respect to mean dose in the DVH-tail

    International Nuclear Information System (INIS)

    Purpose: Recent research has shown that the optimization model hitherto used in high-dose-rate (HDR) brachytherapy corresponds weakly to the dosimetric indices used to evaluate the quality of a dose distribution. Although alternative models that explicitly include such dosimetric indices have been presented, the inclusion of the dosimetric indices explicitly yields intractable models. The purpose of this paper is to develop a model for optimizing dosimetric indices that is easier to solve than those proposed earlier.Methods: In this paper, the authors present an alternative approach for optimizing dose distributions for HDR brachytherapy where dosimetric indices are taken into account through surrogates based on the conditional value-at-risk concept. This yields a linear optimization model that is easy to solve, and has the advantage that the constraints are easy to interpret and modify to obtain satisfactory dose distributions.Results: The authors show by experimental comparisons, carried out retrospectively for a set of prostate cancer patients, that their proposed model corresponds well with constraining dosimetric indices. All modifications of the parameters in the authors' model yield the expected result. The dose distributions generated are also comparable to those generated by the standard model with respect to the dosimetric indices that are used for evaluating quality.Conclusions: The authors' new model is a viable surrogate to optimizing dosimetric indices and quickly and easily yields high quality dose distributions

  7. A thermo-hydro-mechanical coupled model in local thermal non-equilibrium for fractured HDR reservoir with double porosity

    Science.gov (United States)

    Gelet, R.; Loret, B.; Khalili, N.

    2012-07-01

    The constitutive thermo-hydro-mechanical equations of fractured media are embodied in the theory of mixtures applied to three-phase poroelastic media. The solid skeleton contains two distinct cavities filled with the same fluid. Each of the three phases is endowed with its own temperature. The constitutive relations governing the thermomechanical behavior, generalized diffusion and transfer are structured by, and satisfy, the dissipation inequality. The cavities exchange both mass and energy. Mass exchanges are driven by the jump in scaled chemical potential, and energy exchanges by the jump in coldness. The finite element approximation uses the displacement vector, the two fluid pressures and the three temperatures as primary variables. It is used to analyze a generic hot dry rock geothermal reservoir. Three parameters of the model are calibrated from the thermal outputs of Fenton Hill and Rosemanowes HDR reservoirs. The calibrated model is next applied to simulate circulation tests at the Fenton Hill HDR reservoir. The finer thermo-hydro-mechanical response provided by the dual porosity model with respect to a single porosity model is highlighted in a parameter analysis. Emphasis is put on the influence of the fracture spacing, on the effective stress response and on the permeation of the fluid into the porous blocks. The dual porosity model yields a thermally induced effective stress that is less tensile compared with the single porosity response. This effect becomes significant for large fracture spacings. In agreement with field data, fluid loss is observed to be high initially and to decrease with time.

  8. Investigation of Dosimetric Parameters of $^{192}$Ir MicroSelectron v2 HDR Brachytherapy Source Using EGSnrc Monte Carlo Code

    CERN Document Server

    Naeem, Hamza; Zheng, Huaqing; Cao, Ruifen; Pei, Xi; Hu, Liqin; Wu, Yican

    2016-01-01

    The $^{192}$Ir sources are widely used for high dose rate (HDR) brachytherapy treatments. The aim of this study is to simulate $^{192}$Ir MicroSelectron v2 HDR brachytherapy source and calculate the air kerma strength, dose rate constant, radial dose function and anisotropy function established in the updated AAPM Task Group 43 protocol. The EGSnrc Monte Carlo (MC) code package is used to calculate these dosimetric parameters, including dose contribution from secondary electron source and also contribution of bremsstrahlung photons to air kerma strength. The Air kerma strength, dose rate constant and radial dose function while anisotropy functions for the distance greater than 0.5 cm away from the source center are in good agreement with previous published studies. Obtained value from MC simulation for air kerma strength is $9.762\\times 10^{-8} \\textrm{UBq}^{-1}$and dose rate constant is $1.108\\pm 0.13\\%\\textrm{cGyh}^{-1} \\textrm{U}^{-1}$.

  9. Fractionated intraluminal HDR {sup 192}Ir brachytherapy as palliative treatment in patients with endobronchial metastases from non-bronchogenic primaries

    Energy Technology Data Exchange (ETDEWEB)

    Stranzl, H.; Gabor, S.; Mayer, R.; Prettenhofer, U.; Wurzinger, G.; Hackl, A. [University Medical School of Graz (Austria)

    2002-08-01

    Aim: To evaluate the efficacy of iridium-192 high-dose rate (HDR) endobronchial brachytherapy for the palliation of symptoms caused by endobronchial metastases of non-bronchogenic primaries. Patients and method: Between 1991 and 1998, eleven patients (female n=3, male n=8; age: median 66 years, range 44-81 years) underwent intraluminal HDR brachytherapy for histologically confirmed endobronchial metastases from non-pulmonary primary tumors of various sites like urogenital tract (n=5), gastrointestinal tract (n=3), ear/nose/throat (n=2) and breast (n=1). The median time between diagnosis of the primary non-bronchogenic tumor and histopathological diagnosis of the endobronchial metastases was 39 months, range 1-99 months. A total dose of 15-20 Gy was delivered in three to four fractions of 5-6 Gy once a week. No palliative chemotherapy was added. Results: Median follow-up after palliative brachytherapy was 15 months (range 1.4-59 months). Objectively, complete endoscopic response was observed in three (27%) patients, and in five (46%) others partial opening of the initially obstructed airway was achieved. Treatment was judged unsuccessful in three (27%) patients. No patient showed up with local progression. At date of analysis five patients were alive with documented residual tumor (80%) or complete response (20%). Relief of symptoms occurred in the vast majority of patients (n=8, 73%). Conclusion: HDR intraluminal brachytherapy palliates symptoms in patients suffering from endobronchial metastases of nonpulmonary primary tumors. The applied treatment is a safe, effective and well tolerated palliative procedure leading to an improved patient quality of life. (orig.) [German] Hintergrund: Untersuchung des palliativen Effektes einer fraktionierten intraluminalen Iridium-192-High-Dose-Rate-(HDR-)Brachytherapie bei Patienten mit endobronchialen Metastasen eines primaer nicht bronchogenen Tumors. Patienten und Methode: Zwischen April 1991 und September 1998 wurden elf

  10. Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer

    International Nuclear Information System (INIS)

    Purpose: To investigate the feasibility, toxicity, cosmetic outcome, and local control of high-dose-rate (HDR) brachytherapy alone without whole breast external beam irradiation for early-stage breast carcinoma. Methods and Materials: Between June 1997 and August 1999, 32 women diagnosed with a total of 33 AJCC Stage I/II breast carcinomas underwent surgical breast excision and postoperative irradiation using HDR brachytherapy interstitial implantation as part of a multi-institutional clinical Phase I/II protocol. Eligible patients included those with T1, T2, N0, N1 (≤3 nodes positive), and M0 tumors of nonlobular histologic features with negative surgical margins, no extracapsular lymph node extension, and a negative postexcision mammogram. Brachytherapy catheters were placed at the initial excision, reexcision, or either sentinel or full-axillary sampling. Direct visualization, surgical clips, and ultrasound and/or CT scan assisted in the delineation of the target volume, defined as the excision cavity plus a 2-cm margin. High-activity 192Ir (3-10 Ci) was used to deliver 340 cGy/fraction, 2 fractions/d, for 5 consecutive days, to a total dose of 34 Gy to the target volume. Source position and dwell times were calculated using standard volume optimization techniques. Results: The median follow-up of all patients was 33 months, and the mean patient age was 63 years. The mean tumor size was 1.3 cm, and 55% had an extensive intraductal component. Three patients had positive axillary nodes. Two patients experienced moderate perioperative pain that required narcotic analgesics. No peri- or postoperative infections occurred. No wound healing problems and no significant skin reactions related to the implant developed. The Radiation Therapy Oncology Group late radiation morbidity scoring scheme was applied to the entire 33-case cohort. In the assessment of the skin, 30 cases were Grade 0-1 and 3 cases were Grade 2. Subcutaneous toxicity was scored as 11 patients with

  11. Faulting mechanisms and stress regime at the European HDR site of Soultz-sous-Forets, France

    International Nuclear Information System (INIS)

    The state of stress and its implications for shear on fault planes during fluid injection are crucial issues for the HDR (Hot Dry Rock) or EGS (Enhanced or Engineered Geothermal System) concept. This is especially true for hydraulic stimulation experiments, aimed at enhancing the connectivity of a borehole to the natural fracture network, since they tend to induce the shearing of fractures, which is controlled by the local stress regime. During the 2000 and 2003 stimulation tests at Soultz-sous-Forets, France, about 10,000 microearthquakes were located with a surface seismological network. Hundreds of double-couple (DC) focal mechanisms were automatically determined from first-motion polarities using the FPFIT program [Reasenberg, P.A., Oppenheimer, D., 1985. FPFIT, FPPLOT and FPPAGE: Fortran computer programs for calculating and displaying earthquake fault-plane solutions. US Geological Survey Open-File Report 85-739, 25 pp.]. The majority of these mechanisms indicate normal-faulting movement with a more or less pronounced strike-slip component. Some quasi-pure strike-slip events also occurred, especially in the deeper part of the stimulated rock volume, at more than 5 km depth. Although we found a double-couple solution for all events, we tried to observe and quantify the proportion of the non-double-couple (NDC) component in the seismic moment tensor for several microseisms from the 2003 data. The study shows that the NDC is higher for the events in the vicinity of the injection well than for the events far from the well. We used the method of Rivera and Cisternas [Rivera, L., Cisternas, A., 1990. Stress tensor and fault-plane solutions for a population of earthquakes. Bull. Seismol. Soc. Am. 80, 600-614.] to perform the inversion of the deviatoric part of the stress tensor from P-wave polarities. This method was applied to different datasets from the 2000 test, taken from the shallower and deeper parts of the stimulated region. The results show a stable

  12. A CT-based analytical dose calculation method for HDR 192Ir brachytherapy

    International Nuclear Information System (INIS)

    % for both calculation methods. Conclusions: A correction-based dose calculation method has been validated for HDR 192Ir brachytherapy. Its high calculation efficiency makes it feasible for use in treatment planning. Because tissue inhomogeneity effects are small and primary dose predominates in the near-source region, TG-43 is adequate for target dose estimation provided shielding and contrast solution are not used.

  13. SU-E-T-362: Automatic Catheter Reconstruction of Flap Applicators in HDR Surface Brachytherapy

    Energy Technology Data Exchange (ETDEWEB)

    Buzurovic, I; Devlin, P; Hansen, J; O' Farrell, D; Bhagwat, M; Friesen, S; Damato, A; Lewis, J; Cormack, R [Dana-Farber/Brigham and Women' s Cancer Center, Harvard Medical School, Boston, MA (United States)

    2014-06-01

    Purpose: Catheter reconstruction is crucial for the accurate delivery of radiation dose in HDR brachytherapy. The process becomes complicated and time-consuming for large superficial clinical targets with a complex topology. A novel method for the automatic catheter reconstruction of flap applicators is proposed in this study. Methods: We have developed a program package capable of image manipulation, using C++class libraries of The-Visualization-Toolkit(VTK) software system. The workflow for automatic catheter reconstruction is: a)an anchor point is placed in 3D or in the axial view of the first slice at the tip of the first, last and middle points for the curved surface; b)similar points are placed on the last slice of the image set; c)the surface detection algorithm automatically registers the points to the images and applies the surface reconstruction filter; d)then a structured grid surface is generated through the center of the treatment catheters placed at a distance of 5mm from the patient's skin. As a result, a mesh-style plane is generated with the reconstructed catheters placed 10mm apart. To demonstrate automatic catheter reconstruction, we used CT images of patients diagnosed with cutaneous T-cell-lymphoma and imaged with Freiburg-Flap-Applicators (Nucletron™-Elekta, Netherlands). The coordinates for each catheter were generated and compared to the control points selected during the manual reconstruction for 16catheters and 368control point Results: The variation of the catheter tip positions between the automatically and manually reconstructed catheters was 0.17mm(SD=0.23mm). The position difference between the manually selected catheter control points and the corresponding points obtained automatically was 0.17mm in the x-direction (SD=0.23mm), 0.13mm in the y-direction (SD=0.22mm), and 0.14mm in the z-direction (SD=0.24mm). Conclusion: This study shows the feasibility of the automatic catheter reconstruction of flap applicators with a high

  14. Samples of HDR Soultz Injection Microearthquakes: Mechanism Using Alternative Source Models

    Science.gov (United States)

    Jechumtalova, Z.; Sileny, J.

    2011-12-01

    offered by the seismicity induced during the massive fluid injection experiments at the Hot Dry Rock (HDR) site Soultz-sous-Forêts. The site is located in Alsace (France) within the hottest geothermal surface anomaly of the Upper Rhine Graben. From the bulk of the seismicity recorded, we have processed several microearthquakes with magnitudes between M = 1.4 and 1.5 which occurred during the first phase of 2003 fluid injection, when only the borehole GPK3 was stimulated. Mechanisms resulting from the alternative approaches offer the clue to estimate the reliability of the shear vs. non-shear source components, thus indicating the type of the fracturing.

  15. Identifying afterloading PDR and HDR brachytherapy errors using real-time fiber-coupled Al2O3:C dosimetry and a novel statistical error decision criterion

    DEFF Research Database (Denmark)

    Kertzscher, Gustavo; Andersen, Claus Erik; Siebert, Frank-André;

    2011-01-01

    conditions, and (2) test a new statistical error decision concept based on full uncertainty analysis. Materials and methodsPhantom studies of two gynecological cancer PDR and one prostate cancer HDR patient treatment plans were performed using tandem ring applicators or interstitial needles. Imposed...... advantage of a statistical error criterion....

  16. HDR syndrome: a follow-up genotype-phenotype analysis of a de novo missense Thr272Ile mutation in exon 4 of GATA3.

    Science.gov (United States)

    Gomes, T S; Gortner, L; Dockter, G; Leitner, D; Thakker, R V; Rohrer, T

    2012-11-01

    Hypoparathyroidism, sensorineural deafness and renal dysplasia (HDR) syndrome (MIM 146255) is a rare autosomal dominant disorder caused by mutations in the gene encoding GATA3, a dual zinc-finger transcription factor involved in vertebrate embryonic development. In this clinical case study we report on a follow-up of a phenotype associated with a GATA3 mutation. HDR syndrome was clinically diagnosed at age of 1.5 years in a boy with a de novo heterozygous missense (c.815C→T) mutation, Thr272Ile, in exon 4 of the GATA3 gene. Both parents were negative for Thr272Ile.At age of 17 months, the patient had a weight of 10.7, a body length of 78 cm, and a head circumference of 47.5 cm. By the age of 7 years, growth is age-appropriate, severe bilateral hearing loss (dB 60) was corrected by hearing aids. However, cognitive development (auditory sensory me-mory and language abilities) is at the lower ends of the test scores.In conclusion, a mildly impaired clinical course was achieved by the age of 7 years in a patient with HDR syndrome; this report adds to the body of data on genotype-phenotype analysis in HDR syndrome. · PMID:23203342

  17. Gold marker displacement due to needle insertion during HDR-brachytherapy for treatment of prostate cancer: A prospective cone beam computed tomography and kilovoltage on-board imaging (kV-OBI) study

    International Nuclear Information System (INIS)

    To evaluate gold marker displacement due to needle insertion during HDR-brachytherapy for therapy of prostate cancer. 18 patients entered into this prospective evaluation. Three gold markers were implanted into the prostate during the first HDR-brachytherapy procedure after the irradiation was administered. Three days after marker implantation all patients had a CT-scan for planning purpose of the percutaneous irradiation. Marker localization was defined on the digitally-reconstructed-radiographs (DRR) for daily (VMAT technique) or weekly (IMRT) set-up error correction. Percutaneous therapy started one week after first HDR-brachytherapy. After the second HDR-brachytherapy, two weeks after first HDR-brachtherapy, a cone-beam CT-scan was done to evaluate marker displacement due to needle insertion. In case of marker displacement, the actual positions of the gold markers were adjusted on the DRR. The value of the gold marker displacement due to the second HDR-brachytherapy was analyzed in all patients and for each gold marker by comparison of the marker positions in the prostate after soft tissue registration of the prostate of the CT-scans prior the first and second HDR-brachytherapy. The maximum deviation was 5 mm, 7 mm and 12 mm for the anterior-posterior, lateral and superior-inferior direction. At least one marker in each patient showed a significant displacement and therefore new marker positions were adjusted on the DRRs for the ongoing percutaneous therapy. Needle insertion in the prostate due to HDR-brachytherapy can lead to gold marker displacements. Therefore, it is necessary to verify the actual position of markers after the second HDR-brachytherapy. In case of significant deviations, a new DRR with the adjusted marker positions should be generated for precise positioning during the ongoing percutaneous irradiation

  18. Improvements of visual X-ray inspection with optimized digital detector technology. Faster and more reliable inspection with High Dynamic Radiology (HDR); Erweiterung der visuellen Roentgenpruefung durch effizientere digitale Technologien. Mit HDR schneller und sicherer zum Ziel

    Energy Technology Data Exchange (ETDEWEB)

    Bavendiek, Klaus [YXLON International GmbH, Hattingen (Germany)

    2010-07-01

    Improvements in speed and contrast resolution of Digital Detector Arrays (DDA) and significant higher power of X-Ray tubes in combination with a small focal spot open the door to an improved visual inspection of castings for automotive and aerospace applications. The result is a film-like image quality of castings in a live view. For the new image quality the x-ray parameter have to be optimized in energy and the subject contrast has to be increased to avoid that flaws are covered by the noise in the image. HDR - high dynamic radiology - expands the local contrast in the image and transfers the grey values to the range the human inspector can separate. Due to the movement in the image the inspector gets a glas-like impression of the object and the flaws allowing him to do a decision about the 3D position of a flaw in the object. (orig.)

  19. Endoluminal ultrasound and segmental analysis in diagnosis of congenital malformation of the uterus and vagina%腔内超声节段分析法诊断先天性子宫及阴道畸形

    Institute of Scientific and Technical Information of China (English)

    杨雪冰; 王慧芳; 刘云平; 陈秋香; 郭娟; 王诗雅

    2013-01-01

    Objective To investigate the diagnostic value of endoluminal ultrasound (transvaginal and transrectal ultrasound) and segmental analysis with three-dimensional ultrasonography for congenital malformation of the uterus and vagina. Methods A total of 226 patients with clinically confirmed congenital malformations of the uterus and vagina were enrolled and divided into two groups. Group A included 154 cases, the findings of transabdominal or endoluminal two dimensional ultrasonography were retrospectively compared with clinical diagnosis. Group B included 72 cases, the results of segmental analysis by endoluminal three-dimensional ultrasonography were perspective studied and then compared with clinical diagnosis. Results In group A, 99 of 154 cases with congenital malformations of the uterus and vagina were diagnosed by two dimensional ultrasound, while 55 cases were missed or misdiagnosed. The coincidence rate was 64. 29% (99/154). In group B, since the introduction of three dimensional ultrasonography and segmental analysis, 69 of 72 cases were defined, with the coincidence rate of 95. 83% (69/72), while 3 cases were missed diagnosed or misdiagnosed. Conclusion Translu-minal three-dimensional ultrasonography and segmental analysis have essential diagnostic value, which can improve the accuracy of diagnosis and classification of congenital malformation of the uterus and vagina.%目的 探讨应用腔内(经阴道或经直肠)三维超声节段分析法诊断先天性子宫及阴道畸形的价值.方法 将226例先天性子宫及阴道畸形患者分为A、B两组.A组154例,采用回顾性分析,对比分析其经腹或腔内二维超声检查的结果及临床结局;B组72例,采用前瞻性研究,对比分析应用节段分析法经腔内三维超声检查的结果及临床结局.结果 A组154例中,二维超声检查诊断符合率为64.29%(99/154),漏、误诊55例,未进行详细分类;B组72例中,腔内三维超声节段

  20. Análises de protocolos de braquiterapia, por alta taxa de dose, do controle de qualidade de alguns serviços locais, baseados no TG40, TG56 e ARCAL XXX Analysis of the high dose rate brachytherapy protocols of quality assurance programs of some local services, based on TG40, TG56 and ARCAL XXX.

    Directory of Open Access Journals (Sweden)

    Carmen S. Guzmán Calcina

    2001-08-01

    Full Text Available A braquiterapia por alta taxa de dose está recebendo atenção considerável na maioria dos países. Por isso, nos serviços que utilizam este equipamento exige-se que o desenvolvimento de um programa de controle de qualidade seja cada vez mais rigoroso, para garantir não apenas a segurança aos pacientes, mas também aos operadores e demais envolvidos. Este trabalho tem por objetivos fazer um levantamento dos tipos de testes para um equipamento de braquiterapia por alta taxa de dose, propostos pelos protocolos oficiais publicados (TG40, TG56 e ARCAL XXX e avaliar os tipos de testes que atualmente são realizados por alguns serviços de radioterapia, comparando-os com aqueles apresentados nos protocolos citados. Das análises feitas, observou-se que: a quanto aos protocolos oficiais, o TG56 é mais completo que o TG40 e o ARCAL XXX; b quanto às instituições analisadas, estas em geral se basearam no TG56 para elaborar seus próprios protocolos, os quais demonstraram ter também concordância com os outros já citados. Nestes protocolos, a inexistência dos testes anuais foi notada, o que pode ser explicado por sua aparição nas freqüências trimestral e semestral. Do produto deste estudo são apresentadas tabelas dos tipos de testes com suas respectivas freqüências de utilização, das quais um protocolo pode ser inferido para auxiliar na implementação, pelo menos, dos tipos de testes de controle de qualidade básicos e indispensáveis para o equipamento, garantindo, assim, um tratamento adequado aos pacientes e uma melhor segurança ao pessoal envolvido e, conseqüentemente, assegurando a garantia de qualidade na braquiterapia por alta taxa de dose.High dose rate brachytherapy has been increasingly recognized in most countries, and radiotherapy services using this equipment are encouraged to have a very efficient quality assurance program to ensure protection for patients, workers and other personnel involved. The objective of this

  1. Development of a program for calculation of second dose and securities in brachytherapy high dose rate; Elaboracion de un programa para el segundo calculo de la dosis y seguridades en braquiterapia de alta tasa de dosis

    Energy Technology Data Exchange (ETDEWEB)

    Esteve Sanchez, S.; Martinez Albaladejo, M.; Garcia Fuentes, J. D.; Bejar Navarro, M. J.; Capuz Suarez, B.; Moris de Pablos, R.; Colmenares Fernandez, R.

    2015-07-01

    We assessed the reliability of the program with 80 patients in the usual points of prescription of each pathology. The average error of the calculation points is less than 0.3% in 95% of cases, finding the major differences in the axes of the applicators (maximum error -0.798%). The program has proved effective previously testing him with erroneous dosimetry. Thanks to the implementation of this program is achieved by the calculation of the dose and part of the process of quality assurance program in a few minutes, highlighting the case of HDR prostate due to having a limited time. Having separate data sheet allows each institution to its protocols modify parameters. (Author)

  2. Verification of the HDR-test V44 using the computer program RALOC-MOD1/83

    International Nuclear Information System (INIS)

    RALOC-MOD1/83 was extended by a drainage and sump level modul and several component models to serve as a containment systems code for various LWR types. One such application is to simulate the blowdown in a full pressure containment which is important for the short and long term hydrogen distribution. The post test calculation of the containment standard problem experiment HDR-V44 shows a good agreement, to the test data. The code may be used for short and long term predictions, but it was learned that double containments need the representation of the gap between the inner and outer shell into several zones to achieve a good long-term temperature prediction. The present work completes the development, verification and documentation of RALOC-MOD1. (orig.)

  3. Endocavity Ultrasound Hyperthermia for Locally Advanced Cervical Cancer: Patient-specific Modeling, Experimental Verification, and Combination with HDR Brachytherapy

    International Nuclear Information System (INIS)

    The feasibility of targeted hyperthermia delivery by an intrauterine ultrasound applicator to patient-specific treatment volumes in conjunction with HDR brachytherapy was investigated using theory and experiment. 30 HDR brachytherapy treatment plans were inspected to define hyperthermia treatment volumes (HTVs) based on tumor and radiation target volumes. Several typical cases were imported into a patient-specific treatment planning platform that optimized acoustic output power from an endocavity multisectored tubular array to conform temperature and thermal dose to HTVs. Perfusion was within a clinical range of 0.5-3 kg m-3 s-1. Applicators were constructed with 1-3 elements at 6.5-8 MHz with 90 deg. -360 deg. sectoring and 25-35 mm heating length housed in a water-cooled PET catheter. Acoustic output was compared to heating in ex vivo tissue assessed with implanted thermometry. Radiation attenuation through the device was measured in an ionization chamber. The HTV extends 2-4 cm in diameter and 2-4 cm in length. The bladder and rectum can be within 10-12 mm. HTV targets can be covered with temperature clouds >41 deg. and thermal dose t43>5 min with 45 deg. C maximum temperature and rectal temperature <41.5 deg. C. Sectored applicators preferentially direct energy laterally into the parametrium to limit heating of rectum and bladder. Interstitial brachytherapy catheters within the HTV could be used for thermal feedback during HT treatment. Temperature distributions in phantom show preferential heating within sectors and align well with acoustic output. Heating control along the device length and in angle is evident. A 4-6% reduction in radiation transmission through the transducers was observed, which could likely be compensated for in planning. Patient-specific modeling and experimental heating demonstrated 3-D conformal heating capabilities of endocavity ultrasound applicators.

  4. A Pilot Study of Catheter-Based Ultrasound Hyperthermia with HDR Brachytherapy for Treatment of Locally Advanced Cancer of the Prostate and Cervix

    Science.gov (United States)

    Diederich, Chris J.; Wootton, Jeff; Prakash, Punit; Salgaonkar, Vasant; Juang, Titania; Scott, Serena; Chen, Xin; Cunha, Adam; Pouliot, Jean; Hsu, I. C.

    2011-09-01

    Interstitial and endocavity ultrasound devices have been developed specifically for applying hyperthermia within temporary HDR brachytherapy implants during radiation therapy. Catheter-based ultrasound applicators are capable of 3D spatial control of heating in both angle and length of the devices, with enhanced radial penetration of heating compared to other hyperthermia technologies. A pilot study of the combination of catheter based ultrasound with HDR brachytherapy for locally advanced prostate and cervical cancer has been initiated, and preliminary results of the performance and heating distributions are reported herein. The treatment delivery platform consists of a 32 channel RF amplifier and a 48 channel thermocouple monitoring system. Controlling software can monitor and regulate frequency and power to each transducer section as required during the procedure. Interstitial applicators consist of multiple transducer sections of 2-4 cm length×180 deg and 3-4 cm×360 deg. heating patterns to be inserted in specific placed 13g implant catheters. The endocavity device, designed to be inserted within a 6 mm OD plastic tandem catheter within the cervix, consists of 2-3 transducers x dual 180 or 360 deg sectors. 3D temperature based treatment planning and optimization is dovetailed to the HDR optimization based planning to best configure and position the applicators within the catheters, and to determine optimal base power levels to each transducer section. To date we have treated eight cervix implants and four prostate implants. 100% of treatments achieved a goal of >60 min duration, with therapeutic temperatures achieved in all cases. Thermal dosimetry within the hyperthermia target volume (HTV) and clinical target volume (CTV) are reported. Catheter-based ultrasound hyperthermia with HDR appears feasible with therapeutic temperature coverage of the target volume within the prostate or cervix while sparing surrounding more sensitive regions.

  5. A Pilot Study of Catheter-Based Ultrasound Hyperthermia with HDR Brachytherapy for Treatment of Locally Advanced Cancer of the Prostate and Cervix

    International Nuclear Information System (INIS)

    Interstitial and endocavity ultrasound devices have been developed specifically for applying hyperthermia within temporary HDR brachytherapy implants during radiation therapy. Catheter-based ultrasound applicators are capable of 3D spatial control of heating in both angle and length of the devices, with enhanced radial penetration of heating compared to other hyperthermia technologies. A pilot study of the combination of catheter based ultrasound with HDR brachytherapy for locally advanced prostate and cervical cancer has been initiated, and preliminary results of the performance and heating distributions are reported herein. The treatment delivery platform consists of a 32 channel RF amplifier and a 48 channel thermocouple monitoring system. Controlling software can monitor and regulate frequency and power to each transducer section as required during the procedure. Interstitial applicators consist of multiple transducer sections of 2-4 cm lengthx180 deg and 3-4 cmx360 deg. heating patterns to be inserted in specific placed 13g implant catheters. The endocavity device, designed to be inserted within a 6 mm OD plastic tandem catheter within the cervix, consists of 2-3 transducers x dual 180 or 360 deg sectors. 3D temperature based treatment planning and optimization is dovetailed to the HDR optimization based planning to best configure and position the applicators within the catheters, and to determine optimal base power levels to each transducer section. To date we have treated eight cervix implants and four prostate implants. 100% of treatments achieved a goal of >60 min duration, with therapeutic temperatures achieved in all cases. Thermal dosimetry within the hyperthermia target volume (HTV) and clinical target volume (CTV) are reported. Catheter-based ultrasound hyperthermia with HDR appears feasible with therapeutic temperature coverage of the target volume within the prostate or cervix while sparing surrounding more sensitive regions.

  6. Dosimetric verification of source strength for HDR afterloading units with 192Ir- and 60Co- photon sources: comparison of three different international protocols

    International Nuclear Information System (INIS)

    Before clinical use of a brachytherapy source, regulations or recommendations by medical physics societies require an independent measurement of its air kerma strength by a qualified medical physicist. Currently, in addition to 192Ir, also HDR-60Co sources are increasingly coming into operation. However, the existing dosimetry protocols do not provide any guidelines for 60Co sources. The purpose of this work was therefore to compare air Kerma rate measurements as recommended by different dosimetry protocols for 192Ir HDR sources and to test their applicability to 60Co sources. Dosimetric verification of HDR afterloading source specification was performed according to three protocols, DIN 6809-2 (1993) in combination with DGMP-Report 13 (2006), IAEA-TECDOC-1274 (2002) and AAPM Report 41 (1993) for the nuclides 192Ir and 60Co. Measurements of the sources reference air kerma rate were performed with 3 different methods (with a cylindrical chamber both in a solid phantom and in free air, and with a well chamber) and evaluated using all three protocols for each type of source and method of measurement. The measurements with all protocols and methods show deviations from the certified specification smaller than about 1.2% for 192Ir and 2.5% for 60Co sources. The measurements with the well chamber showed the lowest deviations from the certificate value. Air kerma rate measurements for 60Co HDR sources using the existing protocols are possible with accuracy sufficient to verify source calibration as provided by the source certificate. However, extension of the protocols by correction factors for measurement with 60Co sources would be helpful. (author)

  7. SU-E-T-634: Analysis of Volume Based GYN HDR Brachytherapy Plans for Dose Calculation to Organs At Risk(OAR)

    International Nuclear Information System (INIS)

    Purpose: We have analyzed the dose volume histogram of 140 CT based HDR brachytherapy plans and evaluated the dose received to OAR ; rectum, bladder and sigmoid colon based on recommendations from ICRU and Image guided brachytherapy working group for cervical cancer . Methods: Our treatment protocol consist of XRT to whole pelvis with 45 Gy at 1.8Gy/fraction followed by 30 Gy at 6 Gy per fraction by HDR brachytherapy in 2 weeks . The CT compatible tandem and ovoid applicators were used and stabilized with radio opaque packing material. The patient was stabilized using special re-locatable implant table and stirrups for reproducibility of the geometry during treatment. The CT scan images were taken at 3mm slice thickness and exported to the treatment planning computer. The OAR structures, bladder, rectum and sigmoid colon were outlined on the images along with the applicators. The prescription dose was targeted to A left and A right as defined in Manchester system and optimized on geometry . The dosimetry was compared on all plans using the parameter Ci.sec.cGy-1 . Using the Dose Volume Histogram (DVH) obtained from the plans the doses to rectum, sigmoid colon and bladder for ICRU defined points and 2cc volume were analyzed and reported. The following criteria were used for limiting the tolerance dose by volume (D2cc) were calculated. The rectum and sigmoid colon doses were limited to <75Gy. The bladder dose was limited to < 90Gy from both XRT and HDR brachytherapy. Results: The average total (XRT+HDRBT) BED values to prescription volume was 120 Gy. Dose 2cc to rectum was 70Gy +/− 17Gy, dose to 2cc bladder was 82+/−32 Gy. The average Ci.sec.cGy-1 calculated for the HDR plans was 6.99 +/− 0.5 Conclusion: The image based treatment planning enabled to evaluati volume based dose to critical structures for clinical interpretation

  8. SU-E-T-634: Analysis of Volume Based GYN HDR Brachytherapy Plans for Dose Calculation to Organs At Risk(OAR)

    Energy Technology Data Exchange (ETDEWEB)

    Nair, M; Li, C; White, M; Davis, J [Joe Arrington Cancer Center, Lubbock, TX (United States)

    2014-06-15

    Purpose: We have analyzed the dose volume histogram of 140 CT based HDR brachytherapy plans and evaluated the dose received to OAR ; rectum, bladder and sigmoid colon based on recommendations from ICRU and Image guided brachytherapy working group for cervical cancer . Methods: Our treatment protocol consist of XRT to whole pelvis with 45 Gy at 1.8Gy/fraction followed by 30 Gy at 6 Gy per fraction by HDR brachytherapy in 2 weeks . The CT compatible tandem and ovoid applicators were used and stabilized with radio opaque packing material. The patient was stabilized using special re-locatable implant table and stirrups for reproducibility of the geometry during treatment. The CT scan images were taken at 3mm slice thickness and exported to the treatment planning computer. The OAR structures, bladder, rectum and sigmoid colon were outlined on the images along with the applicators. The prescription dose was targeted to A left and A right as defined in Manchester system and optimized on geometry . The dosimetry was compared on all plans using the parameter Ci.sec.cGy-1 . Using the Dose Volume Histogram (DVH) obtained from the plans the doses to rectum, sigmoid colon and bladder for ICRU defined points and 2cc volume were analyzed and reported. The following criteria were used for limiting the tolerance dose by volume (D2cc) were calculated. The rectum and sigmoid colon doses were limited to <75Gy. The bladder dose was limited to < 90Gy from both XRT and HDR brachytherapy. Results: The average total (XRT+HDRBT) BED values to prescription volume was 120 Gy. Dose 2cc to rectum was 70Gy +/− 17Gy, dose to 2cc bladder was 82+/−32 Gy. The average Ci.sec.cGy-1 calculated for the HDR plans was 6.99 +/− 0.5 Conclusion: The image based treatment planning enabled to evaluati volume based dose to critical structures for clinical interpretation.

  9. Technical Note: Removing the stem effect when performing Ir-192 HDR brachytherapy in vivo dosimetry using plastic scintillation detectors: A relevant and necessary step

    International Nuclear Information System (INIS)

    Purpose: The purpose of this study was to investigate whether or not a stem effect removal technique is necessary when performing Ir-192 HDR brachytherapy in vivo dosimetry using a scintillation detector. Methods: A red-green-blue photodiode connected to a multichannel electrometer was used to detect the light emitted from a plastic scintillation detector (PSD) during irradiation with an Ir-192 HDR brachytherapy source. Accuracy in dose measurement was compared with and without the use of stem effect removal techniques. Monochromatic and polychromatic filtration techniques were studied. An in-house template was built for accurate positioning of catheters in which the source and the PSD were inserted. Dose distribution was measured up to 5 cm from source to detector in the radial and longitudinal directions. Results: The authors found the stem effect to be particularly important when the source was close to the optical fiber guide and far from the scintillation component of the detector. It can account for up to (72±3)% of the signal under clinically relevant conditions. The polychromatic filtration outperformed the monochromatic filtration as well as the absence of filtration in regard to dose measurement accuracy. Conclusions: It is necessary to implement a stem effect removal technique when building a PSD for in vivo dosimetry during Ir-192 HDR brachytherapy. The PSD that the authors have developed for this study would be suitable for such an application.

  10. Endocervical ultrasound applicator for integrated hyperthermia and HDR brachytherapy in the treatment of locally advanced cervical carcinoma

    Energy Technology Data Exchange (ETDEWEB)

    Wootton, Jeffery H.; Hsu, I-Chow Joe; Diederich, Chris J. [Thermal Therapy Research Group, Department of Radiation Oncology, University of California, San Francisco, California 94115 (United States) and Joint Graduate Group in Bioengineering, University of California, Berkeley and San Francisco, California 94115 (United States)

    2011-02-15

    Purpose: The clinical success of hyperthermia adjunct to radiotherapy depends on adequate temperature elevation in the tumor with minimal temperature rise in organs at risk. Existing technologies for thermal treatment of the cervix have limited spatial control or rapid energy falloff. The objective of this work is to develop an endocervical applicator using a linear array of multisectored tubular ultrasound transducers to provide 3-D conformal, locally targeted hyperthermia concomitant to radiotherapy in the uterine cervix. The catheter-based device is integrated within a HDR brachytherapy applicator to facilitate sequential and potentially simultaneous heat and radiation delivery. Methods: Treatment planning images from 35 patients who underwent HDR brachytherapy for locally advanced cervical cancer were inspected to assess the dimensions of radiation clinical target volumes (CTVs) and gross tumor volumes (GTVs) surrounding the cervix and the proximity of organs at risk. Biothermal simulation was used to identify applicator and catheter material parameters to adequately heat the cervix with minimal thermal dose accumulation in nontargeted structures. A family of ultrasound applicators was fabricated with two to three tubular transducers operating at 6.6-7.4 MHz that are unsectored (360 deg.), bisectored (2x180 deg.), or trisectored (3x120 deg.) for control of energy deposition in angle and along the device length in order to satisfy anatomical constraints. The device is housed in a 6 mm diameter PET catheter with cooling water flow for endocervical implantation. Devices were characterized by measuring acoustic efficiencies, rotational acoustic intensity distributions, and rotational temperature distributions in phantom. Results: The CTV in HDR brachytherapy plans extends 20.5{+-}5.0 mm from the endocervical tandem with the rectum and bladder typically <8 mm from the target boundary. The GTV extends 19.4{+-}7.3 mm from the tandem. Simulations indicate that for 60

  11. Implant strategies for endocervical and interstitial ultrasound hyperthermia adjunct to HDR brachytherapy for the treatment of cervical cancer

    International Nuclear Information System (INIS)

    Catheter-based ultrasound devices provide a method to deliver 3D conformable heating integrated with HDR brachytherapy delivery. Theoretical characterization of heating patterns was performed to identify implant strategies for these devices which can best be used to apply hyperthermia to cervical cancer. A constrained optimization-based hyperthermia treatment planning platform was used for the analysis. The proportion of tissue ≥41 deg. C in a hyperthermia treatment volume was maximized with constraints Tmax ≤ 47 deg. C, Trectum ≤ 41.5 deg. C, and Tbladder ≤ 42.5 deg. C. Hyperthermia treatment was modeled for generalized implant configurations and complex configurations from a database of patients (n = 14) treated with HDR brachytherapy. Various combinations of endocervical (3600 or 2 x 1800 output; 6 mm OD) and interstitial (1800, 2700, or 3600 output; 2.4 mm OD) applicators within catheter locations from brachytherapy implants were modeled, with perfusion constant (1 or 3 kg m-3 s-1) or varying with location or temperature. Device positioning, sectoring, active length and aiming were empirically optimized to maximize thermal coverage. Conformable heating of appreciable volumes (>200 cm3) is possible using multiple sectored interstitial and endocervical ultrasound devices. The endocervical device can heat >41 deg. C to 4.6 cm diameter compared to 3.6 cm for the interstitial. Sectored applicators afford tight control of heating that is robust to perfusion changes in most regularly spaced configurations. T90 in example patient cases was 40.5-42.7 deg. C (1.9-39.6 EM43deg.C) at 1 kg m-3 s-1 with 10/14 patients ≥41 deg. C. Guidelines are presented for positioning of implant catheters during the initial surgery, selection of ultrasound applicator configurations, and tailored power schemes for achieving T90 ≥ 41 deg. C in clinically practical implant configurations. Catheter-based ultrasound devices, when adhering to the guidelines, show potential to

  12. Implant strategies for endocervical and interstitial ultrasound hyperthermia adjunct to HDR brachytherapy for the treatment of cervical cancer

    Energy Technology Data Exchange (ETDEWEB)

    Wootton, Jeffery H; Prakash, Punit; Hsu, I-Chow Joe; Diederich, Chris J, E-mail: CDiederich@radonc.ucsf.edu [Department of Radiation Oncology, University of California, San Francisco, CA 94115 (United States)

    2011-07-07

    Catheter-based ultrasound devices provide a method to deliver 3D conformable heating integrated with HDR brachytherapy delivery. Theoretical characterization of heating patterns was performed to identify implant strategies for these devices which can best be used to apply hyperthermia to cervical cancer. A constrained optimization-based hyperthermia treatment planning platform was used for the analysis. The proportion of tissue {>=}41 deg. C in a hyperthermia treatment volume was maximized with constraints T{sub max} {<=} 47 deg. C, T{sub rectum} {<=} 41.5 deg. C, and T{sub bladder} {<=} 42.5 deg. C. Hyperthermia treatment was modeled for generalized implant configurations and complex configurations from a database of patients (n = 14) treated with HDR brachytherapy. Various combinations of endocervical (360{sup 0} or 2 x 180{sup 0} output; 6 mm OD) and interstitial (180{sup 0}, 270{sup 0}, or 360{sup 0} output; 2.4 mm OD) applicators within catheter locations from brachytherapy implants were modeled, with perfusion constant (1 or 3 kg m{sup -3} s{sup -1}) or varying with location or temperature. Device positioning, sectoring, active length and aiming were empirically optimized to maximize thermal coverage. Conformable heating of appreciable volumes (>200 cm{sup 3}) is possible using multiple sectored interstitial and endocervical ultrasound devices. The endocervical device can heat >41 deg. C to 4.6 cm diameter compared to 3.6 cm for the interstitial. Sectored applicators afford tight control of heating that is robust to perfusion changes in most regularly spaced configurations. T{sub 90} in example patient cases was 40.5-42.7 deg. C (1.9-39.6 EM{sub 43deg.C}) at 1 kg m{sup -3} s{sup -1} with 10/14 patients {>=}41 deg. C. Guidelines are presented for positioning of implant catheters during the initial surgery, selection of ultrasound applicator configurations, and tailored power schemes for achieving T{sub 90} {>=} 41 deg. C in clinically practical implant

  13. Adaptive error detection for HDR/PDR brachytherapy: Guidance for decision making during real-time in vivo point dosimetry

    Energy Technology Data Exchange (ETDEWEB)

    Kertzscher, Gustavo, E-mail: guke@dtu.dk; Andersen, Claus E., E-mail: clan@dtu.dk [Centre for Nuclear Technologies, Technical University of Denmark, DTU Nutech, Frederiksborgvej 399, DK-4000 Roskilde (Denmark); Tanderup, Kari, E-mail: karitand@rm.dk [Department of Oncology, Aarhus University Hospital and Institute of Clinical Medicine, Aarhus University, Norrebrogade 44, DK-8000 Aarhus (Denmark)

    2014-05-15

    Purpose: This study presents an adaptive error detection algorithm (AEDA) for real-timein vivo point dosimetry during high dose rate (HDR) or pulsed dose rate (PDR) brachytherapy (BT) where the error identification, in contrast to existing approaches, does not depend on an a priori reconstruction of the dosimeter position. Instead, the treatment is judged based on dose rate comparisons between measurements and calculations of the most viable dosimeter position provided by the AEDA in a data driven approach. As a result, the AEDA compensates for false error cases related to systematic effects of the dosimeter position reconstruction. Given its nearly exclusive dependence on stable dosimeter positioning, the AEDA allows for a substantially simplified and time efficient real-time in vivo BT dosimetry implementation. Methods: In the event of a measured potential treatment error, the AEDA proposes the most viable dosimeter position out of alternatives to the original reconstruction by means of a data driven matching procedure between dose rate distributions. If measured dose rates do not differ significantly from the most viable alternative, the initial error indication may be attributed to a mispositioned or misreconstructed dosimeter (false error). However, if the error declaration persists, no viable dosimeter position can be found to explain the error, hence the discrepancy is more likely to originate from a misplaced or misreconstructed source applicator or from erroneously connected source guide tubes (true error). Results: The AEDA applied on twoin vivo dosimetry implementations for pulsed dose rate BT demonstrated that the AEDA correctly described effects responsible for initial error indications. The AEDA was able to correctly identify the major part of all permutations of simulated guide tube swap errors and simulated shifts of individual needles from the original reconstruction. Unidentified errors corresponded to scenarios where the dosimeter position was

  14. Adaptive error detection for HDR/PDR brachytherapy: Guidance for decision making during real-time in vivo point dosimetry

    International Nuclear Information System (INIS)

    Purpose: This study presents an adaptive error detection algorithm (AEDA) for real-timein vivo point dosimetry during high dose rate (HDR) or pulsed dose rate (PDR) brachytherapy (BT) where the error identification, in contrast to existing approaches, does not depend on an a priori reconstruction of the dosimeter position. Instead, the treatment is judged based on dose rate comparisons between measurements and calculations of the most viable dosimeter position provided by the AEDA in a data driven approach. As a result, the AEDA compensates for false error cases related to systematic effects of the dosimeter position reconstruction. Given its nearly exclusive dependence on stable dosimeter positioning, the AEDA allows for a substantially simplified and time efficient real-time in vivo BT dosimetry implementation. Methods: In the event of a measured potential treatment error, the AEDA proposes the most viable dosimeter position out of alternatives to the original reconstruction by means of a data driven matching procedure between dose rate distributions. If measured dose rates do not differ significantly from the most viable alternative, the initial error indication may be attributed to a mispositioned or misreconstructed dosimeter (false error). However, if the error declaration persists, no viable dosimeter position can be found to explain the error, hence the discrepancy is more likely to originate from a misplaced or misreconstructed source applicator or from erroneously connected source guide tubes (true error). Results: The AEDA applied on twoin vivo dosimetry implementations for pulsed dose rate BT demonstrated that the AEDA correctly described effects responsible for initial error indications. The AEDA was able to correctly identify the major part of all permutations of simulated guide tube swap errors and simulated shifts of individual needles from the original reconstruction. Unidentified errors corresponded to scenarios where the dosimeter position was

  15. Development and implementation of a remote audit tool for high dose rate (HDR) Ir-192 brachytherapy using optically stimulated luminescence dosimetry

    International Nuclear Information System (INIS)

    Purpose: The aim of this work was to create a mailable phantom with measurement accuracy suitable for Radiological Physics Center (RPC) audits of high dose-rate (HDR) brachytherapy sources at institutions participating in National Cancer Institute-funded cooperative clinical trials. Optically stimulated luminescence dosimeters (OSLDs) were chosen as the dosimeter to be used with the phantom.Methods: The authors designed and built an 8 × 8 × 10 cm3 prototype phantom that had two slots capable of holding Al2O3:C OSLDs (nanoDots; Landauer, Glenwood, IL) and a single channel capable of accepting all 192Ir HDR brachytherapy sources in current clinical use in the United States. The authors irradiated the phantom with Nucletron and Varian 192Ir HDR sources in order to determine correction factors for linearity with dose and the combined effects of irradiation energy and phantom characteristics. The phantom was then sent to eight institutions which volunteered to perform trial remote audits.Results: The linearity correction factor was kL= (−9.43 × 10−5× dose) + 1.009, where dose is in cGy, which differed from that determined by the RPC for the same batch of dosimeters using 60Co irradiation. Separate block correction factors were determined for current versions of both Nucletron and Varian 192Ir HDR sources and these vendor-specific correction factors differed by almost 2.6%. For the Nucletron source, the correction factor was 1.026 [95% confidence interval (CI) = 1.023–1.028], and for the Varian source, it was 1.000 (95% CI = 0.995–1.005). Variations in lateral source positioning up to 0.8 mm and distal/proximal source positioning up to 10 mm had minimal effect on dose measurement accuracy. The overall dose measurement uncertainty of the system was estimated to be 2.4% and 2.5% for the Nucletron and Varian sources, respectively (95% CI). This uncertainty was sufficient to establish a ±5% acceptance criterion for source strength audits under a formal RPC audit

  16. TU-F-BRF-02: MR-US Prostate Registration Using Patient-Specific Tissue Elasticity Property Prior for MR-Targeted, TRUS-Guided HDR Brachytherapy

    International Nuclear Information System (INIS)

    Purpose: High-dose-rate (HDR) brachytherapy has become a popular treatment modality for prostate cancer. Conventional transrectal ultrasound (TRUS)-guided prostate HDR brachytherapy could benefit significantly from MR-targeted, TRUS-guided procedure where the tumor locations, acquired from the multiparametric MRI, are incorporated into the treatment planning. In order to enable this integration, we have developed a MR-TRUS registration with a patient-specific biomechanical elasticity prior. Methods: The proposed method used a biomechanical elasticity prior to guide the prostate volumetric B-spline deformation in the MRI and TRUS registration. The patient-specific biomechanical elasticity prior was generated using ultrasound elastography, where two 3D TRUS prostate images were acquired under different probe-induced pressures during the HDR procedure, which takes 2-4 minutes. These two 3D TRUS images were used to calculate the local displacement (elasticity map) of two prostate volumes. The B-spline transformation was calculated by minimizing the Euclidean distance between the normalized attribute vectors of the prostate surface landmarks on the MR and TRUS. This technique was evaluated through two studies: a prostate-phantom study and a pilot study with 5 patients undergoing prostate HDR treatment. The accuracy of our approach was assessed through the locations of several landmarks in the post-registration and TRUS images; our registration results were compared with the surface-based method. Results: For the phantom study, the mean landmark displacement of the proposed method was 1.29±0.11 mm. For the 5 patients, the mean landmark displacement of the surface-based method was 3.25±0.51 mm; our method, 1.71±0.25 mm. Therefore, our proposed method of prostate registration outperformed the surfaced-based registration significantly. Conclusion: We have developed a novel MR-TRUS prostate registration approach based on patient-specific biomechanical elasticity prior

  17. Comparison of organ doses for patients undergoing balloon brachytherapy of the breast with HDR 192Ir or electronic sources using Monte Carlo simulations in a heterogeneous human phantom

    International Nuclear Information System (INIS)

    Purpose: Accelerated partial breast irradiation via interstitial balloon brachytherapy is a fast and effective treatment method for certain early stage breast cancers. The radiation can be delivered using a conventional high-dose rate (HDR) 192Ir gamma-emitting source or a novel electronic brachytherapy (eBx) source which uses lower energy x rays that do not penetrate as far within the patient. A previous study [A. Dickler, M. C. Kirk, N. Seif, K. Griem, K. Dowlatshahi, D. Francescatti, and R. A. Abrams, ''A dosimetric comparison of MammoSite high-dose-rate brachytherapy and Xoft Axxent electronic brachytherapy,'' Brachytherapy 6, 164-168 (2007)] showed that the target dose is similar for HDR 192Ir and eBx. This study compares these sources based on the dose received by healthy organs and tissues away from the treatment site. Methods: A virtual patient with left breast cancer was represented by a whole-body, tissue-heterogeneous female voxel phantom. Monte Carlo methods were used to calculate the dose to healthy organs in a virtual patient undergoing balloon brachytherapy of the left breast with HDR 192Ir or eBx sources. The dose-volume histograms for a few organs which received large doses were also calculated. Additional simulations were performed with all tissues in the phantom defined as water to study the effect of tissue inhomogeneities. Results: For both HDR 192Ir and eBx, the largest mean organ doses were received by the ribs, thymus gland, left lung, heart, and sternum which were close to the brachytherapy source in the left breast. eBx yielded mean healthy organ doses that were more than a factor of ∼1.4 smaller than for HDR 192Ir for all organs considered, except for the three closest ribs. Excluding these ribs, the average and median dose-reduction factors were ∼28 and ∼11, respectively. The volume distribution of doses in nearby soft tissue organs that were outside the PTV were also improved with eBx. However, the maximum dose to the closest rib

  18. Computed Tomography-Guided Interstitial HDR Brachytherapy (CT-HDRBT) of the Liver in Patients with Irresectable Intrahepatic Cholangiocarcinoma

    International Nuclear Information System (INIS)

    Purpose: This study was designed to investigate the clinical outcome of patients with irresectable, intrahepatic cholangiocarcinoma (IHC) treated with computed tomography (CT)-guided HDR-brachytherapy (CT-HDRBT) for local tumor ablation.MethodFifteen consecutive patients with histologically proven cholangiocarcinoma were selected for this retrospective study. Patients were treated by high-dose-rate internal brachytherapy (HDRBT) using an Iridium-192 source in afterloading technique through CT-guided percutaneous placed catheters. A total of 27 brachytherapy treatments were performed in these patients between 2006 and 2009. Median tumor enclosing target dose was 20 Gy, and mean target volume of the radiated tumors was 131 (± 90) ml (range, 10–257 ml). Follow-up consisted of clinical visits and magnetic resonance imaging of the liver every third month. Statistical evaluation included survival analysis using the Kaplan–Meier method. Results: After a median follow-up of 18 (range, 1–27) months after local ablation, 6 of the 15 patients are still alive; 4 of them did not get further chemotherapy and are regarded as disease-free. The reached median local tumor control was 10 months; median local tumor control, including repetitive local ablation, was 11 months. Median survival after local ablation was 14 months and after primary diagnosis 21 months. Conclusion: In view of current clinical data on the clinical outcome of cholangiocarcinoma, locally ablative treatment with CT-HDRBT represents a promising and safe technique for patients who are not eligible for tumor resection.

  19. Accident simulation tests at the HDR from pipe rupture to cable fire confirm high safety margins in nuclear power plants

    International Nuclear Information System (INIS)

    The project 'Superheated steam reactor safety program' (PHDR) was a good example of national and international cooperation of numerous research institutes, industrial enterprises and consultants. The first experimental stage concentrated on loss of coolant accident tests and on the strength of various components of the coolant loop. It was followed by tests on the effect of earthquakes and airplane crashes, on the behaviour of the containment during hydrogen release due to extremely improbable core meltdown accidents, and ultimately on the effects of fires. In all these areas, HDR large-scale tests led to important findings and furnished the demonstrative proof that German nuclear power plants have high safety margins even in the case of most severe accidents. Thus they also contributed essentially to ensuring the multi-step safety concept on which German nuclear power plants are based. The results obtained under the overall program, the evaluation of which will presumably not be finished before the end of 1993, are available on electronic data carriers, video demonstration films, and in more than 100 technical reports. (orig.)

  20. Analysis of initiation and growth of a circumferential crack in the HDR-RPV-cylinder under pressurized thermal shock

    International Nuclear Information System (INIS)

    In order to simulate a nuclear emergency cooling situation, longterm cooling tests (pressurized thermal shocks) were carried out under normal operating conditions on the reactor pressure vessel of the HDR (hot steam reactor). Naturally occuring circumferential cracks in the cylindrical part of the RPV, previously induced during cyclic thermal shock tests, were subjected to internal pressure and thermal stresses. The aim of the test was crack initiation and a limited amount of stable crack growth. Analyses, applying fracture mechanical assessment methods, were carried out before and after the test and these checked against the experimental results. To this end, comprehensive numerical analyses, investigations into material property characteristics, non-destructive and destructive (fractographical) tests were carried out. Due to the conservative assumptions, the results of the precalculation lay on the safe side; this was intended as these results served, among other aspects, as the basis for the experimental boundary condition. The post calculation which was based on the actual crack geometry, the measured cooling medium temperature and the material properties local to the crack, was in good agreement with the experimental results. Thus a tool is now available which can be successfully applied to the assessment of cracks in reactor components. (orig.)

  1. Calculation of the dynamic component of the radiation dose in HDR brachytherapy based on Monte Carlo simulations

    International Nuclear Information System (INIS)

    A method for the calculation of the transit doses in HDR brachytherapy based on Monte Carlo simulations has been presented. The transit doses resulting from a linear implant with seven dwell positions is simulated by performing calculations at all positions in which, the moving 192Ir source, instantaneously, had its geometrical centre located exactly between two adjacent dwell positions. Discrete step sizes of 0.25 cm were used to calculate the dose rates and the total transit dose at any of the calculation points evaluated. By comparing this method to the results obtained from Sievert Integrals, we observed dose calculation errors ranging from 32 to 21% for the examples considered. The errors could be much higher for longer treatment lengths where contributions from points near the longitudinal axis of the source become more important. To date, the most accurate method of calculating doses in radiotherapy is by Monte Carlo Simulations but the long computational times associated with it renders its use in treatment planning impracticable. The Sievert Integral algorithms on the other hand are simple, versatile and very easy to use but its accuracy had been repeatedly put into question for low energy isotopes like iridium. We therefore advocate a modification of the Sievert Integral algorithms by superimposing the output from Monte Carlo Simulations on the Sievert Integrals when dealing with low energy isotopes. In this way, we would be combining accuracy, simplicity and reasonable computational times (author)

  2. Combined treatment of localized prostata cancer with HDR-Iridium 192 remote brachytherapy and external beam irradiation

    International Nuclear Information System (INIS)

    Background: The localized prostate cancer can be treated curatively by radiation therapy. The combined treatment of external beam irradiation and HDR-Iridium 192 remote brachytherapy allows higher radiation doses within the tumor without increasing radiation sequelae. Patients and Methods: Patients of our clinic have been treated with this combined procedure since 1991. Between 1991 and 1994 15 patients received 2x9 Gy of high-dose-rate brachytherapy, followed by 36 Gy external beam irradiation (group A). Because of the frequent local failures in group A, the reference dose of external beam irradiation was increased to 50.4 Gy after brachytherapy between 1994 and 1996. Results: Seven of 15 patients (47%) in group A developed a local recurrence after a median of 17 (13 to 30) months. In group B (20 patients) local failure occurred in 3 patients (15%) after 11, 16 and 32 months. Conclusion: The combined radiation therapy of localized prostate cancer cannot substitute radical prostatectomy completely, but it is a promising alternative in the curative treatment in selected patients. (orig.)

  3. Fracture mechanics assessment of cracks in the HDR reactor pressure vessel due to pressurized thermal shock loading

    International Nuclear Information System (INIS)

    The feeding of cold water into the hot ring chamber of a LWR pressure vessel (RPV) during emergency core cooling is treated in this paper on the basis of a series of tests experimentally and analytically. The extensive works in this context have been performed and are under way at Oak Ridge National Laboratory (ORNL) and at University of Tokyo. The thermal shock cyclic loading test and the long term pressurized thermal shock loading test on HDR-RPVs have been carried out. The testing methods and the results of these tests are summarized. Accompanying the tests, the on-line and off-line measurements, the properties of the base metal and the cladding, the metallography and fractography of cracked material, the finite element stress calculation, the fatigue and crack growth in cyclic thermal loading and the long term thermal shocks on the nozzle and the cylinder wall were examined. A few hairline cracks appeared on the cylinder wall after 5000 cycles, and after 9500 cycles, a pronounced crack field was observed. The distribution of the J-integral as a function of time is shown for the cracks in the nozzle and the cylinder. (K.I.)

  4. Analytical simulation of nonlinear response to seismic test excitations of HDR-VKL [Heissdampfreaktor-Versuchskreislauf] piping system

    International Nuclear Information System (INIS)

    The paper describes the analytical modeling, calculations, and results of the posttest nonlinear simulation of high-level seismic testing of the VKL piping system at the HDR Test Facility in Germany. One of the objectives of the tests was to evaluate analytical methods for calculating the nonlinear response of realistic piping systems subjected to high-level seismic excitation that would induce significant plastic deformation. Two out of the six different pipe-support configurations, (ranging from a stiff system with struts and snubbers to a very flexible system with practically no seismic supports), subjected to simulated earthquakes, were tested at very high levels. The posttest nonlinear calculations cover the KWU configuration, a reasonably compliant system with only rigid struts. Responses for 800% safe-shutdown-earthquake loading were calculated using the NONPIPE code. The responses calculated with NONPIPE were found generally to have the same time trends as the measurements but contained under-, over-, and correct estimates of peak values, almost in equal proportions. The only exceptions were the peak strut forces, which were underestimated as a group. The scatter in the peak value estimate of displacements and strut forces was smaller than that for the strains. The possible reasons for the differences and the effort on further analysis are discussed

  5. Performance of VATA64HDR16 ASIC for medical physics applications based on continuous crystals and SiPMs

    International Nuclear Information System (INIS)

    Detectors based on Silicon Photomultipliers (SiPMs) coupled to continuous crystals are being tested in medical physics applications due to their potential high resolution and sensitivity. To cope with the high granularity required for a very good spatial resolution, SiPM matrices with a large amount of elements are needed. To be able to read the information coming from each individual channel, dedicated ASICs are employed. The VATA64HDR16 ASIC is a 64-channel, charge-sensitive amplifier that converts the collected charge into a proportional current or voltage signal. A complete assessment of the suitability of that ASIC for medical physics applications based on continuous crystals and SiPMs has been carried out. The input charge range is linear from 0−2 pC up to 55 pC. The energy resolution obtained at 511 keV is 10% FWHM with a LaBr3 crystal and 16% FWHM with a LYSO crystal. A coincidence timing resolution of 24 ns FWHM is obtained with two LYSO crystals

  6. A simplified analytical approach to estimate the parameters required for strength determination of HDR 192Ir brachytherapy sources using a Farmer-type ionization chamber

    International Nuclear Information System (INIS)

    Measuring the strength of high dose rate (HDR) 192Ir brachytherapy sources on receipt from the vendor is an important component of a quality assurance program. Owing to their ready availability in radiotherapy departments, the Farmer-type ionization chambers are also used to determine the strength of HDR 192Ir brachytherapy sources. The use of a Farmer-type ionization chamber requires the estimation of the scatter correction factor along with positioning error (c) and the constant of proportionality (f) to determine the strength of HDR 192Ir brachytherapy sources. A simplified approach based on a least squares method was developed for estimating the values of f and Ms. The seven distance method was followed to record the ionization chamber readings for parameterization of f and Ms. Analytically calculated values of Ms were used to determine the room scatter correction factor (Ksc). The Monte Carlo simulations were also carried out to calculate f and Ksc to verify the magnitude of the parameters determined by the proposed analytical approach. The value of f determined using the simplified analytical approach was found to be in excellent agreement with the Monte Carlo simulated value (within 0.7%). Analytically derived values of Ksc were also found to be in good agreement with the Monte Carlo calculated values (within 1.47%). Being far simpler than the presently available methods of evaluating f, the proposed analytical approach can be adopted for routine use by clinical medical physicists to estimate f by hand calculations. - Highlights: ► RAKR measurement of a brachytherapy source by 7 distance method requires the evaluation of ‘f’. ► A simplified analytical approach based on least square method to evaluate ‘f’ and ‘Ms’ was developed. ► Parameter ‘f’ calculated by proposed analytical approach was verified using the Monte Carlo method. ► Proposed analytical approach can be adopted for routine use to estimate ‘f’.

  7. Direct measurement of absorbed dose to water in HDR 192Ir brachytherapy: Water calorimetry, ionization chamber, Gafchromic film, and TG-43

    International Nuclear Information System (INIS)

    Purpose: Gafchromic film and ionometric calibration procedures for HDR 192Ir brachytherapy sources in terms of dose rate to water are presented and the experimental results are compared to the TG-43 protocol as well as with the absolute dose measurement results from a water calorimetry-based primary standard. Methods: EBT-1 Gafchromic films, an A1SL Exradin miniature Shonka thimble type chamber, and an SI HDR 1000 Plus well-type chamber (Standard Imaging, Inc., Middleton, WI) with an ADCL traceable Sk calibration coefficient (following the AAPM TG-43 protocol) were used. The Farmer chamber and Gafchromic film measurements were performed directly in water. All results were compared to direct and absolute absorbed dose to water measurements from a 4 deg. C stagnant water calorimeter. Results: Based on water calorimetry, the authors measured the dose rate to water to be 361±7 μGy/(h U) at a 55 mm source-to-detector separation. The dose rate normalized to air-kerma strength for all the techniques agree with the water calorimetry results to within 0.83%. The overall 1-sigma uncertainty on water calorimetry, ionization chamber, Gafchromic film, and TG-43 dose rate measurement amounts to 1.90%, 1.44%, 1.78%, and 2.50%, respectively. Conclusions: This work allows us to build a more realistic uncertainty estimate for absorbed dose to water determination using the TG-43 protocol. Furthermore, it provides the framework necessary for a shift from indirect HDR 192Ir brachytherapy dosimetry to a more accurate, direct, and absolute measurement of absorbed dose to water.

  8. SU-E-T-205: Improving Quality Assurance of HDR Brachytherapy: Verifying Agreement Between Planned and Delivered Dose Distributions Using DICOM RTDose and Advanced Film Dosimetry

    International Nuclear Information System (INIS)

    Purpose: HDR brachytherapy is undergoing significant development, and quality assurance (QA) checks must keep pace. Current recommendations do not adequately verify delivered against planned dose distributions: This is particularly relevant for new treatment planning system (TPS) calculation algorithms (non TG-43 based), and an era of significant patient-specific plan optimisation. Full system checks are desirable in modern QA recommendations, complementary to device-centric individual tests. We present a QA system incorporating TPS calculation, dose distribution export, HDR unit performance, and dose distribution measurement. Such an approach, more common in external beam radiotherapy, has not previously been reported in the literature for brachytherapy. Methods: Our QA method was tested at 24 UK brachytherapy centres. As a novel approach, we used the TPS DICOM RTDose file export to compare planned dose distribution with that measured using Gafchromic EBT3 films placed around clinical brachytherapy treatment applicators. Gamma analysis was used to compare the dose distributions. Dose difference and distance to agreement were determined at prescription Point A. Accurate film dosimetry was achieved using a glass compression plate at scanning to ensure physically-flat films, simultaneous scanning of known dose films with measurement films, and triple-channel dosimetric analysis. Results: The mean gamma pass rate of RTDose compared to film-measured dose distributions was 98.1% at 3%(local), 2 mm criteria. The mean dose difference, measured to planned, at Point A was -0.5% for plastic treatment applicators and -2.4% for metal applicators, due to shielding not accounted for in TPS. The mean distance to agreement was 0.6 mm. Conclusion: It is recommended to develop brachytherapy QA to include full-system verification of agreement between planned and delivered dose distributions. This is a novel approach for HDR brachytherapy QA. A methodology using advanced film

  9. SU-E-T-205: Improving Quality Assurance of HDR Brachytherapy: Verifying Agreement Between Planned and Delivered Dose Distributions Using DICOM RTDose and Advanced Film Dosimetry

    Energy Technology Data Exchange (ETDEWEB)

    Palmer, A L [Portsmouth Hospitals NHS Trust, Portsmouth, Hampshire (United Kingdom); University of Surrey, Guildford, Surrey (United Kingdom); Bradley, D A [University of Surrey, Guildford, Surrey (United Kingdom); Nisbet, A [University of Surrey, Guildford, Surrey (United Kingdom); Royal Surrey County Hospital NHS Foundation Trust, Guildford, Surrey (United Kingdom)

    2014-06-01

    Purpose: HDR brachytherapy is undergoing significant development, and quality assurance (QA) checks must keep pace. Current recommendations do not adequately verify delivered against planned dose distributions: This is particularly relevant for new treatment planning system (TPS) calculation algorithms (non TG-43 based), and an era of significant patient-specific plan optimisation. Full system checks are desirable in modern QA recommendations, complementary to device-centric individual tests. We present a QA system incorporating TPS calculation, dose distribution export, HDR unit performance, and dose distribution measurement. Such an approach, more common in external beam radiotherapy, has not previously been reported in the literature for brachytherapy. Methods: Our QA method was tested at 24 UK brachytherapy centres. As a novel approach, we used the TPS DICOM RTDose file export to compare planned dose distribution with that measured using Gafchromic EBT3 films placed around clinical brachytherapy treatment applicators. Gamma analysis was used to compare the dose distributions. Dose difference and distance to agreement were determined at prescription Point A. Accurate film dosimetry was achieved using a glass compression plate at scanning to ensure physically-flat films, simultaneous scanning of known dose films with measurement films, and triple-channel dosimetric analysis. Results: The mean gamma pass rate of RTDose compared to film-measured dose distributions was 98.1% at 3%(local), 2 mm criteria. The mean dose difference, measured to planned, at Point A was -0.5% for plastic treatment applicators and -2.4% for metal applicators, due to shielding not accounted for in TPS. The mean distance to agreement was 0.6 mm. Conclusion: It is recommended to develop brachytherapy QA to include full-system verification of agreement between planned and delivered dose distributions. This is a novel approach for HDR brachytherapy QA. A methodology using advanced film

  10. An absorbed dose to water standard for HDR 192Ir brachytherapy sources based on water calorimetry: Numerical and experimental proof-of-principle

    International Nuclear Information System (INIS)

    Water calorimetry is an established technique for absorbed dose to water measurements in external beams. In this paper, the feasibility of direct absorbed dose measurements for high dose rate (HDR) iridium-192 (192Ir) sources using water calorimetry is established. Feasibility is determined primarily by a balance between the need to obtain sufficient signal to perform a reproducible measurement, the effect of heat loss on the measured signal, and the positioning uncertainty affecting the source-detector distance. The heat conduction pattern generated in water by the Nucletron microSelectron-HDR 192Ir brachytherapy source was simulated using COMSOL MULTIPHYSICSTM software. Source heating due to radiation self-absorption was calculated using EGSnrcMP. A heat-loss correction kc was calculated as the ratio of the temperature rise under ideal conditions to temperature rise under realistic conditions. The calorimeter setup used a parallel-plate calorimeter vessel of 79 mm diameter and 1.12 mm thick front and rear glass windows located 24 mm apart. Absorbed dose was measured with two sources with nominal air kerma strengths of 38 000 and 21 000 U, at source-detector separations ranging from 24.7 to 27.6 mm and irradiation times of 36.0 to 80.0 s. The preliminary measured dose rate per unit air kerma strength of (0.502±0.007) μGy/(s U) compares well with the TG-43 derived 0.505 μGy/(s U). This work shows that combined dose uncertainties of significantly less than 5% can be achieved with only modest modifications of current water calorimetry techniques and instruments. This work forms the basis of a potential future absolute dose to water standard for HDR 192Ir brachytherapy

  11. An absorbed dose to water standard for HDR 192Ir brachytherapy sources based on water calorimetry: numerical and experimental proof-of-principle.

    Science.gov (United States)

    Sarfehnia, Arman; Stewart, Kristin; Seuntjens, Jan

    2007-12-01

    Water calorimetry is an established technique for absorbed dose to water measurements in external beams. In this paper, the feasibility of direct absorbed dose measurements for high dose rate (HDR) iridium-192 (192Ir) sources using water calorimetry is established. Feasibility is determined primarily by a balance between the need to obtain sufficient signal to perform a reproducible measurement, the effect of heat loss on the measured signal, and the positioning uncertainty affecting the source-detector distance. The heat conduction pattern generated in water by the Nucletron microSelectron-HDR 192Ir brachytherapy source was simulated using COMSOL MULTIPHYSICS software. Source heating due to radiation self-absorption was calculated using EGSnrcMP. A heat-loss correction k(c) was calculated as the ratio of the temperature rise under ideal conditions to temperature rise under realistic conditions. The calorimeter setup used a parallel-plate calorimeter vessel of 79 mm diameter and 1.12 mm thick front and rear glass windows located 24 mm apart. Absorbed dose was measured with two sources with nominal air kerma strengths of 38 000 and 21 000 U, at source-detector separations ranging from 24.7 to 27.6 mm and irradiation times of 36.0 to 80.0 s. The preliminary measured dose rate per unit air kerma strength of (0.502 +/- 0.007) microGy/(s U) compares well with the TG-43 derived 0.505 microGy/(s U). This work shows that combined dose uncertainties of significantly less than 5% can be achieved with only modest modifications of current water calorimetry techniques and instruments. This work forms the basis of a potential future absolute dose to water standard for HDR 192Ir brachytherapy. PMID:18196821

  12. SU-C-BRD-02: A Team Focused Clinical Implementation and Failure Mode and Effects Analysis of HDR Skin Brachytherapy Using Valencia and Leipzig Surface Applicators

    International Nuclear Information System (INIS)

    Purpose: and Leipzig applicators (VLAs) are single-channel brachytherapy surface applicators used to treat skin lesions up to 2cm diameter. Source dwell times can be calculated and entered manually after clinical set-up or ultrasound. This procedure differs dramatically from CT-based planning; the novelty and unfamiliarity could lead to severe errors. To build layers of safety and ensure quality, a multidisciplinary team created a protocol and applied Failure Modes and Effects Analysis (FMEA) to the clinical procedure for HDR VLA skin treatments. Methods: team including physicists, physicians, nurses, therapists, residents, and administration developed a clinical procedure for VLA treatment. The procedure was evaluated using FMEA. Failure modes were identified and scored by severity, occurrence, and detection. The clinical procedure was revised to address high-scoring process nodes. Results: Several key components were added to the clinical procedure to minimize risk probability numbers (RPN): -Treatments are reviewed at weekly QA rounds, where physicians discuss diagnosis, prescription, applicator selection, and set-up. Peer review reduces the likelihood of an inappropriate treatment regime. -A template for HDR skin treatments was established in the clinical EMR system to standardize treatment instructions. This reduces the chances of miscommunication between the physician and planning physicist, and increases the detectability of an error during the physics second check. -A screen check was implemented during the second check to increase detectability of an error. -To reduce error probability, the treatment plan worksheet was designed to display plan parameters in a format visually similar to the treatment console display. This facilitates data entry and verification. -VLAs are color-coded and labeled to match the EMR prescriptions, which simplifies in-room selection and verification. Conclusion: Multidisciplinary planning and FMEA increased delectability and

  13. Adjuvant radiation therapy for the treatment of endometrial cancer: experience with combination of external radiation therapy and high-dose rate brachytherapy; Radioterapia adjuvante no tratamento do cancer de endometrio: experiencia com a associacao de radioterapia externa e braquiterapia de alta taxa de dose

    Energy Technology Data Exchange (ETDEWEB)

    Chen, Michael Jenwei; Novaes, Paulo Eduardo Ribeiro Soares; Pellizzon, Antonio Cassio de Assis; Ferrigno, Robson; Fogaroli, Ricardo Cesar; Maia, Maria Aparecida Conte; Salvajoli, Joao Victor [Hospital do Cancer A.C. Camargo, Sao Paulo, SP (Brazil). Dept. de Radioterapia]. E-mail: michael.chen@ig.com.br; Nishimoto, Ines Nobuko [Hospital do Cancer A.C. Camargo, Sao Paulo, SP (Brazil). Centro de Estudos

    2005-12-01

    Objective: To review the results of adjuvant external beam radiation therapy (EBRT) combined with high-dose rate brachytherapy (HDR-BT) for the treatment of endometrial carcinoma. Materials and methods: We retrospectively evaluated 141 patients treated with EBRT and HDR-BT after surgery between January 1993 and January 2001. EBRT was performed with a median dose of 45 Gy, and HDR-BT was performed with a median dose of 24 Gy, with four weekly insertions of 6 Gy. The median age of the patients was 63 years and the disease stage distribution was: CS I (FIGO), 52.4%; CS II, 13.5%; CS III, 29.8%; CS IV, 4.3%. Results: With a median follow-up of 53.7 months, the disease free survival (DFS) at five years was: CS I, 88.0%; CS II, 70.8%; CS III, 55.1%; CS IV, 50.0% (p = 0.0003). Global survival after five years was: CS I, 79.6%; CS II, 74.0%; CS III, 53.6%; CS IV, 100.0% (p = 0.0062). Factors affecting the DFS were histological grade and serous-papillary histology. Recurrence of the disease was observed in 33 cases, 13 (9.2%) of these occurred in the pelvis, vagina or vaginal vault. EBRT + HDR-BT of the vaginal vault allowed disease control in 90.8% of the cases. Conclusion: Radiation therapy is essential for loco-regional control of endometrial cancer and can achieve excellent cure rates in the initial stages. In more advanced stages, therapeutic failure frequently appears as distant metastases suggesting the need for complementary systemic therapy using new treatment modalities, particularly chemotherapy. (author)

  14. Cuban laboratory proficiency test for calibration of well-type chambers using two types of HDR 192Ir sources

    International Nuclear Information System (INIS)

    The proficiency test by inter-laboratory comparisons is the commonly accepted procedure both for validation of the testing methods and assuring the quality of the calibration undertaken by the competence laboratories. The Secondary Standard Dosimetry Laboratory (SSDL) of Cuba is located at the Centro de Proteccion e Higiene de las Radiaciones (CPHR). The SSDL has recently implemented the calibration methodology of well-type chambers using the High Dose Rate 192Ir sources under activities of the technical co-operation project with the International Atomic Energy Agency. The reference standard of CPHR is traceable to the primary standard of the German National Metrology Institute (Physikalisch-Technische Bundesanstalt - PTB). The method used by the secondary laboratory follows the Technical Document 1274. On this method the source available is measured in a well-type chamber calibrated against the primary standard. Because there is no HDR afterloader at the SSDL, the calibration of the client source can be done only in the hospital set-up. The user's chamber is calibrated by means of a calibrated source. This method has the advantage that the measurement set-up is simplified but problems can arise from the use of different source designs during calibration of the secondary standard at the primary laboratory and calibration of the user's chambers at the hospital set-up. The variation of the calibration coefficient of the PTW 33004 chamber due to the use of different sources and adapters has already been measured experimentally. The larger differences can be found near 4%. All those facts reinforced the idea to conduct a proficiency test to demonstrate that the calibration procedure used by SSDL can be applied in practice and will not lead to the incorrect calibration coefficient within the stated uncertainty

  15. Implant strategies for endocervical and interstitial ultrasound hyperthermia adjunct to HDR brachytherapy for the treatment of cervical cancer

    Science.gov (United States)

    Wootton, Jeffery H.; Prakash, Punit; Hsu, I.-Chow Joe; Diederich, Chris J.

    2011-07-01

    Catheter-based ultrasound devices provide a method to deliver 3D conformable heating integrated with HDR brachytherapy delivery. Theoretical characterization of heating patterns was performed to identify implant strategies for these devices which can best be used to apply hyperthermia to cervical cancer. A constrained optimization-based hyperthermia treatment planning platform was used for the analysis. The proportion of tissue >=41 °C in a hyperthermia treatment volume was maximized with constraints Tmax 200 cm3) is possible using multiple sectored interstitial and endocervical ultrasound devices. The endocervical device can heat >41 °C to 4.6 cm diameter compared to 3.6 cm for the interstitial. Sectored applicators afford tight control of heating that is robust to perfusion changes in most regularly spaced configurations. T90 in example patient cases was 40.5-42.7 °C (1.9-39.6 EM43 °C) at 1 kg m-3 s-1 with 10/14 patients >=41 °C. Guidelines are presented for positioning of implant catheters during the initial surgery, selection of ultrasound applicator configurations, and tailored power schemes for achieving T90 >= 41 °C in clinically practical implant configurations. Catheter-based ultrasound devices, when adhering to the guidelines, show potential to generate conformal therapeutic heating ranging from a single endocervical device targeting small volumes local to the cervix (<2 cm radial) to a combination of a 2 × 180° endocervical and directional interstitial applicators in the lateral periphery to target much larger volumes (6 cm radial), while preferentially limiting heating of the bladder and rectum.

  16. Development of a water calorimetry-based standard for absorbed dose to water in HDR 192Ir brachytherapy

    International Nuclear Information System (INIS)

    Purpose: The aim of this article is to develop and evaluate a primary standard for HDR 192Ir brachytherapy based on 4 deg. C stagnant water calorimetry. Methods: The absolute absorbed dose to water was directly measured for several different Nucletron microSelectron 192Ir sources of air kerma strength ranging between 21 000 and 38 000 U and for source-to-detector separations ranging between 25 and 70 mm. The COMSOL MULTIPHYSICS software was used to accurately calculate the heat transport in a detailed model geometry. Through a coupling of the ''conduction and convection'' module with the ''Navier-Stokes incompressible fluid'' module in the software, both the conductive and convective effects were modeled. Results: A detailed uncertainty analysis resulted in an overall uncertainty in the absorbed dose of 1.90%(1σ). However, this includes a 1.5% uncertainty associated with a nonlinear predrift correction which can be substantially reduced if sufficient time is provided for the system to come to a new equilibrium in between successive calorimetric runs, an opportunity not available to the authors in their clinical setting due to time constraints on the machine. An average normalized dose rate of 361±7 μGy/(h U) at a source-to-detector separation of 55 mm was measured for the microSelectron 192Ir source based on water calorimetry. The measured absorbed dose per air kerma strength agreed to better than 0.8%(1σ) with independent ionization chamber and EBT-1 Gafchromic film reference dosimetry as well as with the currently accepted AAPM TG-43 protocol measurements. Conclusions: This work paves the way toward a primary absorbed dose to water standard in 192Ir brachytherapy.

  17. Evaluation of linear array MOSFET detectors for in vivo dosimetry to measure rectal dose in HDR brachytherapy.

    Science.gov (United States)

    Haughey, Aisling; Coalter, George; Mugabe, Koki

    2011-09-01

    The study aimed to assess the suitability of linear array metal oxide semiconductor field effect transistor detectors (MOSFETs) as in vivo dosimeters to measure rectal dose in high dose rate brachytherapy treatments. The MOSFET arrays were calibrated with an Ir192 source and phantom measurements were performed to check agreement with the treatment planning system. The angular dependence, linearity and constancy of the detectors were evaluated. For in vivo measurements two sites were investigated, transperineal needle implants for prostate cancer and Fletcher suites for cervical cancer. The MOSFETs were inserted into the patients' rectum in theatre inside a modified flatus tube. The patients were then CT scanned for treatment planning. Measured rectal doses during treatment were compared with point dose measurements predicted by the TPS. The MOSFETs were found to require individual calibration factors. The calibration was found to drift by approximately 1% ±0.8 per 500 mV accumulated and varies with distance from source due to energy dependence. In vivo results for prostate patients found only 33% of measured doses agreed with the TPS within ±10%. For cervix cases 42% of measured doses agreed with the TPS within ±10%, however of those not agreeing variations of up to 70% were observed. One of the most limiting factors in this study was found to be the inability to prevent the MOSFET moving internally between the time of CT and treatment. Due to the many uncertainties associated with MOSFETs including calibration drift, angular dependence and the inability to know their exact position at the time of treatment, we consider them to be unsuitable for in vivo dosimetry in rectum for HDR brachytherapy. PMID:21710233

  18. Cirurgia conservadora, radioterapia externa e reforço de dose com braquiterapia de alta taxa de dose: uma nova perspectiva no tratamento de sarcomas de partes moles do adulto Limb-sparing surgery, external beam radiotherapy and boost with high-dose rate brachytherapy: a new perspective for the treatment of soft tissue sarcomas in adults

    Directory of Open Access Journals (Sweden)

    Antonio Cássio Assis Pellizzon

    2002-03-01

    Full Text Available OBJETIVO: Avaliar a influência no controle local de pacientes adultos e portadores de sarcoma de partes moles em extremidades e submetidos a cirurgia conservadora do membro, com braquiterapia de alta taxa de dose (BATD como reforço para a radioterapia externa (RT. MATERIAL E MÉTODOS: Foram avaliados 16 pacientes tratados, de 1993 até 1999. A RT foi utilizada com finalidade pré ou pós-operatória (30--55 Gy e BATD com dose de 18--36 Gy (fx 3--6 Gy BID. Com base no modelo linear quadrático calculou-se a dose efetiva biológica ("biological effective dose" - BED para o tumor e comparou-se seu valor a dados da literatura internacional, que utiliza tratamentos com RT e braquiterapia de baixa taxa de dose (BBTD. RESULTADOS: Os valores médios e medianos da BED para os sarcomas de partes moles foram de 78,5 Gy7 e 80 Gy7. A análise univariada mostrou que a BED para o tumor, quando utilizada BATD, era semelhante ao valor de 83 Gy7 quando utilizada BBTD (p = 0,008. As taxas de controle local, sobrevida livre de doença e sobrevida global atuarial em cinco anos foram de 83,2%, 75% e 93,7%, respectivamente. CONCLUSÕES: A BATD, quando utilizada como método complementar no reforço de dose da RT no tratamento conservador dos sarcomas de partes moles, apresenta taxas de controle local equiparáveis às da literatura internacional; no entanto, estudos com número maior de pacientes e período maior de seguimento são ainda necessários para determinar o verdadeiro potencial da BATD em substituir a BBTD.PURPOSE: To evaluate the influence on local control in adult patients with soft tissue sarcomas of the limbs that underwent limb-sparing surgery and high-dose rate brachytherapy (HDRB in association with teletherapy. MATERIAL AND METHODS: Sixteen patients treated from 1993 to 1999 were reviewed. Teletherapy was used pre- or postoperatively (30--55 Gy in association with HDRB in a dose range of 18--36 Gy (fx 3--6 Gy BID. The linear quadratic model was

  19. Avaliação dosimétrica de uma combinação de aplicadores para braquiterapia de tumores do colo uterino com acometimento da porção distal da vagina Dosimetric evaluation of a combination of brachytherapy applicators for uterine cervix cancer with involvement of the distal vagina

    Directory of Open Access Journals (Sweden)

    Roger Guilherme Rodrigues Guimarães

    2009-08-01

    Full Text Available OBJETIVO: Avaliar uma alternativa de braquiterapia para tumores do colo uterino acometendo a porção distal da vagina, sem aumentar os riscos de toxicidade. MATERIAIS E MÉTODOS: Estudo teórico comparando três diferentes aplicadores de braquiterapia intracavitária de alta taxa de dose: sonda intrauterina e cilindro vaginal (SC; sonda e anel associado ao cilindro vaginal (SA+C e um aplicador virtual com sonda, anel e cilindro vaginal em um único conjunto (SAC. Foram prescritas doses de 7 Gy no ponto A e 5 Gy na superfície ou a 5 mm de profundidade na mucosa vaginal, mantendo as doses nos pontos de reto, bexiga e sigmoide abaixo dos limites de tolerância. Foram comparados os volumes englobados pelas isodoses de 50% (V50, 100% (V100, 150% (V150 e 200% (V200, respectivamente. RESULTADOS: Tanto SA+C quanto SAC apresentaram melhor distribuição de dose quando comparados ao aplicador SC. A distribuição de dose obtida com SA+C foi semelhante à do aplicador SAC, sendo V150 e V200 cerca de 50% maiores para SA+C, todavia, dentro do cilindro. CONCLUSÃO: A utilização de SA+C em uma única aplicação em dois tempos pode ser uma alternativa de tratamento para pacientes que apresentam tumores de colo uterino com acometimento distal da vagina.OBJECTIVE: To evaluate an alternative brachytherapy technique for uterine cervix cancer involving the distal vagina, without increasing the risk of toxicity. MATERIALS AND METHODS: Theoretical study comparing three different high-dose rate intracavitary brachytherapy applicators: intrauterine tandem and vaginal cylinder (TC; tandem/ring applicator combined with vaginal cylinder (TR+C; and a virtual applicator combining both the tandem/ring and vaginal cylinder in a single device (TRC. Prescribed doses were 7 Gy at point A, and 5 Gy on the surface or at a 5 mm depth of the vaginal mucosa. Doses delivered to the rectum, bladder and sigmoid colon were kept below the tolerance limits. Volumes covered by the

  20. Design and implementation of a film dosimetry audit tool for comparison of planned and delivered dose distributions in high dose rate (HDR) brachytherapy

    International Nuclear Information System (INIS)

    A novel phantom is presented for ‘full system’ dosimetric audit comparing planned and delivered dose distributions in HDR gynaecological brachytherapy, using clinical treatment applicators. The brachytherapy applicator dosimetry test object consists of a near full-scatter water tank with applicator and film supports constructed of Solid Water, accommodating any typical cervix applicator. Film dosimeters are precisely held in four orthogonal planes bisecting the intrauterine tube, sampling dose distributions in the high risk clinical target volume, points A and B, bladder, rectum and sigmoid. The applicator position is fixed prior to CT scanning and through treatment planning and irradiation. The CT data is acquired with the applicator in a near clinical orientation to include applicator reconstruction in the system test. Gamma analysis is used to compare treatment planning system exported RTDose grid with measured multi-channel film dose maps. Results from two pilot audits are presented, using Ir-192 and Co-60 HDR sources, with a mean gamma passing rate of 98.6% using criteria of 3% local normalization and 3 mm distance to agreement (DTA). The mean DTA between prescribed dose and measured film dose at point A was 1.2 mm. The phantom was funded by IPEM and will be used for a UK national brachytherapy dosimetry audit. (paper)

  1. A statistical approach to infer the minimum setup distance of a well chamber to the wall or to the floor for 192Ir HDR calibration

    International Nuclear Information System (INIS)

    We propose a new method based on statistical analysis technique to determine the minimum setup distance of a well chamber used in the calibration of 192Ir high dose rate (HDR). The chamber should be placed at least this distance away from any wall or from the floor in order to mitigate the effect of scatter. Three different chambers were included in this study, namely, Sun Nuclear Corporation, Nucletron, and Standard Imaging. The results from this study indicated that the minimum setup distance varies depending on the particular chamber and the room architecture in which the chamber was used. Our result differs from that of a previous study by Podgorsak et al. [Med. Phys. 19, 1311-1314 (1992)], in which 25 cm was suggested, and also differs from that of the International Atomic Energy Agency (IAEA)-TECDOC-1079 report, which suggested 30 cm. The new method proposed in this study may be considered as an alternative approach to determine the minimum setup distance of a well-type chamber used in the calibration of 192Ir HDR

  2. Exploration of joint systems and major horizontal stress direction in HDR drillholes of the Soultz site (Alsace, France)

    Energy Technology Data Exchange (ETDEWEB)

    Genter, A. [BRGM/GIG, Orleans (France); Tenzer, H. [Stadtwerke Bad Urach (Germany)

    1997-12-01

    Borehole imaging logs enable continuous recording of natural and artificial planar discontinuities on the drillhole wall and data of the drillhole geometry to be made. Efforts were made to resolve the orientation and characterization of the natural joint system, the active fault pattern, the alteration zones, the orientation of microcracks and the direction of maximum horizontal stress. Intense logging operations and measurements were carried out in the HDR drillholes GPK1 and EPS1 between 1000 and 3600 m depth in the Muschelkalk, Bunter and Granite at Soultz sous Forets. With the help of investigations on subvertical fractures the orientation of the maximum horizontal stress direction was determined as N175 E{+-}17 . These results are consistent with previous investigations performed in the horeholes GPK-1 and EPS-1. (orig./AKF) [Deutsch] Bohrlochmessungen mit dem akustschen Borehole Televiewer und elektrischen Formation MicroScanner (Imager) sowie dem Azimuthal Resistivity Imager und verschiedenen Sonic-Sonden ermoeglichen eine kontinuierliche Aufnahme sowohl von natuerlichen und kuenstlich erzeugten planaren Diskontinuitaeten an der Bohrlochwand als auch der Bohrlochgeometrie. Es wurden die Orientierung und Charakterisierung des natuerlichen Kluftsystems, das aktive Stoerungsmuster, die Alterationszonen, die Orientierung von Mikrorissen und die Orientierung der maximalen horizontalen Hauptspannungsrichtung ermittelt. Die Verfuegbarkeit von Strukturdaten aus Bohrloechern durch Bohrlochmessungen und hydraulischen Testen ermoeglicht die Bestimmung von hydraulisch aktiven Klueften und deren Beziehung zum regionalen Spannungsfeld. Mit Hilfe spezieller Bohrloch-Logs wurden die Orientierung und Haeufigkeit planarer Diskontinuitaeten und ihre scheinbare Oeffnungsweite sowie die Vorzugsrichtung der verschiedenen scheinbaren Weiten bestimmt. Innerhalb des gemeinsamen europaeischen Hot-Dry-Rock-Geothermal-Forschungsprogramms wurden vielfaeltige Bohrlochmessungen in den

  3. The effect of ambient pressure on well chamber response: Monte Carlo calculated results for the HDR 1000 Plus

    International Nuclear Information System (INIS)

    The determination of the air kerma strength of a brachytherapy seed is necessary for effective treatment planning. Well ionization chambers are used on site at therapy clinics to determine the air kerma strength of seeds. In this work, the response of the Standard Imaging HDR 1000 Plus well chamber to ambient pressure is examined using Monte Carlo calculations. The experimental work examining the response of this chamber as well as other chambers is presented in a companion paper. The Monte Carlo results show that for low-energy photon sources, the application of the standard temperature pressure PTP correction factor produces an over-response at the reduced air densities/pressures corresponding to high elevations. With photon sources of 20 to 40 keV, the normalized PTP corrected chamber response is as much as 10% to 20% over unity for air densities/pressures corresponding to an elevation of 3048 m (10000 ft) above sea level. At air densities corresponding to an elevation of 1524 m (5000 ft), the normalized PTP-corrected chamber response is 5% to 10% over unity for these photon sources. With higher-energy photon sources (>100 keV), the normalized PTP corrected chamber response is near unity. For low-energy β sources of 0.25 to 0.50 MeV, the normalized PTP-corrected chamber response is as much as 4% to 12% over unity for air densities/pressures corresponding to an elevation of 3048 m (10000 ft) above sea level. Higher-energy β sources (>0.75 MeV) have a normalized PTP corrected chamber response near unity. Comparing calculated and measured chamber responses for common 103Pd- and 125I-based brachytherapy seeds show agreement to within 2.7% and 1.9%, respectively. Comparing MCNP calculated chamber responses with EGSnrc calculated chamber responses show agreement to within 3.1% at photon energies of 20 to 40 keV. We conclude that Monte Carlo transport calculations accurately model the response of this well chamber. Further, applying the standard PTP correction factor

  4. HDR prostate monotherapy - Dosimetric effects of implant deformation due to posture change between TRUS- and CT-imaging

    International Nuclear Information System (INIS)

    HDR monotherapy for prostate cancer consists of four fractions. The first fraction is delivered with online TRUS-based treatment planning. For the last three fractions the treatment plan is based on a CT-scan acquired in between fractions 1 and 2. The patient position (high lithotomy, rectal US probe) during TRUS-guided catheter implantation and first fraction differs from the patient position in the CT-scan and the remaining three fractions (lowered legs, no TRUS probe). This study describes the effect of posture changes on dose distributions when a plan designed for the TRUS anatomy is applied to the CT-scan anatomy. The aim is to quantify dosimetrical errors that would result from skipping the use of a planning CT-scan, and rely for all fractions on the TRUS plan. Such a procedure would substantially reduce the involved workload, and would increase patient comfort. For three prostate cancer patients, images were acquired during TRUS-guided catheter implantation. Furthermore, a CT-scan (no US probe in rectum, different position of legs) was acquired and matched with the TRUS set. On both TRUS and CT, prostate, urethra and rectum were delineated and all catheters were traced. For each patient, an optimized treatment plan was designed using TRUS images and contours. Catheters with obtained dwell positions of the TRUS plan were transferred individually to the catheter positions in the CT. Changes in dose distribution due to relocation of catheters were evaluated using DVHs. For all patients the dose distributions changed significantly due to rearrangement of the catheters, having most impact on the urethra (maximum observed change: 32% volume receiving ≥120% of the prescribed dose) and a reduction of PTV coverage (6-28%). Implant deformation when changing from TRUS patient set-up to CT set-up affected negatively the quality of optimized treatment plans. Inclusion of more patients in this study was planned, but because of the observed strong negative effects it is

  5. SU-C-16A-01: In Vivo Source Position Verification in High Dose Rate (HDR) Prostate Brachytherapy Using a Flat Panel Imager: Initial Clinical Experience

    International Nuclear Information System (INIS)

    Purpose: We report our initial clinical experience with a novel position-sensitive source-tracking system based on a flat panel imager. The system has been trialled with 4 prostate HDR brachytherapy patients (8 treatment fractions) in this initial study. Methods: The flat panel imaging system was mounted under a customised carbon fibre couch top assembly (Figure 1). Three gold fiducial markers were implanted into the prostate of each patient at the time of catheter placement. X-ray dwell position markers were inserted into three catheters and a radiograph acquired to locate the implant relative to the imaging device. During treatment, as the HDR source dwells were delivered, images were acquired and processed to determine the position of the source in the patient. Source positions measured by the imaging device were compared to the treatment plan for verification of treatment delivery. Results: Measured dwell positions provided verification of relative dwell spacing within and between catheters, in the coronal plane. Measurements were typically within 2.0mm (0.2mm – 3.3mm, s.d. 0.8mm) of the planned positions over 60 dwells (Figure 2). Discrimination between larger dwell intervals and catheter differentiation were clear. This confirms important delivery attributes such as correct transfer tube connection, source step size, relative catheter positions and therefore overall correct plan selection and delivery. The fiducial markers, visible on the radiograph, provided verification of treatment delivery to the correct anatomical location. The absolute position of the dwells was determined by comparing the measured dwell positions with the x-ray markers from the radiograph, validating the programmed treatment indexer length. The total impact on procedure time was less than 5 minutes. Conclusion: The novel, noninvasive HDR brachytherapy treatment verification system was used clinically with minor impact on workflow. The system allows verification of correct treatment

  6. WE-A-17A-10: Fast, Automatic and Accurate Catheter Reconstruction in HDR Brachytherapy Using An Electromagnetic 3D Tracking System

    Energy Technology Data Exchange (ETDEWEB)

    Poulin, E; Racine, E; Beaulieu, L [CHU de Quebec - Universite Laval, Quebec, Quebec (Canada); Binnekamp, D [Integrated Clinical Solutions and Marketing, Philips Healthcare, Best, DA (Netherlands)

    2014-06-15

    Purpose: In high dose rate brachytherapy (HDR-B), actual catheter reconstruction protocols are slow and errors prompt. The purpose of this study was to evaluate the accuracy and robustness of an electromagnetic (EM) tracking system for improved catheter reconstruction in HDR-B protocols. Methods: For this proof-of-principle, a total of 10 catheters were inserted in gelatin phantoms with different trajectories. Catheters were reconstructed using a Philips-design 18G biopsy needle (used as an EM stylet) and the second generation Aurora Planar Field Generator from Northern Digital Inc. The Aurora EM system exploits alternating current technology and generates 3D points at 40 Hz. Phantoms were also scanned using a μCT (GE Healthcare) and Philips Big Bore clinical CT system with a resolution of 0.089 mm and 2 mm, respectively. Reconstructions using the EM stylet were compared to μCT and CT. To assess the robustness of the EM reconstruction, 5 catheters were reconstructed twice and compared. Results: Reconstruction time for one catheter was 10 seconds or less. This would imply that for a typical clinical implant of 17 catheters, the total reconstruction time would be less than 3 minutes. When compared to the μCT, the mean EM tip identification error was 0.69 ± 0.29 mm while the CT error was 1.08 ± 0.67 mm. The mean 3D distance error was found to be 0.92 ± 0.37 mm and 1.74 ± 1.39 mm for the EM and CT, respectively. EM 3D catheter trajectories were found to be significantly more accurate (unpaired t-test, p < 0.05). A mean difference of less than 0.5 mm was found between successive EM reconstructions. Conclusion: The EM reconstruction was found to be faster, more accurate and more robust than the conventional methods used for catheter reconstruction in HDR-B. This approach can be applied to any type of catheters and applicators. We would like to disclose that the equipments, used in this study, is coming from a collaboration with Philips Medical.

  7. Accelerated partial breast irradiation with iridium-192 multicatheter PDR/HDR brachytherapy. Preliminary results of the German-Austrian multicenter trial

    International Nuclear Information System (INIS)

    Purpose: to evaluate perioperative morbidity, toxicity, and cosmetic outcome in patients treated with interstitial brachytherapy to the tumor bed as the sole irradiation modality after breast-conserving surgery. Patients and methods: from November 1, 2000 to January 31, 2004, 176 women with early-stage breast cancer became partakers in a protocol of tumor bed irradiation alone using pulsed-dose-rate (PDR) or high-dose-rate (HDR) interstitial multicatheter implants. Patients became eligible, if their tumor was an infiltrating carcinoma ≤ 3 cm in diameter, the surgical margins were clear by at least 2 mm, the axilla was surgically staged node-negative, the tumor was estrogen and/or progesterone receptor-positive, well or moderately differentiated (G1/2), the tumor did not contain an extensive intraductal component (EIC) and the patient's age was > 35 years. Implants were positioned using a template guide, delivering either 49.8 Gy in 83 consecutive hours (PDR) or 32.0 Gy in two daily fractions over 4 days (HDR). Perioperative morbidity, toxicity, and cosmetic outcome were assessed. Interim findings of the first 69 patients, who were treated in this multicenter trial, after a median follow-up of 24 months (range, 15-39 months) are presented. Results: one of the 69 patients (1.4%) developed a bacterial infection of the implant. No other perioperative complications, for example bleeding or hematoma, were observed. Acute toxicity was low: 2.9% of the patients (2/69) experienced mild radiodermatitis. Late toxicity: hypersensation/mild pain 7.2% (5/69), intermittent but tolerable pain 1.4% (1/69), mild dyspigmentation 10.1% (7/69), mild fibrosis 11.6% (8/69), moderate fibrosis 1.4% (1/69), mild telangiectasia (2) 11.6% (8/69), and moderate teleangiectasia (1-4 cm2) 1.4% (1/69). Good to excellent cosmetic results were observed in 92.4% of the patients evaluated. All patients (n = 176) remained disease-free to the date of evaluation. Conclusion: this analysis indicates

  8. Accelerated partial breast irradiation with iridium-192 multicatheter PDR/HDR brachytherapy. Preliminary results of the German-Austrian multicenter trial

    Energy Technology Data Exchange (ETDEWEB)

    Ott, O.J.; Lotter, M.; Sauer, R.; Strnad, V. [Dept. of Radiation Oncology, Univ. Hospital Erlangen, Erlangen (Germany); Poetter, R.; Resch, A. [Dept. of Radiotherapy and Radiobiology, Univ. Hospital AKH Wien, Vienna (Austria); Hammer, J. [Dept. of Radiation Oncology, Barmherzige Schwestern Hospital Linz, Linz (Austria); Hildebrandt, G. [Dept. of Radiation Oncology, Univ. Hospital Leipzig, Leipzig (Germany); Poehls, U.; Beckmann, M.W. [Dept. of Gynecology, Univ. Hospital Erlangen, Erlangen (Germany)

    2004-10-01

    Purpose: to evaluate perioperative morbidity, toxicity, and cosmetic outcome in patients treated with interstitial brachytherapy to the tumor bed as the sole irradiation modality after breast-conserving surgery. Patients and methods: from November 1, 2000 to January 31, 2004, 176 women with early-stage breast cancer became partakers in a protocol of tumor bed irradiation alone using pulsed-dose-rate (PDR) or high-dose-rate (HDR) interstitial multicatheter implants. Patients became eligible, if their tumor was an infiltrating carcinoma {<=} 3 cm in diameter, the surgical margins were clear by at least 2 mm, the axilla was surgically staged node-negative, the tumor was estrogen and/or progesterone receptor-positive, well or moderately differentiated (G1/2), the tumor did not contain an extensive intraductal component (EIC) and the patient's age was > 35 years. Implants were positioned using a template guide, delivering either 49.8 Gy in 83 consecutive hours (PDR) or 32.0 Gy in two daily fractions over 4 days (HDR). Perioperative morbidity, toxicity, and cosmetic outcome were assessed. Interim findings of the first 69 patients, who were treated in this multicenter trial, after a median follow-up of 24 months (range, 15-39 months) are presented. Results: one of the 69 patients (1.4%) developed a bacterial infection of the implant. No other perioperative complications, for example bleeding or hematoma, were observed. Acute toxicity was low: 2.9% of the patients (2/69) experienced mild radiodermatitis. Late toxicity: hypersensation/mild pain 7.2% (5/69), intermittent but tolerable pain 1.4% (1/69), mild dyspigmentation 10.1% (7/69), mild fibrosis 11.6% (8/69), moderate fibrosis 1.4% (1/69), mild telangiectasia (< 1 cm{sup 2}) 11.6% (8/69), and moderate teleangiectasia (1-4 cm{sup 2}) 1.4% (1/69). Good to excellent cosmetic results were observed in 92.4% of the patients evaluated. All patients (n = 176) remained disease-free to the date of evaluation. Conclusion

  9. External beam and HDR intracavitary irradiation: an effective tool in the primary treatment of cervical cancer - excellent 10 year results and low side effects

    International Nuclear Information System (INIS)

    Introduction: The purpose of this paper is to present our 15 years experience in the primary treatment of cervical cancer with a combination of external beam irradiation and high dose rate brachytherapy. Survival data will be presented and the safe use of intrauterine HDR applications will be demonstrated. Material and Methods: From August 1980 to December 1990, 303 patients with cancer of the uterine cervix underwent primary irradiation in a combination of external beam and HDR intracavitary treatment at the Department of Radiation Oncology at the Sisters of Mercy Hospital in Linz, Austria. All patients were classified according to the FIGO rules: Stage I 54 patients, stage II 171, stage III 75 and stage IV 3 patients. 8 patients were lost to follow up. The mean follow up time of survivors is 110 months. Results and Discussion: A complete remission could be achieved in 282 patients, which is 93%; persistent tumour was found in 21 patients at the first follow up check 3 to 5 months after completion of irradiation. The actuarial overall survival probability for all patients at 5 and 10 years is 62 % and 42 % respectively, the disease specific survival probability is 68 % and 64 %. The local control rate at 5 and 10 years is 73 % and 72 % respectively. According to stage, disease specific survival lies at 90 % for stage I, 69 % for stage II, and 48 % for stage III and IV at 5 years, and at 10 years 87 %, 66 % and 41 % respectively. The actuarial local control probability for stages I, II, and III/IV is 90 %, 74 %, and 60 % respectively at 5 yr, and 88 %, 74 %, and 56 % at 10 yr. (Kaplan-Meier calculations). From all 303 patients 34 suffered from 40 severe and moderate side effects (glossary of Chassagne and Sismondi). The rate for grade II complications is 10 % and for grade III 3 %. Conclusion: Intrauterine HDR brachycurietherapy in addition to external beam irradiation for primary treatment of invasive carcinoma of the uterine cervix provides the same treatment

  10. Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma--an International Atomic Energy Agency study

    International Nuclear Information System (INIS)

    Background: Previous studies from South Africa have established that fractionated high-dose-rate (HDR) brachytherapy gives the best results in terms of palliation and survival in advanced esophageal cancer. A multicenter, prospective randomized study was therefore conducted under the auspices of the International Atomic Energy Agency to evaluate two HDR regimens. Methods and Materials: Surgically inoperable patients with histologically proven squamous cell cancer of the esophagus, tumor >5 cm in length on barium swallow and/or endoscopy, Karnofsky performance score >50, age 17-70 years, primary disease in the thoracic esophagus, no prior malignancy within the past 5 years, and any N or M status were included in the study. Exclusion criteria included cervical esophagus location, tumor extending 0.05). The overall survival was 7.9 months for the whole group (Group A, 9.1 months; Group B, 6.9 months; p>0.05). On univariate analysis, the presenting weight (p=0.0083), gender (p=0.0038), race (p=0.0105), the presenting dysphagia score (p=0.0083), the treatment center (p=0.0029), and tumor grade (p=0.0029) had an impact on the dysphagia-free survival, and gender (p=0.0011) and performance score (p=0.0060) had an impact on dysphagia-free survival on multivariate analysis. Only age had an impact on overall survival on both univariate (p=0.0430) and multivariate (p=0.0331) analysis. The incidence of strictures (Group A, n=12; Group B, n=13; p>0.05) and fistulas (Group A, n=11; Group B, n=12; p>0.05) was similar in both groups. Conclusion: Fractionated HDR brachytherapy alone is an effective method of palliating advanced esophageal cancers, surpassing the results of any other modality of treatment presently available. Dose fractions of 6 Gy x 3 and 8 Gy x 2 give similar results for dysphagia-free survival, overall survival, strictures, and fistulas and are equally effective in palliation of advanced esophageal cancer

  11. Improvements of visual X-ray inspection with optimized digital detector technology. Faster and more reliable inspection with High Dynamic Radiology (HDR)

    International Nuclear Information System (INIS)

    Improvements in speed and contrast resolution of Digital Detector Arrays (DDA) and significant higher power of X-Ray tubes in combination with a small focal spot open the door to an improved visual inspection of castings for automotive and aerospace applications. The result is a film-like image quality of castings in a live view. For the new image quality the x-ray parameter have to be optimized in energy and the subject contrast has to be increased to avoid that flaws are covered by the noise in the image. HDR - high dynamic radiology - expands the local contrast in the image and transfers the grey values to the range the human inspector can separate. Due to the movement in the image the inspector gets a glas-like impression of the object and the flaws allowing him to do a decision about the 3D position of a flaw in the object. (orig.)

  12. Radiolesão vascular como efeito deletério da braquiterapia intra-arterial com dose elevada de Samário-153 em coelhos hipercolesterolêmicos Vascular radiolesion as a deleterious effect of high-dose-rate intraarterial brachytherapy with Samarium-153 in hypercholesterolemic rabbits

    Directory of Open Access Journals (Sweden)

    Dalton Bertolim Précoma

    2006-10-01

    Full Text Available OBJETIVO: Este estudo tem por objetivo avaliar as alterações vasculares morfológicas e morfométricas induzidas pela braquiterapia com Samário-153 (153 Sm em coelhos hipercolesterolêmicos, com doses elevadas. MÉTODOS: Foram analisados 43 coelhos hipercolesterolêmicos, brancos, da raça New Zealand, e o total de 86 artérias ilíacas submetidas a lesão por balão de angioplastia. Divididos em três grupos: dois (GI irradiados com as doses de 15Gy (n=14 e 60Gy (n=36 e um grupo controle (n=36. Foram realizadas avaliação histológica morfométrica e análise histológica qualitativa para análise tecidual. RESULTADOS: Foram observadas uma redução significativa da neoproliferação intimal (NPI no GI 15 Gy (pOBJECTIVE: This study was designed to evaluate vascular morphological and morphometric changes induced by brachytherapy with samarium-153 (Sm-153 at high doses in hypercholesterolemic rabbits. METHODS: Forty-three New Zealand White hypercholesterolemic rabbits were analyzed, and the total of 86 iliac arteries underwent balloon angioplasty injury. The rabbits were divided into three different groups: two irradiation groups (IG assigned to 15 Gy (n=14 and 60 Gy (n=36 irradiation doses, respectively, and a control group (n = 36. Histomorphometric and qualitative histological analyses were performed for tissue evaluation. RESULTS: Significant reductions were found in neointimal proliferation (NIP (p< 0.0001, media area (MA (p<0.0001 and percent stenosis (p<0.0001 in the 15-Gy IG, compared to the other groups. The 60-Gy IG had the higher rate of NIP, increase in media and vessel areas (VA and percent stenosis. The 60-Gy IG also showed the greatest number of xanthomatous cells (60-Gy IG: 86.11% and 15-Gy IG: 14.29%, p<0.0001 and the highest amount of hyaline amorphous tissue (60-Gy IG:58.33% and 15-Gy IG:0%, p=0.0001 and vascular proliferation (60-Gy IG:30.56% and 15-Gy IG:0%, p=0.0221. No statistically significant differences were found

  13. Endoluminal release of ureteral ligature after hysterectomy.

    Science.gov (United States)

    Wang, Chih-Jen; Lin, Victor Chia-Hsiang; Huang, Ching-Yu

    2016-01-01

    Iatrogenic ureteral injury is a well-recognized complication of abdominal total hysterectomy. We report a case of a 57-year-old female who underwent abdominal total hysterectomy for a uterine myoma and experienced severe right flank pain postoperatively. The imaging study displayed an obstruction of the right distal ureter. Under ureteroscopy, an extraluminal ligature was released with a holmium:yttrium-aluminum-garnet laser. The stenotic segment was immediately relieved. Two months later, the intravenous urogram illustrated patency of the distal ureter with regression of right hydronephrosis. There was no recurrent hydronephrosis during 1 year of follow-up. PMID:25241286

  14. Dosimetric and clinical comparison between MammoSite and interstitial HDR brachytherapy in treatment of early stage breast cancer after conserving surgery

    International Nuclear Information System (INIS)

    Objective: To comparatively study dosimetric evaluation, side effects in early and late stage, and cosmetic outcome between MammoSite and interstitial using high-dose-rate (HDR) brachytherapy accelerated partial breast irradiation (APBI) in early stage breast cancer patient after conserving surgery. Methods: From January 2004 to December 2004, 10 breast cancer cases were treated with HDR 192Ir APBI after Lumpectomy surgery, 6 cases with interstitial brachytherapy, 4 cases with MammoSite. Sources were placed during the operation in all patients, distance from cavity to skin > 5-7 mm in interstitial brachytherapy group, one case is 6.5 mm, 3 cases > 10 mm in MammoSite group. Treatment Target area is 20 mm away from cavity in interstitial brachytherapy group with DHI 0.77, 10 mm away from Balloon margin in MammoSite with DHI 0.73. Results: Follow up 12-24 months while median follow-up was 18 months for the whole group (100%). During the treatment, grade III acute reactions were not seen in both group, grade I or II were seen including: erythema, edema, tenderness and infection. More late toxicity reaction including skin fibrosis, breast tenderness and fat necrosis were observed in interstitial brachytherapy group than that of MammoSite group. Cosmetic outcome evaluation were excellent in 12 months 100% (patient) and 83% (doctor) in interstitial brachytherapy, 100% in MammoSite group, respectively, none recurrence. Conclusions: Interstitial brachytherapy shows more uniformity in dose distribution as well as larger treatment volume, while MammoSite tends to be stable in repeatability and easy in use. Both groups show excellent cosmetic results, with same acute and late reactions. (authors)

  15. Radical radiotherapy treatment (EBRT + HDR-ICRT of carcinoma of the uterine cervix: Outcome in patients treated at a rural center in India

    Directory of Open Access Journals (Sweden)

    Jain Vandana

    2007-01-01

    Full Text Available Aim: To report the outcome of carcinoma of the uterine cervix patients treated radically by external beam radiotherapy (EBRT and high-dose-rate (HDR intracavitary radiotherapy (ICRT. Materials and Methods: Between January 1997 to December 2001, a total of 550 newly diagnosed cases of carcinoma of the uterine cervix were reported in the department. All cases were staged according to the International Federation of Gynecologists and Oncologists (FIGO staging system, but for analytical convenience, the staging was limited to stages I, II, III, and IV. Out of the 550 cases, 214 completed radical radiotherapy (EBRT + HDR-ICRT and were retrospectively analyzed for presence of local residual disease, local recurrence, distant metastases, radiation reactions, and disease-free survival. Results: There were 7 (3.27%, 88 (41.1%, 101 (47.1%, and 18 (8.4% patients in stage I, II, III, and IV, respectively. The median follow-up time for all patients was 43 months (range: 3-93 months and for patients who were disease free till the last follow-up it was 59 months (range: 24-93 months. The overall treatment time (OTT ranged from 52 to 73 days (median 61 days. The 5-year disease-free mean survival rate was 58%, 44%, 33%, and 15%, with 95% confidence interval of 48 to 68, 37 to 51, 24 to 35, and 6 to 24 for stages I, II, III, and IV, respectively. There were 62 (28.97% cases with local residual disease, 35 (16.3% developed local recurrence/distant metastases, 17 (7.9% developed distant metastases, and 9 (4.2% had local recurrence as well. Discussion and Conclusion: The overall outcome was poor in advanced stage disease, but might be improved by increasing the total dose, decreasing overall duration of treatment, and by adding chemotherapy in patients with disease limited to the pelvis.

  16. High dose-rate (HDR) conformal interstitial brachytherapy for locally recurrent rectal cancer. Real-time computed tomography (CT) fluoroscopy guidance and image-based treatment planning

    International Nuclear Information System (INIS)

    The aim of the study is to develop high dose-rate (HDR) conformal interstitial brachytherapy by means of combined real-time computed tomography (CT) fluoroscopy guidance with CT-based treatment planning for locally recurrent rectal carcinoma. The procedures of brachytherapy needle insertion were guided with a helical CT scanner providing real-time fluoroscopy reconstruction. A video monitor placed adjacent to the CT gantry simultaneously allowed the operator to see the process of needle insertion. CT images were transferred by an on-line system to the treatment-planning computer which reconstructed the implant needles and organ contours. The doses in planning target volume were normalized and geometrically optimized. The patients received a dose of 5 Gy per fraction on a daily hyperfractionation schedule at a total dose of 30-50 Gy with or without external radiation therapy. Nine patients were treated for this procedure. Thirteen to 36 needles (average 19.1) were successfully placed at the planning target volume in each patient. The average time for CT fluoroscopy was 370.1 seconds in each procedure. No accident was occurred during needle insertion, but one patient developed fibular nerve palsy after needle removal but gradually recovered. The CT-based treatment planning was faster and more accurate than projection reconstruction with conventional radiograms. Analysis of a dose volume histogram demonstrated conformal dose distribution of the target, while avoiding dose to normal structures with this method. Real-time CT fluoroscopy ensures safety and increases the accuracy of needle placement. Conformal high dose-rate (HDR) interstitial brachytherapy with CT-based treatment planning is an attractive method for locally recurrent rectal cancer. (author)

  17. A dual-plane co-RASOR technique for accurate and rapid tracking and position verification of an Ir-192 source for single fraction HDR brachytherapy

    Science.gov (United States)

    de Leeuw, Hendrik; Moerland, Marinus A.; van Vulpen, Marco; Seevinck, Peter R.; Bakker, Chris J. G.

    2013-11-01

    Effective high-dose-rate (HDR) treatment requires accurate and independent treatment verification to ensure that the treatment proceeds as prescribed, in particular if a high dose is given, as in single fraction therapy. Contrary to CT imaging and fluoroscopy, MR imaging provides high soft tissue contrast. Conventional MR techniques, however, do not offer the temporal resolution in combination with the 3D spatial resolution required for accurate brachytherapy source localization. We have developed an MR imaging method (center-out RAdial Sampling with Off-Resonance (co-RASOR)) that generates high positive contrast in the geometrical center of field perturbing objects, such as HDR brachytherapy sources. co-RASOR generates high positive contrast in the geometric center of an Ir-192 source by applying a frequency offset to center-out encoded data. To obtain high spatial accuracy in 3D with adequate temporal resolution, two orthogonal center-out encoded 2D images are applied instead of a full 3D acquisition. Its accuracy in 3D is demonstrated by 3D MRI and CT. The 2D images show high positive contrast in the geometric center of non-radioactive Ir-192 sources, with signal intensities up to 160% of the average signal intensity in the surrounding medium. The accuracy with which the center of the Ir-192 source is located by the dual-plane MRI acquisition corresponds closely to the accuracy obtained by 3D MRI and CT imaging. The positive contrast is shown to be obtained in homogeneous and in heterogeneous tissue. The dual-plane MRI technique allows the brachytherapy source to be tracked in 3D with millimeter accuracy with a temporal resolution of approximately 4 s.

  18. 江西省东部地区干热岩资源前景分析%Prospect Analysis of Hot Dry Rock (HDR) in Eastern Part of Jiangxi Province

    Institute of Scientific and Technical Information of China (English)

    伯慧; 宋炉生; 夏为平

    2014-01-01

    The abundant and widely distributed HDR is a kind of new renewable energy source with predominance of environmental protection, reliable and sustainable etc. Through comprehensive analysis of strata outcropping, regional structural features, magmatic rock distribution and geothermal geological features in eastern part of Jiangxi Province, have found that the terrestrial heat flow value in the area is rather high, granitoid rock body developed, many presents as large batholith, thus the high heat production hidden rock body with higher thermoconductivity and well preserved radiogenic heat. Only the 11 HDR favorable areas preliminary selected, has HDR re-sources 16.5 billion tons coal equivalent estimated through volumetric method. It follows that prospect of HDR resources in eastern part of Jiangxi Province is excellent, abundant HDR resources are of great significance to the“short of coal and gas without oil”Jiangxi Province, thus to carry out HDR resource investigation and evaluation in the area as soon as possible has been advised.%干热岩分布普遍,储量丰富,作为一种可再生的新型能源,具有环保、可靠、可持续等优势。通过对江西省东部地区的出露地层情况、区域构造特征、岩浆岩分布及地热地质特征等综合分析研究,发现区内大地热流值较高,花岗岩类岩体发育,多呈大型岩基产出,存在热传导率高、放射性热保存较好的高产热率隐伏岩体。仅对初步优选的11个干热岩有利区,用体积法估算干热岩资源量就高达165亿t标准煤。由此可见,江西省东部地区干热岩资源前景良好,丰富的干热岩资源对“缺煤少气无油”的江西省意义重大,建议尽早对江西省东部地区开展干热岩资源的调查评价工作。

  19. Braquiterapia intracoronariana. Tratamento da reestenose intra-stent com o sistema Beta-Cath: experiência inicial na América Latina Intracoronary brachytherapy. Treatment of in-stent restenosis with the Beta-Cath system: initial experience in Latin America

    Directory of Open Access Journals (Sweden)

    Juan Simon Muñoz

    2004-07-01

    Full Text Available OBJETIVO: Avaliar a segurança e eficácia da braquiterapia intracoronariana usando o sistema Beta-CathTM na prevenção da recorrência de restenose intra-stent (RIS, por meio da análise dos resultados clínicos, angiográficos e pelo ultra-som intracoronariano (USIC. MÉTODO: Foram submetidos à angioplastia com cateter-balão, seguida de beta-radiação intracoronariana com o sistema Beta-CathTM (90Sr/Y 30 pacientes com RIS em artérias coronárias nativas e, posteriormente, avaliados. RESULTADOS: Incluíram-se lesões reestenóticas complexas (77% do tipo difuso-proliferativo com extensão elevada (18,66±4,15 mm. O sucesso da braquiterapia foi de 100%. A dose média utilizada foi de 20,7±2,3 Gy, liberada em um período médio de 3,8±2,1 min. No seguimento tardio, o diâmetro luminal mínimo (DLM intra-stent diminuiu discretamente (1,98±0,30mm para 1,84±0,39 aos 6 meses, p=0,13, com uma perda tardia de 0,14±0,18 mm. O DLM intra-segmentar foi significativamente menor do que o intra-stent (1,55±0,40mm vs.1,84±0,39mm, p=0,008, associando-se à perda tardia (0,40±0,29mm vs. 0,14±0,18mm; p=0,0001. No USIC, observou-se discreto incremento do tecido neointimal em 6,8±14,3 mm³ aos 6 meses (p=0,19 e a percentagem de obstrução volumétrica aumentou em 4,7±7,5%. A reestenose binária e a revascularização do vaso-alvo recorreram em 17% dos casos; houve 1 caso (3% de oclusão tardia, associada a infarto do miocárdio. A sobrevida livre de eventos foi de 80%. CONCLUSÃO: O manejo da reestenose intra-stent com a beta-radiação intracoronariana mostrou-se procedimento seguro e eficaz, com alta taxa de sucesso imediato, representando uma opção terapêutica para a inibição da hiperplasia neointimal.OBJECTIVE: To assess the safety and efficacy of intracoronary brachytherapy using the Beta-Cath systemTM for preventing recurrence of in-stent restenosis (ISR, by analyzing clinical, angiographic, and intracoronary ultrasound (ICUS results

  20. Definitive salvage for vaginal recurrence of endometrial cancer: The impact of modern intensity-modulated-radiotherapy with image-based HDR brachytherapy and the interplay of the PORTEC 1 risk stratification

    International Nuclear Information System (INIS)

    Purpose: Data for salvage radiotherapy for recurrent endometrial cancer are limited especially in the era of modern radiotherapy including IMRT and 3-dimensional image-based HDR brachytherapy. Theoretically, modern radiotherapy reduces the dose to critical organs-at-risk and maximizes dose to the target volume, possibly decreasing morbidity and increasing tumor control. Materials and methods: Forty-one patients completing definitive salvage radiotherapy for vaginal recurrence of endometrial cancer from June 2004 to December 2013 were retrospectively reviewed. HDR Brachytherapy was completed using image-based planning with contouring/optimization with each fraction to a median dose of 23.75 Gy in 5 fractions. HDR brachytherapy was preceded by external beam radiotherapy predominately using an IMRT technique (90%) to a median dose of 45 Gy in 25 fractions. Toxicity was reported according to CTCAEv4. Results: At a median follow-up of 18 months (range: 3–78), the clinical complete response rate was 95%. The 3-year local control, distant control, recurrence free survival, and overall survival were 95%, 61%, 68%, and 67%. Significant predictors of both distant failure and overall survival were primary prognostic factors of depth of myometrial invasion, FIGO stage, and FIGO grade. There was no grade 3+ acute toxicity; the 3-year rate of grade 3+ late toxicity was 8%. Conclusions: Salvage IMRT plus 3-dimensional image-based HDR brachytherapy shows excellent tumor control and minimal morbidity for vaginal recurrence of endometrial cancer. Anticipated salvage rates must be taken in the context of primary risk factors including depth of myometrial invasion, FIGO stage, and FIGO grade

  1. Does HDR Pre-Processing Improve the Accuracy of 3D Models Obtained by Means of two Conventional SfM-MVS Software Packages? The Case of the Corral del Veleta Rock Glacier

    Directory of Open Access Journals (Sweden)

    Álvaro Gómez-Gutiérrez

    2015-08-01

    Full Text Available The accuracy of different workflows using Structure-from-Motion and Multi-View-Stereo techniques (SfM-MVS is tested. Twelve point clouds of the Corral del Veleta rock glacier, in Spain, were produced with two different software packages (123D Catch and Agisoft Photoscan, using Low Dynamic Range images and High Dynamic Range compositions (HDR for three different years (2011, 2012 and 2014. The accuracy of the resulting point clouds was assessed using benchmark models acquired every year with a Terrestrial Laser Scanner. Three parameters were used to estimate the accuracy of each point cloud: the RMSE, the Cloud-to-Cloud distance (C2C and the Multiscale-Model-to-Model comparison (M3C2. The M3C2 mean error ranged from 0.084 m (standard deviation of 0.403 m to 1.451 m (standard deviation of 1.625 m. Agisoft Photoscan overcome 123D Catch, producing more accurate and denser point clouds in 11 out 12 cases, being this work, the first available comparison between both software packages in the literature. No significant improvement was observed using HDR pre-processing. To our knowledge, this is the first time that the geometrical accuracy of 3D models obtained using LDR and HDR compositions are compared. These findings may be of interest for researchers who wish to estimate geomorphic changes using SfM-MVS approaches.

  2. Feasibility and early results of interstitial intensity-modulated HDR/PDR brachytherapy (IMBT) with/without complementary external-beam radiotherapy and extended surgery in recurrent pelvic colorectal cancer

    International Nuclear Information System (INIS)

    Background: A new multimodality treatment concept consisting of extended resection and postoperative fractionated intensity-modulated interstitial brachytherapy (IMBT) was introduced for pelvic recurrence of colorectal carcinoma. Patients and Methods: 46 patients received extended resection and single plastic tubes were sutured directly onto the tumor bed. IMBT was started within 2 weeks postoperatively with a median dose of 24.5 Gy (5-35 Gy). Patients were treated either with high-dose-rate brachytherapy (HDR; n=23) or with pulsed-dose-rate brachytherapy (PDR; n=23). 25 patients received complementary 45-Gy external-beam irradiation (EBRT) to the pelvic region after explanting the plastic tubes. Results: Median follow-up was 20.6 months (7-107 months) and mean patient survival 25.7±25.8 months (median 17, range 1-107 months). After 5 years overall survival, disease-free survival and local control rate were 23%, 20% and 33%, significantly influenced by the resectional state. There was a trend in favor of PDR compared to HDR, which reached statistical significance in patients who had not received additional EBRT. Conclusion: The combination of extended surgery and postoperative interstitial IMBT is feasible and offers effective interdisciplinary treatment of recurrent colorectal cancer. In this small and inhomogeneous cohort of patients PDR seems to be more effective than HDR, particularly when application of complementary EBRT is not possible. None of the patients who required resection of distant metastasis survived >2 years in this study. (orig.)

  3. Dosimetric analysis of 3D image-guided HDR brachytherapy planning for the treatment of cervical cancer: is point A-based dose prescription still valid in image-guided brachytherapy?

    Science.gov (United States)

    Kim, Hayeon; Beriwal, Sushil; Houser, Chris; Huq, M Saiful

    2011-01-01

    The purpose of this study was to analyze the dosimetric outcome of 3D image-guided high-dose-rate (HDR) brachytherapy planning for cervical cancer treatment and compare dose coverage of high-risk clinical target volume (HRCTV) to traditional Point A dose. Thirty-two patients with stage IA2-IIIB cervical cancer were treated using computed tomography/magnetic resonance imaging-based image-guided HDR brachytherapy (IGBT). Brachytherapy dose prescription was 5.0-6.0 Gy per fraction for a total 5 fractions. The HRCTV and organs at risk (OARs) were delineated following the GYN GEC/ESTRO guidelines. Total doses for HRCTV, OARs, Point A, and Point T from external beam radiotherapy and brachytherapy were summated and normalized to a biologically equivalent dose of 2 Gy per fraction (EQD2). The total planned D90 for HRCTV was 80-85 Gy, whereas the dose to 2 mL of bladder, rectum, and sigmoid was limited to 85 Gy, 75 Gy, and 75 Gy, respectively. The mean D90 and its standard deviation for HRCTV was 83.2 ± 4.3 Gy. This is significantly higher (p IGBT in HDR cervical cancer treatment needs advanced concept of evaluation in dosimetry with clinical outcome data about whether this approach improves local control and/or decreases toxicities. PMID:20488690

  4. SU-F-19A-02: Comparison of Absorbed Dose to Water Standards for HDR Ir-192 Brachytherapy Between the LCR, Brazil and NRC, Canada

    Energy Technology Data Exchange (ETDEWEB)

    Salata, C; David, M; Almeida, C de [Universidade do Estado do Rio de Janeiro, Rio De Janeiro, RJ (Brazil); El Gamal, I; Cojocaru, C; Mainegra-Hing, E; McEwen, M [National Research Council, Ottawa, ON (Canada)

    2014-06-15

    Purpose: To compare absorbed dose to water standards for HDR brachytherapy dosimetry developed by the Radiological Science Laboratory of Rio de Janeiro State University (LCR) and the National Research Council, Canada (NRC). Methods: The two institutions have separately developed absorbed dose standards based on the Fricke dosimetry system. There are important differences between the two standards, including: preparation and read-out of the Fricke solution, irradiation geometry of the Fricke holder in relation to the Ir-192 source, and determination of the G-value to be used at Ir-192 energies. All measurements for both standards were made directly at the NRC laboratory (i.e., no transfer instrument was used) using a single Ir-192 source (microSelectron v2). In addition, the NRC group has established a self-consistent method to determine the G-value for Ir-192, based on an interpolation between G-values obtained at Co-60 and 250kVp X-rays, and this measurement was repeated using the LCR Fricke solution to investigate possible systematic uncertainties. Results: G-values for Co-60 and 250 kVp x-rays, obtained using the LCR Fricke system, agreed with the NRC values within 0.5 % and 1 % respectively, indicating that the general assumption of universal G-values is appropriate in this case. The standard uncertainty in the determination of G for Ir-192 is estimated to be 0.6 %. For the comparison of absorbed dose measurements at the reference point for Ir-192 (1 cm depth in water, perpendicular to the seed long-axis), the ratio Dw(NRC)/Dw(LCR) was found to be 1.011 with a combined standard uncertainty of 1.7 %, k=1. Conclusion: The agreement in the absorbed dose to water values for the LCR and NRC systems is very encouraging. Combined with the lower uncertainty in this approach compared to the present air-kerma approach, these results reaffirm the use of Fricke solution as a potential primary standard for HDR Ir-192 brachytherapy.

  5. SU-F-19A-02: Comparison of Absorbed Dose to Water Standards for HDR Ir-192 Brachytherapy Between the LCR, Brazil and NRC, Canada

    International Nuclear Information System (INIS)

    Purpose: To compare absorbed dose to water standards for HDR brachytherapy dosimetry developed by the Radiological Science Laboratory of Rio de Janeiro State University (LCR) and the National Research Council, Canada (NRC). Methods: The two institutions have separately developed absorbed dose standards based on the Fricke dosimetry system. There are important differences between the two standards, including: preparation and read-out of the Fricke solution, irradiation geometry of the Fricke holder in relation to the Ir-192 source, and determination of the G-value to be used at Ir-192 energies. All measurements for both standards were made directly at the NRC laboratory (i.e., no transfer instrument was used) using a single Ir-192 source (microSelectron v2). In addition, the NRC group has established a self-consistent method to determine the G-value for Ir-192, based on an interpolation between G-values obtained at Co-60 and 250kVp X-rays, and this measurement was repeated using the LCR Fricke solution to investigate possible systematic uncertainties. Results: G-values for Co-60 and 250 kVp x-rays, obtained using the LCR Fricke system, agreed with the NRC values within 0.5 % and 1 % respectively, indicating that the general assumption of universal G-values is appropriate in this case. The standard uncertainty in the determination of G for Ir-192 is estimated to be 0.6 %. For the comparison of absorbed dose measurements at the reference point for Ir-192 (1 cm depth in water, perpendicular to the seed long-axis), the ratio Dw(NRC)/Dw(LCR) was found to be 1.011 with a combined standard uncertainty of 1.7 %, k=1. Conclusion: The agreement in the absorbed dose to water values for the LCR and NRC systems is very encouraging. Combined with the lower uncertainty in this approach compared to the present air-kerma approach, these results reaffirm the use of Fricke solution as a potential primary standard for HDR Ir-192 brachytherapy

  6. SU-F-BRF-09: A Non-Rigid Point Matching Method for Accurate Bladder Dose Summation in Cervical Cancer HDR Brachytherapy

    International Nuclear Information System (INIS)

    Purpose: To propose and validate a deformable point matching scheme for surface deformation to facilitate accurate bladder dose summation for fractionated HDR cervical cancer treatment. Method: A deformable point matching scheme based on the thin plate spline robust point matching (TPSRPM) algorithm is proposed for bladder surface registration. The surface of bladders segmented from fractional CT images is extracted and discretized with triangular surface mesh. Deformation between the two bladder surfaces are obtained by matching the two meshes' vertices via the TPS-RPM algorithm, and the deformation vector fields (DVFs) characteristic of this deformation is estimated by B-spline approximation. Numerically, the algorithm is quantitatively compared with the Demons algorithm using five clinical cervical cancer cases by several metrics: vertex-to-vertex distance (VVD), Hausdorff distance (HD), percent error (PE), and conformity index (CI). Experimentally, the algorithm is validated on a balloon phantom with 12 surface fiducial markers. The balloon is inflated with different amount of water, and the displacement of fiducial markers is benchmarked as ground truth to study TPS-RPM calculated DVFs' accuracy. Results: In numerical evaluation, the mean VVD is 3.7(±2.0) mm after Demons, and 1.3(±0.9) mm after TPS-RPM. The mean HD is 14.4 mm after Demons, and 5.3mm after TPS-RPM. The mean PE is 101.7% after Demons and decreases to 18.7% after TPS-RPM. The mean CI is 0.63 after Demons, and increases to 0.90 after TPS-RPM. In the phantom study, the mean Euclidean distance of the fiducials is 7.4±3.0mm and 4.2±1.8mm after Demons and TPS-RPM, respectively. Conclusions: The bladder wall deformation is more accurate using the feature-based TPS-RPM algorithm than the intensity-based Demons algorithm, indicating that TPS-RPM has the potential for accurate bladder dose deformation and dose summation for multi-fractional cervical HDR brachytherapy. This work is supported

  7. 秦艽1-羟基-2-甲基-2-(E)-丁烯基-4-焦磷酸还原酶基因(GmHDR)的克隆和表达分析%Cloning and expression analysis of 1-hydroxy-2-methyl-2-(E)-butenyl-4-diphosphate reductase gene (GmHDR)from Gentiana macrophylla

    Institute of Scientific and Technical Information of China (English)

    岑文; 孔维维; 郑鹏; 化文平

    2015-01-01

    Secoiri doids,such as gentiopicroside,are the main active compounds in “Qinj iao”,a traditional Chinese herbal medicine derived from the dried roots of Gentiana macrophylla.These compounds have widely biological and pharmacological effects,such as stomachic,choleretic,anti-hepatotoxic activities,anti-inflammatory,antifungal and antihistamine activities.Secoiridoids belonged to monoterpenoid,were biosynthesized via the secoiridoid pathway (sometimes also called“ridoid pathway”)in high plant.1-hydroxy-2-methyl-2-(E)-butenyl-4-diphosphate reductase (HDR)is one of the key enzymes in the pathway of iridoid biosynthesis.In this paper,we cloned the gene sequence of HDR from G.macrophylla,and analyzed the characteristic of sequence and expression patterns in order to know its roles in secoiridoid biosynthesis.Based on our library generated by high-through sequencing of G.macrophylla transcriptome,we cloned HDR gene from G.macrophylla(named as GmHDR)by RT-PCR.And the GmHDR coding amino acid sequence characterization,such as physicochemical characteristics,signal peptide,transit peptide, subcellular localization,conserved domain and secondary structure,analyzed with bioinformatics methods.Then we also detected the expression patterns of GmHDR in different parts of G.macrophylla by real time PCR.One 1 630-bp length sequence of GmHDR gene was obtained from G.macrophylla.GmHDR contains a completed open read-ing frame (ORF)of 1 392 bp,which encoded a polypeptide with 463 amino acids.GmHDR,the encoding protein by GmHDR,has high homology (identities ≥ 84%)to HDR proteins from Rauvolfia verticillata,Tanacetum parthenium and other plants.One neighbor joining tree was constructed to show evolution ship between GmHDR and HDR proteins from other plants using MEGA5.2 soft.The phylogenetic tree also gave a same conclusion that Gm-HDR had a closed relation with HDR proteins from Catharanthus roseus and Rauvolfia verticillata.Further analysis with bioinformatics methods showed

  8. TRUS-probe integrated MOSkin detectors for rectal wall in vivo dosimetry in HDR brachytherapy: In phantom feasibility study

    International Nuclear Information System (INIS)

    The increasing complexity and high amount of dose per fraction delivered in prostate high dose rate (HDR) brachytherapy treatments call for the implementation of accurate and effective methods for the systematic and independent quality control of the overall treatment procedure. In this study, MOSkin detectors were placed on a trans-rectal ultrasound (TRUS) probe with the aim of performing both imaging and real time rectal wall in vivo dosimetry with the use of just one single instrument. After an adequate calibration of the detectors, which was carried out in a solid water phantom, the use of MOSkins integrated to the TRUS probe was studied in a gel phantom with a typical (simplified) prostate implant. Measured and calculated doses from the treatment planning system were compared, with a resulting very low average discrepancy of −0.6 ± 2.6%. The results are very promising and of particular clinical importance, however, further in vivo investigation is planned to validate the proposed method. - Highlights: • MOSkins were placed on a TRUS probe to perform rectal wall in vivo dosimetry. • Their response was studied in a gel phantom including a typical prostate implant. • The average discrepancy between calculated and measured dose was −0.6 ± 2.6%

  9. Systematic Review of Focal Prostate Brachytherapy and the Future Implementation of Image-Guided Prostate HDR Brachytherapy Using MR-Ultrasound Fusion.

    Science.gov (United States)

    Peach, M Sean; Trifiletti, Daniel M; Libby, Bruce

    2016-01-01

    Prostate cancer is the most common malignancy found in North American and European men and the second most common cause of cancer related death. Since the practice of PSA screening has become common the disease is most often found early and can have a long indolent course. Current definitive therapy treats the whole gland but has considerable long-term side effects. Focal therapies may be able to target the cancer while decreasing dose to organs at risk. Our objective was to determine if focal prostate brachytherapy could meet target objectives while permitting a decrease in dose to organs at risk in a way that would allow future salvage treatments. Further, we wanted to determine if focal treatment results in less toxicity. Utilizing the Medline repository, dosimetric papers comparing whole gland to partial gland brachytherapy and clinical papers that reported toxicity of focal brachytherapy were selected. A total of 9 dosimetric and 6 clinical papers met these inclusion criteria. Together, these manuscripts suggest that focal brachytherapy may be employed to decrease dose to organs at risk with decreased toxicity. Of current technology, image-guided HDR brachytherapy using MRI registered to transrectal ultrasound offers the flexibility and efficiency to achieve such focal treatments. PMID:27293899

  10. Flow characteristics of Hijiori HDR reservoir form circulation test in 1995; Koon tantai Hijiori jikkenjo ni okeru shinbu choryuso yobi junkan shiken (1995 nendo) kekka to ryudo kaiseki

    Energy Technology Data Exchange (ETDEWEB)

    Fukushima, N.; Hyodo, M.; Shinohara, N.; Takasugi, S. [Geothermal Energy Research and Development Co. Ltd., Tokyo (Japan)

    1996-05-01

    This paper reports the result of a preliminary circulation test conducted in fiscal 1995 on a deep reservoir (at a depth of about 2200 m) in the Hijiori hot dry rock experimental field. One water injection well and two production wells were drilled to constitute a circulation loop, to which the circulation test was performed to investigate the flow characteristics thereof. The result revealed the following matters: total amount of injected water of 51500 m{sup 3} resulted in a total fluid recovery rate of about 40%; as a result of well stimulation given twice during the initial stage of the water injection, the continuity impedance in the vicinity of the injection well decreased largely (however, the continuity improvement upon the second attempt was considerably inferior to that from the first attempt); and increase in the water injection amount does not necessarily lead to increase in the production amount. The paper describes additionally that it is extremely difficult to interpret non-linearity between the injection and production amounts by using a model prepared previously with a main objective to analyze the Hijiori HDR circulation system. 1 ref., 9 figs., 1 tab.

  11. Flow characteristic of Hijiori HDR reservoir from circulation test in 1991; Koon tantai Hijiori jikkenjo ni okeru senbu choryuso shiken (1991 nendo) kekka to ryudo kaiseki

    Energy Technology Data Exchange (ETDEWEB)

    Shiga, T.; Hyodo, M.; Shinohara, N.; Takasugi, S. [Geothermal Energy Research and Development Co. Ltd., Tokyo (Japan)

    1996-05-01

    This paper reports one example of flow analyses on a circulation test carried out in fiscal 1991 at the Hijiori hot dry rock experimental field (Yamagata Prefecture). A fluid circulation model was proposed to simulate an HDR circulation system for a shallow reservoir (at a depth of about 1800 m) demonstrated in the circulation test by using an electric circuit network (which expresses continuity impedance in resistance and fluid storage in capacitance). Storage capacity of the reservoir was estimated by deriving time constant of the system from data of time-based change in reservoir pressure associated with transition phenomena during the circulation test. The storage capacity was estimated separately by dividing change of storage in the reservoir by change in the reservoir pressure. To derive the storage in the reservoir, a method to calculate non-recovered flows in the circulation test was utilized. The results of evaluating the reservoir capacity in the shallow reservoir using the above two independent methods were found substantially consistent. 3 refs., 6 figs., 1 tab.

  12. HDR brachytherapy combined with interstitial hyperthermia in locally advanced cervical cancer patients initially treated with concomitant radiochemotherapy – a phase III study

    International Nuclear Information System (INIS)

    Background and purpose: The aim of this randomised trial was to investigate whether hyperthermia (HT) combined with interstitial brachytherapy (ISBT) has any influence on local control (LC), disease-free survival (DFS), or acute and late side effects in patients with advanced cervical cancer. Materials and methods: After radiochemotherapy, consecutive patients with cervical cancer (FIGO stage II–III) were randomly assigned to two treatment groups, either ISBT alone or ISBT combined with interstitial hyperthermia (ISHT). A total of 205 patients were included in the statistical analysis. Once a week, HT, at a temperature above 42.5 °C, was administered for 45 min before and during the HDR BT. Results: The median follow-up time was 45 months (range 3–72 months). An effect of hyperthermia was not detected for disease-free survival (DFS) (log-rank test: p = 0.178) or for local control (LC) (p = 0.991). According to Cox’s analysis, HT did not significantly influence failure or interactions with potential prognostic factors for LC or DFS. Statistical differences were not observed for the distribution of early and late complications between the HT and non HT groups. Conclusions: ISHT is well-tolerated and does not affect treatment-related early or late complications. Improvements in DFS and LC were not observed following the addition of ISHT to ISBT

  13. Precalculations and comparison with experiments simulating seismic events for the system building-soil of a real prototype reactor building (HDR)

    International Nuclear Information System (INIS)

    Within the framework of the German HDR-Research Program, calculations of the response of a reactor building to shaker excitation, impulsive loading (by thrust) and explosive loading (by underground explosions) were performed. These calculations were done for higher level loading than those during a previous program. The response calculations were performed without any knowledge about the results of accompanying experimental investigations which are presented in another paper. The computations are mainly based upon Finite-Element models of the structure. For modelling, elements like trusses, beams, plates, shells and continuum elements were used. In order to account for the various layers of the ground, modelling was partly done by continuum elements with different material behaviour and partly by springs which were dimensioned according to the formulae of the halfspace theory. Though the idealizations of the four models described in this paper are to a certain extent quite different the quality of approximating the experimental results is about the same. The evaluated eigenfrequencies and eigenmodes agree with the measured ones in a very satisfactory manner. In the case of shaker excitations the acceleration amplitudes as a function of frequency can be calculated in a way that deviations from experimental results are generally tolerable. Evaluations of time histories in the case of underground explosions yield the main features of the measured curves. (orig./HP)

  14. Differentiation between radionecrosis and malignant brain tumor recurrence in patients treated by 192Ir HDR brachytherapy: 1H - MRS analysis of the brain metabolic spectrum

    International Nuclear Information System (INIS)

    Computerized tomography (CT) with contrast infusion and Magnetic Resonance Imaging (MRI) do not differentiate radionecrosis and malignant tumor recurrence. Proton Magnetic Resonance Spectroscopy seems to be a new radiological method that could solve this problem. The aim of the study was to evaluate the usability of 1H - MRS in patients after brachytherapy. Sixty patients were treated by 192Ir HDR brachytherapy because of malignant brain tumors (gliomas and brain metastases). Prospectively, 4 months after brachytherapy, 24 patients underwent MRI and 1H - MRS examinations. All patients qualified for the prospective study were in good general condition before and after the brachytherapy (Karnofsky Performance Score (KPS) > 60%). Combined assessment of MRI and 1H - MRS gave us the possibility to differentiate the observed pathological changes. In 18 cases (75%) there was a decrease in tumor volume. The tumor infiltration area was larger than the necrotic area in 5 cases. An isolated recurrence mass was observed in only one case. Neurosurgical brain decompression with pathological mass resection was needed in 6 patients with increased intracranial pressure and enhanced neurological deficits. Histopathological examination confirmed the diagnosis revealed in the 1H - MRS examination in each case. Proton Magnetic Resonance Spectroscopy is helpful in evaluating the influence of radiation on the tumor and the surrounding brain tissue. Moreover, it solves the problem of differentiating between radionecrosis and tumor recurrence. (author)

  15. High-resolution imaging of the layers of the gastrointestinal wall of pig and human specimens using an endoluminal MR receiver coil. Correlation to histology; Hochaufloesende Bildgebung der gastrointestinalen Wandschichten von Schweine- und Humanpraeparaten mittels endoluminaler MR-Spule. Korrelation zur Histologie

    Energy Technology Data Exchange (ETDEWEB)

    Kramer, Sebastian [Radiologie und Nuklearmedizin, Klinikum Dritter Orden (Germany); Palmowski, M.; Macher-Goeppinger, S.; Mueller, M.; Volke, F.; Duex, M.; Kauczor, H.U.; Grenacher, L.

    2009-11-15

    Purpose: High-resolution MR imaging of the layers of the gastrointestinal wall to provide a foundation for tumor staging based on morphological criteria. Materials and Methods: Over a period of 12 months, miscellaneous parts of the gastrointestinal tract of 15 human specimens and 30 porcine specimens were scanned using a 1.5 Tesla clinical MRI scanner combined with an endoluminal receiver coil. The sequences used were T1-weighted opposed-phase, T2-weighted turbo spin echo with fat saturation and fast T2-weighted inversion recovery. The number of differentiable layers, their width and the signal intensity were documented. Then, the results were compared with histological specimens in order to link the imaged wall layers to the anatomical layers. Spearman's Rank Correlation was used to determine the soundness of the link between the images and their related histology. Results: For both human and animal specimens, the MRI scanning produced 3 to 5, maximum 6 (pig), differentiable layers. The mucosa, submucosa and muscularis could be differentiated with a hyperintense, hypointense and intermediary signal, respectively. The subserosal layer displayed a hypointense signal. Conclusion: High-resolution MRI is able to produce differentiable images of the anatomical layers of the gastrointestinal wall in both humans and pigs. Accordingly, it is possible to use MR imaging to diagnose the extent of local tumor infiltration of the gastrointestinal wall. (orig.)

  16. 干热岩热能开发技术进展与思考%Technical Progress and Thinking forDevelopment of Hot Dry Rock (HDR) Geothermal Resources

    Institute of Scientific and Technical Information of China (English)

    曾义金

    2015-01-01

    干热岩地热资源是最具应用价值和利用潜力的清洁能源。我国干热岩资源量巨大,其高效开发对于加快我国能源结构调整、保证能源安全具有重大战略意义。在介绍干热岩地热资源分布、开发利用现状、工程技术进展的基础上,指出基础科学研究、钻井完井技术、大型压裂技术、热能提取技术等是干热岩地热高效开发的重点攻关方向。围绕干热岩地热开发利用存在的硬地层破岩、钻井围岩稳定、缝网压裂、热量交换等技术难题,开展技术攻关,通过示范工程,形成我国干热岩地热开发自主化技术体系,从而加快我国干热岩地热资源的高效开发利用,实现能源结构优化,防治大气污染,改善人民生活,促进经济社会生态环境科学、协调发展。%Hot dry rock (HDR) is the most valuable geothermal resource with the highest potential for development .HDR resources are very rich in China ,and its high‐efficient development would be a strategic significance in domestic adjustment of energy structure and energy security .T hrough the introduction of distribution ,current development and utilization as well as progress in engineering technologies for HDR resources ,the paper pointed out the key research direction in basic science ,drilling and completion tech‐niques ,large‐scale fracturing techniques ,thermal energy extraction etc .for developing HDF resources .In view of the problems that related to penetration of hard formations ,stability of surrounding rocks ,network fracturing ,and heat exchange for HDR development ,more researches should be conducted by providing sample projects to form a technical independently system of HDR resource development ,so as to speed up the development and utilization of HDR geothermal resources efficiently ,optimize energy structure ,mini‐mize atmosphere pollution ,improve living standards of the people ,and keep a scientific and

  17. Validation of a novel robot-assisted 3DUS system for real-time planning and guidance of breast interstitial HDR brachytherapy

    Energy Technology Data Exchange (ETDEWEB)

    Poulin, Eric; Beaulieu, Luc, E-mail: Luc.Beaulieu@phy.ulaval.ca [Département de Physique, de Génie Physique et d’optique et Centre de Recherche sur le Cancer de l’Université Laval, Université Laval, Québec, Québec G1V 0A6, Canada and Département de Radio-oncologie et Axe Oncologie du Centre de Recherche du CHU de Québec, CHU de Québec, 11 Côte du Palais, Québec, Québec G1R 2J6 (Canada); Gardi, Lori; Barker, Kevin; Montreuil, Jacques; Fenster, Aaron [Imaging Research Laboratories, Robarts Research Institute, 100 Perth Drive, London, Ontario N6A 5K8 (Canada)

    2015-12-15

    Purpose: In current clinical practice, there is no integrated 3D ultrasound (3DUS) guidance system clinically available for breast brachytherapy. In this study, the authors present a novel robot-assisted 3DUS system for real-time planning and guidance of breast interstitial high dose rate (HDR) brachytherapy treatment. Methods: For this work, a new computer controlled robotic 3DUS system was built to perform a hybrid motion scan, which is a combination of a 6 cm linear translation with a 30° rotation at both ends. The new 3DUS scanner was designed to fit on a modified Kuske assembly, keeping the current template grid configuration but modifying the frame to allow the mounting of the 3DUS system at several positions. A finer grid was also tested. A user interface was developed to perform image reconstruction, semiautomatic segmentation of the surgical bed as well as catheter reconstruction and tracking. A 3D string phantom was used to validate the geometric accuracy of the reconstruction. The volumetric accuracy of the system was validated with phantoms using magnetic resonance imaging (MRI) and computed tomography (CT) images. In order to accurately determine whether 3DUS can effectively replace CT for treatment planning, the authors have compared the 3DUS catheter reconstruction to the one obtained from CT images. In addition, in agarose-based phantoms, an end-to-end procedure was performed by executing six independent complete procedures with both 14 and 16 catheters, and for both standard and finer Kuske grids. Finally, in phantoms, five end-to-end procedures were performed with the final CT planning for the validation of 3DUS preplanning. Results: The 3DUS acquisition time is approximately 10 s. A paired Student t-test showed that there was no statistical significant difference between known and measured values of string separations in each direction. Both MRI and CT volume measurements were not statistically different from 3DUS volume (Student t-test: p > 0

  18. SU-F-19A-10: Recalculation and Reporting Clinical HDR 192-Ir Head and Neck Dose Distributions Using Model Based Dose Calculation

    International Nuclear Information System (INIS)

    Purpose: To retrospectively re-calculate dose distributions for selected head and neck cancer patients, earlier treated with HDR 192Ir brachytherapy, using Monte Carlo (MC) simulations and compare results to distributions from the planning system derived using TG43 formalism. To study differences between dose to medium (as obtained with the MC code) and dose to water in medium as obtained through (1) ratios of stopping powers and (2) ratios of mass energy absorption coefficients between water and medium. Methods: The MC code Algebra was used to calculate dose distributions according to earlier actual treatment plans using anonymized plan data and CT images in DICOM format. Ratios of stopping power and mass energy absorption coefficients for water with various media obtained from 192-Ir spectra were used in toggling between dose to water and dose to media. Results: Differences between initial planned TG43 dose distributions and the doses to media calculated by MC are insignificant in the target volume. Differences are moderate (within 4–5 % at distances of 3–4 cm) but increase with distance and are most notable in bone and at the patient surface. Differences between dose to water and dose to medium are within 1-2% when using mass energy absorption coefficients to toggle between the two quantities but increase to above 10% for bone using stopping power ratios. Conclusion: MC predicts target doses for head and neck cancer patients in close agreement with TG43. MC yields improved dose estimations outside the target where a larger fraction of dose is from scattered photons. It is important with awareness and a clear reporting of absorbed dose values in using model based algorithms. Differences in bone media can exceed 10% depending on how dose to water in medium is defined

  19. SU-F-19A-10: Recalculation and Reporting Clinical HDR 192-Ir Head and Neck Dose Distributions Using Model Based Dose Calculation

    Energy Technology Data Exchange (ETDEWEB)

    Carlsson Tedgren, A [Linkoping University, Linkoping, Linkoping (Sweden); Persson, M; Nilsson, J [Karolinska hospital, Stockholm, Stockholm (Sweden)

    2014-06-15

    Purpose: To retrospectively re-calculate dose distributions for selected head and neck cancer patients, earlier treated with HDR 192Ir brachytherapy, using Monte Carlo (MC) simulations and compare results to distributions from the planning system derived using TG43 formalism. To study differences between dose to medium (as obtained with the MC code) and dose to water in medium as obtained through (1) ratios of stopping powers and (2) ratios of mass energy absorption coefficients between water and medium. Methods: The MC code Algebra was used to calculate dose distributions according to earlier actual treatment plans using anonymized plan data and CT images in DICOM format. Ratios of stopping power and mass energy absorption coefficients for water with various media obtained from 192-Ir spectra were used in toggling between dose to water and dose to media. Results: Differences between initial planned TG43 dose distributions and the doses to media calculated by MC are insignificant in the target volume. Differences are moderate (within 4–5 % at distances of 3–4 cm) but increase with distance and are most notable in bone and at the patient surface. Differences between dose to water and dose to medium are within 1-2% when using mass energy absorption coefficients to toggle between the two quantities but increase to above 10% for bone using stopping power ratios. Conclusion: MC predicts target doses for head and neck cancer patients in close agreement with TG43. MC yields improved dose estimations outside the target where a larger fraction of dose is from scattered photons. It is important with awareness and a clear reporting of absorbed dose values in using model based algorithms. Differences in bone media can exceed 10% depending on how dose to water in medium is defined.

  20. Radiobiological restrictions and tolerance doses of repeated single-fraction hdr-irradiation of intersecting small liver volumes for recurrent hepatic metastases

    Directory of Open Access Journals (Sweden)

    Wust Peter

    2010-05-01

    Full Text Available Abstract Background To assess radiobiological restrictions and tolerance doses as well as other toxic effects derived from repeated applications of single-fraction high dose rate irradiation of small liver volumes in clinical practice. Methods Twenty patients with liver metastases were treated repeatedly (2 - 4 times at identical or intersecting locations by CT-guided interstitial brachytherapy with varying time intervals. Magnetic resonance imaging using the hepatocyte selective contrast media Gd-BOPTA was performed before and after treatment to determine the volume of hepatocyte function loss (called pseudolesion, and the last acquired MRI data set was merged with the dose distributions of all administered brachytherapies. We calculated the BED (biologically equivalent dose for a single dose d = 2 Gy for different α/β values (2, 3, 10, 20, 100 based on the linear-quadratic model and estimated the tolerance dose for liver parenchyma D90 as the BED exposing 90% of the pseudolesion in MRI. Results The tolerance doses D90 after repeated brachytherapy sessions were found between 22 - 24 Gy and proved only slightly dependent on α/β in the clinically relevant range of α/β = 2 - 10 Gy. Variance analysis showed a significant dependency of D90 with respect to the intervals between the first irradiation and the MRI control (p 90 and the pseudolesion's volume. No symptoms of liver dysfunction or other toxic effects such as abscess formation occurred during the follow-up time, neither acute nor on the long-term. Conclusions Inactivation of liver parenchyma occurs at a BED of approx. 22 - 24 Gy corresponding to a single dose of ~10 Gy (α/β ~ 5 Gy. This tolerance dose is consistent with the large potential to treat oligotopic and/or recurrent liver metastases by CT-guided HDR brachytherapy without radiation-induced liver disease (RILD. Repeated small volume irradiation may be applied safely within the limits of this study.

  1. Characterization of TLD-100 in powders for dosimetric quality control of {sup 192} Ir sources used in brachytherapy of high dose rate; Caracterizacion de TLD-100 en polvo para control de calidad dosimetrico de fuentes de Ir{sup 192} usadas en braquiterapia de alta tasa de dosis

    Energy Technology Data Exchange (ETDEWEB)

    Loaiza C, S.P

    2007-07-01

    The Secondary Standard Dosimetric at the National Institute of Nuclear Research (ININ) calibrated a lot of powdered TLD-100 (LiF:Mg,Ti) in terms of absorbed dose to water D{sub w} for the energy of: {sup 60}Co, {sup 137C}s, X rays of 250 and 50 kVp. Later on, it is carried out an interpolation of the calibration for the energy of the {sup 192}Ir. This calibration is part of a dosimetric quality control program, to solve the problems of traceability for the measurements carried out by the users of {sup 192}Ir sources employed in the treatments of High Dose Rate Brachytherapy (HDR) at the Mexican Republic. The calibrations of the radiation beams are made with the following protocols: IAEA TRS-398 for the {sup 60}Co for D{sub w}, using a secondary standard ionization chamber PTW N30013 calibrated in D{sub w} by the National Research Council (NRC, Canada). AAPM TG-43 for D{sub w} in terms of the strength kerma Sk, calibrating this last one quantity for the {sup 137}Cs radioactive source, with a well chamber HDR 1000 PLUS traceable to the University of Wisconsin (US). AAPM TG-61 for X ray of 250 and 50 kVp for D{sub w} start to Ka using field standard a Farmer chamber PTW 30001 traceable to K for the Central Laboratory of Electric Industries (CLEI, France). The calibration curves (CC) they built for the response of the powder TLD: R{sub TLD} vs D{sub w}: For the energy of {sup 60}Co, {sup 137}Cs, X rays of 250 and 50 kVp. Fitting them with the least square method weighed by means of a polynomial of second grade that corrects the supra linearity of the response. iii. Each one of the curves was validated with a test by lack of fitting and for the Anderson Darling normality test, using the software MINITAB in both cases. iv. The sensibility factor (F{sub s}) for each energy corresponds to the slope of the CC, v. The F{sub s} for the two {sup 192}Ir sources used are interpolated: one for a Micro Selectron source and the other one a Vari Source source. Finally, a couple of

  2. Comparison of absorbed dose in the cervix carcinoma therapy by brachytherapy of high dose rate using the conventional planning and Monte Carlo simulation; Comparacao da dose absorvida no tratamento do cancer ginecologico por braquiterapia de alta taxa de dose utilizando o planejamento convencional do tratamento e simulacao de Monte Carlo

    Energy Technology Data Exchange (ETDEWEB)

    Silva, Aneli Oliveira da

    2010-07-01

    This study aims to compare the doses received for patients submitted to brachytherapy High Dose Rate (HDR) brachytherapy, a method of treatment of the cervix carcinoma, performed in the planning system PLATO BPS with the doses obtained by Monte Carlo simulation using the radiation transport code MCNP 5 and one female anthropomorphic phantom based on voxel, the FAX. The implementation of HDR brachytherapy treatment for the cervix carcinoma consists of the insertion of an intrauterine probe and an intravaginal probe (ring or ovoid) and then two radiographs are obtained, anteroposterior (AP) and lateral (LAT) to confirm the position of the applicators in the patient and to allow the treatment planning and the determination of the absorbed dose at points of interest: rectum, bladder, sigmoid and point A, which corresponds anatomically to the crossings of the uterine arteries with ureters The absorbed doses obtained with the code MCNP 5, with the exception of the absorbed dose in the rectum and sigmoid for the simulation considering a point source of {sup 192}Ir, are lower than the absorbed doses from PLATO BPS calculations because the MCNP 5 considers the chemical compositions and densities of FAX body, not considering the medium as water. When considering the Monte Carlo simulation for a source with dimensions equal to that used in the brachytherapy irradiator used in this study, the values of calculated absorbed dose to the bladder, to the rectum, to the right point A and to the left point A were respectively lower than those determined by the treatment planning system in 33.29, 5.01, 22.93 and 19.04%. These values are almost all larger than the maximum acceptable deviation between patient planned and administered doses (5 %). With regard to the rectum and bladder, which are organs that must be protected, the present results are in favor of the radiological protection of patients. The point A, that is on the isodose of 100%, used to tumor treatment, the results

  3. Stem effect of a Ce3+ doped SiO2 optical dosimeter irradiated with a 192Ir HDR brachytherapy source

    International Nuclear Information System (INIS)

    brachytherapy. • The dosimeter accuracy was studied with an HDR Ir-192 brachytherapy source. • Dosimeter uncertainties neglecting the stem effect resulted to be generally less than 4.3%. • Accuracy further improves by correcting the readings for the noise generated due to the stem effect

  4. Temperature dependence of a Ce3+ doped SiO2 radioluminescent dosimeter for in vivo dose measurements in HDR brachytherapy

    International Nuclear Information System (INIS)

    Fiber-optic-coupled scintillation dosimeters are characterized by their small active volume if compared to other existing systems, and are therefore particularly suited for internal in vivo dosimetry. Due to possible differences between calibration conditions (i.e., room temperature) and conditions of clinical application (i.e., body temperature), their temperature dependence should be accurately studied. In this work, the temperature dependence of a Ce3+ doped SiO2 scintillation detector coupled to a SiO2 optical fibre was investigated for high dose rate brachytherapy applications. To this aim, two sets of irradiations with two different Ir-192 sources were performed in a water bath phantom at water temperatures ranging between 17 °C and 40.4 °C (Experiment 1). The relative response of the dosimeter was collected and analyzed. The same experiment was repeated with a second optical fibre which was designed without the active Ce3+ doped part at its end (Experiment 2) as well as by changing the length of the passive fibre inserted in water (Experiment 3). The two sets of measurements of experiment 1 were in accordance, indicating a linear increase with temperature of the scintillator sensitivity, with an average increase of 0.27 ± 0.2%/°C. In experiment 2, a 0.5%/°C increase of the collected signal resulted for the passive fibre. No significant difference of the temperature coefficient was found by changing the length of the fibre inserted in water (experiment 3). The obtained results show that a temperature-specific correction factor should be adopted at temperatures different than room temperature (e.g. for in vivo internal dosimetry). Further studies are required to understand the observations. - Highlights: • A 0.9 mm diameter scintillation detector was recently developed for in vivo dosimetry in brachytherapy. • Temperature dependence of the dosimeter was studied with an HDR Ir-192 brachytherapy source. • Dosimeter sensitivity results to

  5. 4D analysis of influence of patient movement and anatomy alteration on the quality of 3D U/S-based prostate HDR brachytherapy treatment delivery

    International Nuclear Information System (INIS)

    Purpose: Modern HDR brachytherapy treatment for prostate cancer based on the 3D ultrasound (U/S) plays increasingly important role. The purpose of this study is to investigate possible patient movement and anatomy alteration between the clinical image set acquisition, made after the needle implantation, and the patient irradiation and their influence on the quality of treatment. Methods: The authors used 3D U/S image sets and the corresponding treatment plans based on a 4D-treatment planning procedure: plans of 25 patients are obtained right after the needle implantation (clinical plan is based on this 3D image set) and just before and after the treatment delivery. The authors notice the slight decrease of treatment quality with increase of time gap between the clinical image set acquisition and the patient irradiation. 4D analysis of dose-volume-histograms (DVHs) for prostate: CTV1 = PTV, and urethra, rectum, and bladder as organs at risk (OARs) and conformity index (COIN) is presented, demonstrating the effect of prostate, OARs, and needles displacement. Results: The authors show that in the case that the patient body movement/anatomy alteration takes place, this results in modification of DVHs and radiobiological parameters, hence the plan quality. The observed average displacement of needles (1 mm) and of prostate (0.57 mm) is quite small as compared with the average displacement noted in several other reports [A. A. Martinez et al., Int. J. Radiat. Oncol., Biol., Phys. 49(1), 61-69 (2001); S. J. Damore et al., Int. J. Radiat. Oncol., Biol., Phys. 46(5), 1205-1211 (2000); P. J. Hoskin et al., Radiotherm. Oncol. 68(3), 285-288 (2003); E. Mullokandov et al., Int. J. Radiat. Oncol., Biol., Phys. 58(4), 1063-1071 (2004)] in the literature. Conclusions: Although the decrease of quality of dosimetric and radiobiological parameters occurs, this does not cause clinically unacceptable changes to the 3D dose distribution, according to our clinical protocol.

  6. Radiobiological restrictions and tolerance doses of repeated single-fraction hdr-irradiation of intersecting small liver volumes for recurrent hepatic metastases

    International Nuclear Information System (INIS)

    To assess radiobiological restrictions and tolerance doses as well as other toxic effects derived from repeated applications of single-fraction high dose rate irradiation of small liver volumes in clinical practice. Twenty patients with liver metastases were treated repeatedly (2 - 4 times) at identical or intersecting locations by CT-guided interstitial brachytherapy with varying time intervals. Magnetic resonance imaging using the hepatocyte selective contrast media Gd-BOPTA was performed before and after treatment to determine the volume of hepatocyte function loss (called pseudolesion), and the last acquired MRI data set was merged with the dose distributions of all administered brachytherapies. We calculated the BED (biologically equivalent dose for a single dose d = 2 Gy) for different α/β values (2, 3, 10, 20, 100) based on the linear-quadratic model and estimated the tolerance dose for liver parenchyma D90 as the BED exposing 90% of the pseudolesion in MRI. The tolerance doses D90 after repeated brachytherapy sessions were found between 22 - 24 Gy and proved only slightly dependent on α/β in the clinically relevant range of α/β = 2 - 10 Gy. Variance analysis showed a significant dependency of D90 with respect to the intervals between the first irradiation and the MRI control (p < 0.05), and to the number of interventions. In addition, we observed a significant inverse correlation (p = 0.037) between D90 and the pseudolesion's volume. No symptoms of liver dysfunction or other toxic effects such as abscess formation occurred during the follow-up time, neither acute nor on the long-term. Inactivation of liver parenchyma occurs at a BED of approx. 22 - 24 Gy corresponding to a single dose of ~10 Gy (α/β ~ 5 Gy). This tolerance dose is consistent with the large potential to treat oligotopic and/or recurrent liver metastases by CT-guided HDR brachytherapy without radiation-induced liver disease (RILD). Repeated small volume irradiation may be applied

  7. Development of a fast 3D treatment planning platform for clinical interstitial microwave hyperthermia within free-hand obliquely implanted HDR catheters

    Science.gov (United States)

    Scott, Serena J.; Salgaonkar, Vasant A.; Prakash, Punit; Curto, Sergio; Hsu, I.-Chow; Diederich, Chris J.

    2015-03-01

    A treatment planning platform for interstitial microwave hyperthermia was developed for practical, free-hand clinical implants. Such implants, consisting of non-parallel, moderately curved antennas with varying insertion depths, are used in HDR brachytherapy for treating locally advanced cancer. Numerical models for commercially available MA251 antennas (915 MHz, BSD Medical) were developed in COMSOL Multiphysics, a finite element analysis software package. To expedite treatment planning, electric fields, power deposition and temperature rises were computed for a single straight antenna in 2D axisymmetric geometry. A precomputed library of electric field and temperature solutions was created for a range of insertion depths (5-12 cm) and blood perfusion rates (0.5-5 kg/m3/s). 3D models of multiple antennas and benchtop phantoms experiments using temperature-sensitive liquid crystal paper to monitor heating by curved antennas were performed for comparative evaluation of the treatment planning platform. A patient-customizable hyperthermia treatment planning software package was developed in MATLAB with capabilities to interface with a commercial radiation therapy planning platform (Oncentra, Nucleotron), import patient and multicatheter implant geometries, calculate insertion depths, and perform hyperthermia planning with antennas operating in asynchronous or synchronous mode. During asynchronous operation, the net power deposition and temperature rises were approximated as a superposition sum of the respective quantities for one single antenna. During synchronous excitation, a superposition of complex electrical fields was performed with appropriate phasing to compute power deposition. Electric fields and temperatures from the pre-computed single-antenna library were utilized following appropriate non-rigid coordinate transformations. Comparison to 3D models indicated that superposition of electric fields around parallel antennas is valid when they are at least 15 mm

  8. SU-E-T-580: On the Significance of Model Based Dosimetry for Breast and Head and Neck 192Ir HDR Brachytherapy

    Energy Technology Data Exchange (ETDEWEB)

    Peppa, V; Pappas, E; Pantelis, E; Papagiannis, P [Medical Physics Laboratory, Medical School, University of Athens, Athens (Greece); Major, T; Polgar, C [National Institute of Oncology, Budapest (Hungary)

    2015-06-15

    Purpose: To assess the dosimetric and radiobiological differences between TG43-based and model-based dosimetry in the treatment planning of {sup 192}Ir HDR brachytherapy for breast and head and neck cancer. Methods: Two cohorts of 57 Accelerated Partial Breast Irradiation (APBI) and 22 head and neck (H&N) patients with oral cavity carcinoma were studied. Dosimetry for the treatment plans was performed using the TG43 algorithm of the Oncentra Brachy v4.4 treatment planning system (TPS). Corresponding Monte Carlo (MC) simulations were performed using MCNP6 with input files automatically prepared by the BrachyGuide software tool from DICOM RT plan data. TG43 and MC data were compared in terms of % dose differences, Dose Volume Histograms (DVHs) and related indices of clinical interest for the Planning Target Volume (PTV) and the Organs-At-Risk (OARs). A radiobiological analysis was also performed using the Equivalent Uniform Dose (EUD), mean survival fraction (S) and Tumor Control Probability (TCP) for the PTV, and the Normal Tissue Control Probability (N TCP) and the generalized EUD (gEUD) for the OARs. Significance testing of the observed differences performed using the Wilcoxon paired sample test. Results: Differences between TG43 and MC DVH indices, associated with the increased corresponding local % dose differences observed, were statistically significant. This is mainly attributed to their consistency however, since TG43 agrees closely with MC for the majority of DVH and radiobiological parameters in both patient cohorts. Differences varied considerably among patients only for the ipsilateral lung and ribs in the APBI cohort, with a strong correlation to target location. Conclusion: While the consistency and magnitude of differences in the majority of clinically relevant DVH indices imply that no change is needed in the treatment planning practice, individualized dosimetry improves accuracy and addresses instances of inter-patient variability observed. Research

  9. SU-E-T-270: Quality Control of Source Strength and Indexer Length in HDR Brachytherapy Using Sun Nuclear Mapcheck2

    International Nuclear Information System (INIS)

    Purpose: The goal of this work was to evaluate Sun Nuclear MapCheck2 capability for quantitative determination of both HDR source strength and position. Predictive power of Mapcheck2 dose matrix, originated by a microSelectron-v2 source from 22mm distance, was investigated. Methods: A Mick MultiDoc phantom with the 1400mm indexer length mark aligned over MapCheck2 central detector plus two additional 5cm plastic slabs were used as a composite phantom. Dose readings were transformed by applying published source anisotropy corrections and experimentally established radial dose and relative sensitivity factors. Angular dependence was not considered. Only readings from diodes located 2cm around the central detector were evaluated. The reproducibility of a fit between transformed dose readings and the ratio of virtual source strength and the square of source-detector distance was investigated. Four parameters were considered in the model: virtual source strength, lateral, longitudinal and vertical source positions. Final source strength calibration factor was calculated from the ratio of reference measurements and results from the fit. Results: Original lateral and longitudinal source position estimations had systematic errors of 0.39mm and 0.75mm. After subtracting these errors, both source positions were predicted with a standard deviation of 0.15mm. Results for vertical positions were reproducible with a standard deviation of 0.05mm. The difference between calculated and reference source strengths from 34 independent measurement setups had a standard deviation of 0.3%. The coefficient of determination for the linear regression between known indexer lengths and results from the fit in the range 1400mm ± 5mm was 0.985. Conclusions: ource strength can be estimated with MapCheck2 at appropriate accuracy levels for quality control. Verification of indexer length with present implementation is more accurate than visual alternatives. Results can be improved by designing a

  10. WE-A-17A-06: Evaluation of An Automatic Interstitial Catheter Digitization Algorithm That Reduces Treatment Planning Time and Provide Means for Adaptive Re-Planning in HDR Brachytherapy of Gynecologic Cancers

    International Nuclear Information System (INIS)

    Purpose: To evaluate an automatic interstitial catheter digitization algorithm that reduces treatment planning time and provide means for adaptive re-planning in HDR Brachytherapy of Gynecologic Cancers. Methods: The semi-automatic catheter digitization tool utilizes a region growing algorithm in conjunction with a spline model of the catheters. The CT images were first pre-processed to enhance the contrast between the catheters and soft tissue. Several seed locations were selected in each catheter for the region growing algorithm. The spline model of the catheters assisted in the region growing by preventing inter-catheter cross-over caused by air or metal artifacts. Source dwell positions from day one CT scans were applied to subsequent CTs and forward calculated using the automatically digitized catheter positions. This method was applied to 10 patients who had received HDR interstitial brachytherapy on an IRB approved image-guided radiation therapy protocol. The prescribed dose was 18.75 or 20 Gy delivered in 5 fractions, twice daily, over 3 consecutive days. Dosimetric comparisons were made between automatic and manual digitization on day two CTs. Results: The region growing algorithm, assisted by the spline model of the catheters, was able to digitize all catheters. The difference between automatic and manually digitized positions was 0.8±0.3 mm. The digitization time ranged from 34 minutes to 43 minutes with a mean digitization time of 37 minutes. The bulk of the time was spent on manual selection of initial seed positions and spline parameter adjustments. There was no significance difference in dosimetric parameters between the automatic and manually digitized plans. D90% to the CTV was 91.5±4.4% for the manual digitization versus 91.4±4.4% for the automatic digitization (p=0.56). Conclusion: A region growing algorithm was developed to semi-automatically digitize interstitial catheters in HDR brachytherapy using the Syed-Neblett template. This automatic

  11. Determination of absorbed dose in water at the reference point D(r{sub 0},{theta}{sub 0}) for an {sup 192}Ir HDR brachytherapy source using a Fricke system

    Energy Technology Data Exchange (ETDEWEB)

    Austerlitz, C.; Mota, H. C.; Sempau, J.; Benhabib, S. M.; Campos, D.; Allison, R.; Almeida, C. E. de; Zhu, D.; Sibata, C. H. [Department of Radiation Oncology, East Carolina University, Greenville, North Carolina 27834 (United States); Institut de Tecniques Energetiques, Universitat Politecnica de Catalunya, 08028 Barcelona (Spain); Department of Radiation Oncology, East Carolina University, Greenville, North Carolina 27834 (United States); Laboratorio de Cie circumflex ncias Radiologicas, Universidade do Estado do Rio de Janeiro, 20550 Rio de Janeiro (Brazil); Department of Radiation Oncology, East Carolina University, Greenville, North Carolina 27834 (United States)

    2008-12-15

    A ring-shaped Fricke device was developed to measure the absolute dose on the transverse bisector of a {sup 192}Ir high dose rate (HDR) source at 1 cm from its center in water, D(r{sub 0},{theta}{sub 0}). It consists of a polymethylmethacrylate (PMMA) rod (axial axis) with a cylindrical cavity at its center to insert the {sup 192}Ir radioactive source. A ring cavity around the source with 1.5 mm thickness and 5 mm height is centered at 1 cm from the central axis of the source. This ring cavity is etched in a disk shaped base with 2.65 cm diameter and 0.90 cm thickness. The cavity has a wall around it 0.25 cm thick. This ring is filled with Fricke solution, sealed, and the whole assembly is immersed in water during irradiations. The device takes advantage of the cylindrical geometry to measure D(r{sub 0},{theta}{sub 0}). Irradiations were performed with a Nucletron microselectron HDR unit loaded with an {sup 192}Ir Alpha Omega radioactive source. A Spectronic 1001 spectrophotometer was used to measure the optical absorbance using a 1 mL quartz cuvette with 1.00 cm light pathlength. The PENELOPE Monte Carlo code (MC) was utilized to simulate the Fricke device and the {sup 192}Ir Alpha Omega source in detail to calculate the perturbation introduced by the PMMA material. A NIST traceable calibrated well type ionization chamber was used to determine the air-kerma strength, and a published dose-rate constant was used to determine the dose rate at the reference point. The time to deliver 30.00 Gy to the reference point was calculated. This absorbed dose was then compared to the absorbed dose measured by the Fricke solution. Based on MC simulation, the PMMA of the Fricke device increases the D(r{sub 0},{theta}{sub 0}) by 2.0%. Applying the corresponding correction factor, the D(r{sub 0},{theta}{sub 0}) value assessed with the Fricke device agrees within 2.0% with the expected value with a total combined uncertainty of 3.43%(k=1). The Fricke device provides a promising

  12. Prostate cancer brachytherapy; Braquiterapia de cancer de prostata

    Energy Technology Data Exchange (ETDEWEB)

    Abreu, Carlos Eduardo Vita; Silva, Joao L. F. [Hospital Sirio Libanes, Sao Paulo, SP (Brazil). Centro de Oncologia. Dep. de Radioterapia; Srougi, Miguel; Nesrallah, Adriano [Universidade Federal de Sao Paulo (UNIFESP), SP (Brazil). Escola Paulista de Medicina (EPM). Disciplina de Urologia]. E-mail: cevitabr@mandic.com.br

    1999-07-01

    The transperineal brachytherapy with {sup 125}I/Pd{sup 103} seed implantation guided by transurethral ultrasound must be presented as therapeutical option of low urinary morbidity in patients with localized prostate cancer. The combined clinical staging - including Gleason and initial PSA - must be encouraged, for definition of a group of low risk and indication of exclusive brachytherapy. Random prospective studies are necessary in order to define the best role of brachytherapy, surgery and external beam radiation therapy.

  13. Dosimetry in intravascular brachytherapy; Calculos dosimetricos em braquiterapia intravascular

    Energy Technology Data Exchange (ETDEWEB)

    Campos, Laelia Pumilla Botelho

    2000-03-01

    Among the cardiovascular diseases responsible for deaths in the adult population in almost all countries of the world, the most common is acute myocardial infarction, which generally occurs because of the occlusion of one or more coronary arteries. Several diagnostic techniques and therapies are being tested for the treatment of coronary artery disease. Balloon angioplasty has been a popular treatment which is less invasive than traditional surgeries involving revascularization of the myocardium, thus promising a better quality of life for patients. Unfortunately, the rate of restenosis (re-closing of the vessel) after balloon angioplasty is high (approximately 30-50% within the first year after treatment).Recently, the idea of delivering high radiation doses to coronary arteries to avoid or delay restenosis has been suggested. Known as intravascular brachytherapy, the technique has been used with several radiation sources, and researchers have obtained success in decreasing the rate of restenosis in some patient populations. In order to study the radiation dosimetry in the patient and radiological protection for the attending staff for this therapy, radiation dose distributions for monoenergetic electrons and photons (at nine discrete energies) were calculated for blood vessels of diameter 0.15, o,30 and 0.45 cm with balloon and wire sources using the radiation transport code MCNP4B. Specific calculations were carried out for several candidate radionuclides as well. Two s tent sources (metallic prosthesis that put inside of patient's artery through angioplasty) employing {sup 32} P are also simulated. Advantages and disadvantages of the various radionuclides and source geometries are discussed. The dosimetry developed here will aid in the realization of the benefits obtained in patients for this promising new technology. (author)

  14. SU-E-T-525: Dose Volume Histograms (DVH) Analysis and Comparison with ICRU Point Doses in MRI Guided HDR Brachytherapy for Cervical Cancer

    Energy Technology Data Exchange (ETDEWEB)

    Badkul, R; McClinton, C; Kumar, P; Mitchell, M [University of Kansas Medical Center, Kansas City, KS (United States)

    2014-06-01

    .1 overestimated the bladder ICRU point dose up to 43% for conventional-techniques.Bladder-D2 provided a good estimation of ICRU bladder point-doses(within 3.6%) for conventional-techniques. This correlation is not observed for MGO plans perhaps due to steering of isodose line, leading to unpredictable dwell-weighting. Conclusion: MRI based HDR-planning provides accurate delineation of tumor volumes and normal structures, and optimized tumor-coverage can be achieved with acceptable normal-tissue doses. This study showed that for conventional techniques D0.1 rectum dose and D2 bladder dose are good representation of ICRU-reference-point doses.

  15. Comparison of methods for the measurement of radiation dose distributions in high dose rate (HDR) brachytherapy: Ge-doped optical fiber, EBT3 Gafchromic film, and PRESAGE® radiochromic plastic

    International Nuclear Information System (INIS)

    Purpose: Dose distribution measurement in clinical high dose rate (HDR) brachytherapy is challenging, because of the high dose gradients, large dose variations, and small scale, but it is essential to verify accurate treatment planning and treatment equipment performance. The authors compare and evaluate three dosimetry systems for potential use in brachytherapy dose distribution measurement: Ge-doped optical fibers, EBT3 Gafchromic film with multichannel analysis, and the radiochromic material PRESAGE® with optical-CT readout. Methods: Ge-doped SiO2 fibers with 6 μm active core and 5.0 mm length were sensitivity-batched and their thermoluminescent properties used via conventional heating and annealing cycles. EBT3 Gafchromic film of 30 μm active thickness was calibrated in three color channels using a nominal 6 MV linear accelerator. A 48-bit transmission scanner and advanced multichannel analysis method were utilized to derive dose measurements. Samples of the solid radiochromic polymer PRESAGE®, 60 mm diameter and 100 mm height, were analyzed with a parallel beam optical CT scanner. Each dosimetry system was used to measure the dose as a function of radial distance from a Co-60 HDR source, with results compared to Monte Carlo TG-43 model data. Each system was then used to measure the dose distribution along one or more lines through typical clinical dose distributions for cervix brachytherapy, with results compared to treatment planning system (TPS) calculations. Purpose-designed test objects constructed of Solid Water and held within a full-scatter water tank were utilized. Results: All three dosimetry systems reproduced the general shape of the isolated source radial dose function and the TPS dose distribution. However, the dynamic range of EBT3 exceeded those of doped optical fibers and PRESAGE®, and the latter two suffered from unacceptable noise and artifact. For the experimental conditions used in this study, the useful range from an isolated HDR

  16. SU-E-T-263: Point Dose Variation Using a Single Ir-192 HDR Brachytherapy Plan for Two Treatments with a Single Tandem-Ovoid Insertion for Cervical Cancer

    International Nuclear Information System (INIS)

    Purpose: To evaluate the point dose variations between Ir-192 HDR treatments on two consecutive days using a single tandem-ovoid insertion without replanning in cervical cancer patients. Methods: This study includes eleven cervical cancer patients undergoing HDR brachytherapy with a prescribed dose of 28 Gy in 4 fractions. Each patient had two tandemovoid insertions one week apart. Each insertion was treated on consecutive days with rescanning and replanning prior to each treatment. To study the effect of no replanning for day 2 treatments, the day 1 plan dwell position and dwell time with decay were applied to the day 2 CT dataset. The point dose variations on the prescription point H (defined according to American Brachytherapy Society), and normal tissue doses at point B, bladder, rectum and vaginal mucosa (based on ICRU Report 38) were obtained. Results: Without replanning, the mean point H dose variation was 4.6 ± 10.7% on the left; 2.3 ± 2.9% on the right. The mean B point variation was 3.8 ± 4.9% on the left; 3.6 ± 4.7% on the right. The variation in the left vaginal mucosal point was 12.2 ± 10.7%; 9.5 ± 12.5% on the right; the bladder point 5.5 ± 7.4%; and the rectal point 7.9 ± 9.1%. Conclusion: Without replanning, there are variations both in the prescription point and the normal tissue point doses. The latter can vary as much as 10% or more. This is likely due to the steep dose gradient from brachytherapy compounded by shifts in the positions of the applicator in relationship to the patients anatomy. Imaging prior to each treatment and replanning ensure effective and safe brachytherapy are recommended

  17. Experimental and Monte Carlo study of the effect of the presence of dry air, cortical bone inhomogeneities and source position on dose distribution of the mHDR-v2 source

    Directory of Open Access Journals (Sweden)

    Rakesh M Chandola

    2012-01-01

    Full Text Available Background: Recently it was data wise established that there is a considerable dose difference due to source position from the surface of the patient, and due to the presence of inhomogeneities. Aim: It aims at to find out the dose difference due to source position, and inhomogenieties in water phantom of high dose rate (HDR 192 Ir mHDR-v2 source by experiment and by Monte Carlo (MC simulation GEANT4 code. Materials and Methods: The measured study of the source was done using an in-air ionization chamber, water phantom while the calculated study was done by modeling the water phantom and its water, inhomogeneities, position of source, and points of calculation. Results: The measured and calculated dose differences are 5.48 to 6.46% and 5.43 to 6.44% respectively higher in the presence of dry air and 4.40 to 4.90% and 4.38 to 4.88% respectively lower in the presence of cortical bone. However, for the study of the effect of source position on dose distribution, when the source was positioned at a 1 cm distance from the surface of water phantom, the near points between 1 cm and 2 cm are 2 to 3.5% and 2.1-3.7% underdose and for distant points from 3 cm to 8 cm from the source are 4 to 15% and 4.1 to 15.8% underdose for measured and calculated studies, respectively, to the dose when the source was positioned at midpoint of water phantom. Conclusion: These results can be used in the treatment planning system.

  18. Positional variability of a tandem applicator system in HDR brachytherapy for primary treatment of cervix cancer. Analysis of the anatomic pelvic position and comparison of the applicator positions during five insertions

    Energy Technology Data Exchange (ETDEWEB)

    Wulf, J.; Popp, K.; Oppitz, U.; Baier, K.; Flentje, M. [Dept. of Radiotherapy, Univ. of Wuerzburg (Germany)

    2004-04-01

    Purpose: evaluation of the inter- and intraindividual applicator variability of multiple high-dose-rate (HDR) brachytherapy applications for primary treatment of cancer of the uterine cervix. Material and methods: retrospective analysis of 460 pairs of orthogonal X-ray films for conventional treatment in 92 patients with five intrauterine applications using an HDR tandem applicator. Measurement of the position of the applicator origin relative to a bony reference system in three dimensions. Evaluation of the differences of the applicator position in all 460 applications (interindividual variability), of the five applications in a single patient (intraindividual variability) and of the intraindividual variability relative to the applicator position at the first application. Results: the position of the applicator origin in the pelvis ranged from 23 mm cranial and 55 mm caudal to the top of femoral heads, 23 mm right and 27 mm left to the pelvic midline, and 6-53 mm dorsal to the mid of the femoral heads. Standard deviation (SD) of interindividual applicator variability was 12.9 mm (minimum/maximum -55/+23 mm, mean -13.6 mm) in longitudinal, 5.1 mm (-27/+23 mm, mean 1.6 mm) in lateral, and 7.6 mm (6/53 mm, mean 26 mm) in anterior-posterior [AP] direction. SD of intraindividual variability was 5.5 mm (-21/+23 mm, mean 0 mm) in longitudinal, 2.5 mm (-17/+19 mm, mean 0 mm) in lateral, and 4.2 mm (-15/+18 mm, mean 0 mm) in AP direction compared to intraindividual variability relative to the first insertion with an SD of 8.9 mm (-23/+36 mm, mean 2.8 mm) in longitudinal, 4.0 mm (-11/+23 mm, mean 0 mm) in lateral, and 6.8 mm (-27/+17 mm, mean -0.8 mm) in AP direction. Conclusion: intraindividual applicator variability is significantly smaller than interindividual variability. Applicator-related procedures such as midline shielding or dose matching of tele- and brachytherapy should be performed with information on at least one individual applicator position. (orig.)

  19. Percutaneous endoluminal angioplasty of post endarterectomy carotid stenoses

    International Nuclear Information System (INIS)

    Percutaneous transluminal angioplasty of the carotid artery was performed in four patients with recurrent stenosis following endarterectomy. Balloon catheter dilatation was successful in 3 of the 4 lesions. Post dilatation angiography demonstrated an increase in luminal diameter: there were no neurological complications with the procedure. PTA appears to be an effective method of treating recurrent stenosis following carotid endarterectomy. (orig.)

  20. Percutaneous Endoluminal Bypass of Iliac Aneurysms with a Covered Stent

    International Nuclear Information System (INIS)

    To evaluate the feasibility of percutaneous treatment of iliac aneurysms, a covered stent was inserted in nine men suffering from common iliac artery aneurysms (six cases), external iliac aneurysms (one case), or pseudoaneurysms (two cases). Placement of the stent was successful in all patients. In one patient, an endoprosthesis thrombosed after 15 days, but was successfully treated by thrombolysis and additional stent placement. At the follow-up examinations (mean period 22 months) all stent-grafts had remained patent. No late leakage or stenosis was observed

  1. Endoluminal US: experiments with nonvascular uses in animals.

    Science.gov (United States)

    Goldberg, B B; Liu, J B; Merton, D A; Kurtz, A B

    1990-04-01

    Catheters containing miniature ultrasound (US) transducers, originally developed for intravascular evaluation of plaque, were used in a series of in vivo and in vitro animal experiments to image a variety of nonvascular lumina. Measurements of the wall thickness and echotexture of the urethra, urinary bladder, ureter, renal pelvis, bile ducts, small bowel, fallopian tubes, and uterus were carried out. Close correlation between the US images and actual anatomic specimens was obtained. Structures outside of the lumen were identified and confirmed with both direct visualization and radiographic localization. Two small stones artificially inserted into the renal pelvis and a polyp-like projection artificially created within the fallopian tube were clearly identified by using the US probe. These initial US studies demonstrate the potential feasibility of these miniature transducers contained within catheters for intraluminal analysis in humans. PMID:2179992

  2. Using the Computed Tomography in Comparison to the Orthogonal Radiography Based Treatment Planning in High dose Rate (HDR) Brachytherapy in Cervical Uteri Cancer Patients; A Single Institution Feasibility Study

    International Nuclear Information System (INIS)

    corresponding p value of (p=0.53 and p=0.005) for the rectum and the bladder respectively. Conclusions: CT based treatment planning for HDR brachytherapy of cervical uteri cancer is reliable and more accurate in definition and calculation of the dose to the target as well as the critical organs. It allows dose calculation based on the actual volume rather than points or bony landmarks.

  3. CT based HDR brachytherapy for intracavitary applications

    International Nuclear Information System (INIS)

    Brachytherapy is most commonly used in combination with external radiotherapy for gynecological cancers of cervix, vagina and endometrium. The characteristic rapid fall off of the dose in brachytherapy makes it useful to deliver a localized high dose to tumor. In gynecological applications the dose limiting critical structures are bladder and rectum. The dose received by rectum and bladder has been an interesting issue all these decades. This work presents the dosimetric and planning aspects of CT based High Dose Rate brachytherapy for intracavitary applications

  4. Radiation Protection in Brachytherapy. Report of the SEFM Task Group on Brachytherapy; Proteccion radiologica en Braquiterapia. Informe del grupo de trabajo de Braquiterapia de la SEFM

    Energy Technology Data Exchange (ETDEWEB)

    Perez-Calatayud, J.; Corredoira Silva, E.; Crispin Contreras, V.; Eudaldo Puell, T.; Frutos Baraja, J. de; Pino Sorroche, F.; Pujades Claumarchirant, M. C.; Richart Sancho, J.

    2015-07-01

    This document presents the report of the Brachytherapy Task Group of the Spanish Society of Medical Physics. It is dedicated to the radiation protection aspects involved in brachytherapy. The aim of this work is to include the more relevant aspects related to radiation protection issues that appear in clinical practice, and for the current equipment in Spain. Basically this report focuses on the typical contents associated with high dose rate brachytherapy with {sup 1}92Ir and {sup 6}0Co sources, and permanent seed implants with {sup 1}25I, {sup 1}03Pd and {sup 1}31Cs, which are the most current and widespread modalities. Ophthalmic brachytherapy (COMS with {sup 1}25I, {sup 1}06Ru, {sup 9}0Sr) is also included due to its availability in a significant number of spanish hospitals. The purpose of this report is to assist to the medical physicist community in establishing a radiation protection program for brachytherapy procedures, trying to solve some ambiguities in the application of legal requirements and recommendations in clinical practice. (Author)

  5. The natural seismic hazard and induced seismicity of the european HDR (hot dry rock) geothermal energy project at Soultz-sous-Forets (Bas-Rhin, France); Alea sismique naturel et sismicite induite du projet geothermique europeen RCS (roche chaude seche) de Soultz-sous-Forets (Bas-Rhin, France)

    Energy Technology Data Exchange (ETDEWEB)

    Helm, J.A.

    1996-06-07

    Development of the Soultz-sous-Forets HDR (Hot Dry Rock) geothermal energy project will involve important fluid injections which will induce micro-seismic events. This thesis discusses the natural seismicity of the region and induced seismicity associated with fluid injections. A catalogue of all historical and instrument seismicity of the Soultz-sous-Forets (SSF) region has been compiled. This seismicity does not correspond to movements along the major tectonic features of the region. The area around SSF has been identified as being one where high heat flow corresponds to low seismicity. The largest well documented seismic event in the region which took place in 1952 had an epicentral intensity of VI. All important data pertaining to the series of seismic events which took place in the region from August to October 1952 have been collected and are presented. This work details the installation and operation of a permanent 3 station network of accelerometers and seismometers around the HDR site. Also the installation and operation of a mobile network of vertical seismometers during fluid injections. 167 micro-seismic events were recorded on the surface network, with magnitudes from -0.5 to 1.9. The preferential alignment of the micro-seismic cloud is N160 deg. Individual focal mechanisms of the larger seismic events correspond to an extensional tectonic regime. Stress inversion of P wave polarities indicates that the maximum stress is vertical and the intermediate and minimum stress axes horizontal. The largest of the horizontal stresses is orientated N124 deg and the smallest N34 deg. Induced seismic movement is taking place on pre-existing fractures controlled by the in situ stress seismic movement is taking place on pre-existing tectonic fractures controlled by the in situ stress field, and the largest of the induced events had a magnitude 1.9. This level of seismicity does not pose any environmental hazard to the region around Soultz-sous-Forets. (author) 151

  6. Brachytherapy in childhood rhabdomyosarcoma treatment; Braquiterapia no tratamento do rabdomiossarcoma da infancia

    Energy Technology Data Exchange (ETDEWEB)

    Novaes, Paulo Eduardo Ribeiro dos Santos

    1995-07-01

    A retrospective study of 21 children with rhabdomyosarcoma treated by brachytherapy to the primary site of the tumor at the Radiotherapy Department of the A.C.Camargo Hospital between january/1980 to june/1993 was undertaken. The main objectives were to comprove the utility of brachytherapy in childhood rhabdomyosarcoma, to evaluate the local control and survival, in association with chemotherapy, to analyze the late effects of the treatment and to determinate the preferential technique to each clinical situation. All patients received brachytherapy to the tumor site. The radioactive isotopes employed were Gold{sup 198}, Cesium{sup 137} and Iridium{sup 192}. The brachytherapy techniques depended on the tumor site, period of treatment, availability of the radioactive material and stage of the disease. Patients treated exclusively by brachytherapy received 40 Gy to 60 Gy. When brachytherapy was associated with external radiotherapy the dose ranged from 20 Gy to 40 Gy. Local control was achieved in 18 of 20 patients (90%). The global survival and local control survival rates were 61.9% (13/21 patients) and 72,2% (13/18 patients) respectively. (author)

  7. Use of Monte Carlo Methods in brachytherapy; Uso del metodo de Monte Carlo en braquiterapia

    Energy Technology Data Exchange (ETDEWEB)

    Granero Cabanero, D.

    2015-07-01

    The Monte Carlo method has become a fundamental tool for brachytherapy dosimetry mainly because no difficulties associated with experimental dosimetry. In brachytherapy the main handicap of experimental dosimetry is the high dose gradient near the present sources making small uncertainties in the positioning of the detectors lead to large uncertainties in the dose. This presentation will review mainly the procedure for calculating dose distributions around a fountain using the Monte Carlo method showing the difficulties inherent in these calculations. In addition we will briefly review other applications of the method of Monte Carlo in brachytherapy dosimetry, as its use in advanced calculation algorithms, calculating barriers or obtaining dose applicators around. (Author)

  8. Endobronchial and endoesophageal high dose rate brachytherapy for malignant airway and digestive tract obstructions

    International Nuclear Information System (INIS)

    Purpose/Objective: High dose rate brachytherapy has had a rapid increase in use for endo-luminal treatment especially in tracheobronchial and esophageal carcinoma. The increase in utilization of this modality has outpaced the development of treatment indications, standardization of dose prescription and specification, and reporting of outcome. The course will address these issues. Treatment of endobronchial carcinoma by high dose rate brachytherapy will be discussed covering a survey of low dose, medium dose, and high dose rate treatments reported in the literature to provide prospective. Indications, treatment protocol and results of the author for HDR (including 47 patients treated with medium dose rate) will be discussed, covering more than 500 patients treated on dose searching protocols. Results will include improvement in obstruction (using the obstruction score), symptoms (using the fourtiered symptom complex scores), recurrence patterns, oxygen saturation, performance status, and survival (including cause of death). Complications discussed will be immediate i.e., pneumothorax, and delayed such as fatal hemoptysis, and radiation bronchitis/stenosis. Treatment recommendations for radiation bronchitis/stenosis will be covered. Esophageal brachytherapy for more than 100 patients will be discussed. Procedure, treatment protocols for palliative treatment (both initial disease and recurrence) and for curative intent will be discussed. The curative intent protocol consists of radiation only (external and endoluminal) vs radiation and chemotherapy (reduced dose of external with concurrent 5-FU + Cis-Platinum), then endoluminal brachytherapy. For curative patients, results will include survival and long term complications. Treatment complications to be discussed include perforation, stricture and ulceration

  9. Endoluminal Diagnosis of Early Gastric Cancer and Its Precursors: Bridging the Gap Between Endoscopy and Pathology.

    Science.gov (United States)

    Uedo, Noriya; Yao, Kenshi

    2016-01-01

    Although dye-based and image-enhanced endoscopic techniques have revolutionized endoscopic diagnosis, conventional white light endoscopy still plays an important role in the diagnosis of early gastric cancer (EGC) during routine endoscopy. Chromoendoscopy reveals morphological characteristics of the mucosal lesions by enhancing mucosal contrast, while narrow-band imaging (NBI) facilitates detailed evaluation of the vascular architecture and surface features. Positive diagnostic findings of EGC on white light imaging and indigo carmine chromoendoscopy are a sharply demarcated lesion and irregularity in surface morphology or color. Magnifying NBI further improves diagnostic accuracy of white light imaging and chromoendoscopy. We review our approach to the endoscopic diagnosis of (pre-)malignant lesions in the stomach and discuss in detail novel endoscopic microvascular architectural patterns which further leverage diagnostic biopsy yield. We expect that further improvement of endoscopic techniques and correlative studies will close the gap between endoscopy and pathology. PMID:27573777

  10. Self-expanding endoluminal prosthesis in an acute occlusion due to left colon tumor

    International Nuclear Information System (INIS)

    Endoscopic use of self-expanding prostheses is described in two patients with acute mechanical occlusion of left colon, treated in the emergence service of our center allowing us to improve the hydroelectric symptomatic status of patients, as well as the colon preparation. This latter avoided an emergence surgery and decompression colostomy; surgery was programmed for the subsequent five ones. Anatomicalpathological results confirmed the presence of large seal-ring colon's adenocarcinomas in the descendent colon in a patient, and in the sigmoid colon in another one.. (author)

  11. Percutaneous Endoluminal Stent-Graft Repair of an Old Traumatic Femoral Arteriovenous Fistula

    International Nuclear Information System (INIS)

    A stent-graft was custom made to close a high-flow traumatic arteriovenous fistula of the left superficial femoral artery, present for 30 years, in a 60-year-old man with congestive heart failure and ischemic ulceration in the left foot. A balloon expandable Palmaz stent (P394; 2.5 mm x 3.9 cm) was covered with a polytetrafluoroethylene (PTFE) graft and was inserted percutaneously through an 11 Fr vascular sheath. Follow-up Doppler ultrasound at 6 months demonstrated occlusion of the arteriovenous fistula, patency of the artery, and luminal integrity of the artery and vein

  12. Mock circulatory system for the evaluation of left ventricular assist devices, endoluminal prostheses, and vascular diseases.

    Science.gov (United States)

    Legendre, Daniel; Fonseca, Jeison; Andrade, Aron; Biscegli, José Francisco; Manrique, Ricardo; Guerrino, Domingos; Prakasan, Akash Kuzhiparambil; Ortiz, Jaime Pinto; Lucchi, Julio Cesar

    2008-06-01

    A new digital computer mock circulatory system has been developed in order to replicate the physiologic and pathophysiologic characteristics of the human cardiovascular system. The computer performs the acquisition of pressure, flow, and temperature in an open loop system. A computer program has been developed in Labview programming environment to evaluate all these physical parameters. The acquisition system was composed of pressure, flow, and temperature sensors and also signal conditioning modules. In this study, some results of flow, cardiac frequencies, pressures, and temperature were evaluated according to physiologic ventricular states. The results were compared with literature data. In further works, performance investigations will be conducted on a ventricular assist device and endoprosthesis. Also, this device should allow for evaluation of several kinds of vascular diseases. PMID:18422796

  13. Endoluminal placement of stent-graft for the treatment of peripheral saccular aneurysm

    International Nuclear Information System (INIS)

    To determine the therapeutic effect of stent grafting in the treatment of saccular aneurysms of the peripheral artery. Eight patients (M:F=7:1 ; age:22-72(mean, 47) years) with ten saccular aneurysms of the peripheral artery who underwent stent grafting were included in this study. The etiologies of the aneurysms were Behcet's disease in four patients, atherosclerosis in two, trauma in one and'undcertain' in one; they were located at the common iliac artery in three cases, the renal artery in two, the subclavian artery in two, the anterior tibial artery in one, and at both the proximal and distal anastomotic sites of the common carotid-internal carotid bypass graft. In two cases, stent grafting and coils were used to embolize collateral vessels. Post-procedural evaluations involved the use of computerd tomography, Doppler sonography and magnetic resonance imaging. The mean follow-up period was 14.7 (range, 4-36) monthes. The saccular aneurysms were successfully excluded in all cases. Post-procedural angiography revealed minor leakage in two cases, but at follow-up these showed complete exclusion. Follow-up evaluation also revealed complete resolution in five cases and complete thrombosis accompanied by size reduction in three. In patients with aneurysms of the proximal and distal ends of a common carotid-internal carotid bypass graft, total occlusion occurred in the stent graft. Percutaneous stent-graft insertion is an effective and convenient method for the treatment of peripheral arterial aneurysms, and is an alternative to vascular surgery

  14. HDR intralumenal brachytherapy in bronchial cancer: review of our experience

    International Nuclear Information System (INIS)

    The main indications for brachytherapy in the treatment of endobronchial cancer are dyspnea. postobstructive pneumonia and atelectasis, cough and hemoptysis resulting from broncus obstruction by exophytic intralumenal tumor growth. High Dose Rate intralumenal brachytherapy (HDRBT) may be combined with external beam radiotherapy (EBRT), in particular as almost all tumors are too large for HDRBT alone. From January 1992 to September 1995 we treated 268 patients affected by bronchial cancer, with EBRT combined with HDRBT. All patients were staged as IIIa-IIIb-IV but KPS was >60 and expectancy of life > than 3 months. After bronchoscopy and Tc simulation we found that almost 10% of patients were downstaged. Treatment was always realized delivering 60 Gy to the tumour volume and 50 Gy to the mediastinal structures with EBRT. Brachytherapy was performed during the radiotherapy course. In 38 patients HDRBT was realized just one time, at the beginning of EBRT, with a dose of 10 Gy calculated at 1cm from the central axis of the catheter. In 47 HDRBT was performed twice (at the beginning and at the end of EBRT) with a dose of 7 Gy calculated at 1 cm from the central axis. From 1994 we started a 3 fractions protocol (Timing: days 1.15.30) with a dose of 5 Gy calculated at 0.5 cm from the axis. Of the 183 patients introduced in the protocol 170 received the three fractions of HDRBT and 13 were excluded from the study for personal or clinical reasons. In 97% of cases the application did not need general anesthesia; local anesthesia has been sufficient supplemented by some drug for sedation and coughing. Anyway both bronchoscopy and HDRBT (with anterior-posterior and lateral chest X-ray) are performed in the same shielded room without the necessity of displacing the patient. In almost 60% of treatments we used just one endobronchial applicator. In case of tumor involvement of the carina, two applicators were introduced. By this a larger tumor volume can be treated with adequate doses. Tolerance was good for the 96% of therapies performed, no toxicity was recorded. We have obtained till now a response rate of 88% for dyspnea, of 83% for cough of 97% for hemoptysis. In 50% there was a radiographic reduction of the mass measurable before therapy

  15. Automatic Level Control for Video Cameras towards HDR Techniques

    Directory of Open Access Journals (Sweden)

    de With PeterHN

    2010-01-01

    Full Text Available We give a comprehensive overview of the complete exposure processing chain for video cameras. For each step of the automatic exposure algorithm we discuss some classical solutions and propose their improvements or give new alternatives. We start by explaining exposure metering methods, describing types of signals that are used as the scene content descriptors as well as means to utilize these descriptors. We also discuss different exposure control types used for the control of lens, integration time of the sensor, and gain control, such as a PID control, precalculated control based on the camera response function, and propose a new recursive control type that matches the underlying image formation model. Then, a description of commonly used serial control strategy for lens, sensor exposure time, and gain is presented, followed by a proposal of a new parallel control solution that integrates well with tone mapping and enhancement part of the image pipeline. Parallel control strategy enables faster and smoother control and facilitates optimally filling the dynamic range of the sensor to improve the SNR and an image contrast, while avoiding signal clipping. This is archived by the proposed special control modes used for better display and correct exposure of both low-dynamic range and high-dynamic range images. To overcome the inherited problems of limited dynamic range of capturing devices we discuss a paradigm of multiple exposure techniques. Using these techniques we can enable a correct rendering of difficult class of high-dynamic range input scenes. However, multiple exposure techniques bring several challenges, especially in the presence of motion and artificial light sources such as fluorescent lights. In particular, false colors and light-flickering problems are described. After briefly discussing some known possible solutions for the motion problem, we focus on solving the fluorescence-light problem. Thereby, we propose an algorithm for the detection of fluorescent lights from the image itself and define a set of remedial actions, to minimize false color and light-flickering problems.

  16. Varian HDR surface applicators - commissioning and clinical implementation.

    Science.gov (United States)

    Iftimia, Ileana; McKee, Andrea B; Halvorsen, Per H

    2016-01-01

    The purpose of this study was to validate the dosimetric performance of Varian surface applicators with the source vertically positioned and develop procedures for clinical implementation. The Varian surface applicators with the source verti-cally positioned provide a wide range of apertures making them clinically advanta-geous, though the steep dose gradient in the region of 3-4 mm prescription depth presents multiple challenges. The following commissioning tests were performed: 1) verification of functional integrity and physical dimensions; and 2) dosimetric measurements to validate data provided by Varian as well as data obtained using the Acuros algorithm for heterogeneity corrected dose calculation. A solid water (SW) phantom was scanned and the Acuros algorithm was used to compute the dose at 5 mm depth and at surface for all applicators. Two sets of reference dose measurements were performed, with the source positioned at (i) -10 mm and (ii) -15 mm from the center of the first nominal dwell position. Measurements were taken at 5 mm depth in a SW phantom and in air at the applicator surface. The results were then compared to the vendor's data and to the Acuros calculated dose. Relative dose measurements using Gafchromic films were taken at a depth of 4 mm in SW. Percent depth ionization (PDI) measurements using ion chamber were performed in SW. The profiles generated from film measurements and the PDI plots were compared with those computed using the Acuros algorithm and vendor's data, when available. Preliminary leakage tests were performed using opti-cally stimulated luminescence dosimeters (OSLDs) and the results were compared with Acuros predictions. All applicators were found to be functional with physical dimensions within 1 mm of specifications. For scenario (ii) measurements taken in SW at 5 mm depth and in air at the surface of each applicator were within 10% and 4% agreement with vendor's data, respectively. Compared with Acuros predic-tions, these measurements were within 6% and 5%, respectively. Measurements taken for scenario (i) showed reduced agreement with both the vendor's data as well as the Acuros calculations, especially when using the 10 mm applicator. The full widths of the measured dose profiles were within 2 mm of those predicted by Acuros at the 90% dose level. The PDI plots and measured leakage dose were in good agreement with vendor's data and Acuros predictions. Based on the dosimetric results, a quality assurance program and procedures for clinical implementation were developed. Treatment planning will be performed using scenario (ii). The 10mm applicator will not be released for clinical use. A prescription depth of 4mm is recommended, to ensure full coverage at 3 mm and a minimum dose of 90% of prescribed dose at 4 mm depth. PMID:27074486

  17. Dosimetric equivalence of nonstandard HDR brachytherapy catheter patterns

    International Nuclear Information System (INIS)

    Purpose: To determine whether alternative high dose rate prostate brachytherapy catheter patterns can result in similar or improved dose distributions while providing better access and reducing trauma. Materials and Methods: Standard prostate cancer high dose rate brachytherapy uses a regular grid of parallel needle positions to guide the catheter insertion. This geometry does not easily allow the physician to avoid piercing the critical structures near the penile bulb nor does it provide position flexibility in the case of pubic arch interference. This study used CT datasets with 3 mm slice spacing from ten previously treated patients and digitized new catheters following three hypothetical catheter patterns: conical, bi-conical, and fireworks. The conical patterns were used to accommodate a robotic delivery using a single entry point. The bi-conical and fireworks patterns were specifically designed to avoid the critical structures near the penile bulb. For each catheter distribution, a plan was optimized with the inverse planning algorithm, IPSA, and compared with the plan used for treatment. Irrelevant of catheter geometry, a plan must fulfill the RTOG-0321 dose criteria for target dose coverage (V100Prostate>90%) and organ-at-risk dose sparing (V75Bladder75Rectum125Urethra<<1 cc). Results: The three nonstandard catheter patterns used 16 nonparallel, straight divergent catheters, with entry points in the perineum. Thirty plans from ten patients with prostate sizes ranging from 26 to 89 cc were optimized. All nonstandard patterns fulfilled the RTOG criteria when the clinical plan did. In some cases, the dose distribution was improved by better sparing the organs-at-risk. Conclusion: Alternative catheter patterns can provide the physician with additional ways to treat patients previously considered unsuited for brachytherapy treatment (pubic arch interference) and facilitate robotic guidance of catheter insertion. In addition, alternative catheter patterns may decrease toxicity by avoidance of the critical structures near the penile bulb while still fulfilling the RTOG criteria.

  18. Dosimetric equivalence of nonstandard HDR brachytherapy catheter patterns

    Energy Technology Data Exchange (ETDEWEB)

    Cunha, J. A. M.; Hsu, I-C.; Pouliot, J. [University of California, San Francisco, California 94115 (United States)

    2009-01-15

    Purpose: To determine whether alternative high dose rate prostate brachytherapy catheter patterns can result in similar or improved dose distributions while providing better access and reducing trauma. Materials and Methods: Standard prostate cancer high dose rate brachytherapy uses a regular grid of parallel needle positions to guide the catheter insertion. This geometry does not easily allow the physician to avoid piercing the critical structures near the penile bulb nor does it provide position flexibility in the case of pubic arch interference. This study used CT datasets with 3 mm slice spacing from ten previously treated patients and digitized new catheters following three hypothetical catheter patterns: conical, bi-conical, and fireworks. The conical patterns were used to accommodate a robotic delivery using a single entry point. The bi-conical and fireworks patterns were specifically designed to avoid the critical structures near the penile bulb. For each catheter distribution, a plan was optimized with the inverse planning algorithm, IPSA, and compared with the plan used for treatment. Irrelevant of catheter geometry, a plan must fulfill the RTOG-0321 dose criteria for target dose coverage (V{sub 100}{sup Prostate}>90%) and organ-at-risk dose sparing (V{sub 75}{sup Bladder}<1 cc, V{sub 75}{sup Rectum}<1 cc, V{sub 125}{sup Urethra}<<1 cc). Results: The three nonstandard catheter patterns used 16 nonparallel, straight divergent catheters, with entry points in the perineum. Thirty plans from ten patients with prostate sizes ranging from 26 to 89 cc were optimized. All nonstandard patterns fulfilled the RTOG criteria when the clinical plan did. In some cases, the dose distribution was improved by better sparing the organs-at-risk. Conclusion: Alternative catheter patterns can provide the physician with additional ways to treat patients previously considered unsuited for brachytherapy treatment (pubic arch interference) and facilitate robotic guidance of catheter insertion. In addition, alternative catheter patterns may decrease toxicity by avoidance of the critical structures near the penile bulb while still fulfilling the RTOG criteria.

  19. Interactive Augmentation of Live Images using a HDR Stereo Camera

    Directory of Open Access Journals (Sweden)

    Jens Anhenn

    2008-02-01

    Full Text Available Adding virtual objects to real environments plays an important role in todays computer graphics: Typical examples are virtual furniture in a real room and virtual characters in real movies. For a believable appearance, consistent lighting of the virtual objects is required. We present an augmented reality system that displays virtual objects with consistent illumination and shadows in the image of a simple webcam. We use two high dynamic range video cameras with fisheye lenses permanently recording the environment illumination. A sampling algorithm selects a few bright parts in one of the wide angle images and the corresponding points in the second camera image. The 3D position can then be calculated using epipolar geometry. Finally, the selected point lights are used in a multi pass algorithm to draw the virtual object with shadows. To validate our approach, we compare the appearance and shadows of the synthetic objects with real objects.

  20. Aktuelle Entwicklungen in der Strahlentherapie des Prostatakarzinoms: HDR-Brachytherapie

    OpenAIRE

    Knocke-Abulesz TH

    2004-01-01

    In der primären Therapie des Prostatakarzinoms ist die Seed-Implantation neben der radikalen Prostatektomie und der konformalen 3D-geplanten Teletherapie in den letzten Jahren insbesondere bei den lokal begrenzten Tumoren die dritte etablierte Behandlungstechnik geworden. In den USA werden bereits fast ein Drittel der Patienten mit dieser Technik behandelt. Im Gegensatz hierzu wurde in der Strahlentherapie in den letzten beiden Jahrzehnten die Langzeit-Implantation von Nukliden bei den mei...

  1. Spatial imaging in color and HDR: prometheus unchained

    Science.gov (United States)

    McCann, John J.

    2013-03-01

    The Human Vision and Electronic Imaging Conferences (HVEI) at the IS and T/SPIE Electronic Imaging meetings have brought together research in the fundamentals of both vision and digital technology. This conference has incorporated many color disciplines that have contributed to the theory and practice of today's imaging: color constancy, models of vision, digital output, high-dynamic-range imaging, and the understanding of perceptual mechanisms. Before digital imaging, silver halide color was a pixel-based mechanism. Color films are closely tied to colorimetry, the science of matching pixels in a black surround. The quanta catch of the sensitized silver salts determines the amount of colored dyes in the final print. The rapid expansion of digital imaging over the past 25 years has eliminated the limitations of using small local regions in forming images. Spatial interactions can now generate images more like vision. Since the 1950's, neurophysiology has shown that post-receptor neural processing is based on spatial interactions. These results reinforced the findings of 19th century experimental psychology. This paper reviews the role of HVEI in color, emphasizing the interaction of research on vision and the new algorithms and processes made possible by electronic imaging.

  2. Divergence of Cs-137 sources fluence used in brachytherapy; Divergencia da fluencia de fontes de Cs-137 usadas em braquiterapia

    Energy Technology Data Exchange (ETDEWEB)

    Vianello, E.A.; Almeida, C.E. de [Laboratorio de Ciencias Radiologicas- LCR-DBB (UERJ). R. Sao Francisco Xavier, 524- Pav. HLC, sala 136 terreo- CEP 20.550- 013. Rio de Janeiro (Brazil)

    1998-12-31

    In this work the experimental determination of correction factor for fluence divergence (kln) of linear Cs-137 sources CDCS J4, with Farmer ionization chamber model 2571 in a central and perpendicular plan to source axis, for distances range from 1 to 7 cm., has been presented. The experimental results were compared to calculating by Kondo and Randolph (1960) isotropic theory and Bielajew (1990) anisotropic theory. (Author)

  3. Determinacion de la eficacia de la braquiterapia en tratamiento de cáncer basada en mineria de datos

    OpenAIRE

    Reparaz, D.; Merlino, Hernán; Rancan, Claudio; Rodríguez, D.; Britos, Paola Verónica; García Martínez, Ramón

    2008-01-01

    En las últimas décadas, hemos sido testigos de vertiginosos cambios en las tecnologías existentes. En este marco de rápida evolución, no podemos dejar afuera los avances producidos en las ciencias de salud. Frente a dichos cambios, aparecen en la medicina nuevas alternativas para el tratamiento de enfermedades. Al encontrarnos frente a estas nuevas alternativas, comienza a tomar mayor importancia el concepto de calidad de vida, ligada a cada uno de los tratamientos. Para el tratamiento del...

  4. Importance of the elemental composition in brachytherapy with neutrons; Importancia de la composicion elemental en braquiterapia con neutrones

    Energy Technology Data Exchange (ETDEWEB)

    Paredes G, L.; Balcazar G, M. [ININ, A.P. 18-1027, 11801 Mexico D.F. (Mexico); Azorin N, J. [UAM-I, 09340 Mexico D.F. (Mexico); Francois L, J.L. [ICN-UNAM, 04510 Mexico D.F. (Mexico)

    2004-07-01

    An analysis is presented of as the small differences that exist in the elementary composition of the wicked tumors, healthy fabrics and some material substitutes of fabric employees in dosimetry, they generate variations in the value of the kerma coefficient and consequently in the absorbed dose of neutrons in the interval 11 eV to 29 MeV. These differences make that the coefficient of kerma of neutrons average for the considered wicked tumors, be between 6% and 7% smaller that the coefficient of kerma of neutrons average for soft fabric, in the interval of interest in therapy with quick neutrons. These results have a special importance during the process of planning of brachytherapy treatments with sources of {sup 252} Cf, to optimize and to individualize the treatments to the patients. (Author)

  5. Obtention of brachytherapy seeds by sealing process using polymer; Obtencao de sementes de braquiterapia pelo processo de selagem com polimero

    Energy Technology Data Exchange (ETDEWEB)

    Lana, Diogo Alberto P.D.; Ferraz, Wilmar B.; Santos, Ana Maria M., E-mail: amms@cdtn.br [Centro de Desenvolvimento da Tecnologia Nuclear (CDTN/CNEN-MG), Belo Horizonte, MG (Brazil); Carvalho, Luiz Claudio F.M. Garcia [Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG (Brazil)

    2012-08-15

    Brachytherapy is an advanced cancer treatment where radioactive seeds or sources are placed near or directly into the tumor thus reducing the radiation exposure in the surrounding healthy tissues. Several kinds of seeds have been developed in order to obtain a better dose distribution around them and with a lower cost manufacturing. These seeds consist of an encapsulation (titanium or stainless steel tube), a radionuclide carrier, and X-ray marker. The usual sealing process of the seeds is done with laser welding, but this process can promote radionuclide volatilization. In this paper, we present a new sealing process using epoxy resin and characterizations of two epoxy resins. These resins were characterized by Fourier transform infrared spectroscopic (FTIR), ultraviolet-visible spectroscopy (UV-vis) and differential scanning calorimetry (DSC). Interactions of the resins and of the sealed seeds in a simulated body fluid (SBF) were evaluated by scanning electron microscopy (SEM), energy dispersive X-ray spectroscopy (EDS), and by a counting gamma-rays. (author)

  6. Endoluminal brachytherapy in the treatment of oesophageal cancer: technique description, case report and review of the literature

    Directory of Open Access Journals (Sweden)

    Luisa Castilla

    2015-07-01

    Full Text Available Endoesophageal brachytherapy is a useful technique for the palliative treatment of dysphagia in advanced oesophageal cancer. This technique offers good results on dysphagia control and quality of life. We report the case of a patient treated with this technique presenting complete response to the dysphagia. We describe endoesophageal brachyterapy technique and we comment on the literature.

  7. Metal stent and endoluminal high-dose rate 192iridium brachytherapy in palliative treatment of malignant biliary tract obstruction

    International Nuclear Information System (INIS)

    Since December 1989, 9 patients with inoperable malignant biliary tract obstruction were treated palliatively by a combined modality treatment consisting of placement of a permanent biliary endoprosthesis followed by intraluminal high dose-rate 192Ir brachytherapy. A dose of 10 Gy was delivered in a hyperfractionated schedule at the point of reference in a distance of 7.5 mm of centre of the source. External small field radiotherapy (50.4 Gy, 1.8 Gy per day, 5 fractions per week) was also given in six cases (M/O, Karnofsky >60%). In 9/9 cases an unrestrained bile flow and an interruption of pruritus was achieved, in 78% (7/9) of cases the duration of palliation was as long as the survival time (median survival time 7.5 months). (orig.)

  8. The value of diagnostic imaging in the classification of endoleaks as a complication of endoluminal grafting of aortic aneurysms

    International Nuclear Information System (INIS)

    Objective: to describe a series of endoleak cases and their respective classification. Materials and methods: the authors developed a retrospective study of endoleaks diagnosed at their institution in the period between 2005 and 2009. Twenty cases were included to illustrate the different types of endoleaks. Results: seventy percent of the patients were men, and the ages ranged from 43 to 91 years (mean, 76.3 years). Thirteen cases were observed in the infrarenal abdominal aorta, four in the thoracic aorta, two in the iliac artery, and one in the carotid territory. Ultrasonography was the method utilized for diagnosis in three cases, and computed tomography in the other 17 cases. Classification: 60% type I, 25% type II, 15% type III. Other endoleak types were not observed in the present series. Conclusion: early diagnosis and correct classification of endoleaks are crucial for an appropriate management of cases. The knowledge of endoleaks subtypes is fundamental in the education of physicians specialized in radiology and imaging diagnosis as well as for vascular surgeons. (author)

  9. Endoluminal calprotectin measurement in assessment of pouchitis and a new index of disease activity: a pilot study

    OpenAIRE

    Annamaria Pronio; Annalisa Di-Filippo; Paola Mariani; Annarita Vestri; Chiara Montesani; Monica Boirivant

    2016-01-01

    Pouchitis is the most common complication following proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis (UC). To provide a standardized definition of pouchitis clinical, endoscopic and histological markers were grouped and weighted in the pouch disease activity index (PDAI). However, the delay in the assessment of the final score due to the time requested for histological analysis remains the main obstacle to the index implementation in clinical practice so that the use o...

  10. Intravenous, contrast-enhanced MR colonography using air as endoluminal contrast agent: Impact on colorectal polyp detection

    International Nuclear Information System (INIS)

    Purpose: To compare diagnostic accuracy and patient tolerance of MR colonography with intravenous contrast and luminal air (MRC) to conventional colonoscopy (CC). Materials and methods: IRB approval and written informed consent were obtained. Forty-six patients, both screening and symptomatic, underwent MRC followed by CC. The MRC technique employed 3D T1W spoiled gradient echo sequences performed after the administration of gadopenetate dimeglumine, with parallel imaging. The diagnostic accuracy and tolerance of patients for MRC was compared to CC. Results: Twenty-four polyps were detected in eighteen patients with CC (5 polyps ≥10 mm, 4 polyps 6–9 mm, 15 polyps ≤5 mm). MRC was 66.7% (12/18) sensitive and 96.4% (27/28) specific for polyp detection on a per-patient basis. When analyzed by polyp size, sensitivity and specificity of MRC was 100% (5/5) and 100% (19/19), respectively, for lesions greater than 10 mm, 100% (4/4) and 100% (20/20) for lesions 6–9 mm, and sensitivity of 20% (3/15) lesions less than 5 mm. The sensitivity and specificity of MRC for detecting significant lesions (>6 mm) was 100% (9/9) and 100% (15/15), respectively. Regarding tolerance of the exams, there were no significant differences between MRC and CC. Thirty-five percent (n = 16) of patients preferred MRC as a future screening test compared to 33% (n = 15) for CC. Conclusion: MRC using air as an intraluminal contrast agent is a feasible and well-tolerated technique for detecting colonic polyps ≥6 mm in size. Further studies are warranted.

  11. Intravenous, contrast-enhanced MR colonography using air as endoluminal contrast agent: Impact on colorectal polyp detection.

    LENUS (Irish Health Repository)

    Keeling, Aoife N

    2010-12-03

    PURPOSE: To compare diagnostic accuracy and patient tolerance of MR colonography with intravenous contrast and luminal air (MRC) to conventional colonoscopy (CC). MATERIALS AND METHODS: IRB approval and written informed consent were obtained. Forty-six patients, both screening and symptomatic, underwent MRC followed by CC. The MRC technique employed 3D T1W spoiled gradient echo sequences performed after the administration of gadopenetate dimeglumine, with parallel imaging. The diagnostic accuracy and tolerance of patients for MRC was compared to CC. RESULTS: Twenty-four polyps were detected in eighteen patients with CC (5 polyps ≥10mm, 4 polyps 6-9mm, 15 polyps ≤5mm). MRC was 66.7% (12\\/18) sensitive and 96.4% (27\\/28) specific for polyp detection on a per-patient basis. When analyzed by polyp size, sensitivity and specificity of MRC was 100% (5\\/5) and 100% (19\\/19), respectively, for lesions greater than 10mm, 100% (4\\/4) and 100% (20\\/20) for lesions 6-9mm, and sensitivity of 20% (3\\/15) lesions less than 5mm. The sensitivity and specificity of MRC for detecting significant lesions (>6mm) was 100% (9\\/9) and 100% (15\\/15), respectively. Regarding tolerance of the exams, there were no significant differences between MRC and CC. Thirty-five percent (n=16) of patients preferred MRC as a future screening test compared to 33% (n=15) for CC. CONCLUSION: MRC using air as an intraluminal contrast agent is a feasible and well-tolerated technique for detecting colonic polyps ≥6mm in size. Further studies are warranted.

  12. Intravenous, contrast-enhanced MR colonography using air as endoluminal contrast agent: Impact on colorectal polyp detection.

    LENUS (Irish Health Repository)

    Keeling, Aoife N

    2012-02-01

    PURPOSE: To compare diagnostic accuracy and patient tolerance of MR colonography with intravenous contrast and luminal air (MRC) to conventional colonoscopy (CC). MATERIALS AND METHODS: IRB approval and written informed consent were obtained. Forty-six patients, both screening and symptomatic, underwent MRC followed by CC. The MRC technique employed 3D T1W spoiled gradient echo sequences performed after the administration of gadopenetate dimeglumine, with parallel imaging. The diagnostic accuracy and tolerance of patients for MRC was compared to CC. RESULTS: Twenty-four polyps were detected in eighteen patients with CC (5 polyps >\\/=10mm, 4 polyps 6-9mm, 15 polyps <\\/=5mm). MRC was 66.7% (12\\/18) sensitive and 96.4% (27\\/28) specific for polyp detection on a per-patient basis. When analyzed by polyp size, sensitivity and specificity of MRC was 100% (5\\/5) and 100% (19\\/19), respectively, for lesions greater than 10mm, 100% (4\\/4) and 100% (20\\/20) for lesions 6-9mm, and sensitivity of 20% (3\\/15) lesions less than 5mm. The sensitivity and specificity of MRC for detecting significant lesions (>6mm) was 100% (9\\/9) and 100% (15\\/15), respectively. Regarding tolerance of the exams, there were no significant differences between MRC and CC. Thirty-five percent (n=16) of patients preferred MRC as a future screening test compared to 33% (n=15) for CC. CONCLUSION: MRC using air as an intraluminal contrast agent is a feasible and well-tolerated technique for detecting colonic polyps >\\/=6mm in size. Further studies are warranted.

  13. Ruthenium-106 brachytherapy for uveal melanomas. Preliminary results: a single institutional experience; Braquiterapia com rutenio-106 em melanomas uveais. Resultados preliminares: experiencia uni-instuticional

    Energy Technology Data Exchange (ETDEWEB)

    Dias, Rodrigo Souza; Giordani, Adelmo Jose; Segreto, Helena Regina Comodo; Segreto, Roberto Araujo [Universidade Federal de Sao Paulo/Escola Paulista de Medicina (Unifesp/EPM), Sao Paulo, SP (Brazil). Departamento de Medicina. Setor de Radioterapia ; Erwenne, Clelia Maria; Teixeira, Luiz Fernando [Universidade Federal de Sao Paulo/Escola Paulista de Medicina (UNIFESP/EPM), Sao Paulo, SP (Brazil). Dept. de Oftalmologia]. E-mail: segreto. dmed@epm.br

    2007-03-15

    Objective: To analyze the early response of uveal melanomas in patients treated with ruthenium-106 brachytherapy. Materials And Methods: In the period between April 2002 and July 2003, 20 patients diagnosed with uveal melanoma were submitted to ruthenium-106 brachytherapy. The calculated dose delivered at the apex of the tumor ranged between 55 Gy and 100 Gy. Patients with lesions greater than 5 mm were submitted to transpupillary thermotherapy concomitantly with ophthalmic plaque insertion. Results: As regards the lesions site, 75% of the lesions were located in the choroid, 15% in the iris, and the remainder 10% in the ciliary body. In a median 19-month-follow-up, the progression-free survival for brachytherapy was 69%, and 87% for associated brachytherapy and transpupillary thermotherapy. A significant tumor height reduction was observed after treatment. No patient was submitted to enucleation. Conclusion: Our preliminary results show that ruthenium-106 brachytherapy is an appropriate method for conservative treatment of patients with uveal melanomas in terms of local management, ocular and visual acuity preservation with an acceptable complications incidence rate. (author)

  14. Development of a voxel phantom specific for simulation of eye brachytherapy; Desenvolvimeto de um fantoma de voxel especifico para simulacao de braquiterapia ocular

    Energy Technology Data Exchange (ETDEWEB)

    Santos, Marcilio S.; Lima, Fernando R.A., E-mail: msilveira.fisica@gmail.com, E-mail: falima@cnen.gov.br [Centro Regional de Ciencias Nucleares do Nordeste (CRCN-NE/CNEN-PE), Recife, PE (Brazil); Universidade Federal de Pernambuco (UFPE), Recife, PE (Brazil). Departamento de Energia Nuclear; Vieira, Jose W., E-mail: jose-wilson59@live.com [lnstituto Federal de Educacao, Ciencia e Tecnologia de Pernambuco (IFPE), Recife, PE (Brazil)

    2013-11-01

    The ophthalmic brachytherapy involves inserting a plate with seeds of radioactive material in the patient's eye for the treatment of tumors. The radiation dose to be taken by the patient is prescribed by physicians and time of application of the material is calculated from calibration curves supplied by the manufacturers of the plates. To estimate the dose absorbed by the patient, in a series of diagnostic tests, it is necessary to perform simulations using a computational model of exposure. These models are composed primarily by a anthropomorphic phantom, and a Monte Carlo code. The coupling of a phantom voxel whole body to a Monte Carlo code is a complex process because the computer model simulations with exposure takes time, knowledge of the code used and various adjustments to be implemented. The problem is aggravated even more complex when you want to radiate one region of the body. In this work we developed a phantom, specifically the region containing the eyeball, from MASH (Male Adult voxel). This model was coupled to the Monte Carlo code EGSnrc (Electron Gamma Shower) together with an algorithm simulator source of I-125 , considering only its effect of higher energy range.

  15. Characteristics of the radiochromic film Gafchromictm EBT3 model for use in brachytherapy; Caracterizacao do filme radiocromico Gafchromictm modelo EBT3 para uso em braquiterapia

    Energy Technology Data Exchange (ETDEWEB)

    Luvizotto, Jessica

    2015-07-01

    Brachytherapy is a radiotherapy treatment modality using radioactive sealed sources within walking distance of the tumor, reducing the risk of applying an unwanted dose to adjacent healthy tissues. For brachytherapy is reliable, it is necessary to establish a dosimetric practices program aimed at determining the optimal dose of radiation for this radiotherapy practice. This paper presents the application of two methodologies for the dosimetry using radiochromic films. Experimental measurements were performed with EBT3 films in phantoms consisting of homogeneous and heterogeneous material (lung, bone and soft tissue) built especially for dose measurements in brachytherapy. The processing and analysis of the resulting images of the experimental procedure were performed with ImageJ software and MATLAB. The results were evaluated from comparisons dose of experimental measurements and simulations obtained by the Monte Carlo method. (author)

  16. Comparison between calculation methods of dose rates in gynecologic brachytherapy; Comparacion entre metodos de calculo de tasa de dosis en braquiterapia ginecologica8

    Energy Technology Data Exchange (ETDEWEB)

    Vianello, E.A.; Biaggio, M.F.; Dr, M.F.; Almeida, C.E. de [Laboratorio de Ciencias Radiologicas- (L.C.R.)-D.B.B.- UERJ- R. Sao Francisco Xavier, 524- Pav. HLC- sala 136- CEP 20550-013 Rio de Janeiro (Brazil)

    1998-12-31

    In treatments with radiations for gynecologic tumors is necessary to evaluate the quality of the results obtained by different calculation methods for the dose rates on the points of clinical interest (A, rectal, vesicle). The present work compares the results obtained by two methods. The Manual Calibration Method (MCM) tri dimensional (Vianello E., et.al. 1998), using orthogonal radiographs for each patient in treatment, and the Theraplan/T P-11 planning system (Thratonics International Limited 1990) this last one verified experimentally (Vianello et.al. 1996). The results show that MCM can be used in the physical-clinical practice with a percentile difference comparable at the computerized programs. (Author)

  17. Set the initial reference state of a team brachytherapy high dose rate; Establecimiento del estado de referencia inicial de un equipo de braquiterapia de alta tasa de dosis

    Energy Technology Data Exchange (ETDEWEB)

    Clemente Gutierrez, F.; Diaz Fuentes, R.; Cabello Murillo, E.; Casa de Julian, M. A. de la; Ferrando Sanchez, A.; Adaimi Hernandez, P.

    2011-07-01

    You have set the initial reference state for a team of high-rate brachytherapy doses according to the recommendations made in the text used as a reference, being always within the functional tolerances established for the team, or the number associated with each test. The team was ready for clinical use under the provisions of Royal Decree 1566/1998 of Quality Control in Radiotherapy.

  18. Use of Monte Carlo Methods for determination of isodose curves in brachytherapy; Uso de tecnicas Monte Carlo para determinacao de curvas de isodose em braquiterapia

    Energy Technology Data Exchange (ETDEWEB)

    Vieira, Jose Wilson

    2001-08-01

    Brachytherapy is a special form of cancer treatment in which the radioactive source is very close to or inside the tumor with the objective of causing the necrosis of the cancerous tissue. The intensity of cell response to the radiation varies according to the tissue type and degree of differentiation. Since the malign cells are less differentiated than the normal ones, they are more sensitive to the radiation. This is the basis for radiotherapy techniques. Institutes that work with the application of high dose rates use sophisticated computer programs to calculate the necessary dose to achieve the necrosis of the tumor and the same time, minimizing the irradiation of tissues and organs of the neighborhood. With knowledge the characteristics of the source and the tumor, it is possible to trace isodose curves with the necessary information for planning the brachytherapy in patients. The objective of this work is, using Monte Carlo techniques, to develop a computer program - the ISODOSE - which allows to determine isodose curves in turn of linear radioactive sources used in brachytherapy. The development of ISODOSE is important because the available commercial programs, in general, are very expensive and practically inaccessible to small clinics. The use of Monte Carlo techniques is viable because they avoid problems inherent to analytic solutions as, for instance , the integration of functions with singularities in its domain. The results of ISODOSE were compared with similar data found in the literature and also with those obtained at the institutes of radiotherapy of the 'Hospital do Cancer do Recife' and of the 'Hospital Portugues do Recife'. ISODOSE presented good performance, mainly, due to the Monte Carlo techniques, that allowed a quite detailed drawing of the isodose curves in turn of linear sources. (author)

  19. Dosimetric study for characterization of a postal system of quality control in brachytherapy; Estudo dosimetrico para caracterizacao de um sistema postal de controle de qualidade em braquiterapia

    Energy Technology Data Exchange (ETDEWEB)

    Alves, Victor Gabriel Leandro, E-mail: vgalves@inca.gov.b [Instituto Nacional do Cancer (INCa), Rio de Janeiro, RJ (Brazil); Queiroz Filho, Pedro Pacheco de; Santos, Denison de Souza, E-mail: queiroz@ird.gov.b, E-mail: santosd@ird.gov.b [Instituto de Radioprotecao e Dosimetria (IRD/CNEN-RJ), Rio de Janeiro, RJ (Brazil); Begalli, Marcia, E-mail: begalli@uerj.b [Universidade do Estado do Rio de Janeiro (IF/UERJ), RJ (Brazil). Inst. de Fisica

    2009-07-01

    This work presents a dosimetric study of a postal system, to be developed for measurements of brachytherapy. It was projected a PMMA phantom with orifices for insertion of the high dose {sup 192}Ir source and the T L dosemeters. The system was characterized with using of Monte Carlo simulations, using the dosimetric magnitudes defined at the T G-43 of AAPM, as function of radial dose g(f)

  20. Assessment of dose-volume histograms in brachytherapy 3D high-rate; Evaluacion de los histogramas dosis volumen en braquiterapia de alta tasa 3D

    Energy Technology Data Exchange (ETDEWEB)

    Gomez Barrado, A.; Tripero Oter, J.; Sanchez Jimenez, E.; Sanchez-Reyes, A.

    2013-07-01

    The use of systems of treatment planning using 3D reconstruction algorithms are becoming more frequent in brachytherapy treatments. The implementation of these systems entails great qualitative and quantitative procedural changes in the way to evaluate the clinical dosimetry about the 2D classical systems. This paper describes the experience of our Centre in employment and prescription dose using histograms dose-volume in the treatment of brachytherapy of high rate. (Author)

  1. Prototypes of phosphorus-32 sealed sources for use in Brachytherapy; Prototipo de fuente radiactiva de fosforo para uso medico en braquiterapia

    Energy Technology Data Exchange (ETDEWEB)

    Anaya Garro, Olgger; Vela Mora, Mariano; Revilla Silva, Angel Revilla [Instituto Peruano de Energia Nuclear (IPEN), Lima (Peru)]. E-mail: oanaya@ipen.gob.pe; mvela@ipen.gob.pe; arevilla@ipen.gob.pe

    2005-07-01

    It has developed prototypes of phosphorus-32 sealed sources for use in Brachytherapy. This one was made in two stages, at the first one, we designed and constructed the container (capsule), the filling system and the sealed system; at the second one, we made the irradiation of the capsules containing the 'target'. The prototypes was made of aluminum in cylindrical geometry. During the irradiation test was made using two different dimensions: one of 1 mm outer diameter and 1 cm length and another one of 0.8 mm outer diameter and 5 mm length. They were radiated in the core of the RP-10 research reactor, at 7.93 x10{sup 13} n/cm{sup 2}.s thermal neutron flux during 27 operation cycles. Activities of 144.53 MBq (3.91 mCi) and 107.67 MBq (2.91 mCi) was obtained for each case. This activities are adequate to restenosis and for some tumors treatment. We can observed that the capsules irradiated passed visual inspection in its physical integrity (leakage and geometry). It has been demonstrated, that the beta radiation for his minor power of penetration and its high interaction, causes major local damage to the malignant tissue, minimizing the damage of the healthy surrounding tissues. It has been advisable to use for the treatment of illnesses of the circulatory system and some tumors. At the present, the source of strontium-90 are the most beta ray source used, but of this one are obtained as fission product of uranium target, where valuable radioactive waste is generated, whereas if we were using phosphorus-32 that we propose, radioactive waste would not be generated since it would take place directly as sealed source, for reaction (n, {beta}). (author)

  2. Doses of radiation in the environment of patients undergoing treatment of ophthalmic brachytherapy; Dosis de radiaciones en el entorno de pacientes sometidos a tratamientos de braquiterapia oftalmica

    Energy Technology Data Exchange (ETDEWEB)

    Terron Leon, J. A.; Moreno Reyes, J. C.; Perales Molina, A.; Miras, H.; Ortiz, M.; Macias, J.

    2013-07-01

    This paper presents results for measures of dose made to different patient undergoing treatment with ophthalmic brachytherapy. The aim of these measures has been, on the one hand, verify assessments relating to radiation protection in the memory of the installation and, on the other hand, experimental measures that can serve to reduce the perception of the radiological risk professionals have. (Author)

  3. Disfunção sexual em pacientes com câncer do colo uterino avançado submetidas à radioterapia exclusiva Sexual dysfunction in patients with advanced cervical cancer submitted to exclusive radiotherapy

    Directory of Open Access Journals (Sweden)

    Bebiana Calisto Bernardo

    2007-02-01

    Full Text Available OBJETIVO: identificar disfunções sexuais em pacientes com câncer de colo uterino submetidas à radioterapia exclusiva pela técnica de braquiterapia de alta taxa de dose. MÉTODOS: foi realizado um estudo descritivo do tipo corte transversal no período de janeiro a junho de 2004. O estudo envolveu 71 pacientes selecionadas de acordo o perfil estabelecido e que vinham sendo seguidas no ambulatório de pélvis do Hospital do Câncer de Pernambuco. Os dados foram coletados a partir de um questionário estruturado, complementado por um exame ginecológico visando investigar queixas de disfunção sexual após a radioterapia. Foi utilizado o programa estatístico Epi-Info 6.04 para processamento e análise dos dados. A análise descritiva foi feita pela média, mediana, valores máximo e mínimo. Para análise bivariada foram realizados os testes de homogeneidade marginal e McNemar, considerando um nível de significância de 5%. RESULTADOS: das complicações ginecológicas identificadas, destacam-se fibrose, estenose e atrofia vaginais (98,6, 76,1 e 71,8% dos casos, respectivamente. As disfunções sexuais identificadas foram: frigidez e falta de lubrificação, de excitação e de orgasmo, que ocorreram em 76,1% dos casos, falta de libido em 40,8% e vaginismo em 5,6% dos casos. CONCLUSÕES: as disfunções sexuais são freqüentes em pacientes com câncer do colo uterino avançado tratadas com radioterapia exclusiva utilizando o protocolo de braquiterapia de alta taxa de dose. Atenção específica deve ser dada à anamnese sexual e ao exame ginecológico durante o acompanhamento destas pacientes.PURPOSE: to identify sexual dysfunctions in patients with cancer of the uterine cervix submitted to exclusive radiotherapy, using the high dose rate (HDR brachytherapy technique. METHODS: a descriptive transversal study from January to June of 2004. The study involved 71 selected patients who had been followed in the pelvis outpatient clinic from the

  4. Etienne Vernaz's application file for the HDR (accreditation to supervise research) diploma

    International Nuclear Information System (INIS)

    This document contains the curriculum vitae of the candidate who is a researcher for the CEA (he heads the Laboratory for investigation of material alterability), and then a presentation of his personal and professional approach to scientific research and the main topics he has studied which mainly deal with the alteration of vitreous materials in storing conditions: structure and characterization, thermal and mechanical properties, irradiation effects, aqueous corrosion mechanisms, interactions with other materials, and so on. The author also outlines his ability to supervise and lead researches, his interest in environment issues, and his works on the long term behaviour of irradiated glasses and fuels. A list of publication is provides as well as several scientific articles

  5. MESURE VECTORIELLE DE CHAMP ÉLECTRIQUE DC-THZ PAR VOIE OPTIQUE (HDR)

    OpenAIRE

    Gaborit, Gwenaël

    2014-01-01

    From DC to THz Vectorial Electric Field measurement via Optical Probing: This work is focused on the non-invasive and ultra-wide band characterization of the electric-field, basedon the linear electro-optic (EO) effect. The analytical, numerical et experimental analyses of the EO crystals and relatedimplementations have led to the development of innovative pigtailed sensors. Thanks to their frequency response spreading over nine decades of frequency and to their measurement dynamics reaching ...

  6. Dose verification in HDR brachytherapy and IMRT with Fricke gel-layer dosimeters

    Energy Technology Data Exchange (ETDEWEB)

    Gambarini, G.; Negri, A.; Bartesaghi, G.; Pirola, L. [Department of Physics, Universita degli Studi di Milano, Italy (Italy); Carrara, M.; Gambini, I.; Tomatis, S.; Fallai, C.; Zonca, G. [Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy (Italy); Stokucova, J. [Faculty Hospital Na Bulovce, Prague, Czech Republic (Czech Republic)

    2009-10-15

    At the Department of Physics of the Universita degli Studi di Milano in collaboration with the Medical Physics Unit and the Radiotherapy Unit of the Fondazione IRCCS Istituto Nazionale dei Tumori di Milano the research of a dosimetric technique based on Fricke gel layers and optical analysis in under study. In fact, Fricke gel layer dosimeters (FGLD) have various advantages such as the tissue-equivalence for photons in the clinical energy interval, the possibility to obtain the spatial information about continuous dose distribution and not only a point dose distribution as it is for example in the case of ionization chambers, TLD or diodes and the possibility to obtain the information about 3D dose distributions. In this work, specific applications of FGLD to absolute dosimetry in radiotherapy have been studied, i.e. in-phantom measurements of complex intensity modulated radiation therapy fields (IMRT) and complex brachytherapy fields. (Author)

  7. On source models for (192)Ir HDR brachytherapy dosimetry using model based algorithms.

    Science.gov (United States)

    Pantelis, Evaggelos; Zourari, Kyveli; Zoros, Emmanouil; Lahanas, Vasileios; Karaiskos, Pantelis; Papagiannis, Panagiotis

    2016-06-01

    A source model is a prerequisite of all model based dose calculation algorithms. Besides direct simulation, the use of pre-calculated phase space files (phsp source models) and parameterized phsp source models has been proposed for Monte Carlo (MC) to promote efficiency and ease of implementation in obtaining photon energy, position and direction. In this work, a phsp file for a generic (192)Ir source design (Ballester et al 2015) is obtained from MC simulation. This is used to configure a parameterized phsp source model comprising appropriate probability density functions (PDFs) and a sampling procedure. According to phsp data analysis 15.6% of the generated photons are absorbed within the source, and 90.4% of the emergent photons are primary. The PDFs for sampling photon energy and direction relative to the source long axis, depend on the position of photon emergence. Photons emerge mainly from the cylindrical source surface with a constant probability over  ±0.1 cm from the center of the 0.35 cm long source core, and only 1.7% and 0.2% emerge from the source tip and drive wire, respectively. Based on these findings, an analytical parameterized source model is prepared for the calculation of the PDFs from data of source geometry and materials, without the need for a phsp file. The PDFs from the analytical parameterized source model are in close agreement with those employed in the parameterized phsp source model. This agreement prompted the proposal of a purely analytical source model based on isotropic emission of photons generated homogeneously within the source core with energy sampled from the (192)Ir spectrum, and the assignment of a weight according to attenuation within the source. Comparison of single source dosimetry data obtained from detailed MC simulation and the proposed analytical source model show agreement better than 2% except for points lying close to the source longitudinal axis. PMID:27191179

  8. A method of quality audit for treatment planning system for intracavitary HDR brachytherapy

    International Nuclear Information System (INIS)

    High dose rate brachytherapy is a multipurpose modality. Quality audit (QAu) is an independent examination and evaluation of quality assurance activities and results of an institution. Both clinical and physical aspects of patient treatments must be subjected to careful control and planning to achieve a high degree of accuracy in radiation therapy treatments. Comprehensive quality assurance (QA) programmes should be established to cover all steps from dose prescription to dose delivery. These programmes should include detailed internal checks performed by the radiotherapy centres and external audits made by independent bodies. A systematic and independent examination and evaluation to determine whether quality activities and results comply with planned arrangements and whether the arrangements are implemented effectively and are suitable to achieve objectives is called quality audit. One purpose of a quality audit (QAu) is to evaluate the need for improvement or corrective action

  9. Long-time water level observations at the HDR-testsite Soultz-sous-Forets

    Energy Technology Data Exchange (ETDEWEB)

    Dornstaedter, J.; Heinemann-Glutsch, B.; Zaske, J. [GTC-Kappelmeyer GmbH, Karlsruhe (Germany)

    1997-12-01

    Pressure or water level measurements have been performed by GTC in different wells at the geothermal testsite Soultz-sous-Forets for six years now. The water lever variations are mainly influenced by earth tides, barometric pressure variations, hydraulic testing and stimulation. The small scale variations are influenced by tidal and barometric forcing functions, the large scale variations by hydraulic testing and stimulation. By analyzing such measurements it is possible to get important information about the hydrualic connections between the boreholes, as well as aquifer parameters. (orig./AKF)

  10. Snapback testing of the HDR reactor pressure vessel and a primary steam pipe under operating conditions

    International Nuclear Information System (INIS)

    A remotely operated snapback excitation system was used for vibration tests under different operating conditions (temperature 20-2850C, internal pressure 0-70 bar). The measured acceleration-, displacement- and strain time histories were analyzed to identify the influence of temperature and internal pressure on the vibration behavior of a real system in its real environment. Additionally, the measurement results were compared with results of pretest calculations of the test load cases. (orig./HP)

  11. Upgrade of main separation planes (HDR) of steam generator primary and secondary headers and side manholes

    International Nuclear Information System (INIS)

    Repairs performed during the Bohunice V-1 reactor and Bohunice V-2 reactor operation are briefly described. Grooves were repaired in all headers in turn. Crack indications were found in the border area between the austenitic weld deposit and the basic material, and the sealing surfaces of primary header covers were repaired by local grinding-out and welding. Special devices and technologies were developed for this purpose. An upgrade of the main separation planes was elaborated in order to replace nickel seals with graphite-based seals. The upgrade technology has already been applied to 2 pieces of primary header covers, the other upgrade technologies will be applied starting from 1999. (M.D.)

  12. The drama of illumination: artist's approaches to the creation of HDR in paintings and prints

    Science.gov (United States)

    Parraman, Carinna

    2010-02-01

    For many centuries artists have considered and depicted illumination in art, from the effect of sunlight on objects at different times of the day, of shadows and highlights as cast by the moon, through indirect light as that through an open window or the artificial light of the candle or firelight. The presentation will consider artists who were fascinated by the phenomena of natural and artificial illumination and how they were able to render the natural world as a form of dynamic range through pigment. Artists have been long aware of the psychological aspects of the juxtaposition of colour in exploiting the optical qualities and arranging visual effects in painting and prints. Artists in the 16th century were attempting to develop an extended dynamic range through multi-colour, wood-block printing. Artists working at the height of naturalist realism in the 17th through the 19th century were fascinated by the illusory nature of light on objects. The presentation will also consider the interpretation of dynamic range through the medium of mezzotint, possibly the most subtle of printing methods, which was used by printers to copy paintings, and to create highly original works of art containing a dynamic range of tones.

  13. On source models for 192Ir HDR brachytherapy dosimetry using model based algorithms

    Science.gov (United States)

    Pantelis, Evaggelos; Zourari, Kyveli; Zoros, Emmanouil; Lahanas, Vasileios; Karaiskos, Pantelis; Papagiannis, Panagiotis

    2016-06-01

    A source model is a prerequisite of all model based dose calculation algorithms. Besides direct simulation, the use of pre-calculated phase space files (phsp source models) and parameterized phsp source models has been proposed for Monte Carlo (MC) to promote efficiency and ease of implementation in obtaining photon energy, position and direction. In this work, a phsp file for a generic 192Ir source design (Ballester et al 2015) is obtained from MC simulation. This is used to configure a parameterized phsp source model comprising appropriate probability density functions (PDFs) and a sampling procedure. According to phsp data analysis 15.6% of the generated photons are absorbed within the source, and 90.4% of the emergent photons are primary. The PDFs for sampling photon energy and direction relative to the source long axis, depend on the position of photon emergence. Photons emerge mainly from the cylindrical source surface with a constant probability over  ±0.1 cm from the center of the 0.35 cm long source core, and only 1.7% and 0.2% emerge from the source tip and drive wire, respectively. Based on these findings, an analytical parameterized source model is prepared for the calculation of the PDFs from data of source geometry and materials, without the need for a phsp file. The PDFs from the analytical parameterized source model are in close agreement with those employed in the parameterized phsp source model. This agreement prompted the proposal of a purely analytical source model based on isotropic emission of photons generated homogeneously within the source core with energy sampled from the 192Ir spectrum, and the assignment of a weight according to attenuation within the source. Comparison of single source dosimetry data obtained from detailed MC simulation and the proposed analytical source model show agreement better than 2% except for points lying close to the source longitudinal axis.

  14. Stephane Gin's application file for the HDR (accreditation to supervise research) diploma

    International Nuclear Information System (INIS)

    This document contains a curriculum vitae of the candidate who is a researcher in the Marcoule CEA, and then a presentation of his personal and professional approach to scientific research and the main topic he has been studying, i.e. the long term behaviour of nuclear glasses. He indicates the numerous works performed in collaboration with other researchers, his supervision activities. He provides a list of his scientific publications, and three articles: Use of orthophosphate complexing agents to investigate mechanisms limiting the alteration kinetics of French SON 68 nuclear glass; Alteration kinetics of a simplified nuclear glass in an aqueous medium: effects of solution chemistry and of protective gel properties on diminishing the alteration rate; French SON 68 nuclear glass alteration mechanisms on contact with clay media

  15. Intermediate and high level earthquakes testing at the HDR - overview, objectives, results

    International Nuclear Information System (INIS)

    The main objective of these earthquake investigations is the verification of calculation methods relating to structure dynamics which are used for the seismic design of nuclear power plants. Structures analyzed by tests and precalculations were the reactor building, the reactor pressure vessel, two large-diameter piping systems and one of the flood water tanks. Excitation methods used were eccentric mass shakers, snapback devices, explosives and solid propellant rockets. Some of the tests involving excitation of the building by shakers and two of the blast tests were carried out with the reactor pressure vessel and the pipes under operating conditions. The precalculations using both linear and nonlinear methods were made by German industry groups, independent experts groups and international partners. Soil-structure interaction can be determined accurately by means of simplified methods using frequency dependent soil springs. The reduction in the eigenfrequencies of the building when the load was increased by a factor of 25 could be predicted. Comparison of the results obtained for the vibrational behaviour of the building show that a simplification to the rotationally symmetric shell model appears to be a reasonable compromise between simple beam models and sophisticated 3D-shell models. The strong decrease in eigenfrequencies observed in the experiments during the transition from empty to partly filled reactor pressure vessel, and the resultant change of the mode shapes was perfectly reflected if the virtual mass of water was introduced in the calculation. Damping values evaluated from the measurements demonstrate that for some structures damping can remain low, even at levels of response leading to local yielding, while for other structures damping was very high at a rather low level of response. It appears that the use of generalized damping values for the seismic analysis of mechanical and structural systems is not appropriate. (orig./HP)

  16. Determination of the dose around an ovoid for treatments in intracavitary brachytherapy Hdr

    International Nuclear Information System (INIS)

    On this work the results of the dosimetric measurements are presented around an ovoid of 2 cm diameter. The measurements were carried out using a water mannequin, an ovoid, a radiation gamma source of 192Ir and thermoluminescent dosemeters. The dosimetry was realized in the direction of the rectum and bladder. To know the effect of the shielding of the devices type Manchester in the dose, the thermoluminescent dosemeters were irradiated to a radiation gamma source of 192Ir contained in the Gamma med Plus equipment. The planning was realized normalizing the calculation to 2.5 cm from the applicator center on the transverse plane (2.5, 0, 0). The results show that the dose distribution for an ovoid without shielding is more uniform in the transversal plane to the source axis. The results were compared with the calculated results by means of the planning system BrachyVision. While the absorbed dose distribution around an ovoid with shielding is completely anisotropic. This anisotropic is due to the shielding. (Author)

  17. Comparison of dosimetry methods to obtain rectum dosage in HDR-brachytherapy of cervix carcinoma

    International Nuclear Information System (INIS)

    In 75 applications the measured actual rectum dosage was analyzed retrospectively. Using graphic approximation methods in conjunction with the localization radiographs the expected dose values at 5 detector points of the intrarectal semiconductor dosimeter and at the ICRU rectal reference point were determined. Prospectively for 11 additional applications the expected dosage for various points within the rectum were computed during therapy planning and additionally for specific reference points corresponding to Fletcher's lymphatic trapezoid and Chassagne's pelvic wall points. The retrospective evaluation showed that 95% of values determined by graphic approximation methods varied by as much as ±30% from measured values. Factors causing errors were incorrect assessment of the applicator's spatial positioning, non-orthogonal radiographs, incorrect calibration of the semiconductor probe, movement of applicator and/or probe in the time between radiograph and application. In the prospective group 95% of deviations between measured and calculated values lay within an interval of ±40%. Possible sources of error could be similar to those in using the graphic approximation, although the reconstruction of spatial positioning of the applicator is possibly more exact. Doses determined at the ICRU rectal reference point were 5.6±2.5 Gy in the retrospective analysis and 6.1±1.6 Gy in the prospective study. The standard deviation of measured values at the specific reference points was ±30%. The mean dosage distribution was nearly symmetrical with regard to the body axis. Reasons for the relatively large standard deviation are e.g. difficulties in defining the reference points as well as in identifying them on the radiographs, also differences in applicator positioning. The retrospective analysis led to a larger error than the prospective one. The graphic approximation method should only be utilized when computer-assisted treatment planning is not possible. Conspicuous are the differences between values obtained in computer planning and actual measured values. As these deviations cannot always be explained unequivocally, both computation and measurement should always be conducted in order to obtain an adequate survey of dosage distribution within the rectum. Computer planning offers the additional advantage of determining the dose at various other reference points. (orig./MG)

  18. HDR brachytherapy. An option for preventing nonmalignant obstruction in patients after lung transplantation

    International Nuclear Information System (INIS)

    Purpose: Interventional bronchoscopy is the main treatment modality in managing benign airway obstructions following lung transplantation. We analyzed the effect of intraluminal brachytherapy on preventing recurrence of hyperplastic tissue. Patients and methods: From September 2002 to September 2004, a total of 24 intraluminal brachytherapy applications were carried out on 12 lung transplant patients in 15 different locations. A single dose of 3 Gy was calculated at a 5-mm distance from the catheter surface; the target volume included a stenosis plus safety interval of 0.5-1.0 cm. Results: All patients had a mean 10.6 local interventions (Argon plasma coagulation, balloon dilatations, stenting) over 4.4 months before the first application of endobronchial brachytherapy, with a mean amount of 2.4 applications per month. The mean forced expiratory volume in 1 s (FEV1) was 2,219 ml in the 3 months before application of brachytherapy. After endobronchial brachytherapy, all patients experienced improvement in clinical status and respiratory function. The mean level of FEV1 in the 3 months after application was 2,435 ml (p = 0.02), and the number of invasive interventions dropped to a mean rate of 5.2 interventions in the 5.1 months after the first intervention, with an amount of 1 application per month. No treatment-related complications were seen. Four patients were treated twice, 1 patient three times, and 1 patient four times at the same localization. Conclusions: Recurrent symptomatic benign airway obstruction from hyperplastic tissue in the bronchus after lung transplantation can be successfully treated with intraluminal high-dose-rate brachytherapy with a dose of 3 Gy at a 5-mm distance from the catheter surface and a longitudinal safety margin of 1 cm. (orig.)

  19. HDR brachytherapy. An option for preventing nonmalignant obstruction in patients after lung transplantation

    Energy Technology Data Exchange (ETDEWEB)

    Meyer, A.; Karstens, J.H.; Christiansen, H. [Medical School Hannover (Germany). Dept. of Radiation Oncology; Warszawski-Baumann, A.; Baumann, R. [Medical School Hannover (Germany). Dept. of Radiation Oncology; Medical Practice for Radiotherapy and Radiation Oncology, Hannover (Germany); Gottlieb, J.; Welte, T. [Medical School Hannover (Germany). Dept. of Respiratory Medicine

    2012-12-15

    Purpose: Interventional bronchoscopy is the main treatment modality in managing benign airway obstructions following lung transplantation. We analyzed the effect of intraluminal brachytherapy on preventing recurrence of hyperplastic tissue. Patients and methods: From September 2002 to September 2004, a total of 24 intraluminal brachytherapy applications were carried out on 12 lung transplant patients in 15 different locations. A single dose of 3 Gy was calculated at a 5-mm distance from the catheter surface; the target volume included a stenosis plus safety interval of 0.5-1.0 cm. Results: All patients had a mean 10.6 local interventions (Argon plasma coagulation, balloon dilatations, stenting) over 4.4 months before the first application of endobronchial brachytherapy, with a mean amount of 2.4 applications per month. The mean forced expiratory volume in 1 s (FEV1) was 2,219 ml in the 3 months before application of brachytherapy. After endobronchial brachytherapy, all patients experienced improvement in clinical status and respiratory function. The mean level of FEV1 in the 3 months after application was 2,435 ml (p = 0.02), and the number of invasive interventions dropped to a mean rate of 5.2 interventions in the 5.1 months after the first intervention, with an amount of 1 application per month. No treatment-related complications were seen. Four patients were treated twice, 1 patient three times, and 1 patient four times at the same localization. Conclusions: Recurrent symptomatic benign airway obstruction from hyperplastic tissue in the bronchus after lung transplantation can be successfully treated with intraluminal high-dose-rate brachytherapy with a dose of 3 Gy at a 5-mm distance from the catheter surface and a longitudinal safety margin of 1 cm. (orig.)

  20. Near-catheter dosimetry of a HDR brachytherapy source using Gafchromic film

    International Nuclear Information System (INIS)

    High dose rate intraluminal brachytherapy treatments can be delivered using as few as one or two afterloading catheters, delivering doses of up to 10 Gy at 10 mm, leading to high dose gradients and extreme hot spots close to the catheter. These conditions have the potential to damage the patient's health tissues, possibly leading to necrosis, or even death from uncontrolled bleeding. Ionisation chambers and solid state detectors are limited in their usefulness for near-catheter dosimetry because of their physical size and in some cases energy and dose rate dependence. In contrast, radiochromic film has a large dose–response range, excellent spatial resolution, near-energy independence for megavoltage photons and the ability to measure dose in two dimensions, making it ideal for this application. The aim of this study was to measure the location and relative magnitude of any dosimetric hot spots produced by a typical endobronchial treatment plan. The study also investigated the effect of the step size of the 192Ir source on both the dose hot spots and dose distribution. Our measurements show that for a typical single catheter treatment with 2.5 mm step size the maximum dose hot spots at the catheter surface are up to 37 times the prescription dose, up to 40 times for a 5 mm step size, and up to 46 times for a 10 mm step size. It is important that brachytherapy clinicians and physicists understand that hot spot magnitude increases with source step sizes and are aware of the risks associated with this form of brachytherapy treatment.

  1. Dose verification in HDR brachytherapy and IMRT with Fricke gel-layer dosimeters

    International Nuclear Information System (INIS)

    At the Department of Physics of the Universita degli Studi di Milano in collaboration with the Medical Physics Unit and the Radiotherapy Unit of the Fondazione IRCCS Istituto Nazionale dei Tumori di Milano the research of a dosimetric technique based on Fricke gel layers and optical analysis in under study. In fact, Fricke gel layer dosimeters (FGLD) have various advantages such as the tissue-equivalence for photons in the clinical energy interval, the possibility to obtain the spatial information about continuous dose distribution and not only a point dose distribution as it is for example in the case of ionization chambers, TLD or diodes and the possibility to obtain the information about 3D dose distributions. In this work, specific applications of FGLD to absolute dosimetry in radiotherapy have been studied, i.e. in-phantom measurements of complex intensity modulated radiation therapy fields (IMRT) and complex brachytherapy fields. (Author)

  2. Simulation of atmosphere stratification in the HDR test facility with the CONTAIN code

    International Nuclear Information System (INIS)

    The test E11.2 'Hydrogen distribution in loop flow geometry', which was performed in the Heissdampf Reaktor containment test facility in Germany, was simulated with the CONTAIN computer code. The predicted pressure history and thermal stratification are in relatively good agreement with the measurements. The compositional stratification within the containment was qualitatively well predicted, although the degree of the stratification in the dome area was slightly underestimated. The analysis of simulation results enabled a better understanding of the physical phenomena during the test.(author)

  3. Study for HDR cross-link for formation flight satellite systems

    Science.gov (United States)

    Nishinaga, Nozomu; Takayama, Yoshihisa; Takahashi, Takashi; Ogawa, Yasuo; Kubooka, Toshihiro; Umehara, Hiroaki

    2003-07-01

    In this paper we studied about optical and millimeter radio wave cross-link for formation flight communication satellite system in a geostationary orbit. In formation flight system, since the distance among the satellites becomes short compared with the conventional inter satellite comunication link, the size and the weight of the communication system can be reduced. If the high data rate cross-link among the satellites which is equal to the whole transponder bandwidth can be established, the functionally distributed communications satellite system can be constructed. Then, by exchanging a part of the satellite system without the physical contact, in other words, by exchange some old satellites and new ones, the fully reconfigurable and long lifetime (from the point of the function) satellite communication system which can follow the paradigm shift in the terrestrial communications technology can be realize. On the other hand, however, since the maximum of relative angle error among two satellites is enlarged, the tracking becomes difficult. In this study, it turns the electric power which is gotten from the shortening the distance to making beam width large. Here, we examine communication among two satellites (10Km distance) where the data rate is 1Gbps.

  4. Une carte de saillance adaptée aux images HDR

    OpenAIRE

    Petit, Josselin; BREMOND, Roland; TAREL, Jean Philippe

    2008-01-01

    A ce jour, l'évaluation de la qualité des algorithmes de reproduction de tons (tone mapping operators, ou TMO) n'a été faite que pour des situations statiques, alors que l'essentiel des applications des images de synthèse (vidéo, télévision, cinéma, jeux vidéos) proposent des images dynamiques. Nous pensons que le problème de l'évaluation dynamique des TMO peut être résolu si l'on dispose d'un modèle capable de prédire l'orientation du regard dans des images dynamiques, qui conduirait à une m...

  5. Does Measurement of Esophagogastric Junction Distensibility by EndoFLIP Predict Therapy-responsiveness to Endoluminal Fundoplication in Patients With Gastroesophageal Reflux Disease?

    OpenAIRE

    Smeets, Fabiënne G M; Keszthelyi, Daniel; Bouvy, Nicole D.; Ad A. M. Masclee; Conchillo, José M

    2015-01-01

    Background/Aims In patients with gastroesophageal reflux disease (GERD), an increased esophagogastric junction (EGJ) distensibility has been described. Assessment of EGJ distensibility with the endoscopic functional luminal imaging probe (EndoFLIP) technique might identify patients responsive to transoral incisionless fundoplication (TIF), whereas postoperative measurement of EGJ distensibility might provide insight into the antireflux mechanism of TIF. Therefore, we investigated the value of...

  6. Conversion électro-optique du signal et découplage actif d'un capteur IRM endoluminal à liaison optique

    OpenAIRE

    Saniour, Isabelle; Aydé, Reina; Perrier, Anne-Laure; Gaborit, Gwenaël; Duvillaret, Lionel; Dahdah, Jean; Sablong, Raphaël; Beuf, Olivier

    2015-01-01

    International audience Une boucle endoluminale radiofréquence (RF) située à proximité de la zone à examiner permet d'avoir localement un rapport signal sur bruit élevé qui peut être mis à profit pour augmenter la résolution spatiale des images de RM. Ce type de capteur permet en particulier d'analyser la paroi de l'intestin qui permettrait d'améliorer le bilan d'extension tumorale [1]. Malheureusement, les câbles coaxiaux, couramment utilisés pour transmettre le signal RMN et le courant né...

  7. High-dose intracoronary irradiation after De Novo stent implantation. Results of the EVEREST (evaluation of Endoluminal Radiation in Elective Stenting) trial

    International Nuclear Information System (INIS)

    Purpose: This randomized study was designed to compare the efficacy of high-dose coronary β-radiation after intravascular ultrasound-(IVUS)guided direct stenting with sham treatment in patients with de novo lesions. Patients and Methods: 32 patients were enrolled in the study protocol. Following angioplasty procedure, intracoronary brachytherapy was performed with the Novoste trademark Beta-Cath System. The prescribed dose was 24 Gy referred to the lamina elastica externa. Quantitative coronary angiography and IVUS were performed to analyze the treated coronary vessel. Results: Angiographic results revealed a significantly smaller minimal lumen diameter compared with the postprocedural minimal lumen diameter within the stented segment (p=0.004) in the nonirradiated group. The same significant result was observed in the injured segment of the nonirradiated patients (p=0.011). The IVUS data revealed a significant increase of the plaque volume after 8 months in the nonirradiated group compared to the postprocedural value (irradiated 5.41±8.83 mm3 vs. nonirradiated 21.11±16.08 mm3; p=0.001). Late luminal loss was significantly greater in the nonirradiated group (p=0.004). The primary clinical endpoint (death, myocardial infarction, repeat target lesion revascularization, percutaneous revascularization, coronary artery bypass surgery) was reached by seven irradiated (33.3%) and four (18.2%) nonirradiated patients (p=0.623). Late stent thrombosis was observed in one irradiated patient. Conclusion: The EVEREST trial has demonstrated the feasibility of high-dose intracoronary brachytherapy in de novo coronary lesions. There is a significant reduction of neointimal proliferation within the stented segment. Nevertheless, this benefit is vitiated by an increase of restenotic lesions outside the stent segment. (orig.)

  8. European geothermal research program - Pechelbronn - Soultz sous Forets. Cost-benefit model for the HDR process. Europaeisches Erdwaermeprojekt Pechelbronn - Soultz sous Forets. Kosten-Nutzen-Modell fuer das HDR-Verfahren

    Energy Technology Data Exchange (ETDEWEB)

    Milles, U. (comp.)

    1991-04-01

    Within the framework of several european geothermal research projects a cost-benefit-model for geothermal heat and electric power generation has been worked out. The analysis bases on the computer program HRD-Economic-Cost-Evaluation-Program (HDREC), which is able to quantify thermal conductivity of geothermal reservoirs and operation cost of the equipment in dependence of a life service of 25-30 years. For six possible sites is shown, that in dependence of geological facts the cost of electric power generation have a optimal depth and circulation rate. (BWI).

  9. Dosimetric evaluation of a combination of brachytherapy applicators for uterine cervix cancer with involvement of the distal vagina; Avaliacao dosimetrica de uma combinacao de aplicadores para braquiterapia de tumores do colo uterino com acometimento da porcao distal da vagina

    Energy Technology Data Exchange (ETDEWEB)

    Guimaraes, Roger Guilherme Rodrigues [Real e Benemerita Sociedade Portuguesa de Beneficencia, Sao Paulo, SP (Brazil). Servico de Radioterapia Estereotactica; Carvalho, Heloisa de Andrade; Stuart, Silvia Radwanski; Rubo, Rodrigo Augusto [Universidade de Sao Paulo (USP), SP (Brazil). Hospital das Clinicas. Servico de Radioterapia], e-mail: handrade@hcnet.usp.br; Seraide, Rodrigo Migotto [Centro de Oncologia Campinas, SP (Brazil)

    2009-07-15

    Objective: To evaluate an alternative brachytherapy technique for uterine cervix cancer involving the distal vagina, without increasing the risk of toxicity. Materials And Methods: Theoretical study comparing three different high-dose rate intracavitary brachytherapy applicators: intrauterine tandem and vaginal cylinder (TC); tandem/ring applicator combined with vaginal cylinder (TR+C); and a virtual applicator combining both the tandem/ring and vaginal cylinder in a single device (TRC). Prescribed doses were 7 Gy at point A, and 5 Gy on the surface or at a 5 mm depth of the vaginal mucosa. Doses delivered to the rectum, bladder and sigmoid colon were kept below the tolerance limits. Volumes covered by the isodoses, respectively, 50% (V50), 100% (V100), 150% (V150) and 200% (V200) were compared. Results: Both the combined TR+C and TRC presented a better dose distribution as compared with the TC applicator. The TR+C dose distribution was similar to the TRC dose, with V150 and V200 being about 50% higher for TR+C (within the cylinder). Conclusion: Combined TR+C in a two-time single application may represent an alternative therapy technique for patients affected by uterine cervix cancer involving the distal vagina. (author)

  10. Staff dose of hospitalization in the treatment of patients in ophthalmic brachytherapy with 125 I; Dosis al personal de hospitalizacion en el tratamiento de pacientes de braquiterapia oftalmica con I-125

    Energy Technology Data Exchange (ETDEWEB)

    Terron Leon, J. A.; Gomez Palacios, M.; Moreno Reyes, J. C.; Perales Molina, A.

    2013-07-01

    The objective of this work, therefore, has been the evaluation of the dose levels which nursing staff can receive in care for ophthalmic brachytherapy patients treated with 125 I from measurements made on the same, evaluating, in an experimental way, job security following the PR rules laid down for these treatments. (Author)

  11. Study and development of methodology for radioactive iodine fixation in polymeric substrate for manufacturing sources used in brachytherapy; Estudo e desenvolvimento de metodologia para fixacao de iodo radioativo em substrato polimerico para confeccao de fontes utilizadas em braquiterapia

    Energy Technology Data Exchange (ETDEWEB)

    Rodrigues, Bruna T.; Souza, Carla D.; Benega, Marcos A.G. and others, E-mail: bteigarodrigues@gmail.com, E-mail: carladdsouza@yahoo.com.br, E-mail: marcosagbenega@gmail.com [Instituto de Pesquisas Energeticas e Nucleares (IPEN/CNEN-SP), Sao Paulo, SP (Brazil). Centro de Tecnologia das Radiacoes

    2014-07-01

    According global estimates of Globocan 2012 project of the International Agency for Research of Cancer, of the World Health Organization, there were 14,1 million new cases of cancer and a total of 8,2 million deaths from cancer. Also show that in 2030, the overall load will be 21,4 million new cases and 13,2 million cancer deaths. One of the prostate cancer therapy is brachytherapy, used in early and middle stages of the disease. It is made with the introduction of seeds with radioactive material within the tumor or in nearby regions, affecting the minimum surrounding tissues. The aim of this work is the study and developing the deposition of radioactive iodine on the polymeric substrate method, and an analysis relating the efficiency of the method to implementation in the laboratory of brachytherapy from IPEN. Iodine-125 is adsorbed on an epoxy resin solution. The objective of this study is to offer a new proposal for seeds. The results will give the data for the radiation protection and the procedures for radioactive waste management.

  12. Brachytherapy with Iodine-125 seeds in initial prostate cancer treatment: preliminary results and complications; Braquiterapia com sementes de Iodo-125 no tratamento do cancer inicial de prostata: resultados e complicacoes preliminares

    Energy Technology Data Exchange (ETDEWEB)

    Penna, Antonio Belmiro R. Campbell [Universidade Federal, Rio de Janeiro, RJ (Brazil). Faculdade de Medicina. Programa de Pos-graduacao em Radiologia]. E-mail: info@radiobot.com.br; Bernabe, Antonio Jose S. [Sociedade Brasileira de Urologia, Rio de Janeiro, RJ (Brazil); Marchiori, Edson [Universidade Federal Fluminense, Niteroi, RJ (Brazil). Dept. de Radiologia

    2005-07-01

    Low-dose rate brachytherapy as monotherapy is a treatment option for early stage prostate cancer. It consists of the permanent implantation of Iodine-125 seeds in the gland of patients with PSA{<=} 10ng/ml, Gleason {<=} 6 and clinical stage from T1 until T2b. The 68 patients enrolled in this study were treated by the technique developed at the Northwest Pacific Hospital, Seattle, USA. Sixty four patients treated with low-dose rate brachytherapy were followed for 4-48 months (median = 32 months). The treatment results were based on the periodic evaluation of the total PSA values and it was found that, after this time, 55% of patients had total PSA equal or below 1ng/ml. Post-implant morbidities were evaluated, showing that 89% presented negligible or low grade side effects. Low-dose rate brachytherapy is an appealing option for the treatment of early stage prostate cancer because of its successful local control and low morbidity. (author)

  13. Preparation of a program for the independent verification of the brachytherapy planning systems calculations; Confeccion de un programa para la verificacion independiente de los calculos de los sistemas de planificacion en braquiterapia

    Energy Technology Data Exchange (ETDEWEB)

    V Carmona, V.; Perez-Calatayud, J.; Lliso, F.; Richart Sancho, J.; Ballester, F.; Pujades-Claumarchirant, M.C.; Munoz, M.

    2010-07-01

    In this work a program is presented that independently checks for each patient the treatment planning system calculations in low dose rate, high dose rate and pulsed dose rate brachytherapy. The treatment planning system output text files are automatically loaded in this program in order to get the source coordinates, the desired calculation point coordinates and the dwell times when it is the case. The source strength and the reference dates are introduced by the user. The program allows implementing the recommendations about independent verification of the clinical brachytherapy dosimetry in a simple and accurate way, in few minutes. (Author).

  14. Calibration of a {sup 19} {sup 2}Ir source for high dose brachytherapy using various techniques; Calibracion de una fuente de {sup 192} Ir para braquiterapia de alta tasa de dosis mediante diversas tecnicas

    Energy Technology Data Exchange (ETDEWEB)

    Montilla Prieto, Tedicel C., E-mail: tcdicel@gmaiLcam [Instituto de Oncologia Dr. Miguel Perez Carreno, Barbula (Venezuela, Bolivarian Republic of). Departamento de Fisica y Dosimetria; Padron Rivero, Alvaro D., E-mail: alvarodpadronr@yahoo.com.ve [Universidad de Carabobo, Barbula (Venezuela, Bolivarian Republic of). Facultad de Ciencias de la Salud. Departamento de Ciencias Fisiologicas

    2013-10-01

    In this research we studied three experimental procedures for calibration of a source of {sup 192}Ir to high dose rate for clinical brachytherapy use, and thus were compared and analysis of the advantages and disadvantages of each. For this study we quantified the value of the current kerma rate reference in air by three procedures: source calibration using a well chamber, with an cylindrical ionization chamber in air, and a cylindrical ionization chamber on a phantom, and this magnitude was compared with the value provided by the manufacturer of the source and thereby obtaining the deviation corresponding . Thus, it was found that the deviation corresponding to the source calibration making use of a well chamber, remained within tolerance, while the cylindrical ionization chamber in air and on phantom exceeded the standards established in some documents. However, although both the measurement in air and in the phantom are the procedures for the final calibration source, these can be used to verify that the delivered dose are in tolerance.

  15. Verification of the calculation program for brachytherapy planning system of high dose rate (PLATO); Programa de verificacion del calculo para un sistema de planificacion de braquiterapia de alta tasa de dosis (PLATO)

    Energy Technology Data Exchange (ETDEWEB)

    Almansa, J.; Alaman, C.; Perez-Alija, J.; Herrero, C.; Real, R. del; Ososrio, J. L.

    2011-07-01

    In our treatments are performed brachytherapy high dose rate since 2007. The procedures performed include gynecological intracavitary treatment and interstitial. The treatments are performed with a source of Ir-192 activity between 5 and 10 Ci such that small variations in treatment times can cause damage to the patient. In addition the Royal Decree 1566/1998 on Quality Criteria in radiotherapy establishes the need to verify the monitor units or treatment time in radiotherapy and brachytherapy. All this justifies the existence of a redundant system for brachytherapy dose calculation that can reveal any abnormality is present.

  16. Comparative analysis of 2D and 3D dosimetry with brachytherapy high dose rate cervix carcinoma un operated; Analisis comparativo de dosimetria 2D y 3D con braquiterapia de alta tasa de dosis

    Energy Technology Data Exchange (ETDEWEB)

    Garcia Castejon, M. A.; Penedo Cobos, J. M.; Rincon Perez, M.; Gomez Alonso, S.; Luna Tirado, J.; Perez Casas, A. M.

    2011-07-01

    It has recently been installed in our department based on an SPB CT images, and found that the dose at points H is less than that obtained by calculations based on radiographs. This study aims to analyze this discrepancy in the transition from 2D to 3D calculation in patients with carcinoma of the cervix not operated.

  17. Monte Carlo simulation of gynecologic brachytherapy treatment of high rate considering the heterogeneity; Simulacion Monte Carlo de un tratamiento de braquiterapia ginecologica de alta tasa teniendo en cuenta las heterogeneidades

    Energy Technology Data Exchange (ETDEWEB)

    Berenguer Serrano, R.; Rivera Jimenez, M.; Nunez Quintanilla, A. T.; Vara Olivas, V. de la; Gutierrez Perez, M.; Sabater Martin, S.

    2011-07-01

    The objective of this study was to compare the dosimetric distribution of gynecological brachytherapy treatment with high dose rate Ir-192 source as does a conventional planner versus dosimetric distribution obtained by Monte Carlo simulation taking into account (addition to the geometry of the source), gynecologic vaginal applicator (tube and vaginal cylinder or dome) and the anatomy of the patient. In particular we assessed the effect of the presence of iodinated contrast in the bladder of the patient.

  18. Evaluation of failure modes of computerized planning phase of interstitial implants with high dose rate brachytherapy using HFMEA; Avaliacao dos modos de falha do planejamento computadorizado em implantes intersticiais com braquiterapia de alta taxa de dose usando HFMEA

    Energy Technology Data Exchange (ETDEWEB)

    Biazotto, Bruna; Tokarski, Marcio, E-mail: bruna@ceb.unicamp.br [Universidade Estadual de Campinas (UNICAMP), SP (Brazil). Centro de Engenharia Biomedica

    2014-08-15

    This paper evaluates the failure modes of the computerized planning step in interstitial implants with high dose rate brachytherapy. The prospective tool of risk management Health Care Failure Mode and Effects Analysis (HFMEA) was used. Twelve subprocesses were identified, and 33 failure modes of which 21 justified new safety actions, and 9 of them were intolerable risks. The method proved itself useful in identifying failure modes, but laborious and subjective in their assessment. The main risks were due to human factors, which require training and commitment of management to their mitigation. (author)

  19. Measure of the uncertainty associated with the reconstruction of applicators in adaptive guided brachytherapy by resonance; Medida de la incertidumbre asociada a la reconstruccion de aplicadores en braquiterapia adaptativa guiada por resonancia

    Energy Technology Data Exchange (ETDEWEB)

    Torres Pozas, S.; Federico, M.; Perez Molina, J. L.; Marti Asenjo, J.; Sanchez Carrascal, M.; Macias verde, D.; Ruiz Egea, E.; Lara Jimenez, P.; Martin Oliva, R.

    2013-07-01

    The objective of this study is to assess the uncertainty introduced in the process to rebuild the catheters using three methods, manual reconstruction from a template elaborate service, auto-rebuild with the software included in the TPS and reconstruction from radiopaque mannequins in CT and subsequent merger. (Author)

  20. Analysis of the uncertainty of semiconductor diodes in dosimetry in vivo of brachytherapy treatments; Analisis de la incertidumbre de diodos semiconductores en dosimetria in vivo de tratamientos de braquiterapia

    Energy Technology Data Exchange (ETDEWEB)

    Sanchez, K.; Rodriguez, P.; Prieto, D.; Esteve, S.; Colmenares, R.; Bejar, M. J.; Ordonez, J.; Capuz, B.; Moris, R.

    2013-07-01

    Brachytherapy involves the administration of high doses in some parts of healthy tissue, especially in the organ at risk coming to the region of prescription, as it is the case of the rectum and bladder in various gynecological treatments. The possibility of trying to know the actual dose in vivo through the use of dosimeters of semiconductor diode could be. However, to know if you can have certainty in these measures it is necessary to establish the uncertainty previously. The objective of this work consists in estimating the intrinsic uncertainty of diodes and compare it with other dosimetry uncertainties such as the one given the displacement of these between the planning and administration of treatment. (Author)

  1. Volume study pre and post-implant brachytherapy prostate for establishment of PTV margins; Estudio de volumenes pre y post-implante en braquiterapia de prostata para establecimiento de margenes del PTV

    Energy Technology Data Exchange (ETDEWEB)

    Jimenez Dominguez, M.; Carrasco Herrera, M.; Baeza Trujillo, M.; Herrador Cordoba, M.

    2011-07-01

    Treatment of prostate cancer by permanent implantation of radioactive seeds is now a good alternative to radical surgery or radiotherapy, as it provides a good tumor control while the risk is reduced by a lower complication irradiation of adjacent healthy organs. The large volume change during seed implantation occurs in the prostate of the patient, makes it important to consider margins around the organs of interest both to ensure optimal coverage and minimal tumor irradiation of healthy tissue. Analyze how the volume varies during and after implantation and establish a margin around the prostate to the practice of our hospital are the two objectives of this work.

  2. Study and parameters survey for iodine-125 source dosimetry to be applied in brachytherapy; Estudo e levantamentos de parametros para dosimetria de fontes de iodo-125 aplicadas em braquiterapia

    Energy Technology Data Exchange (ETDEWEB)

    Moura, Eduardo Santana de

    2011-07-01

    The use of brachytherapy technique with iodine-125 seeds to prostate cancer treatment has been used for decades with good clinical outcomes. To aim the Brazilian population necessities, IPEN-CNEN/SP developed the iodine-125 seed prototype with national technology. The objectives of this work are the development and the study of dosimetric procedures associates with the experimental acquisition of the useful parameters for the iodine-125 dosimetric characterization and to evaluate if the developed procedures, in this work, have the basic conditions to determinate the dosimetric analysis, that are fundamental for clinical procedures. The dosimeters selected for the analysis are the TLD-100 (LiF:Mg,Ti), initially these dosimeters were submitted for two selection steps to choose the dosimeters more reproducible for the dosimetric analysis. The two steps were the selection by the mass of the dosimeters and the reproducibility after four irradiation series in a Cobalt-60 irradiator (CTR-IPEN). Afterwards these steps, the dosimeters were irradiated in linear accelerator with 6 MV energy (Service of Radiotherapy - Hospital Israelita Albert Einstein) to yield the individual calibration factors to each dosimeter. After, the dosimeters were used to the irradiations with iodine-125 seed, 6711 model, (GE-Healthcare). The irradiations and others analysis with iodine-125 seeds yield the useful values for the determination of the parameters suggested by the AAPM (American Association of Physicists in Medicine): constant of dose rate, geometry function, dose radial function and anisotropy function. The results showed good agreement with the values published by the literature, for the same iodine- 125 model, this fact confirms that the realized parameters will be able to be used for the IPEN-CNEN iodine-125 seeds dosimetry and quality control. (author)

  3. Preparation and determination of kerma for Iridium 192 sources of low dose rate for brachytherapy; Preparacion y determinacion del kerma de fuentes de iridio-192 de baja tasa de dosis para braquiterapia

    Energy Technology Data Exchange (ETDEWEB)

    Tendilla, J.I.; Tovar M, V.; Mitsoura, E.; Aguilar H, F.; Alanis M, J. [Instituto Nacional de Investigaciones Nucleares, C.P. 52045-1, Salazar, Esrado de Mexico, D.F. (Mexico)

    2000-07-01

    The practice of Brachytherapy with Iridium-192 sources of low dose rate (0.4 - 0.8 Gy/h) is a technique used in the treatment of diverse illnesses. in this work the preparation, quality control and calibration are presented in terms of kerma in air of Iridium-192 using as target these recycled Iridium-Platinum wires. The targets were obtained as decayed sources of different radio therapeutical centers in the country and they were characterized by Scanning electron microscopy in order to determine their chemical composition. Subsequently it was developed an experimental design to establish the effect of neutron flux, geometrical array and irradiation time over the activity and percentage of the sources homogeneity. The homogeneity was determined by auto radiography and by Gamma spectroscopy. Once the optimal irradiation conditions were established, it is determined the apparent activity and kerma in air using a well type ionization chamber with traceability to a primary laboratory. Iridium-192 sources were obtained with an average homogeneity 96 %, apparent activity 282.129 {+-} 0.531 M Bq and kerma in air 0.03200 {+-} 0.00006 m Gy m/h A. (Author)

  4. Study of the radiation levels in low dose rate brachytherapy zones of the National Institute of Neoplastic Illnesses; Estudio de los Niveles de Radiacion en Zonas de Braquiterapia de Baja Tasa de Dosis del Instituto Nacional de Enfermedades Neoplasicas

    Energy Technology Data Exchange (ETDEWEB)

    Figueroa J, N.; Mora Y, B. [Instituto Nacional de Enfermedades Neoplasicas, Lima (Peru)]. e-mail: navorf01@yahoo.es

    2006-07-01

    The present study has as objective to evaluate the radiation levels of the Brachytherapy work areas of low dose rate (Gammateque, nurses station and of hospitalization rooms of patients RIC of 4th, 5th Floor-East) and to estimate the effective dose of the occupationally exposed personnel and the public in general. The measurements of the dose rate in these areas, were registered with a radiations monitor Inspector trademark, during a period of 60 days, without altering the routinary work conditions. The more high levels of environmental dose equivalent rate registered in the different work areas its are of 1.41 and 47.78 {mu}Sv/h rooms 1 and 2 in the Gammateque environments, in the hospitalization rooms of the 4th and 5th floor in the point 1 are of 40.77 and 23.67, {mu}Sv/h respectively and in the point 2 are of 129.19 and 39.93, {mu}Sv/h respectively, and in the nurses station of the 4th and 5th floor its are respectively of 7.62 u Sv/h and 0.45 u Sv/h. According to the carried out measurements and the permanency in the work place is possible to estimate the effective dose involved to the occupationally exposed personnel. The personnel that works in Gammateque could be receiving respectively as maximum dose 0.61 mSv/month, and the personnel that works in the nurses station of 13.17 and 0.78 mSv/year in the 4th and 5th floor. These registered differences among the two floors are due to that the 5th floor counts with the shielding systems (screen) contrary to the 4th, another of the factors is the distribution form of the patient beds RIC. We should have present that the radiation levels although in some cases it is very high, however, they are below of the permissible limits according to standards, but it is still possible to reduce even more, the radiation levels in the critical points fulfilling with the ALARA principle. (Author)

  5. Development of an automation system for iodine-125 brachytherapy seed production by (Nd:YAG) laser welding; Automacao do processo de soldagem a laser (Nd:YAG) para confeccao das sementes de iodo-125 utilizadas em braquiterapia

    Energy Technology Data Exchange (ETDEWEB)

    Somessari, Samir Luiz

    2010-07-01

    The aim of this work is to develop an automation system for iodine-125 radioactive seed production by (Nd:YAG) laser welding, which has been used successfully in Low Dose Rate (LDR) brachytherapy treatment. This small seed consists of a welded titanium capsule, with 0.8mm in diameter and 4.5mm in length, containing iodine-125 adsorbed onto a silver rod. The iodine-125 seeds are implanted into the human prostate to irradiate the tumor for cancer treatment. Nowadays, the Radiation Technology Center, at IPEN-CNEN/SP imports and distributes 36,000 iodine-125 seeds per year, for the clinics and hospitals in the country. However, the Brazilian market potential is now over 8,000 iodine-125 seeds per month. The local production of these iodine-125 radioactive sources becomes a priority for the Institute, in order to reduce the price and the problems of prostate cancer management. It will permit to spread their use to a largest number of patients in Brazil. On the other hand, the industrial automation plays an important role for iodine-125 seeds in order to increase the productivity, with high quality and assurance, avoiding human factors, implementing and operating with Good Manufacturing Practices (GMP). The technology consists of appliance electronic and electro-mechanical parts and components to control machines and processes. The automation system technology for iodine-125 seed production developed in this work was mainly assembled employing Programmable Logic Controller (PLC), stepper motors, drivers, (Nd:YAG) laser welding machine, photoelectric sensors and supervisory. (author)

  6. Methodology, results and experience of independent brachytherapy plan verifications based on DICOM standard; Implementacion, resultados y experiencia de una verificacion independiente de tratamientos de braquiterapia basada en el estandar DICOM

    Energy Technology Data Exchange (ETDEWEB)

    Ferrando Sanchez, A.; Pardo Perez, E.; Castro Novals, J.; Casa de Julian, M. A. de la; Cabello Murillo, E.; Diaz Fuentes, R.; Molina Lopez, M. Y.

    2013-09-01

    The use of a high dose rate source together with an afterloading treatment delivery in brachytherapy plans allows for dose modulation minimizing dose to staff. An independent verification of the exported data to the treatment station is required by local regulations (being also a widely accepted recommendation on the international literature). We have developed a methodology under home brew code to import DICOM treatment data onto an Excel spreadsheet that is able to calculate dose on given reference points using the TG-43 formalism of the AAPM3-5. It employs analytic fits of anisotropy factor and radial dose function for different sources. The end point implementations we present here allow merging in one step an independent verification and a treatment printout. The use of DICOM standard makes our code versatile and provides greater compatibility with respect to current treatment planning systems. (Author)

  7. Dosimetric comparison between a planning system and Radiochromic-EBT2 films in surface brachytherapy treatments of high rate; Comparacion dosimetrica entre un sistema de planificacion y peliculas radiocromicas EBT2 en tratamientos de braquiterapia superficial de alta tasa

    Energy Technology Data Exchange (ETDEWEB)

    Gutierrez Ramos, S. M.; Carrasco Herrera, M. a.; Vicent, D.; Rodriguez, C.; Herrador, M.

    2013-07-01

    The objective of this work is to study a situation in which, the accuracy of the calculation of the planner may be limited, superficial brachytherapy treatment. It has relative to the dose obtained with the planner with that obtained with film radiochromic EBT2. (Author)

  8. Influence of modifications in the positioning of phantoms in the Monte Carlo computational simulation of the prostate brachytherapy; Influencia de alteracoes no posicionamento de fantomas nas simulacoes computacionais Monte Carlo de braquiterapia de prostata

    Energy Technology Data Exchange (ETDEWEB)

    Barbosa, Antonio Konrado de Santana; Vieira, Jose Wilson, E-mail: konrado.radiologia@gmail.co, E-mail: jose.wilson59@uol.com.b [Instituto Federal de Educacao, Ciencia e Tecnologia (IFPE), Recife, PE (Brazil); Costa, Kleber Souza Silva [Faculdade Integrada de Pernambuco (FACIPE), Recife, PE (Brazil); Lima, Fernando Roberto de Andrade, E-mail: falima@cnen.gov.b [Centro Regional de Ciencias Nucleares do Nordeste (CRCN-NE/CNEN-PE), Recife, PE (Brazil)

    2011-07-01

    Radiotherapy simulation procedures using Monte Carlo methods have shown to be increasingly important to the improvement of cancer fighting strategies. Within this context, brachytherapy is one of the most used methods to ensure better life quality when compared to other therapeutic modalities. These procedures are planned with the use of sectional exams with the patient in lying position. However, it is known that alteration of body posture after the procedure has an influence in the localization of many organs. This study had the aim to identify and to measure the influence of such alterations in MC brachytherapy simulations. In order to do so, prostate brachytherapy with the use of Iodine-125 radionuclide was chosen as model. Simulations were carried out with 108 events using EGSnrc code associated to MASH phantom in orthostatic and supine positions. Significant alterations were found, especially regarding bladder, small intestine and testicles. (author)

  9. Interstitial brachytherapy with 192-IR in treatment of recurrent malignant primary brain tumors. Braquiterapia intersticial con iridio-192 en el tratamiento de recidivas de tumores cerebrales tras cirugia y radioterapia

    Energy Technology Data Exchange (ETDEWEB)

    Cardenes, R.; Martinez, R.; Victoria, C.; Nuez, L.; Clavo, B.; Sancedo, G. (Clinica Puerta de Hierro. Madrid (Spain))

    1994-01-01

    Seven patients with recurrent malignant primary brain tumors after surgery and radiation therapy were treated at the Clinica Puerta de Hierro (Madrid) by interstitial brachytherapy with 192-Ir sources. Implantations were performed using computerized tomography and dose prescription were determined following the Paris system rules for interstitial implants. The means dose deliberated was 50 to 65 Gy to the reference isodoses. At the last follow-up all patients except for one are alive and without evidence of progression of the disease. (Author) 35 refs.

  10. Quality control of planning system of treatment for esophageal tumors with high dose rate brachytherapy; Controle de qualidade do sistema de planejamento de tratamento das neoplasias do esofago com braquiterapia de alta taxa de dose

    Energy Technology Data Exchange (ETDEWEB)

    Silva, Penha M.; Ferreira, Fernando J.; Guedes, Laura M.A.; Manso, Luiz A.P. [Instituto Nacional do Cancer, Rio de Janeiro, RJ (Brazil). Setor de Fisica Medica; Castro, Betina W. [Instituto Nacional do Cancer, Rio de Janeiro, RJ (Brazil). Servico de Radioterapia; Ferreira, Maria A. [Instituto Nacional do Cancer, Rio de Janeiro, RJ (Brazil). Servico de Endoscopia

    2001-07-01

    An equation to control the quality of treatment for oesophageal tumors with high dose rate brachytherapy was adopted by the section of physics of the Instituto Nacional de Cancer. It was tested in 394 insertions in 20 (5.1%) a difference greater than 3% was observed between the duration of treatment calculated by the software of the equipment and the duration calculated by the equation. The largest difference observed was 9% in one insertion. By correcting the position of the patient on the X-ray table it has been possible to diminish this difference. (author)

  11. Implementation of three-dimensional planning in brachytherapy of high dose rate for gynecology therapies; Implementacao de planejamento tridimensional em braquiterapia de alta taxa de dose para tratamentos ginecologicos

    Energy Technology Data Exchange (ETDEWEB)

    Sales, Camila Pessoa de

    2015-09-01

    This work aims to implement the three-dimensional (3D) planning for gynecological brachytherapy treatments. For this purpose, tests of acceptance and commissioning of brachytherapy equipment were performed to establish a quality and periodic assurance program. For this purpose, an important step was searching for a material to be used as a dummy source, since the applicators do not have any specific dummy. In addition, the validation of the use of applicators library was made for reconstruction in computed tomography (CT) and magnetic resonance imaging (MRI). In order to validate 3D planning, comparison of doses in dose assessment points used in bidimensional (2D) plans have been performed with volumetric doses to adjacent organs to the tumor. Finally, a protocol was established for 3D brachytherapy planning alternately using magnetic resonance image (MRI) and CT images, making evaluation of the dose in the tumor through the recording of MR and CT images. It was not possible to find a suitable material that could be used as dummy in MRI. However, the acquisition of the license's library for the applicators made possible the 3D planning based on MRI. No correlation was found between volumetric and specific doses analyzed, showing the importance of the implementation of 3D planning. The average ratio between D{sub 2cc} and ICRU{sub Bladder} dose was 1,74, 22% higher than the ratio found by others authors. For the rectum, D{sub 2cc} was less than dose point for 60% of fractions; the average difference was 12,5%. The average ratio between D{sub 2cc} and point dose rectum, 0,85, is equivalent to the value showed by Kim et al, 0,91. The D{sub 2cc} for sigmoid was 69% higher than point dose used, unless it was not possible compare this value, since the sigmoid point used in the 2D procedures is not used in others institutes. Relative dose in 2 cc of sigmoid was 57% of the prescription dose, the same value was found by in literature. This work enabled the implementation of a viable brachytherapy 3D protocol planning, using MRI for the first fraction of the treatment and CT images for the subsequent fractions. (author)

  12. Comparison between methods for fixing radioactive iodine in silver substrate for manufacturing brachytherapy sources; Comparacao entre metodos de fixacao do iodo radioativo em substrato de prata para confeccao de fontes utilizadas em braquiterapia

    Energy Technology Data Exchange (ETDEWEB)

    Souza, Carla Daruich

    2012-07-01

    Among the different ways to treat prostate cancer, brachytherapy with iodine- 125 seeds is an option that provides good results and fewer side effects. In the present study several deposition methods of radioactive iodine in a silver substrate were compared in order to choose the most suitable alternative for the routine production to be implemented at IPEN's laboratory. The methodology used was chosen based on the available infrastructure and experience of the researchers present. Therefore, the {sup 131}I was used for testing (same chemical behavior as {sup 131}I). Four methods were selected: Method 1 (test based on electrodeposition method developed by D.Kubiatowicz) presented 65.16% efficiency; Method 2 (chemical reaction based on the method developed by D. Kubiatowicz - HCl) with the result of 70.80% efficiency; method 3 (chemical reaction based on the method developed by Dr. Maria Elisa Rostelato) with 55.80% efficiency; Method 4 (IQ-IPEN) resulted in 99% efficiency. Since this method has more radioactive material fixation (which represents virtually the entire cost of the seed), the final price is the cheapest. This method is the suggested one to be implemented in the IPEN's laboratory for brachytherapy sources production. Besides, the method is the fasted one. (author)

  13. Applicability of a prototype for determination of absorbed dose using brachytherapy equipment with Ir-192 sources; Aplicabilidade de um prototipo para determinacao da dose absorvida utilizando equipamentos de braquiterapia com fontes de IR-192

    Energy Technology Data Exchange (ETDEWEB)

    Souza, Vivianne Lucia Bormann; Almeida, Mayara Gabriella Oliveira de; Vieira, Rafaela Etelvina de Amorim; Silva, Waldecy Ananias da; Nascimento, Rizia Keila, E-mail: vlsouza@cnen.gov.br, E-mail: mayaradqf@hotmail.com, E-mail: rodriguesss@hootmail.com, E-mail: waldecy@cnen.gov.br, E-mail: riziakeila@hotmail.com [Centro Regional de Ciencias Nucleares do Nordeste (CRCN-NE/CNEN-PE), Recife, PE (Brazil)

    2014-07-01

    This work aims at the development and improvement of a device to perform the absolute dosimetry sources of Ir-192 using the Fricke solution contained in a flask. The Fricke solution used was prepared using amounts of ferrous ammonium sulfate, sodium chloride and sulfuric acid, diluted with water tri distilled pre-established in the literature. The spectrophotometer used was a UV-VIS spectrophotometer (Beckman DU-640 Counter) for measuring the optical density at wavelength 304 nm. The calculation for determining the radial dose takes into account the radial distance and the angle formed with the transverse axis of the source. As the results obtained can be seen that the states of Pernambuco, Ceara, Paraiba e Piaui are in accordance with the recommendations of international standards of the International Atomic Energy Agency (IAEA), which considers not acceptable a difference greater than 5% of prescribed dose and measured dose.

  14. Simulation Monte Carlo as a method of verification of the characterization of fountains in ophthalmic brachytherapy; Simulacion Monte Carlo como metodo de verificacion de la caracterizacion de fuentes en braquiterapia oftalmica

    Energy Technology Data Exchange (ETDEWEB)

    Ortiz Lora, A.; Miras del Rio, H.; Terron Leon, J. A.

    2013-07-01

    Following the recommendations of the IAEA, and as a further check, they have been Monte Carlo simulation of each one of the plates that are arranged at the Hospital. The objective of the work is the verification of the certificates of calibration and intends to establish criteria of action for its acceptance. (Author)

  15. In vivo dosimetry HDR brachytherapy prostate with source CO-60: Results of measures in a point urethra

    International Nuclear Information System (INIS)

    In this study we present and analyze the results of the in vivo dosimetry made a point of urethra with a group of 30 patients treated with brachytherapy prostate high rate with Co-60 source. Taking into account the uncertainties, the results and integration, globally evaluate this system DIV. This DIV system, due to its ease of calibration and use, and provides a relatively simple integration way to avoid serious errors in administering treatment. (Author)

  16. Characterisation of a Fricke gel compound adopted to produce dosimetric catheters for in vivo dose measurements in HDR brachytherapy

    International Nuclear Information System (INIS)

    Radiation doses delivered to the patient during high dose rate brachytherapy treatments are susceptible to many inaccuracies and may not accurately match the planned doses. Novel Fricke gel dosimetric catheters (FGDC) were developed in the laboratory to be used for in vivo measurements of high dose rate brachytherapy treatments and represent possible tools to increase treatment accuracy. In this study, the dosimetric compound adopted to achieve FGDC was studied in terms of dose sensitivity and linearity, and some potentialities and limits of its application were investigated. Results show that at doses higher than 400 cGy, the dosimeter response is linear with the delivered dose until a saturation effect is observed at doses higher than 2800 cGy. However, saturation is reached at lower doses as well with dose rates higher than 400 cGy/min.

  17. Characterisation of a Fricke gel compound adopted to produce dosimetric catheters for in vivo dose measurements in HDR brachytherapy

    Energy Technology Data Exchange (ETDEWEB)

    Carrara, M. [Medical Physics Unit, Fondazione IRCCS ' Istituto Nazionale Tumori' , Via Venezian 1, I-20133 Milan (Italy); Gambarini, G., E-mail: grazia.gambarini@mi.infn.it [Physics Department, Universita degli Studi, Via Celoria 16, I-20133 Milan (Italy); INFN, Sezione di Milano, Via Celoria 16, I-20133 Milan (Italy); Borroni, M.; Tomatis, S. [Medical Physics Unit, Fondazione IRCCS ' Istituto Nazionale Tumori' , Via Venezian 1, I-20133 Milan (Italy); Negri, A. [Physics Department, Universita degli Studi, Via Celoria 16, I-20133 Milan (Italy); INFN, Sezione di Milano, Via Celoria 16, I-20133 Milan (Italy); Pirola, L. [Physics Department, Universita degli Studi, Via Celoria 16, I-20133 Milan (Italy); Cerrotta, A.; Fallai, C. [Radiotherapy Unit, Fondazione IRCCS ' Istituto Nazionale Tumori' , Via Venezian 1, I-20133 Milan (Italy); Zonca, G. [Medical Physics Unit, Fondazione IRCCS ' Istituto Nazionale Tumori' , Via Venezian 1, I-20133 Milan (Italy)

    2011-10-01

    Radiation doses delivered to the patient during high dose rate brachytherapy treatments are susceptible to many inaccuracies and may not accurately match the planned doses. Novel Fricke gel dosimetric catheters (FGDC) were developed in the laboratory to be used for in vivo measurements of high dose rate brachytherapy treatments and represent possible tools to increase treatment accuracy. In this study, the dosimetric compound adopted to achieve FGDC was studied in terms of dose sensitivity and linearity, and some potentialities and limits of its application were investigated. Results show that at doses higher than 400 cGy, the dosimeter response is linear with the delivered dose until a saturation effect is observed at doses higher than 2800 cGy. However, saturation is reached at lower doses as well with dose rates higher than 400 cGy/min.

  18. Monte Carlo modeling of 60 Co HDR brachytherapy source in water and in different solid water phantom materials

    Directory of Open Access Journals (Sweden)

    Sahoo S

    2010-01-01

    Full Text Available The reference medium for brachytherapy dose measurements is water. Accuracy of dose measurements of brachytherapy sources is critically dependent on precise measurement of the source-detector distance. A solid phantom can be precisely machined and hence source-detector distances can be accurately determined. In the present study, four different solid phantom materials such as polymethylmethacrylate (PMMA, polystyrene, Solid Water, and RW1 are modeled using the Monte Carlo methods to investigate the influence of phantom material on dose rate distributions of the new model of BEBIG 60 Co brachytherapy source. The calculated dose rate constant is 1.086 ± 0.06% cGy h−1 U−1 for water, PMMA, polystyrene, Solid Water, and RW1. The investigation suggests that the phantom material